run_accession	experiment_title	study_accession	aligned	sample_accession	altitude	assembly_quality	assembly_software	bam_aspera	bam_bytes	bam_ftp	bam_galaxy	bam_md5	base_count	binning_software	bio_material	bisulfite_protocol	broad_scale_environmental_context	broker_name	cage_protocol	cell_line	cell_type	center_name	checklist	chip_ab_provider	chip_protocol	chip_target	collected_by	collection_date	collection_date_end	collection_date_start	completeness_score	contamination_score	control_experiment	country	cultivar	culture_collection	depth	description	dev_stage	dnase_protocol	ecotype	elevation	environment_biome	environment_feature	environment_material	environmental_medium	environmental_sample	experiment_accession	experiment_alias	experiment_target	experimental_factor	experimental_protocol	extraction_protocol	faang_library_selection	fastq_aspera	fastq_bytes	fastq_ftp	fastq_galaxy	fastq_md5	file_location	first_created	first_public	germline	hi_c_protocol	host	host_body_site	host_genotype	host_gravidity	host_growth_conditions	host_phenotype	host_scientific_name	host_sex	host_status	host_tax_id	identified_by	instrument_model	instrument_platform	investigation_type	isolate	isolation_source	last_updated	lat	library_construction_protocol	library_gen_protocol	library_layout	library_max_fragment_size	library_min_fragment_size	library_name	library_pcr_isolation_protocol	library_prep_date	library_prep_date_format	library_prep_latitude	library_prep_location	library_prep_longitude	library_selection	library_source	library_strategy	local_environmental_context	location	location_end	location_start	lon	marine_region	mating_type	ncbi_reporting_standard	nominal_length	nominal_sdev	pcr_isolation_protocol	ph	project_name	protocol_label	read_count	read_strand	restriction_enzyme	restriction_enzyme_target_sequence	restriction_site	rna_integrity_num	rna_prep_3_protocol	rna_prep_5_protocol	rna_purity_230_ratio	rna_purity_280_ratio	rt_prep_protocol	run_alias	run_date	salinity	sample_alias	sample_capture_status	sample_collection	sample_description	sample_material	sample_prep_interval	sample_prep_interval_units	sample_storage	sample_storage_processing	sample_title	replicate	DepMap_ID	CCLE_Name	cell_line_name	condition	PERT_TYPE	PERT_ENSEMBL	PERT_GENE	control_samples	pert_time	pert_time_units	pert_concentration	pert_concentration_units	sampling_campaign	sampling_platform	sampling_site	tax_id	scientific_name	secondary_project	secondary_sample_accession	secondary_study_accession	sequencing_date	sequencing_date_format	sequencing_location	sequencing_longitude	sequencing_method	sequencing_primer_catalog	sequencing_primer_lot	sequencing_primer_provider	serotype	serovar	sex	specimen_voucher	sra_aspera	sra_bytes	sra_ftp	sra_galaxy	sra_md5	status	strain	study_alias	study_title	sub_species	sub_strain	submission_accession	submission_tool	submitted_aspera	submitted_bytes	submitted_format	submitted_ftp	submitted_galaxy	submitted_host_sex	submitted_md5	submitted_read_type	tag	target_gene	taxonomic_classification	taxonomic_identity_marker	temperature	tissue_lib	tissue_type	transposase_protocol	variety
SRR5579517	NextSeq 500 sequencing: GSM2633708: T47D_Ribociclib_3_6 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149841									194578725							T47D		GEO																NextSeq 500 sequencing: GSM2633708: T47D_Ribociclib_3_6 Homo sapiens RNA-Seq										SRX2837619	GSM2633708						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/007/SRR5579517/SRR5579517.fastq.gz	116794007	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/007/SRR5579517/SRR5579517.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/007/SRR5579517/SRR5579517.fastq.gz	65aed96a03affd7b0a12670a2058ebd4		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		2594383											GSM2633708_r1			GSM2633708			T47D_Ribociclib_3_6						T47D_Ribociclib_3_6		ACH-000147	T47D_BREAST	T47D_BREAST	RIBOCICLIB	DRUG			SRR5579503,SRR5579504	6	hours	3	micromolar				9606	Homo sapiens		SRS2211784	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/007/SRR5579517	78566749	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/007/SRR5579517	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/007/SRR5579517	d2001f89ed8e7dc7bf0720026d1a1741	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579518	NextSeq 500 sequencing: GSM2633708: T47D_Ribociclib_3_6 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149841									201847800							T47D		GEO																NextSeq 500 sequencing: GSM2633708: T47D_Ribociclib_3_6 Homo sapiens RNA-Seq										SRX2837619	GSM2633708						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/008/SRR5579518/SRR5579518.fastq.gz	116076256	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/008/SRR5579518/SRR5579518.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/008/SRR5579518/SRR5579518.fastq.gz	6e253b3f70f77c0d59addd274edc6d71		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		2691304											GSM2633708_r2			GSM2633708			T47D_Ribociclib_3_6						T47D_Ribociclib_3_6		ACH-000147	T47D_BREAST	T47D_BREAST	RIBOCICLIB	DRUG			SRR5579503,SRR5579504	6	hours	3	micromolar				9606	Homo sapiens		SRS2211784	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/008/SRR5579518	77569095	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/008/SRR5579518	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/008/SRR5579518	8c5bb27628d683901fd47ee6cc006e84	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579421	NextSeq 500 sequencing: GSM2633660: T47D_Ribociclib_3_24 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149890									434227725							T47D		GEO																NextSeq 500 sequencing: GSM2633660: T47D_Ribociclib_3_24 Homo sapiens RNA-Seq										SRX2837571	GSM2633660						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/001/SRR5579421/SRR5579421.fastq.gz	258576421	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/001/SRR5579421/SRR5579421.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/001/SRR5579421/SRR5579421.fastq.gz	f7f69b79cb18cf383a675021c561e0c2		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		5789703											GSM2633660_r1			GSM2633660			T47D_Ribociclib_3_24						T47D_Ribociclib_3_24		ACH-000147	T47D_BREAST	T47D_BREAST	RIBOCICLIB	DRUG			SRR5579407,SRR5579408	24	hours	3	micromolar				9606	Homo sapiens		SRS2211736	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/001/SRR5579421	173697465	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/001/SRR5579421	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/001/SRR5579421	49e08d4ba4e94f43c11d19aa2150dbde	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579422	NextSeq 500 sequencing: GSM2633660: T47D_Ribociclib_3_24 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149890									450013050							T47D		GEO																NextSeq 500 sequencing: GSM2633660: T47D_Ribociclib_3_24 Homo sapiens RNA-Seq										SRX2837571	GSM2633660						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/002/SRR5579422/SRR5579422.fastq.gz	256409521	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/002/SRR5579422/SRR5579422.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/002/SRR5579422/SRR5579422.fastq.gz	aa2d5e491c463fa146f373f1f2f92207		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		6000174											GSM2633660_r2			GSM2633660			T47D_Ribociclib_3_24						T47D_Ribociclib_3_24		ACH-000147	T47D_BREAST	T47D_BREAST	RIBOCICLIB	DRUG			SRR5579407,SRR5579408	24	hours	3	micromolar				9606	Homo sapiens		SRS2211736	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/002/SRR5579422	171079759	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/002/SRR5579422	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/002/SRR5579422	fb62d7b6c30fac1cd4a75884b0f818cd	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579515	NextSeq 500 sequencing: GSM2633707: T47D_Ribociclib_0.3_6 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149842									236245125							T47D		GEO																NextSeq 500 sequencing: GSM2633707: T47D_Ribociclib_0.3_6 Homo sapiens RNA-Seq										SRX2837618	GSM2633707						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/005/SRR5579515/SRR5579515.fastq.gz	140838884	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/005/SRR5579515/SRR5579515.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/005/SRR5579515/SRR5579515.fastq.gz	dfc24c116b942e0d6cc6ec9a1fc00506		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		3149935											GSM2633707_r1			GSM2633707			T47D_Ribociclib_0.3_6						T47D_Ribociclib_0.3_6		ACH-000147	T47D_BREAST	T47D_BREAST	RIBOCICLIB	DRUG			SRR5579503,SRR5579504	6	hours	0.3	micromolar				9606	Homo sapiens		SRS2211783	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/005/SRR5579515	94675214	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/005/SRR5579515	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/005/SRR5579515	cef9ff786e6ec832b5c413cc0b871297	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579516	NextSeq 500 sequencing: GSM2633707: T47D_Ribociclib_0.3_6 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149842									244131075							T47D		GEO																NextSeq 500 sequencing: GSM2633707: T47D_Ribociclib_0.3_6 Homo sapiens RNA-Seq										SRX2837618	GSM2633707						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/006/SRR5579516/SRR5579516.fastq.gz	139213934	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/006/SRR5579516/SRR5579516.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/006/SRR5579516/SRR5579516.fastq.gz	145d6ed33a008c0ba9f0544ff5294e79		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		3255081											GSM2633707_r2			GSM2633707			T47D_Ribociclib_0.3_6						T47D_Ribociclib_0.3_6		ACH-000147	T47D_BREAST	T47D_BREAST	RIBOCICLIB	DRUG			SRR5579503,SRR5579504	6	hours	0.3	micromolar				9606	Homo sapiens		SRS2211783	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/006/SRR5579516	92957028	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/006/SRR5579516	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/006/SRR5579516	f2cd3f604494cffac6d32fbb816ca886	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579419	NextSeq 500 sequencing: GSM2633659: T47D_Ribociclib_0.3_24 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149891									664454700							T47D		GEO																NextSeq 500 sequencing: GSM2633659: T47D_Ribociclib_0.3_24 Homo sapiens RNA-Seq										SRX2837570	GSM2633659						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/009/SRR5579419/SRR5579419.fastq.gz	396142504	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/009/SRR5579419/SRR5579419.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/009/SRR5579419/SRR5579419.fastq.gz	421c5e7aff25e000f155ac570b5672f4		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		8859396											GSM2633659_r1			GSM2633659			T47D_Ribociclib_0.3_24						T47D_Ribociclib_0.3_24		ACH-000147	T47D_BREAST	T47D_BREAST	RIBOCICLIB	DRUG			SRR5579407,SRR5579408	24	hours	0.3	micromolar				9606	Homo sapiens		SRS2211735	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/009/SRR5579419	266009355	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/009/SRR5579419	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/009/SRR5579419	971affd8e7807482fb9b7d3c1f4b2c6e	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579420	NextSeq 500 sequencing: GSM2633659: T47D_Ribociclib_0.3_24 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149891									688519350							T47D		GEO																NextSeq 500 sequencing: GSM2633659: T47D_Ribociclib_0.3_24 Homo sapiens RNA-Seq										SRX2837570	GSM2633659						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/000/SRR5579420/SRR5579420.fastq.gz	392457217	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/000/SRR5579420/SRR5579420.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/000/SRR5579420/SRR5579420.fastq.gz	5c5c72c1ef2f00b971e6af10bd78e29e		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		9180258											GSM2633659_r2			GSM2633659			T47D_Ribociclib_0.3_24						T47D_Ribociclib_0.3_24		ACH-000147	T47D_BREAST	T47D_BREAST	RIBOCICLIB	DRUG			SRR5579407,SRR5579408	24	hours	0.3	micromolar				9606	Homo sapiens		SRS2211735	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/000/SRR5579420	261705307	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/000/SRR5579420	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/000/SRR5579420	87ade91ada494b132194ce6771a16c18	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579513	NextSeq 500 sequencing: GSM2633706: T47D_Palbociclib_3_6 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149843									339849150							T47D		GEO																NextSeq 500 sequencing: GSM2633706: T47D_Palbociclib_3_6 Homo sapiens RNA-Seq										SRX2837617	GSM2633706						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/003/SRR5579513/SRR5579513.fastq.gz	202487045	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/003/SRR5579513/SRR5579513.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/003/SRR5579513/SRR5579513.fastq.gz	07dfebe7ddbe1c8755f0afcff05ea08e		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		4531322											GSM2633706_r1			GSM2633706			T47D_Palbociclib_3_6						T47D_Palbociclib_3_6		ACH-000147	T47D_BREAST	T47D_BREAST	PALBOCICLIB	DRUG			SRR5579503,SRR5579504	6	hours	3	micromolar				9606	Homo sapiens		SRS2211782	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/003/SRR5579513	136048879	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/003/SRR5579513	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/003/SRR5579513	ea813f2f567cb42d4759df90aa66a9a8	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579514	NextSeq 500 sequencing: GSM2633706: T47D_Palbociclib_3_6 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149843									350692425							T47D		GEO																NextSeq 500 sequencing: GSM2633706: T47D_Palbociclib_3_6 Homo sapiens RNA-Seq										SRX2837617	GSM2633706						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/004/SRR5579514/SRR5579514.fastq.gz	199915835	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/004/SRR5579514/SRR5579514.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/004/SRR5579514/SRR5579514.fastq.gz	dc5815181d8fc12cd6d640976042607c		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		4675899											GSM2633706_r2			GSM2633706			T47D_Palbociclib_3_6						T47D_Palbociclib_3_6		ACH-000147	T47D_BREAST	T47D_BREAST	PALBOCICLIB	DRUG			SRR5579503,SRR5579504	6	hours	3	micromolar				9606	Homo sapiens		SRS2211782	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/004/SRR5579514	133411643	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/004/SRR5579514	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/004/SRR5579514	d6e2d0053257550e902771d5c0d1ef42	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579417	NextSeq 500 sequencing: GSM2633658: T47D_Palbociclib_3_24 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149892									393844050							T47D		GEO																NextSeq 500 sequencing: GSM2633658: T47D_Palbociclib_3_24 Homo sapiens RNA-Seq										SRX2837569	GSM2633658						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/007/SRR5579417/SRR5579417.fastq.gz	233187845	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/007/SRR5579417/SRR5579417.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/007/SRR5579417/SRR5579417.fastq.gz	8c6751d37ce849ea2220df7b13bc656d		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		5251254											GSM2633658_r1			GSM2633658			T47D_Palbociclib_3_24						T47D_Palbociclib_3_24		ACH-000147	T47D_BREAST	T47D_BREAST	PALBOCICLIB	DRUG			SRR5579407,SRR5579408	24	hours	3	micromolar				9606	Homo sapiens		SRS2211733	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/007/SRR5579417	156581246	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/007/SRR5579417	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/007/SRR5579417	18b2140cd293885f29bf102abf4544e9	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579418	NextSeq 500 sequencing: GSM2633658: T47D_Palbociclib_3_24 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149892									405271575							T47D		GEO																NextSeq 500 sequencing: GSM2633658: T47D_Palbociclib_3_24 Homo sapiens RNA-Seq										SRX2837569	GSM2633658						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/008/SRR5579418/SRR5579418.fastq.gz	229402987	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/008/SRR5579418/SRR5579418.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/008/SRR5579418/SRR5579418.fastq.gz	8b6482c99280684b62040bd9c7961043		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		5403621											GSM2633658_r2			GSM2633658			T47D_Palbociclib_3_24						T47D_Palbociclib_3_24		ACH-000147	T47D_BREAST	T47D_BREAST	PALBOCICLIB	DRUG			SRR5579407,SRR5579408	24	hours	3	micromolar				9606	Homo sapiens		SRS2211733	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/008/SRR5579418	152981025	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/008/SRR5579418	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/008/SRR5579418	646b229d12baa0cf1c2a8eb86699a89f	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579511	NextSeq 500 sequencing: GSM2633705: T47D_Palbociclib_0.3_6 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149844									204784050							T47D		GEO																NextSeq 500 sequencing: GSM2633705: T47D_Palbociclib_0.3_6 Homo sapiens RNA-Seq										SRX2837616	GSM2633705						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/001/SRR5579511/SRR5579511.fastq.gz	122467852	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/001/SRR5579511/SRR5579511.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/001/SRR5579511/SRR5579511.fastq.gz	c175a256cf1e8ecc0f863778f7d05545		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		2730454											GSM2633705_r1			GSM2633705			T47D_Palbociclib_0.3_6						T47D_Palbociclib_0.3_6		ACH-000147	T47D_BREAST	T47D_BREAST	PALBOCICLIB	DRUG			SRR5579503,SRR5579504	6	hours	0.3	micromolar				9606	Homo sapiens		SRS2211780	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/001/SRR5579511	82258507	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/001/SRR5579511	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/001/SRR5579511	981e64544422e046767c19d687eb308f	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579512	NextSeq 500 sequencing: GSM2633705: T47D_Palbociclib_0.3_6 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149844									213588600							T47D		GEO																NextSeq 500 sequencing: GSM2633705: T47D_Palbociclib_0.3_6 Homo sapiens RNA-Seq										SRX2837616	GSM2633705						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/002/SRR5579512/SRR5579512.fastq.gz	122313352	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/002/SRR5579512/SRR5579512.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/002/SRR5579512/SRR5579512.fastq.gz	f134c1a48ac9eb4231ea4594acb82f73		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		2847848											GSM2633705_r2			GSM2633705			T47D_Palbociclib_0.3_6						T47D_Palbociclib_0.3_6		ACH-000147	T47D_BREAST	T47D_BREAST	PALBOCICLIB	DRUG			SRR5579503,SRR5579504	6	hours	0.3	micromolar				9606	Homo sapiens		SRS2211780	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/002/SRR5579512	81610074	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/002/SRR5579512	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/002/SRR5579512	e466224f20e0031985492e0b8a05c777	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579415	NextSeq 500 sequencing: GSM2633657: T47D_Palbociclib_0.3_24 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149893									250373925							T47D		GEO																NextSeq 500 sequencing: GSM2633657: T47D_Palbociclib_0.3_24 Homo sapiens RNA-Seq										SRX2837568	GSM2633657						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/005/SRR5579415/SRR5579415.fastq.gz	149290810	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/005/SRR5579415/SRR5579415.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/005/SRR5579415/SRR5579415.fastq.gz	85d636f1e61dd4c88072cf5ccd4b9178		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		3338319											GSM2633657_r1			GSM2633657			T47D_Palbociclib_0.3_24						T47D_Palbociclib_0.3_24		ACH-000147	T47D_BREAST	T47D_BREAST	PALBOCICLIB	DRUG			SRR5579407,SRR5579408	24	hours	0.3	micromolar				9606	Homo sapiens		SRS2211734	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/005/SRR5579415	100405113	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/005/SRR5579415	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/005/SRR5579415	7dd761439521a3c37ec2b9fd0a2528f0	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579416	NextSeq 500 sequencing: GSM2633657: T47D_Palbociclib_0.3_24 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149893									261012525							T47D		GEO																NextSeq 500 sequencing: GSM2633657: T47D_Palbociclib_0.3_24 Homo sapiens RNA-Seq										SRX2837568	GSM2633657						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/006/SRR5579416/SRR5579416.fastq.gz	148950693	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/006/SRR5579416/SRR5579416.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/006/SRR5579416/SRR5579416.fastq.gz	73f516e2274b6104e9a825fbfae1b5a5		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		3480167											GSM2633657_r2			GSM2633657			T47D_Palbociclib_0.3_24						T47D_Palbociclib_0.3_24		ACH-000147	T47D_BREAST	T47D_BREAST	PALBOCICLIB	DRUG			SRR5579407,SRR5579408	24	hours	0.3	micromolar				9606	Homo sapiens		SRS2211734	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/006/SRR5579416	99515522	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/006/SRR5579416	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/006/SRR5579416	026432c79153975e1b490aa5afa523c6	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579503	NextSeq 500 sequencing: GSM2633701: T47D_Control_0_6 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149848									436801650							T47D		GEO																NextSeq 500 sequencing: GSM2633701: T47D_Control_0_6 Homo sapiens RNA-Seq										SRX2837612	GSM2633701						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/003/SRR5579503/SRR5579503.fastq.gz	260725579	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/003/SRR5579503/SRR5579503.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/003/SRR5579503/SRR5579503.fastq.gz	6c8d66c4d374a980b12f0daf86f445d3		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		5824022											GSM2633701_r1			GSM2633701			T47D_Control_0_6						T47D_Control_0_6		ACH-000147	T47D_BREAST	T47D_BREAST	CONTROL	CONTROL			SRR5579503,SRR5579504	6	hours	0	micromolar				9606	Homo sapiens		SRS2211777	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/003/SRR5579503	174956894	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/003/SRR5579503	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/003/SRR5579503	6d9084fa109b1591a3f45f99eab04651	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579504	NextSeq 500 sequencing: GSM2633701: T47D_Control_0_6 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149848									451306725							T47D		GEO																NextSeq 500 sequencing: GSM2633701: T47D_Control_0_6 Homo sapiens RNA-Seq										SRX2837612	GSM2633701						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/004/SRR5579504/SRR5579504.fastq.gz	257860069	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/004/SRR5579504/SRR5579504.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/004/SRR5579504/SRR5579504.fastq.gz	5fc187af54cf18f3f89fd75d529f42ad		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		6017423											GSM2633701_r2			GSM2633701			T47D_Control_0_6						T47D_Control_0_6		ACH-000147	T47D_BREAST	T47D_BREAST	CONTROL	CONTROL			SRR5579503,SRR5579504	6	hours	0	micromolar				9606	Homo sapiens		SRS2211777	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/004/SRR5579504	171884707	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/004/SRR5579504	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/004/SRR5579504	b1d0397ba5a06e397d73087bb2e27ca5	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579407	NextSeq 500 sequencing: GSM2633653: T47D_Control_0_24 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149897									458869275							T47D		GEO																NextSeq 500 sequencing: GSM2633653: T47D_Control_0_24 Homo sapiens RNA-Seq										SRX2837564	GSM2633653						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/007/SRR5579407/SRR5579407.fastq.gz	273277058	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/007/SRR5579407/SRR5579407.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/007/SRR5579407/SRR5579407.fastq.gz	f1ffa90a09e06752a6dec7dc0b9174fa		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		6118257											GSM2633653_r1			GSM2633653			T47D_Control_0_24						T47D_Control_0_24		ACH-000147	T47D_BREAST	T47D_BREAST	CONTROL	CONTROL			SRR5579407,SRR5579408	24	hours	0	micromolar				9606	Homo sapiens		SRS2211729	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/007/SRR5579407	183405602	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/007/SRR5579407	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/007/SRR5579407	a96587c47e5b2b294965e08bf7d479cf	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579408	NextSeq 500 sequencing: GSM2633653: T47D_Control_0_24 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149897									474574425							T47D		GEO																NextSeq 500 sequencing: GSM2633653: T47D_Control_0_24 Homo sapiens RNA-Seq										SRX2837564	GSM2633653						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/008/SRR5579408/SRR5579408.fastq.gz	270417380	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/008/SRR5579408/SRR5579408.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/008/SRR5579408/SRR5579408.fastq.gz	94012c35ccc565d501758618b03bfb8b		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		6327659											GSM2633653_r2			GSM2633653			T47D_Control_0_24						T47D_Control_0_24		ACH-000147	T47D_BREAST	T47D_BREAST	CONTROL	CONTROL			SRR5579407,SRR5579408	24	hours	0	micromolar				9606	Homo sapiens		SRS2211729	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/008/SRR5579408	180230772	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/008/SRR5579408	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/008/SRR5579408	92207b7eb43f4b882f72ef5c94734d78	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579509	NextSeq 500 sequencing: GSM2633704: T47D_Abemaciclib_3_6_rep2 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149845									446352900							T47D		GEO																NextSeq 500 sequencing: GSM2633704: T47D_Abemaciclib_3_6_rep2 Homo sapiens RNA-Seq										SRX2837615	GSM2633704						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/009/SRR5579509/SRR5579509.fastq.gz	268121451	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/009/SRR5579509/SRR5579509.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/009/SRR5579509/SRR5579509.fastq.gz	165b999b7d3201e23347617e1ecb29e8		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		5951372											GSM2633704_r1			GSM2633704			T47D_Abemaciclib_3_6_rep2						T47D_Abemaciclib_3_6_rep2		ACH-000147	T47D_BREAST	T47D_BREAST	ABEMACICLIB	DRUG			SRR5579503,SRR5579504	6	hours	3	micromolar				9606	Homo sapiens		SRS2211781	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/009/SRR5579509	180094804	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/009/SRR5579509	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/009/SRR5579509	ac1e6bd2d0cc1a983bcdafc514514e82	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579510	NextSeq 500 sequencing: GSM2633704: T47D_Abemaciclib_3_6_rep2 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149845									465150450							T47D		GEO																NextSeq 500 sequencing: GSM2633704: T47D_Abemaciclib_3_6_rep2 Homo sapiens RNA-Seq										SRX2837615	GSM2633704						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/000/SRR5579510/SRR5579510.fastq.gz	267523735	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/000/SRR5579510/SRR5579510.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/000/SRR5579510/SRR5579510.fastq.gz	5d094268cdc1be37a490df7e1cbaa75e		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		6202006											GSM2633704_r2			GSM2633704			T47D_Abemaciclib_3_6_rep2						T47D_Abemaciclib_3_6_rep2		ACH-000147	T47D_BREAST	T47D_BREAST	ABEMACICLIB	DRUG			SRR5579503,SRR5579504	6	hours	3	micromolar				9606	Homo sapiens		SRS2211781	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/000/SRR5579510	178513155	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/000/SRR5579510	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/000/SRR5579510	eb99e4e6a0c276289bfaa508e9adc2d4	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579507	NextSeq 500 sequencing: GSM2633703: T47D_Abemaciclib_3_6_rep1 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149846									360611100							T47D		GEO																NextSeq 500 sequencing: GSM2633703: T47D_Abemaciclib_3_6_rep1 Homo sapiens RNA-Seq										SRX2837614	GSM2633703						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/007/SRR5579507/SRR5579507.fastq.gz	215576126	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/007/SRR5579507/SRR5579507.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/007/SRR5579507/SRR5579507.fastq.gz	fa2bd3789d4ec321974d443583047270		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		4808148											GSM2633703_r1			GSM2633703			T47D_Abemaciclib_3_6_rep1						T47D_Abemaciclib_3_6_rep1		ACH-000147	T47D_BREAST	T47D_BREAST	ABEMACICLIB	DRUG			SRR5579503,SRR5579504	6	hours	3	micromolar				9606	Homo sapiens		SRS2211779	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/007/SRR5579507	144791524	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/007/SRR5579507	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/007/SRR5579507	a7ef83871082545c15a0d3517bd69417	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579508	NextSeq 500 sequencing: GSM2633703: T47D_Abemaciclib_3_6_rep1 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149846									373327725							T47D		GEO																NextSeq 500 sequencing: GSM2633703: T47D_Abemaciclib_3_6_rep1 Homo sapiens RNA-Seq										SRX2837614	GSM2633703						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/008/SRR5579508/SRR5579508.fastq.gz	213609769	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/008/SRR5579508/SRR5579508.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/008/SRR5579508/SRR5579508.fastq.gz	8f182c6cd5b84f39603c0adff61f6f52		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		4977703											GSM2633703_r2			GSM2633703			T47D_Abemaciclib_3_6_rep1						T47D_Abemaciclib_3_6_rep1		ACH-000147	T47D_BREAST	T47D_BREAST	ABEMACICLIB	DRUG			SRR5579503,SRR5579504	6	hours	3	micromolar				9606	Homo sapiens		SRS2211779	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/008/SRR5579508	142514110	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/008/SRR5579508	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/008/SRR5579508	53a62ad80b6cc8f99fef29a96fab126f	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579413	NextSeq 500 sequencing: GSM2633656: T47D_Abemaciclib_3_24_rep2 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149894									422048400							T47D		GEO																NextSeq 500 sequencing: GSM2633656: T47D_Abemaciclib_3_24_rep2 Homo sapiens RNA-Seq										SRX2837567	GSM2633656						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/003/SRR5579413/SRR5579413.fastq.gz	252359871	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/003/SRR5579413/SRR5579413.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/003/SRR5579413/SRR5579413.fastq.gz	e23d2bf33c3bb1ed8258556e04e23418		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		5627312											GSM2633656_r1			GSM2633656			T47D_Abemaciclib_3_24_rep2						T47D_Abemaciclib_3_24_rep2		ACH-000147	T47D_BREAST	T47D_BREAST	ABEMACICLIB	DRUG			SRR5579407,SRR5579408	24	hours	3	micromolar				9606	Homo sapiens		SRS2211732	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/003/SRR5579413	169634746	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/003/SRR5579413	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/003/SRR5579413	25184f4481ef2452fd884da5ed4a3a35	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579414	NextSeq 500 sequencing: GSM2633656: T47D_Abemaciclib_3_24_rep2 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149894									439108650							T47D		GEO																NextSeq 500 sequencing: GSM2633656: T47D_Abemaciclib_3_24_rep2 Homo sapiens RNA-Seq										SRX2837567	GSM2633656						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/004/SRR5579414/SRR5579414.fastq.gz	251198132	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/004/SRR5579414/SRR5579414.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/004/SRR5579414/SRR5579414.fastq.gz	cabb72ab8c0e6fe2d3f5f2abfd17f729		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		5854782											GSM2633656_r2			GSM2633656			T47D_Abemaciclib_3_24_rep2						T47D_Abemaciclib_3_24_rep2		ACH-000147	T47D_BREAST	T47D_BREAST	ABEMACICLIB	DRUG			SRR5579407,SRR5579408	24	hours	3	micromolar				9606	Homo sapiens		SRS2211732	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/004/SRR5579414	167725433	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/004/SRR5579414	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/004/SRR5579414	ab874d40f48270a98b0b15c4a41b1bf8	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579411	NextSeq 500 sequencing: GSM2633655: T47D_Abemaciclib_3_24_rep1 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149895									428575050							T47D		GEO																NextSeq 500 sequencing: GSM2633655: T47D_Abemaciclib_3_24_rep1 Homo sapiens RNA-Seq										SRX2837566	GSM2633655						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/001/SRR5579411/SRR5579411.fastq.gz	254870186	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/001/SRR5579411/SRR5579411.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/001/SRR5579411/SRR5579411.fastq.gz	16e1214ae4698d81fae94c5119bf6888		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		5714334											GSM2633655_r1			GSM2633655			T47D_Abemaciclib_3_24_rep1						T47D_Abemaciclib_3_24_rep1		ACH-000147	T47D_BREAST	T47D_BREAST	ABEMACICLIB	DRUG			SRR5579407,SRR5579408	24	hours	3	micromolar				9606	Homo sapiens		SRS2211731	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/001/SRR5579411	171264907	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/001/SRR5579411	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/001/SRR5579411	85aa68cbd4615548fdc268de190184a3	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579412	NextSeq 500 sequencing: GSM2633655: T47D_Abemaciclib_3_24_rep1 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149895									443905575							T47D		GEO																NextSeq 500 sequencing: GSM2633655: T47D_Abemaciclib_3_24_rep1 Homo sapiens RNA-Seq										SRX2837566	GSM2633655						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/002/SRR5579412/SRR5579412.fastq.gz	252475636	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/002/SRR5579412/SRR5579412.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/002/SRR5579412/SRR5579412.fastq.gz	9e89b0693a03b94829837961f308ccb4		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		5918741											GSM2633655_r2			GSM2633655			T47D_Abemaciclib_3_24_rep1						T47D_Abemaciclib_3_24_rep1		ACH-000147	T47D_BREAST	T47D_BREAST	ABEMACICLIB	DRUG			SRR5579407,SRR5579408	24	hours	3	micromolar				9606	Homo sapiens		SRS2211731	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/002/SRR5579412	168508398	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/002/SRR5579412	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/002/SRR5579412	8fae70cb85a346738a4f1a88bb516867	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579505	NextSeq 500 sequencing: GSM2633702: T47D_Abemaciclib_0.3_6 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149847									363804150							T47D		GEO																NextSeq 500 sequencing: GSM2633702: T47D_Abemaciclib_0.3_6 Homo sapiens RNA-Seq										SRX2837613	GSM2633702						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/005/SRR5579505/SRR5579505.fastq.gz	217651451	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/005/SRR5579505/SRR5579505.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/005/SRR5579505/SRR5579505.fastq.gz	4453bdc0644fa8090ecf2983a3fcb74c		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		4850722											GSM2633702_r1			GSM2633702			T47D_Abemaciclib_0.3_6						T47D_Abemaciclib_0.3_6		ACH-000147	T47D_BREAST	T47D_BREAST	ABEMACICLIB	DRUG			SRR5579503,SRR5579504	6	hours	0.3	micromolar				9606	Homo sapiens		SRS2211778	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/005/SRR5579505	146218207	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/005/SRR5579505	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/005/SRR5579505	8c6678027405591ebb037a9dd2d4e696	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579506	NextSeq 500 sequencing: GSM2633702: T47D_Abemaciclib_0.3_6 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149847									377263050							T47D		GEO																NextSeq 500 sequencing: GSM2633702: T47D_Abemaciclib_0.3_6 Homo sapiens RNA-Seq										SRX2837613	GSM2633702						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/006/SRR5579506/SRR5579506.fastq.gz	216067269	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/006/SRR5579506/SRR5579506.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/006/SRR5579506/SRR5579506.fastq.gz	d679f2e77188099f21b68dda3e435b04		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		5030174											GSM2633702_r2			GSM2633702			T47D_Abemaciclib_0.3_6						T47D_Abemaciclib_0.3_6		ACH-000147	T47D_BREAST	T47D_BREAST	ABEMACICLIB	DRUG			SRR5579503,SRR5579504	6	hours	0.3	micromolar				9606	Homo sapiens		SRS2211778	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/006/SRR5579506	144208684	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/006/SRR5579506	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/006/SRR5579506	69ba0d4bd4b29f3ae6622ea45b4fa8be	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579409	NextSeq 500 sequencing: GSM2633654: T47D_Abemaciclib_0.3_24 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149896									355678875							T47D		GEO																NextSeq 500 sequencing: GSM2633654: T47D_Abemaciclib_0.3_24 Homo sapiens RNA-Seq										SRX2837565	GSM2633654						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/009/SRR5579409/SRR5579409.fastq.gz	211689038	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/009/SRR5579409/SRR5579409.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/009/SRR5579409/SRR5579409.fastq.gz	746e4ddd8db4e3326fce9a0856540731		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		4742385											GSM2633654_r1			GSM2633654			T47D_Abemaciclib_0.3_24						T47D_Abemaciclib_0.3_24		ACH-000147	T47D_BREAST	T47D_BREAST	ABEMACICLIB	DRUG			SRR5579407,SRR5579408	24	hours	0.3	micromolar				9606	Homo sapiens		SRS2211730	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/009/SRR5579409	142257578	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/009/SRR5579409	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/009/SRR5579409	aae2681905dd248e0cb64554de19a273	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579410	NextSeq 500 sequencing: GSM2633654: T47D_Abemaciclib_0.3_24 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149896									368490525							T47D		GEO																NextSeq 500 sequencing: GSM2633654: T47D_Abemaciclib_0.3_24 Homo sapiens RNA-Seq										SRX2837565	GSM2633654						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/000/SRR5579410/SRR5579410.fastq.gz	209846360	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/000/SRR5579410/SRR5579410.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/000/SRR5579410/SRR5579410.fastq.gz	4c8c9c013d0ca9ec8274131d2fb53688		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		4913207											GSM2633654_r2			GSM2633654			T47D_Abemaciclib_0.3_24						T47D_Abemaciclib_0.3_24		ACH-000147	T47D_BREAST	T47D_BREAST	ABEMACICLIB	DRUG			SRR5579407,SRR5579408	24	hours	0.3	micromolar				9606	Homo sapiens		SRS2211730	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/000/SRR5579410	140091863	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/000/SRR5579410	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/000/SRR5579410	5ebd5671783bf9dd745e40ec2c372964	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579526	NextSeq 500 sequencing: GSM2633716: MCF7_Ribociclib_3_6 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149833									748852050							MCF7		GEO																NextSeq 500 sequencing: GSM2633716: MCF7_Ribociclib_3_6 Homo sapiens RNA-Seq										SRX2837627	GSM2633716						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/006/SRR5579526/SRR5579526.fastq.gz	446650859	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/006/SRR5579526/SRR5579526.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/006/SRR5579526/SRR5579526.fastq.gz	6ac487275c1c2154db6126901fbb6271		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		9984694											GSM2633716_r1			GSM2633716			MCF7_Ribociclib_3_6						MCF7_Ribociclib_3_6		ACH-000019	MCF7_BREAST	MCF7_BREAST	RIBOCICLIB	DRUG			SRR5579527,SRR5579519	6	hours	3	micromolar				9606	Homo sapiens		SRS2211792	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/006/SRR5579526	298877171	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/006/SRR5579526	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/006/SRR5579526	22759a90708db157d9d7ac89131d0477	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579538	NextSeq 500 sequencing: GSM2633728: MCF7_Ribociclib_3_24 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149821									990695100							MCF7		GEO																NextSeq 500 sequencing: GSM2633728: MCF7_Ribociclib_3_24 Homo sapiens RNA-Seq										SRX2837639	GSM2633728						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/008/SRR5579538/SRR5579538.fastq.gz	586203204	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/008/SRR5579538/SRR5579538.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/008/SRR5579538/SRR5579538.fastq.gz	68b3d79237674b68bb41a1fa6794cd30		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		13209268											GSM2633728_r1			GSM2633728			MCF7_Ribociclib_3_24						MCF7_Ribociclib_3_24		ACH-000019	MCF7_BREAST	MCF7_BREAST	RIBOCICLIB	DRUG			SRR5579539,SRR5579531	24	hours	3	micromolar				9606	Homo sapiens		SRS2211803	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/008/SRR5579538	391554549	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/008/SRR5579538	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/008/SRR5579538	a3eca55dec2e15f18fcd0de6d49388e4	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579525	NextSeq 500 sequencing: GSM2633715: MCF7_Ribociclib_0.3_6 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149834									930157575							MCF7		GEO																NextSeq 500 sequencing: GSM2633715: MCF7_Ribociclib_0.3_6 Homo sapiens RNA-Seq										SRX2837626	GSM2633715						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/005/SRR5579525/SRR5579525.fastq.gz	557066925	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/005/SRR5579525/SRR5579525.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/005/SRR5579525/SRR5579525.fastq.gz	8c18ae8e61cf9ccdbfd3b9969eb4b5d2		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		12402101											GSM2633715_r1			GSM2633715			MCF7_Ribociclib_0.3_6						MCF7_Ribociclib_0.3_6		ACH-000019	MCF7_BREAST	MCF7_BREAST	RIBOCICLIB	DRUG			SRR5579527,SRR5579519	6	hours	0.3	micromolar				9606	Homo sapiens		SRS2211789	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/005/SRR5579525	372660292	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/005/SRR5579525	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/005/SRR5579525	8edf53f1d2684333219a723ef75e661a	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579537	NextSeq 500 sequencing: GSM2633727: MCF7_Ribociclib_0.3_24 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149822									787741425							MCF7		GEO																NextSeq 500 sequencing: GSM2633727: MCF7_Ribociclib_0.3_24 Homo sapiens RNA-Seq										SRX2837638	GSM2633727						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/007/SRR5579537/SRR5579537.fastq.gz	467610718	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/007/SRR5579537/SRR5579537.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/007/SRR5579537/SRR5579537.fastq.gz	9b4353c4778dc2cbfdd83358b5fb035b		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		10503219											GSM2633727_r1			GSM2633727			MCF7_Ribociclib_0.3_24						MCF7_Ribociclib_0.3_24		ACH-000019	MCF7_BREAST	MCF7_BREAST	RIBOCICLIB	DRUG			SRR5579527,SRR5579519	6	hours	0.3	micromolar				9606	Homo sapiens		SRS2211804	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/007/SRR5579537	312735086	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/007/SRR5579537	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/007/SRR5579537	1d3868bb97d94eb5087dd8c440005b50	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579524	NextSeq 500 sequencing: GSM2633714: MCF7_Palbociclib_3_6 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149835									932029425							MCF7		GEO																NextSeq 500 sequencing: GSM2633714: MCF7_Palbociclib_3_6 Homo sapiens RNA-Seq										SRX2837625	GSM2633714						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/004/SRR5579524/SRR5579524.fastq.gz	557314551	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/004/SRR5579524/SRR5579524.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/004/SRR5579524/SRR5579524.fastq.gz	de49d6572c87813f415c69e77f629863		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		12427059											GSM2633714_r1			GSM2633714			MCF7_Palbociclib_3_6						MCF7_Palbociclib_3_6		ACH-000019	MCF7_BREAST	MCF7_BREAST	PALBOCICLIB	DRUG			SRR5579527,SRR5579519	6	hours	3	micromolar				9606	Homo sapiens		SRS2211790	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/004/SRR5579524	372673567	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/004/SRR5579524	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/004/SRR5579524	2ad790e182cf7f26fb2eaf07b4525a98	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579536	NextSeq 500 sequencing: GSM2633726: MCF7_Palbociclib_3_24 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149823									791748675							MCF7		GEO																NextSeq 500 sequencing: GSM2633726: MCF7_Palbociclib_3_24 Homo sapiens RNA-Seq										SRX2837637	GSM2633726						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/006/SRR5579536/SRR5579536.fastq.gz	469258075	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/006/SRR5579536/SRR5579536.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/006/SRR5579536/SRR5579536.fastq.gz	8498200104e95442b42ae08dc3a1ffb7		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		10556649											GSM2633726_r1			GSM2633726			MCF7_Palbociclib_3_24						MCF7_Palbociclib_3_24		ACH-000019	MCF7_BREAST	MCF7_BREAST	PALBOCICLIB	DRUG			SRR5579539,SRR5579531	24	hours	3	micromolar				9606	Homo sapiens		SRS2211802	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/006/SRR5579536	313761467	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/006/SRR5579536	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/006/SRR5579536	d2f3b83a9a876715ef2dfb7745c5ccb1	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579523	NextSeq 500 sequencing: GSM2633713: MCF7_Palbociclib_0.3_6 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149836									931387050							MCF7		GEO																NextSeq 500 sequencing: GSM2633713: MCF7_Palbociclib_0.3_6 Homo sapiens RNA-Seq										SRX2837624	GSM2633713						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/003/SRR5579523/SRR5579523.fastq.gz	556292231	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/003/SRR5579523/SRR5579523.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/003/SRR5579523/SRR5579523.fastq.gz	1c5587262b02b9efb8f034f30787770f		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		12418494											GSM2633713_r1			GSM2633713			MCF7_Palbociclib_0.3_6						MCF7_Palbociclib_0.3_6		ACH-000019	MCF7_BREAST	MCF7_BREAST	PALBOCICLIB	DRUG			SRR5579527,SRR5579519	6	hours	0.3	micromolar				9606	Homo sapiens		SRS2211791	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/003/SRR5579523	371921443	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/003/SRR5579523	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/003/SRR5579523	be867ff00dc6d5772b0f298993845742	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579535	NextSeq 500 sequencing: GSM2633725: MCF7_Palbociclib_0.3_24 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149824									805005900							MCF7		GEO																NextSeq 500 sequencing: GSM2633725: MCF7_Palbociclib_0.3_24 Homo sapiens RNA-Seq										SRX2837636	GSM2633725						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/005/SRR5579535/SRR5579535.fastq.gz	475675134	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/005/SRR5579535/SRR5579535.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/005/SRR5579535/SRR5579535.fastq.gz	f4c8056db63ffed094bccc08c3686950		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		10733412											GSM2633725_r1			GSM2633725			MCF7_Palbociclib_0.3_24						MCF7_Palbociclib_0.3_24		ACH-000019	MCF7_BREAST	MCF7_BREAST	PALBOCICLIB	DRUG			SRR5579539,SRR5579531	24	hours	0.3	micromolar				9606	Homo sapiens		SRS2211801	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/005/SRR5579535	317840696	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/005/SRR5579535	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/005/SRR5579535	63b32598ca2c0180b7ec10fcaa5770c8	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579527	NextSeq 500 sequencing: GSM2633717: MCF7_Control_0_6_rep2 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149832									894686175							MCF7		GEO																NextSeq 500 sequencing: GSM2633717: MCF7_Control_0_6_rep2 Homo sapiens RNA-Seq										SRX2837628	GSM2633717						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/007/SRR5579527/SRR5579527.fastq.gz	531362511	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/007/SRR5579527/SRR5579527.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/007/SRR5579527/SRR5579527.fastq.gz	1f2f6c996b00be93103559fab4ba844c		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		11929149											GSM2633717_r1			GSM2633717			MCF7_Control_0_6_rep2						MCF7_Control_0_6_rep2		ACH-000019	MCF7_BREAST	MCF7_BREAST	CONTROL	CONTROL			SRR5579527,SRR5579519	6	hours	0	micromolar				9606	Homo sapiens		SRS2211793	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/007/SRR5579527	354860198	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/007/SRR5579527	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/007/SRR5579527	c621707f3b3027fb94824649ef7d6940	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579519	NextSeq 500 sequencing: GSM2633709: MCF7_Control_0_6_rep1 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149840									694895775							MCF7		GEO																NextSeq 500 sequencing: GSM2633709: MCF7_Control_0_6_rep1 Homo sapiens RNA-Seq										SRX2837620	GSM2633709						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/009/SRR5579519/SRR5579519.fastq.gz	410527725	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/009/SRR5579519/SRR5579519.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/009/SRR5579519/SRR5579519.fastq.gz	112c7d1bf417b695e41f7566bad5f1a5		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		9265277											GSM2633709_r1			GSM2633709			MCF7_Control_0_6_rep1						MCF7_Control_0_6_rep1		ACH-000019	MCF7_BREAST	MCF7_BREAST	CONTROL	CONTROL			SRR5579527,SRR5579519	6	hours	0	micromolar				9606	Homo sapiens		SRS2211785	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/009/SRR5579519	274250520	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/009/SRR5579519	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/009/SRR5579519	68e8a10b7f2e0c487bca57c74fda8dd7	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579539	NextSeq 500 sequencing: GSM2633729: MCF7_Control_0_24_rep2 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149820									912318300							MCF7		GEO																NextSeq 500 sequencing: GSM2633729: MCF7_Control_0_24_rep2 Homo sapiens RNA-Seq										SRX2837640	GSM2633729						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/009/SRR5579539/SRR5579539.fastq.gz	537586131	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/009/SRR5579539/SRR5579539.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/009/SRR5579539/SRR5579539.fastq.gz	ea9809bb7233372dd5525baf66188112		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		12164244											GSM2633729_r1			GSM2633729			MCF7_Control_0_24_rep2						MCF7_Control_0_24_rep2		ACH-000019	MCF7_BREAST	MCF7_BREAST	CONTROL	CONTROL			SRR5579539,SRR5579531	24	hours	0	micromolar				9606	Homo sapiens		SRS2211805	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/009/SRR5579539	358607738	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/009/SRR5579539	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/009/SRR5579539	49fe03cbe49a60382d3f469545646a07	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579531	NextSeq 500 sequencing: GSM2633721: MCF7_Control_0_24_rep1 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149828									946962600							MCF7		GEO																NextSeq 500 sequencing: GSM2633721: MCF7_Control_0_24_rep1 Homo sapiens RNA-Seq										SRX2837632	GSM2633721						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/001/SRR5579531/SRR5579531.fastq.gz	559760736	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/001/SRR5579531/SRR5579531.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/001/SRR5579531/SRR5579531.fastq.gz	cfe6e489f819f74b5babc40fa820a74a		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		12626168											GSM2633721_r1			GSM2633721			MCF7_Control_0_24_rep1						MCF7_Control_0_24_rep1		ACH-000019	MCF7_BREAST	MCF7_BREAST	CONTROL	CONTROL			SRR5579539,SRR5579531	24	hours	0	micromolar				9606	Homo sapiens		SRS2211797	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/001/SRR5579531	373730329	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/001/SRR5579531	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/001/SRR5579531	c7547e810a274578c9eed4945e7cdb5a	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579530	NextSeq 500 sequencing: GSM2633720: MCF7_Abemaciclib_3_6_rep2 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149829									807319875							MCF7		GEO																NextSeq 500 sequencing: GSM2633720: MCF7_Abemaciclib_3_6_rep2 Homo sapiens RNA-Seq										SRX2837631	GSM2633720						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/000/SRR5579530/SRR5579530.fastq.gz	478003015	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/000/SRR5579530/SRR5579530.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/000/SRR5579530/SRR5579530.fastq.gz	4b2a290e08892dd2467910f081660d05		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		10764265											GSM2633720_r1			GSM2633720			MCF7_Abemaciclib_3_6_rep2						MCF7_Abemaciclib_3_6_rep2		ACH-000019	MCF7_BREAST	MCF7_BREAST	ABEMACICLIB	DRUG			SRR5579527,SRR5579519	6	hours	3	micromolar				9606	Homo sapiens		SRS2211796	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/000/SRR5579530	321277462	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/000/SRR5579530	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/000/SRR5579530	45886f05d8f2a260f798cf73b3ae65f6	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579522	NextSeq 500 sequencing: GSM2633712: MCF7_Abemaciclib_3_6_rep1 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149837									932339250							MCF7		GEO																NextSeq 500 sequencing: GSM2633712: MCF7_Abemaciclib_3_6_rep1 Homo sapiens RNA-Seq										SRX2837623	GSM2633712						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/002/SRR5579522/SRR5579522.fastq.gz	547942498	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/002/SRR5579522/SRR5579522.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/002/SRR5579522/SRR5579522.fastq.gz	260a2094b0f734c3a4dd67c418206dca		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		12431190											GSM2633712_r1			GSM2633712			MCF7_Abemaciclib_3_6_rep1						MCF7_Abemaciclib_3_6_rep1		ACH-000019	MCF7_BREAST	MCF7_BREAST	ABEMACICLIB	DRUG			SRR5579527,SRR5579519	6	hours	3	micromolar				9606	Homo sapiens		SRS2211788	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/002/SRR5579522	367687891	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/002/SRR5579522	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/002/SRR5579522	fd4b557aeb5fd9edb7326206a59f4c6d	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579542	NextSeq 500 sequencing: GSM2633732: MCF7_Abemaciclib_3_24_rep2 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149878									230387775							MCF7		GEO																NextSeq 500 sequencing: GSM2633732: MCF7_Abemaciclib_3_24_rep2 Homo sapiens RNA-Seq										SRX2837643	GSM2633732						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/002/SRR5579542/SRR5579542.fastq.gz	133260914	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/002/SRR5579542/SRR5579542.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/002/SRR5579542/SRR5579542.fastq.gz	205005ddc29943f8414f0b9b15af3e70		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		3071837											GSM2633732_r1			GSM2633732			MCF7_Abemaciclib_3_24_rep2						MCF7_Abemaciclib_3_24_rep2		ACH-000019	MCF7_BREAST	MCF7_BREAST	ABEMACICLIB	DRUG			SRR5579527,SRR5579519	6	hours	3	micromolar				9606	Homo sapiens		SRS2211808	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/002/SRR5579542	91015391	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/002/SRR5579542	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/002/SRR5579542	db4cc0fa02ba500330f11cfebce2e046	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579534	NextSeq 500 sequencing: GSM2633724: MCF7_Abemaciclib_3_24_rep1 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149825									383667450							MCF7		GEO																NextSeq 500 sequencing: GSM2633724: MCF7_Abemaciclib_3_24_rep1 Homo sapiens RNA-Seq										SRX2837635	GSM2633724						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/004/SRR5579534/SRR5579534.fastq.gz	224428234	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/004/SRR5579534/SRR5579534.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/004/SRR5579534/SRR5579534.fastq.gz	91c10e355cea0b00a09ccaef8b3f674b		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		5115566											GSM2633724_r1			GSM2633724			MCF7_Abemaciclib_3_24_rep1						MCF7_Abemaciclib_3_24_rep1		ACH-000019	MCF7_BREAST	MCF7_BREAST	ABEMACICLIB	DRUG			SRR5579539,SRR5579531	24	hours	3	micromolar				9606	Homo sapiens		SRS2211800	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/004/SRR5579534	152199205	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/004/SRR5579534	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/004/SRR5579534	222b4564057f8a1025597690f5206839	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579529	NextSeq 500 sequencing: GSM2633719: MCF7_Abemaciclib_1_6_rep2 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149830									656603850							MCF7		GEO																NextSeq 500 sequencing: GSM2633719: MCF7_Abemaciclib_1_6_rep2 Homo sapiens RNA-Seq										SRX2837630	GSM2633719						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/009/SRR5579529/SRR5579529.fastq.gz	390957923	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/009/SRR5579529/SRR5579529.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/009/SRR5579529/SRR5579529.fastq.gz	38ade7c223b9d698a3fca0c18ee7e422		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		8754718											GSM2633719_r1			GSM2633719			MCF7_Abemaciclib_1_6_rep2						MCF7_Abemaciclib_1_6_rep2		ACH-000019	MCF7_BREAST	MCF7_BREAST	ABEMACICLIB	DRUG			SRR5579527,SRR5579519	6	hours	1	micromolar				9606	Homo sapiens		SRS2211795	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/009/SRR5579529	262750070	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/009/SRR5579529	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/009/SRR5579529	dcd794b0ee749c5bb6232012e25705a3	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579521	NextSeq 500 sequencing: GSM2633711: MCF7_Abemaciclib_1_6_rep1 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149838									933810000							MCF7		GEO																NextSeq 500 sequencing: GSM2633711: MCF7_Abemaciclib_1_6_rep1 Homo sapiens RNA-Seq										SRX2837622	GSM2633711						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/001/SRR5579521/SRR5579521.fastq.gz	553513947	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/001/SRR5579521/SRR5579521.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/001/SRR5579521/SRR5579521.fastq.gz	6dc966356561f67b1059bcc8dae0cfea		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		12450800											GSM2633711_r1			GSM2633711			MCF7_Abemaciclib_1_6_rep1						MCF7_Abemaciclib_1_6_rep1		ACH-000019	MCF7_BREAST	MCF7_BREAST	ABEMACICLIB	DRUG			SRR5579527,SRR5579519	6	hours	1	micromolar				9606	Homo sapiens		SRS2211786	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/001/SRR5579521	371037268	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/001/SRR5579521	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/001/SRR5579521	81f1f29c8a9f857c3e749b434079de11	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579541	NextSeq 500 sequencing: GSM2633731: MCF7_Abemaciclib_1_24_rep2 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149879									598640475							MCF7		GEO																NextSeq 500 sequencing: GSM2633731: MCF7_Abemaciclib_1_24_rep2 Homo sapiens RNA-Seq										SRX2837642	GSM2633731						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/001/SRR5579541/SRR5579541.fastq.gz	354214242	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/001/SRR5579541/SRR5579541.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/001/SRR5579541/SRR5579541.fastq.gz	007f30f220ef3d469f6b37c73bf57df1		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		7981873											GSM2633731_r1			GSM2633731			MCF7_Abemaciclib_1_24_rep2						MCF7_Abemaciclib_1_24_rep2		ACH-000019	MCF7_BREAST	MCF7_BREAST	ABEMACICLIB	DRUG			SRR5579539,SRR5579531	24	hours	2	micromolar				9606	Homo sapiens		SRS2211807	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/001/SRR5579541	236944541	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/001/SRR5579541	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/001/SRR5579541	dfe07fe65f422cef9ba27f5d4c5d536b	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579533	NextSeq 500 sequencing: GSM2633723: MCF7_Abemaciclib_1_24_rep1 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149826									870023400							MCF7		GEO																NextSeq 500 sequencing: GSM2633723: MCF7_Abemaciclib_1_24_rep1 Homo sapiens RNA-Seq										SRX2837634	GSM2633723						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/003/SRR5579533/SRR5579533.fastq.gz	516072362	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/003/SRR5579533/SRR5579533.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/003/SRR5579533/SRR5579533.fastq.gz	2adf24cad69141e56a1a06bfd0681d4e		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		11600312											GSM2633723_r1			GSM2633723			MCF7_Abemaciclib_1_24_rep1						MCF7_Abemaciclib_1_24_rep1		ACH-000019	MCF7_BREAST	MCF7_BREAST	ABEMACICLIB	DRUG			SRR5579527,SRR5579519	6	hours	1	micromolar				9606	Homo sapiens		SRS2211799	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/003/SRR5579533	345169400	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/003/SRR5579533	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/003/SRR5579533	dcf537b8234f9f4207c0b61d4abbba29	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579528	NextSeq 500 sequencing: GSM2633718: MCF7_Abemaciclib_0.3_6_rep2 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149831									723299625							MCF7		GEO																NextSeq 500 sequencing: GSM2633718: MCF7_Abemaciclib_0.3_6_rep2 Homo sapiens RNA-Seq										SRX2837629	GSM2633718						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/008/SRR5579528/SRR5579528.fastq.gz	430022135	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/008/SRR5579528/SRR5579528.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/008/SRR5579528/SRR5579528.fastq.gz	71681673c4334b5c85296244b5db66f4		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		9643995											GSM2633718_r1			GSM2633718			MCF7_Abemaciclib_0.3_6_rep2						MCF7_Abemaciclib_0.3_6_rep2		ACH-000019	MCF7_BREAST	MCF7_BREAST	ABEMACICLIB	DRUG			SRR5579527,SRR5579519	6	hours	0.3	micromolar				9606	Homo sapiens		SRS2211794	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/008/SRR5579528	287830572	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/008/SRR5579528	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/008/SRR5579528	c2816b62b86a9ea46d38490598015c3f	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579520	NextSeq 500 sequencing: GSM2633710: MCF7_Abemaciclib_0.3_6_rep1 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149839									709222725							MCF7		GEO																NextSeq 500 sequencing: GSM2633710: MCF7_Abemaciclib_0.3_6_rep1 Homo sapiens RNA-Seq										SRX2837621	GSM2633710						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/000/SRR5579520/SRR5579520.fastq.gz	419791831	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/000/SRR5579520/SRR5579520.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/000/SRR5579520/SRR5579520.fastq.gz	3c205ced835d6f1f5f772b301a79c278		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		9456303											GSM2633710_r1			GSM2633710			MCF7_Abemaciclib_0.3_6_rep1						MCF7_Abemaciclib_0.3_6_rep1		ACH-000019	MCF7_BREAST	MCF7_BREAST	ABEMACICLIB	DRUG			SRR5579527,SRR5579519	6	hours	0.3	micromolar				9606	Homo sapiens		SRS2211787	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/000/SRR5579520	280703243	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/000/SRR5579520	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/000/SRR5579520	c3e8c13520aea6381995ea6a2829865c	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579540	NextSeq 500 sequencing: GSM2633730: MCF7_Abemaciclib_0.3_24_rep2 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149819									908238525							MCF7		GEO																NextSeq 500 sequencing: GSM2633730: MCF7_Abemaciclib_0.3_24_rep2 Homo sapiens RNA-Seq										SRX2837641	GSM2633730						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/000/SRR5579540/SRR5579540.fastq.gz	535225126	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/000/SRR5579540/SRR5579540.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/000/SRR5579540/SRR5579540.fastq.gz	100ea42233105e77be3d4c912eefdcfb		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		12109847											GSM2633730_r1			GSM2633730			MCF7_Abemaciclib_0.3_24_rep2						MCF7_Abemaciclib_0.3_24_rep2		ACH-000019	MCF7_BREAST	MCF7_BREAST	ABEMACICLIB	DRUG			SRR5579539,SRR5579531	24	hours	0.3	micromolar				9606	Homo sapiens		SRS2211806	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/000/SRR5579540	357485748	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/000/SRR5579540	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/000/SRR5579540	ee26f82be4f8f60baa54cca67be43903	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579532	NextSeq 500 sequencing: GSM2633722: MCF7_Abemaciclib_0.3_24_rep1 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149827									953214825							MCF7		GEO																NextSeq 500 sequencing: GSM2633722: MCF7_Abemaciclib_0.3_24_rep1 Homo sapiens RNA-Seq										SRX2837633	GSM2633722						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/002/SRR5579532/SRR5579532.fastq.gz	565243895	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/002/SRR5579532/SRR5579532.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/002/SRR5579532/SRR5579532.fastq.gz	55618761cdc81b6fb22d16a0990ea6e9		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		12709531											GSM2633722_r1			GSM2633722			MCF7_Abemaciclib_0.3_24_rep1						MCF7_Abemaciclib_0.3_24_rep1		ACH-000019	MCF7_BREAST	MCF7_BREAST	ABEMACICLIB	DRUG			SRR5579527,SRR5579519	6	hours	0.3	micromolar				9606	Homo sapiens		SRS2211798	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/002/SRR5579532	377709024	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/002/SRR5579532	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/002/SRR5579532	6292f3be8c40b4809ce8990862ec7328	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579501	NextSeq 500 sequencing: GSM2633700: HS578T_Ribociclib_3_6 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149849									255610875							HS578T		GEO																NextSeq 500 sequencing: GSM2633700: HS578T_Ribociclib_3_6 Homo sapiens RNA-Seq										SRX2837611	GSM2633700						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/001/SRR5579501/SRR5579501.fastq.gz	154728763	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/001/SRR5579501/SRR5579501.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/001/SRR5579501/SRR5579501.fastq.gz	7e22463f8cc3f578bbace2636c55db84		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		3408145											GSM2633700_r1			GSM2633700			HS578T_Ribociclib_3_6						HS578T_Ribociclib_3_6		ACH-000148	HS578T_BREAST	HS578T_BREAST	RIBOCICLIB	DRUG			SRR5579488,SRR5579487	6	hours	3	micromolar				9606	Homo sapiens		SRS2211776	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/001/SRR5579501	103878329	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/001/SRR5579501	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/001/SRR5579501	68179e4b29ea3c962f4861c1eeb16a5d	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579502	NextSeq 500 sequencing: GSM2633700: HS578T_Ribociclib_3_6 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149849									266328825							HS578T		GEO																NextSeq 500 sequencing: GSM2633700: HS578T_Ribociclib_3_6 Homo sapiens RNA-Seq										SRX2837611	GSM2633700						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/002/SRR5579502/SRR5579502.fastq.gz	154517313	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/002/SRR5579502/SRR5579502.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/002/SRR5579502/SRR5579502.fastq.gz	a4ac500f79b2141d20b77ca879399b20		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		3551051											GSM2633700_r2			GSM2633700			HS578T_Ribociclib_3_6						HS578T_Ribociclib_3_6		ACH-000148	HS578T_BREAST	HS578T_BREAST	RIBOCICLIB	DRUG			SRR5579488,SRR5579487	6	hours	3	micromolar				9606	Homo sapiens		SRS2211776	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/002/SRR5579502	103056435	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/002/SRR5579502	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/002/SRR5579502	543b5f0092ca47e6d7f39ba7d412784b	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579405	NextSeq 500 sequencing: GSM2633652: HS578T_Ribociclib_3_24 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149898									422393100							HS578T		GEO																NextSeq 500 sequencing: GSM2633652: HS578T_Ribociclib_3_24 Homo sapiens RNA-Seq										SRX2837563	GSM2633652						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/005/SRR5579405/SRR5579405.fastq.gz	252860894	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/005/SRR5579405/SRR5579405.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/005/SRR5579405/SRR5579405.fastq.gz	5ca0b57bb3451db3547b72c301fedbda		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		5631908											GSM2633652_r1			GSM2633652			HS578T_Ribociclib_3_24						HS578T_Ribociclib_3_24		ACH-000148	HS578T_BREAST	HS578T_BREAST	RIBOCICLIB	DRUG			SRR5579391,SRR5579392	24	hours	3	micromolar				9606	Homo sapiens		SRS2211728	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/005/SRR5579405	169365046	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/005/SRR5579405	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/005/SRR5579405	dc84faa36442aa55a7aca50177d7cf67	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579406	NextSeq 500 sequencing: GSM2633652: HS578T_Ribociclib_3_24 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149898									437168850							HS578T		GEO																NextSeq 500 sequencing: GSM2633652: HS578T_Ribociclib_3_24 Homo sapiens RNA-Seq										SRX2837563	GSM2633652						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/006/SRR5579406/SRR5579406.fastq.gz	250725337	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/006/SRR5579406/SRR5579406.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/006/SRR5579406/SRR5579406.fastq.gz	1873e7731f0cd9b32d48180e36175106		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		5828918											GSM2633652_r2			GSM2633652			HS578T_Ribociclib_3_24						HS578T_Ribociclib_3_24		ACH-000148	HS578T_BREAST	HS578T_BREAST	RIBOCICLIB	DRUG			SRR5579391,SRR5579392	24	hours	3	micromolar				9606	Homo sapiens		SRS2211728	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/006/SRR5579406	166812777	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/006/SRR5579406	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/006/SRR5579406	0d8c53327ef45bd998db87ccb18c9bbd	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579499	NextSeq 500 sequencing: GSM2633699: HS578T_Ribociclib_0.3_6 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149850									350839275							HS578T		GEO																NextSeq 500 sequencing: GSM2633699: HS578T_Ribociclib_0.3_6 Homo sapiens RNA-Seq										SRX2837610	GSM2633699						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/009/SRR5579499/SRR5579499.fastq.gz	211520128	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/009/SRR5579499/SRR5579499.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/009/SRR5579499/SRR5579499.fastq.gz	fa568a06495de146262d1022a9787755		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		4677857											GSM2633699_r1			GSM2633699			HS578T_Ribociclib_0.3_6						HS578T_Ribociclib_0.3_6		ACH-000148	HS578T_BREAST	HS578T_BREAST	RIBOCICLIB	DRUG			SRR5579488,SRR5579487	6	hours	0.3	micromolar				9606	Homo sapiens		SRS2211775	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/009/SRR5579499	141896943	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/009/SRR5579499	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/009/SRR5579499	7745f97ecef1fe590592e1fa260a410b	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579500	NextSeq 500 sequencing: GSM2633699: HS578T_Ribociclib_0.3_6 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149850									365705250							HS578T		GEO																NextSeq 500 sequencing: GSM2633699: HS578T_Ribociclib_0.3_6 Homo sapiens RNA-Seq										SRX2837610	GSM2633699						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/000/SRR5579500/SRR5579500.fastq.gz	211049637	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/000/SRR5579500/SRR5579500.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/000/SRR5579500/SRR5579500.fastq.gz	36b518642e203ad8451c8c97f9560bd9		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		4876070											GSM2633699_r2			GSM2633699			HS578T_Ribociclib_0.3_6						HS578T_Ribociclib_0.3_6		ACH-000148	HS578T_BREAST	HS578T_BREAST	RIBOCICLIB	DRUG			SRR5579488,SRR5579487	6	hours	0.3	micromolar				9606	Homo sapiens		SRS2211775	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/000/SRR5579500	140626098	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/000/SRR5579500	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/000/SRR5579500	4668d5c07c43c67f1b2175db43b1fb7d	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579403	NextSeq 500 sequencing: GSM2633651: HS578T_Ribociclib_0.3_24 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149899									458810475							HS578T		GEO																NextSeq 500 sequencing: GSM2633651: HS578T_Ribociclib_0.3_24 Homo sapiens RNA-Seq										SRX2837562	GSM2633651						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/003/SRR5579403/SRR5579403.fastq.gz	274691368	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/003/SRR5579403/SRR5579403.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/003/SRR5579403/SRR5579403.fastq.gz	b29d8eee041a7acd3bdccb2aac8a903f		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		6117473											GSM2633651_r1			GSM2633651			HS578T_Ribociclib_0.3_24						HS578T_Ribociclib_0.3_24		ACH-000148	HS578T_BREAST	HS578T_BREAST	RIBOCICLIB	DRUG			SRR5579391,SRR5579392	24	hours	0.3	micromolar				9606	Homo sapiens		SRS2211726	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/003/SRR5579403	184051864	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/003/SRR5579403	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/003/SRR5579403	aaa8b61769fc58518628f96360881243	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579404	NextSeq 500 sequencing: GSM2633651: HS578T_Ribociclib_0.3_24 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149899									474654375							HS578T		GEO																NextSeq 500 sequencing: GSM2633651: HS578T_Ribociclib_0.3_24 Homo sapiens RNA-Seq										SRX2837562	GSM2633651						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/004/SRR5579404/SRR5579404.fastq.gz	272007324	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/004/SRR5579404/SRR5579404.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/004/SRR5579404/SRR5579404.fastq.gz	377abf3c068484e1806fa96bbc913a88		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		6328725											GSM2633651_r2			GSM2633651			HS578T_Ribociclib_0.3_24						HS578T_Ribociclib_0.3_24		ACH-000148	HS578T_BREAST	HS578T_BREAST	RIBOCICLIB	DRUG			SRR5579391,SRR5579392	24	hours	0.3	micromolar				9606	Homo sapiens		SRS2211726	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/004/SRR5579404	181008127	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/004/SRR5579404	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/004/SRR5579404	eca9461e69b1322954da20b768cb16e5	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579497	NextSeq 500 sequencing: GSM2633698: HS578T_Palbociclib_3_6 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149851									459958350							HS578T		GEO																NextSeq 500 sequencing: GSM2633698: HS578T_Palbociclib_3_6 Homo sapiens RNA-Seq										SRX2837609	GSM2633698						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/007/SRR5579497/SRR5579497.fastq.gz	276697942	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/007/SRR5579497/SRR5579497.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/007/SRR5579497/SRR5579497.fastq.gz	407536dd5231c2e79c8c4eef16d0a38d		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		6132778											GSM2633698_r1			GSM2633698			HS578T_Palbociclib_3_6						HS578T_Palbociclib_3_6		ACH-000148	HS578T_BREAST	HS578T_BREAST	PALBOCICLIB	DRUG			SRR5579488,SRR5579487	6	hours	3	micromolar				9606	Homo sapiens		SRS2211774	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/007/SRR5579497	185537592	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/007/SRR5579497	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/007/SRR5579497	04f59e33f1fcc3ea5103203af06817c6	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579498	NextSeq 500 sequencing: GSM2633698: HS578T_Palbociclib_3_6 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149851									477743025							HS578T		GEO																NextSeq 500 sequencing: GSM2633698: HS578T_Palbociclib_3_6 Homo sapiens RNA-Seq										SRX2837609	GSM2633698						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/008/SRR5579498/SRR5579498.fastq.gz	275235071	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/008/SRR5579498/SRR5579498.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/008/SRR5579498/SRR5579498.fastq.gz	7314d0e578b9c3c7726f9a7f678bb426		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		6369907											GSM2633698_r2			GSM2633698			HS578T_Palbociclib_3_6						HS578T_Palbociclib_3_6		ACH-000148	HS578T_BREAST	HS578T_BREAST	PALBOCICLIB	DRUG			SRR5579488,SRR5579487	6	hours	3	micromolar				9606	Homo sapiens		SRS2211774	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/008/SRR5579498	183307603	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/008/SRR5579498	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/008/SRR5579498	486288fefb29a6f96ad4ec2e30507455	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579401	NextSeq 500 sequencing: GSM2633650: HS578T_Palbociclib_3_24 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149900									289583700							HS578T		GEO																NextSeq 500 sequencing: GSM2633650: HS578T_Palbociclib_3_24 Homo sapiens RNA-Seq										SRX2837561	GSM2633650						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/001/SRR5579401/SRR5579401.fastq.gz	172571624	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/001/SRR5579401/SRR5579401.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/001/SRR5579401/SRR5579401.fastq.gz	a7f519c0415db3a6c6f348a640741037		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		3861116											GSM2633650_r1			GSM2633650			HS578T_Palbociclib_3_24						HS578T_Palbociclib_3_24		ACH-000148	HS578T_BREAST	HS578T_BREAST	PALBOCICLIB	DRUG			SRR5579391,SRR5579392	24	hours	3	micromolar				9606	Homo sapiens		SRS2211727	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/001/SRR5579401	115585853	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/001/SRR5579401	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/001/SRR5579401	a757798d0ed1c3ba436dddee4e5ea5e3	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579402	NextSeq 500 sequencing: GSM2633650: HS578T_Palbociclib_3_24 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149900									298039950							HS578T		GEO																NextSeq 500 sequencing: GSM2633650: HS578T_Palbociclib_3_24 Homo sapiens RNA-Seq										SRX2837561	GSM2633650						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/002/SRR5579402/SRR5579402.fastq.gz	170023748	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/002/SRR5579402/SRR5579402.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/002/SRR5579402/SRR5579402.fastq.gz	2b3a4db11afa2af5f0a5773d62e2f96f		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		3973866											GSM2633650_r2			GSM2633650			HS578T_Palbociclib_3_24						HS578T_Palbociclib_3_24		ACH-000148	HS578T_BREAST	HS578T_BREAST	PALBOCICLIB	DRUG			SRR5579391,SRR5579392	24	hours	3	micromolar				9606	Homo sapiens		SRS2211727	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/002/SRR5579402	113109308	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/002/SRR5579402	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/002/SRR5579402	c54428050512c1c06390fdb4d54b26c7	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579495	NextSeq 500 sequencing: GSM2633697: HS578T_Palbociclib_0.3_6 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149852									431106675							HS578T		GEO																NextSeq 500 sequencing: GSM2633697: HS578T_Palbociclib_0.3_6 Homo sapiens RNA-Seq										SRX2837608	GSM2633697						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/005/SRR5579495/SRR5579495.fastq.gz	260100354	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/005/SRR5579495/SRR5579495.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/005/SRR5579495/SRR5579495.fastq.gz	481ba19cc72a7d883a44b143b2a4d1f0		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		5748089											GSM2633697_r1			GSM2633697			HS578T_Palbociclib_0.3_6						HS578T_Palbociclib_0.3_6		ACH-000148	HS578T_BREAST	HS578T_BREAST	PALBOCICLIB	DRUG			SRR5579488,SRR5579487	6	hours	0.3	micromolar				9606	Homo sapiens		SRS2211773	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/005/SRR5579495	174486378	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/005/SRR5579495	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/005/SRR5579495	df874faddf28d09ee80d93e1814fad7a	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579496	NextSeq 500 sequencing: GSM2633697: HS578T_Palbociclib_0.3_6 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149852									451367475							HS578T		GEO																NextSeq 500 sequencing: GSM2633697: HS578T_Palbociclib_0.3_6 Homo sapiens RNA-Seq										SRX2837608	GSM2633697						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/006/SRR5579496/SRR5579496.fastq.gz	260905677	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/006/SRR5579496/SRR5579496.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/006/SRR5579496/SRR5579496.fastq.gz	704ded7209eac19a255f90facc32f0a6		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		6018233											GSM2633697_r2			GSM2633697			HS578T_Palbociclib_0.3_6						HS578T_Palbociclib_0.3_6		ACH-000148	HS578T_BREAST	HS578T_BREAST	PALBOCICLIB	DRUG			SRR5579488,SRR5579487	6	hours	0.3	micromolar				9606	Homo sapiens		SRS2211773	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/006/SRR5579496	173877689	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/006/SRR5579496	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/006/SRR5579496	dab116e28851b4ded4c4261d6be7d909	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579399	NextSeq 500 sequencing: GSM2633649: HS578T_Palbociclib_0.3_24 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149901									379209825							HS578T		GEO																NextSeq 500 sequencing: GSM2633649: HS578T_Palbociclib_0.3_24 Homo sapiens RNA-Seq										SRX2837560	GSM2633649						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/009/SRR5579399/SRR5579399.fastq.gz	227106642	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/009/SRR5579399/SRR5579399.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/009/SRR5579399/SRR5579399.fastq.gz	e2fb77619a2e975020292fee04bf3dc1		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		5056131											GSM2633649_r1			GSM2633649			HS578T_Palbociclib_0.3_24						HS578T_Palbociclib_0.3_24		ACH-000148	HS578T_BREAST	HS578T_BREAST	PALBOCICLIB	DRUG			SRR5579391,SRR5579392	24	hours	0.3	micromolar				9606	Homo sapiens		SRS2211725	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/009/SRR5579399	152177352	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/009/SRR5579399	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/009/SRR5579399	256864dfd204444aa3f041583f0b96b4	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579400	NextSeq 500 sequencing: GSM2633649: HS578T_Palbociclib_0.3_24 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149901									394298550							HS578T		GEO																NextSeq 500 sequencing: GSM2633649: HS578T_Palbociclib_0.3_24 Homo sapiens RNA-Seq										SRX2837560	GSM2633649						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/000/SRR5579400/SRR5579400.fastq.gz	226250266	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/000/SRR5579400/SRR5579400.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/000/SRR5579400/SRR5579400.fastq.gz	d0c2591711f5467d80173ab79509c296		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		5257314											GSM2633649_r2			GSM2633649			HS578T_Palbociclib_0.3_24						HS578T_Palbociclib_0.3_24		ACH-000148	HS578T_BREAST	HS578T_BREAST	PALBOCICLIB	DRUG			SRR5579391,SRR5579392	24	hours	0.3	micromolar				9606	Homo sapiens		SRS2211725	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/000/SRR5579400	150587620	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/000/SRR5579400	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/000/SRR5579400	cc8cd1ec952cd106fcd286eed55b2669	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579487	NextSeq 500 sequencing: GSM2633693: HS578T_Control_0_6 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149856									409944075							HS578T		GEO																NextSeq 500 sequencing: GSM2633693: HS578T_Control_0_6 Homo sapiens RNA-Seq										SRX2837604	GSM2633693						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/007/SRR5579487/SRR5579487.fastq.gz	247481174	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/007/SRR5579487/SRR5579487.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/007/SRR5579487/SRR5579487.fastq.gz	536457b9c627195b15e8b2bd48987adf		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		5465921											GSM2633693_r1			GSM2633693			HS578T_Control_0_6						HS578T_Control_0_6		ACH-000148	HS578T_BREAST	HS578T_BREAST	CONTROL	CONTROL			SRR5579488,SRR5579487	6	hours	0	micromolar				9606	Homo sapiens		SRS2211769	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/007/SRR5579487	166063486	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/007/SRR5579487	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/007/SRR5579487	55e85f42c18ef2be4353543026e67635	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579488	NextSeq 500 sequencing: GSM2633693: HS578T_Control_0_6 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149856									426495450							HS578T		GEO																NextSeq 500 sequencing: GSM2633693: HS578T_Control_0_6 Homo sapiens RNA-Seq										SRX2837604	GSM2633693						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/008/SRR5579488/SRR5579488.fastq.gz	246719671	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/008/SRR5579488/SRR5579488.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/008/SRR5579488/SRR5579488.fastq.gz	92597f6d490eb226f8988d3c05771995		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		5686606											GSM2633693_r2			GSM2633693			HS578T_Control_0_6						HS578T_Control_0_6		ACH-000148	HS578T_BREAST	HS578T_BREAST	CONTROL	CONTROL			SRR5579488,SRR5579487	6	hours	0	micromolar				9606	Homo sapiens		SRS2211769	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/008/SRR5579488	164449304	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/008/SRR5579488	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/008/SRR5579488	a5e580388f668a2713e98b5e3c121e1f	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579391	NextSeq 500 sequencing: GSM2633645: HS578T_Control_0_24 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149905									1558425							HS578T		GEO																NextSeq 500 sequencing: GSM2633645: HS578T_Control_0_24 Homo sapiens RNA-Seq										SRX2837556	GSM2633645						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/001/SRR5579391/SRR5579391.fastq.gz	533024	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/001/SRR5579391/SRR5579391.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/001/SRR5579391/SRR5579391.fastq.gz	2645b827f79b043ea941211fc79425dc		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		20779											GSM2633645_r1			GSM2633645			HS578T_Control_0_24						HS578T_Control_0_24		ACH-000148	HS578T_BREAST	HS578T_BREAST	CONTROL	CONTROL			SRR5579391,SRR5579392	24	hours	0	micromolar				9606	Homo sapiens		SRS2211721	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/001/SRR5579391	624633	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/001/SRR5579391	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/001/SRR5579391	b12c1b7c53e55b45c040683ad1116ca9	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579392	NextSeq 500 sequencing: GSM2633645: HS578T_Control_0_24 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149905									1565325							HS578T		GEO																NextSeq 500 sequencing: GSM2633645: HS578T_Control_0_24 Homo sapiens RNA-Seq										SRX2837556	GSM2633645						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/002/SRR5579392/SRR5579392.fastq.gz	505331	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/002/SRR5579392/SRR5579392.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/002/SRR5579392/SRR5579392.fastq.gz	42f17b8456c35b36e098a706ee11105f		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		20871											GSM2633645_r2			GSM2633645			HS578T_Control_0_24						HS578T_Control_0_24		ACH-000148	HS578T_BREAST	HS578T_BREAST	CONTROL	CONTROL			SRR5579391,SRR5579392	24	hours	0	micromolar				9606	Homo sapiens		SRS2211721	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/002/SRR5579392	589889	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/002/SRR5579392	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/002/SRR5579392	6840da1ef751545b6092b983552ae79f	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579493	NextSeq 500 sequencing: GSM2633696: HS578T_Abemaciclib_3_6_rep2 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149853									148294800							HS578T		GEO																NextSeq 500 sequencing: GSM2633696: HS578T_Abemaciclib_3_6_rep2 Homo sapiens RNA-Seq										SRX2837607	GSM2633696						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/003/SRR5579493/SRR5579493.fastq.gz	90086197	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/003/SRR5579493/SRR5579493.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/003/SRR5579493/SRR5579493.fastq.gz	cebb5d5bda90af949795e0c1d7efbb53		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		1977264											GSM2633696_r1			GSM2633696			HS578T_Abemaciclib_3_6_rep2						HS578T_Abemaciclib_3_6_rep2		ACH-000148	HS578T_BREAST	HS578T_BREAST	ABEMACICLIB	DRUG			SRR5579488,SRR5579487	6	hours	3	micromolar				9606	Homo sapiens		SRS2211772	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/003/SRR5579493	60614751	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/003/SRR5579493	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/003/SRR5579493	b0b7bd0abc1a09e50c44209a4d1dce35	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579494	NextSeq 500 sequencing: GSM2633696: HS578T_Abemaciclib_3_6_rep2 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149853									155818575							HS578T		GEO																NextSeq 500 sequencing: GSM2633696: HS578T_Abemaciclib_3_6_rep2 Homo sapiens RNA-Seq										SRX2837607	GSM2633696						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/004/SRR5579494/SRR5579494.fastq.gz	90698196	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/004/SRR5579494/SRR5579494.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/004/SRR5579494/SRR5579494.fastq.gz	7a2b48bb4cce51c9adf89f0b2538c334		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		2077581											GSM2633696_r2			GSM2633696			HS578T_Abemaciclib_3_6_rep2						HS578T_Abemaciclib_3_6_rep2		ACH-000148	HS578T_BREAST	HS578T_BREAST	ABEMACICLIB	DRUG			SRR5579488,SRR5579487	6	hours	3	micromolar				9606	Homo sapiens		SRS2211772	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/004/SRR5579494	60639250	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/004/SRR5579494	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/004/SRR5579494	a5ab63dfc8e18e74725eb546014807eb	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579491	NextSeq 500 sequencing: GSM2633695: HS578T_Abemaciclib_3_6_rep1 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149854									348498225							HS578T		GEO																NextSeq 500 sequencing: GSM2633695: HS578T_Abemaciclib_3_6_rep1 Homo sapiens RNA-Seq										SRX2837606	GSM2633695						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/001/SRR5579491/SRR5579491.fastq.gz	209999246	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/001/SRR5579491/SRR5579491.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/001/SRR5579491/SRR5579491.fastq.gz	7b39ca2a2d5625377f349239500cf108		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		4646643											GSM2633695_r1			GSM2633695			HS578T_Abemaciclib_3_6_rep1						HS578T_Abemaciclib_3_6_rep1		ACH-000148	HS578T_BREAST	HS578T_BREAST	ABEMACICLIB	DRUG			SRR5579488,SRR5579487	6	hours	3	micromolar				9606	Homo sapiens		SRS2211771	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/001/SRR5579491	140993604	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/001/SRR5579491	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/001/SRR5579491	8b30270b2e874609d4a5ef9fd6c67735	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579492	NextSeq 500 sequencing: GSM2633695: HS578T_Abemaciclib_3_6_rep1 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149854									363460875							HS578T		GEO																NextSeq 500 sequencing: GSM2633695: HS578T_Abemaciclib_3_6_rep1 Homo sapiens RNA-Seq										SRX2837606	GSM2633695						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/002/SRR5579492/SRR5579492.fastq.gz	209708208	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/002/SRR5579492/SRR5579492.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/002/SRR5579492/SRR5579492.fastq.gz	372ca5bd5c1138baa3edd919cbd20584		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		4846145											GSM2633695_r2			GSM2633695			HS578T_Abemaciclib_3_6_rep1						HS578T_Abemaciclib_3_6_rep1		ACH-000148	HS578T_BREAST	HS578T_BREAST	ABEMACICLIB	DRUG			SRR5579488,SRR5579487	6	hours	3	micromolar				9606	Homo sapiens		SRS2211771	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/002/SRR5579492	139877828	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/002/SRR5579492	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/002/SRR5579492	ac20d3c9175334282646a2c6c56c3a6f	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579397	NextSeq 500 sequencing: GSM2633648: HS578T_Abemaciclib_3_24_rep2 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149902									424164150							HS578T		GEO																NextSeq 500 sequencing: GSM2633648: HS578T_Abemaciclib_3_24_rep2 Homo sapiens RNA-Seq										SRX2837559	GSM2633648						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/007/SRR5579397/SRR5579397.fastq.gz	255254973	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/007/SRR5579397/SRR5579397.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/007/SRR5579397/SRR5579397.fastq.gz	a0cb1ce36c8951433160316876105338		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		5655522											GSM2633648_r1			GSM2633648			HS578T_Abemaciclib_3_24_rep2						HS578T_Abemaciclib_3_24_rep2		ACH-000148	HS578T_BREAST	HS578T_BREAST	ABEMACICLIB	DRUG			SRR5579391,SRR5579392	24	hours	3	micromolar				9606	Homo sapiens		SRS2211724	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/007/SRR5579397	171292098	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/007/SRR5579397	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/007/SRR5579397	2cb7a06a998e7488778c5222257d1399	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579398	NextSeq 500 sequencing: GSM2633648: HS578T_Abemaciclib_3_24_rep2 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149902									441443625							HS578T		GEO																NextSeq 500 sequencing: GSM2633648: HS578T_Abemaciclib_3_24_rep2 Homo sapiens RNA-Seq										SRX2837559	GSM2633648						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/008/SRR5579398/SRR5579398.fastq.gz	254506039	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/008/SRR5579398/SRR5579398.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/008/SRR5579398/SRR5579398.fastq.gz	8dcbcf7c61a2cfc5dc4eccaf3168ce1f		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		5885915											GSM2633648_r2			GSM2633648			HS578T_Abemaciclib_3_24_rep2						HS578T_Abemaciclib_3_24_rep2		ACH-000148	HS578T_BREAST	HS578T_BREAST	ABEMACICLIB	DRUG			SRR5579391,SRR5579392	24	hours	3	micromolar				9606	Homo sapiens		SRS2211724	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/008/SRR5579398	169663460	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/008/SRR5579398	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/008/SRR5579398	94c670e36ca11b8bb92edab54489b974	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579395	NextSeq 500 sequencing: GSM2633647: HS578T_Abemaciclib_3_24_rep1 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149903									247904100							HS578T		GEO																NextSeq 500 sequencing: GSM2633647: HS578T_Abemaciclib_3_24_rep1 Homo sapiens RNA-Seq										SRX2837558	GSM2633647						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/005/SRR5579395/SRR5579395.fastq.gz	147130158	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/005/SRR5579395/SRR5579395.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/005/SRR5579395/SRR5579395.fastq.gz	e1c5e81b2f9d30049dba7e1ec54b9ae6		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		3305388											GSM2633647_r1			GSM2633647			HS578T_Abemaciclib_3_24_rep1						HS578T_Abemaciclib_3_24_rep1		ACH-000148	HS578T_BREAST	HS578T_BREAST	ABEMACICLIB	DRUG			SRR5579391,SRR5579392	24	hours	3	micromolar				9606	Homo sapiens		SRS2211722	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/005/SRR5579395	98649047	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/005/SRR5579395	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/005/SRR5579395	e82ec6e6521918b55390240bed94a579	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579396	NextSeq 500 sequencing: GSM2633647: HS578T_Abemaciclib_3_24_rep1 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149903									255701400							HS578T		GEO																NextSeq 500 sequencing: GSM2633647: HS578T_Abemaciclib_3_24_rep1 Homo sapiens RNA-Seq										SRX2837558	GSM2633647						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/006/SRR5579396/SRR5579396.fastq.gz	145171496	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/006/SRR5579396/SRR5579396.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/006/SRR5579396/SRR5579396.fastq.gz	17b5b36c43729637b63cc0a535bf869a		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		3409352											GSM2633647_r2			GSM2633647			HS578T_Abemaciclib_3_24_rep1						HS578T_Abemaciclib_3_24_rep1		ACH-000148	HS578T_BREAST	HS578T_BREAST	ABEMACICLIB	DRUG			SRR5579391,SRR5579392	24	hours	3	micromolar				9606	Homo sapiens		SRS2211722	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/006/SRR5579396	96691655	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/006/SRR5579396	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/006/SRR5579396	2e311f5102bd71cb1597ce308991305b	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579489	NextSeq 500 sequencing: GSM2633694: HS578T_Abemaciclib_0.3_6 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149855									313612425							HS578T		GEO																NextSeq 500 sequencing: GSM2633694: HS578T_Abemaciclib_0.3_6 Homo sapiens RNA-Seq										SRX2837605	GSM2633694						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/009/SRR5579489/SRR5579489.fastq.gz	189566999	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/009/SRR5579489/SRR5579489.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/009/SRR5579489/SRR5579489.fastq.gz	651df7b5d4b1e92a758721944557e25f		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		4181499											GSM2633694_r1			GSM2633694			HS578T_Abemaciclib_0.3_6						HS578T_Abemaciclib_0.3_6		ACH-000148	HS578T_BREAST	HS578T_BREAST	ABEMACICLIB	DRUG			SRR5579488,SRR5579487	6	hours	0.3	micromolar				9606	Homo sapiens		SRS2211770	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/009/SRR5579489	127231695	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/009/SRR5579489	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/009/SRR5579489	bbc3b79fa4f8cea8995e749847a4de6d	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579490	NextSeq 500 sequencing: GSM2633694: HS578T_Abemaciclib_0.3_6 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149855									327619200							HS578T		GEO																NextSeq 500 sequencing: GSM2633694: HS578T_Abemaciclib_0.3_6 Homo sapiens RNA-Seq										SRX2837605	GSM2633694						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/000/SRR5579490/SRR5579490.fastq.gz	189786236	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/000/SRR5579490/SRR5579490.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/000/SRR5579490/SRR5579490.fastq.gz	57c296bcd1e8db5f006638fcbb0655b6		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		4368256											GSM2633694_r2			GSM2633694			HS578T_Abemaciclib_0.3_6						HS578T_Abemaciclib_0.3_6		ACH-000148	HS578T_BREAST	HS578T_BREAST	ABEMACICLIB	DRUG			SRR5579488,SRR5579487	6	hours	0.3	micromolar				9606	Homo sapiens		SRS2211770	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/000/SRR5579490	126551234	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/000/SRR5579490	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/000/SRR5579490	5a58aa642c6ae438142facd99db6b84c	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579393	NextSeq 500 sequencing: GSM2633646: HS578T_Abemaciclib_0.3_24 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149904									479702550							HS578T		GEO																NextSeq 500 sequencing: GSM2633646: HS578T_Abemaciclib_0.3_24 Homo sapiens RNA-Seq										SRX2837557	GSM2633646						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/003/SRR5579393/SRR5579393.fastq.gz	287038372	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/003/SRR5579393/SRR5579393.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/003/SRR5579393/SRR5579393.fastq.gz	0da5544bb4eff1960335d6f2abc59add		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		6396034											GSM2633646_r1			GSM2633646			HS578T_Abemaciclib_0.3_24						HS578T_Abemaciclib_0.3_24		ACH-000148	HS578T_BREAST	HS578T_BREAST	ABEMACICLIB	DRUG			SRR5579391,SRR5579392	24	hours	0.3	micromolar				9606	Homo sapiens		SRS2211723	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/003/SRR5579393	192252132	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/003/SRR5579393	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/003/SRR5579393	a95be3547a78dcacadfb84d4b7d0b636	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579394	NextSeq 500 sequencing: GSM2633646: HS578T_Abemaciclib_0.3_24 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149904									496646625							HS578T		GEO																NextSeq 500 sequencing: GSM2633646: HS578T_Abemaciclib_0.3_24 Homo sapiens RNA-Seq										SRX2837557	GSM2633646						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/004/SRR5579394/SRR5579394.fastq.gz	284676937	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/004/SRR5579394/SRR5579394.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/004/SRR5579394/SRR5579394.fastq.gz	77e9a69dee7773d3930f3781b0dd49a2		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		6621955											GSM2633646_r2			GSM2633646			HS578T_Abemaciclib_0.3_24						HS578T_Abemaciclib_0.3_24		ACH-000148	HS578T_BREAST	HS578T_BREAST	ABEMACICLIB	DRUG			SRR5579391,SRR5579392	24	hours	0.3	micromolar				9606	Homo sapiens		SRS2211723	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/004/SRR5579394	189405040	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/004/SRR5579394	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/004/SRR5579394	34eb669956fe54b4371bc4c4d2861001	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579485	NextSeq 500 sequencing: GSM2633692: HCC1806_Ribociclib_3_6 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149857									319605750							HCC1806		GEO																NextSeq 500 sequencing: GSM2633692: HCC1806_Ribociclib_3_6 Homo sapiens RNA-Seq										SRX2837603	GSM2633692						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/005/SRR5579485/SRR5579485.fastq.gz	192123175	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/005/SRR5579485/SRR5579485.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/005/SRR5579485/SRR5579485.fastq.gz	36780863b6186f01b2a2553f918b4652		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		4261410											GSM2633692_r1			GSM2633692			HCC1806_Ribociclib_3_6						HCC1806_Ribociclib_3_6		ACH-000624	HCC1806_BREAST	HCC1806_BREAST	RIBOCICLIB	DRUG			SRR5579471,SRR5579472	6	hours	3	micromolar				9606	Homo sapiens		SRS2211768	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/005/SRR5579485	128815639	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/005/SRR5579485	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/005/SRR5579485	90985ef67d8a6ce3774909df622e6fa2	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579486	NextSeq 500 sequencing: GSM2633692: HCC1806_Ribociclib_3_6 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149857									331641600							HCC1806		GEO																NextSeq 500 sequencing: GSM2633692: HCC1806_Ribociclib_3_6 Homo sapiens RNA-Seq										SRX2837603	GSM2633692						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/006/SRR5579486/SRR5579486.fastq.gz	191058507	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/006/SRR5579486/SRR5579486.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/006/SRR5579486/SRR5579486.fastq.gz	e26557084bfd57d03b8973f60073faa2		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		4421888											GSM2633692_r2			GSM2633692			HCC1806_Ribociclib_3_6						HCC1806_Ribociclib_3_6		ACH-000624	HCC1806_BREAST	HCC1806_BREAST	RIBOCICLIB	DRUG			SRR5579471,SRR5579472	6	hours	3	micromolar				9606	Homo sapiens		SRS2211768	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/006/SRR5579486	127276959	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/006/SRR5579486	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/006/SRR5579486	d0c07b5950fb6cf2d84c246be16d493f	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579389	NextSeq 500 sequencing: GSM2633644: HCC1806_Ribociclib_3_24 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149906									355181850							HCC1806		GEO																NextSeq 500 sequencing: GSM2633644: HCC1806_Ribociclib_3_24 Homo sapiens RNA-Seq										SRX2837555	GSM2633644						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/009/SRR5579389/SRR5579389.fastq.gz	211606397	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/009/SRR5579389/SRR5579389.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/009/SRR5579389/SRR5579389.fastq.gz	367d0f7592904b3418439702c83546ac		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		4735758											GSM2633644_r1			GSM2633644			HCC1806_Ribociclib_3_24						HCC1806_Ribociclib_3_24		ACH-000624	HCC1806_BREAST	HCC1806_BREAST	RIBOCICLIB	DRUG			SRR5579375,SRR5579376	24	hours	3	micromolar				9606	Homo sapiens		SRS2211720	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/009/SRR5579389	141729869	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/009/SRR5579389	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/009/SRR5579389	5057c499c3d3a0186a1d656fc64006ec	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579390	NextSeq 500 sequencing: GSM2633644: HCC1806_Ribociclib_3_24 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149906									367881975							HCC1806		GEO																NextSeq 500 sequencing: GSM2633644: HCC1806_Ribociclib_3_24 Homo sapiens RNA-Seq										SRX2837555	GSM2633644						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/000/SRR5579390/SRR5579390.fastq.gz	209769753	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/000/SRR5579390/SRR5579390.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/000/SRR5579390/SRR5579390.fastq.gz	a92ea7fe86d014d27c7cdb70470beea7		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		4905093											GSM2633644_r2			GSM2633644			HCC1806_Ribociclib_3_24						HCC1806_Ribociclib_3_24		ACH-000624	HCC1806_BREAST	HCC1806_BREAST	RIBOCICLIB	DRUG			SRR5579375,SRR5579376	24	hours	3	micromolar				9606	Homo sapiens		SRS2211720	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/000/SRR5579390	139548200	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/000/SRR5579390	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/000/SRR5579390	cc4fad5c436348a41fb9b8aec64e8788	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579483	NextSeq 500 sequencing: GSM2633691: HCC1806_Ribociclib_0.3_6 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149858									331622475							HCC1806		GEO																NextSeq 500 sequencing: GSM2633691: HCC1806_Ribociclib_0.3_6 Homo sapiens RNA-Seq										SRX2837602	GSM2633691						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/003/SRR5579483/SRR5579483.fastq.gz	198847211	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/003/SRR5579483/SRR5579483.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/003/SRR5579483/SRR5579483.fastq.gz	772121510cf658a162fa5ec2248b4db2		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		4421633											GSM2633691_r1			GSM2633691			HCC1806_Ribociclib_0.3_6						HCC1806_Ribociclib_0.3_6		ACH-000624	HCC1806_BREAST	HCC1806_BREAST	RIBOCICLIB	DRUG			SRR5579471,SRR5579472	6	hours	0.3	micromolar				9606	Homo sapiens		SRS2211766	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/003/SRR5579483	133331783	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/003/SRR5579483	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/003/SRR5579483	71efebbf14de50e4e1eef00f7240c973	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579484	NextSeq 500 sequencing: GSM2633691: HCC1806_Ribociclib_0.3_6 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149858									343230975							HCC1806		GEO																NextSeq 500 sequencing: GSM2633691: HCC1806_Ribociclib_0.3_6 Homo sapiens RNA-Seq										SRX2837602	GSM2633691						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/004/SRR5579484/SRR5579484.fastq.gz	196988548	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/004/SRR5579484/SRR5579484.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/004/SRR5579484/SRR5579484.fastq.gz	5401f73cbbb59c780abc231e48264141		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		4576413											GSM2633691_r2			GSM2633691			HCC1806_Ribociclib_0.3_6						HCC1806_Ribociclib_0.3_6		ACH-000624	HCC1806_BREAST	HCC1806_BREAST	RIBOCICLIB	DRUG			SRR5579471,SRR5579472	6	hours	0.3	micromolar				9606	Homo sapiens		SRS2211766	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/004/SRR5579484	131200634	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/004/SRR5579484	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/004/SRR5579484	016e2f6e504683e25b1d8985f7166837	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579387	NextSeq 500 sequencing: GSM2633643: HCC1806_Ribociclib_0.3_24 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149907									597879075							HCC1806		GEO																NextSeq 500 sequencing: GSM2633643: HCC1806_Ribociclib_0.3_24 Homo sapiens RNA-Seq										SRX2837554	GSM2633643						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/007/SRR5579387/SRR5579387.fastq.gz	356253186	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/007/SRR5579387/SRR5579387.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/007/SRR5579387/SRR5579387.fastq.gz	de3bd1fa1c2ea57b871959ce06bbc468		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		7971721											GSM2633643_r1			GSM2633643			HCC1806_Ribociclib_0.3_24						HCC1806_Ribociclib_0.3_24		ACH-000624	HCC1806_BREAST	HCC1806_BREAST	RIBOCICLIB	DRUG			SRR5579375,SRR5579376	24	hours	0.3	micromolar				9606	Homo sapiens		SRS2211718	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/007/SRR5579387	238616154	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/007/SRR5579387	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/007/SRR5579387	2fb1b656ee9b9e60b7664bb0f4e5c21c	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579388	NextSeq 500 sequencing: GSM2633643: HCC1806_Ribociclib_0.3_24 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149907									618372375							HCC1806		GEO																NextSeq 500 sequencing: GSM2633643: HCC1806_Ribociclib_0.3_24 Homo sapiens RNA-Seq										SRX2837554	GSM2633643						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/008/SRR5579388/SRR5579388.fastq.gz	352285468	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/008/SRR5579388/SRR5579388.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/008/SRR5579388/SRR5579388.fastq.gz	80f2410d89457b2759a054dfc432261b		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		8244965											GSM2633643_r2			GSM2633643			HCC1806_Ribociclib_0.3_24						HCC1806_Ribociclib_0.3_24		ACH-000624	HCC1806_BREAST	HCC1806_BREAST	RIBOCICLIB	DRUG			SRR5579375,SRR5579376	24	hours	0.3	micromolar				9606	Homo sapiens		SRS2211718	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/008/SRR5579388	234318823	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/008/SRR5579388	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/008/SRR5579388	1399471ca9fa8c0dd39300de4d06bcd3	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579481	NextSeq 500 sequencing: GSM2633690: HCC1806_Palbociclib_3_6 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149859									293367300							HCC1806		GEO																NextSeq 500 sequencing: GSM2633690: HCC1806_Palbociclib_3_6 Homo sapiens RNA-Seq										SRX2837601	GSM2633690						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/001/SRR5579481/SRR5579481.fastq.gz	175424792	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/001/SRR5579481/SRR5579481.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/001/SRR5579481/SRR5579481.fastq.gz	b2a940be7d823635d6822e427618e333		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		3911564											GSM2633690_r1			GSM2633690			HCC1806_Palbociclib_3_6						HCC1806_Palbociclib_3_6		ACH-000624	HCC1806_BREAST	HCC1806_BREAST	PALBOCICLIB	DRUG			SRR5579471,SRR5579472	6	hours	3	micromolar				9606	Homo sapiens		SRS2211767	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/001/SRR5579481	117557431	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/001/SRR5579481	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/001/SRR5579481	0ed2feb1a3b083ae4e6cb724bec1e8f7	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579482	NextSeq 500 sequencing: GSM2633690: HCC1806_Palbociclib_3_6 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149859									302579700							HCC1806		GEO																NextSeq 500 sequencing: GSM2633690: HCC1806_Palbociclib_3_6 Homo sapiens RNA-Seq										SRX2837601	GSM2633690						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/002/SRR5579482/SRR5579482.fastq.gz	173176474	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/002/SRR5579482/SRR5579482.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/002/SRR5579482/SRR5579482.fastq.gz	bcce2adc75c322be0234a85904b2210f		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		4034396											GSM2633690_r2			GSM2633690			HCC1806_Palbociclib_3_6						HCC1806_Palbociclib_3_6		ACH-000624	HCC1806_BREAST	HCC1806_BREAST	PALBOCICLIB	DRUG			SRR5579471,SRR5579472	6	hours	3	micromolar				9606	Homo sapiens		SRS2211767	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/002/SRR5579482	115288335	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/002/SRR5579482	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/002/SRR5579482	fda7ace9d3fc413122344f64a62cc4e4	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579385	NextSeq 500 sequencing: GSM2633642: HCC1806_Palbociclib_3_24 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149908									580292325							HCC1806		GEO																NextSeq 500 sequencing: GSM2633642: HCC1806_Palbociclib_3_24 Homo sapiens RNA-Seq										SRX2837553	GSM2633642						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/005/SRR5579385/SRR5579385.fastq.gz	344702615	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/005/SRR5579385/SRR5579385.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/005/SRR5579385/SRR5579385.fastq.gz	ad2cc7ded5e85b26228623af9fb0f9da		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		7737231											GSM2633642_r1			GSM2633642			HCC1806_Palbociclib_3_24						HCC1806_Palbociclib_3_24		ACH-000624	HCC1806_BREAST	HCC1806_BREAST	PALBOCICLIB	DRUG			SRR5579375,SRR5579376	24	hours	3	micromolar				9606	Homo sapiens		SRS2211719	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/005/SRR5579385	230793473	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/005/SRR5579385	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/005/SRR5579385	f188c3538604b0064ae9f02cf31213aa	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579386	NextSeq 500 sequencing: GSM2633642: HCC1806_Palbociclib_3_24 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149908									597611025							HCC1806		GEO																NextSeq 500 sequencing: GSM2633642: HCC1806_Palbociclib_3_24 Homo sapiens RNA-Seq										SRX2837553	GSM2633642						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/006/SRR5579386/SRR5579386.fastq.gz	339556388	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/006/SRR5579386/SRR5579386.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/006/SRR5579386/SRR5579386.fastq.gz	e1c54c756841039bf9f97b1c25268f13		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		7968147											GSM2633642_r2			GSM2633642			HCC1806_Palbociclib_3_24						HCC1806_Palbociclib_3_24		ACH-000624	HCC1806_BREAST	HCC1806_BREAST	PALBOCICLIB	DRUG			SRR5579375,SRR5579376	24	hours	3	micromolar				9606	Homo sapiens		SRS2211719	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/006/SRR5579386	225776544	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/006/SRR5579386	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/006/SRR5579386	602a30ef902df3f37ae09bb6ec7e26c1	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579479	NextSeq 500 sequencing: GSM2633689: HCC1806_Palbociclib_0.3_6 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149860									350561850							HCC1806		GEO																NextSeq 500 sequencing: GSM2633689: HCC1806_Palbociclib_0.3_6 Homo sapiens RNA-Seq										SRX2837600	GSM2633689						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/009/SRR5579479/SRR5579479.fastq.gz	210360578	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/009/SRR5579479/SRR5579479.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/009/SRR5579479/SRR5579479.fastq.gz	c99e434b47d7ec11ff90ff86b2fbb1fe		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		4674158											GSM2633689_r1			GSM2633689			HCC1806_Palbociclib_0.3_6						HCC1806_Palbociclib_0.3_6		ACH-000624	HCC1806_BREAST	HCC1806_BREAST	PALBOCICLIB	DRUG			SRR5579471,SRR5579472	6	hours	0.3	micromolar				9606	Homo sapiens		SRS2211765	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/009/SRR5579479	140975472	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/009/SRR5579479	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/009/SRR5579479	857a5a8532fe0e290645a09fb492f32f	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579480	NextSeq 500 sequencing: GSM2633689: HCC1806_Palbociclib_0.3_6 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149860									365088375							HCC1806		GEO																NextSeq 500 sequencing: GSM2633689: HCC1806_Palbociclib_0.3_6 Homo sapiens RNA-Seq										SRX2837600	GSM2633689						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/000/SRR5579480/SRR5579480.fastq.gz	209845935	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/000/SRR5579480/SRR5579480.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/000/SRR5579480/SRR5579480.fastq.gz	c7f88b55cd958398120ff465370ff1b9		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		4867845											GSM2633689_r2			GSM2633689			HCC1806_Palbociclib_0.3_6						HCC1806_Palbociclib_0.3_6		ACH-000624	HCC1806_BREAST	HCC1806_BREAST	PALBOCICLIB	DRUG			SRR5579471,SRR5579472	6	hours	0.3	micromolar				9606	Homo sapiens		SRS2211765	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/000/SRR5579480	139716681	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/000/SRR5579480	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/000/SRR5579480	d20e016fc6831bb90c54b706c298e96c	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579383	NextSeq 500 sequencing: GSM2633641: HCC1806_Palbociclib_0.3_24 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149909									496901925							HCC1806		GEO																NextSeq 500 sequencing: GSM2633641: HCC1806_Palbociclib_0.3_24 Homo sapiens RNA-Seq										SRX2837552	GSM2633641						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/003/SRR5579383/SRR5579383.fastq.gz	296095264	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/003/SRR5579383/SRR5579383.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/003/SRR5579383/SRR5579383.fastq.gz	540f42b235c0fe0e9b67d6f6c6796e4e		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		6625359											GSM2633641_r1			GSM2633641			HCC1806_Palbociclib_0.3_24						HCC1806_Palbociclib_0.3_24		ACH-000624	HCC1806_BREAST	HCC1806_BREAST	PALBOCICLIB	DRUG			SRR5579375,SRR5579376	24	hours	0.3	micromolar				9606	Homo sapiens		SRS2211717	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/003/SRR5579383	198264742	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/003/SRR5579383	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/003/SRR5579383	8e7e51d2a8f676121681f88afcc6eec1	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579384	NextSeq 500 sequencing: GSM2633641: HCC1806_Palbociclib_0.3_24 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149909									517251225							HCC1806		GEO																NextSeq 500 sequencing: GSM2633641: HCC1806_Palbociclib_0.3_24 Homo sapiens RNA-Seq										SRX2837552	GSM2633641						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/004/SRR5579384/SRR5579384.fastq.gz	294911127	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/004/SRR5579384/SRR5579384.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/004/SRR5579384/SRR5579384.fastq.gz	bd554dfae98e91c3b211875a1e29c4a4		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		6896683											GSM2633641_r2			GSM2633641			HCC1806_Palbociclib_0.3_24						HCC1806_Palbociclib_0.3_24		ACH-000624	HCC1806_BREAST	HCC1806_BREAST	PALBOCICLIB	DRUG			SRR5579375,SRR5579376	24	hours	0.3	micromolar				9606	Homo sapiens		SRS2211717	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/004/SRR5579384	196105535	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/004/SRR5579384	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/004/SRR5579384	f8db475d2a686189ea421498661a6d86	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579471	NextSeq 500 sequencing: GSM2633685: HCC1806_Control_0_6 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149864									540708450							HCC1806		GEO																NextSeq 500 sequencing: GSM2633685: HCC1806_Control_0_6 Homo sapiens RNA-Seq										SRX2837596	GSM2633685						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/001/SRR5579471/SRR5579471.fastq.gz	324354346	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/001/SRR5579471/SRR5579471.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/001/SRR5579471/SRR5579471.fastq.gz	880897f3f8f4dba7a366ed262a07aaec		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		7209446											GSM2633685_r1			GSM2633685			HCC1806_Control_0_6						HCC1806_Control_0_6		ACH-000624	HCC1806_BREAST	HCC1806_BREAST	CONTROL	CONTROL			SRR5579471,SRR5579472	6	hours	0	micromolar				9606	Homo sapiens		SRS2211761	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/001/SRR5579471	217410443	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/001/SRR5579471	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/001/SRR5579471	d3cfacd92869a088057669d7d8bf05e0	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579472	NextSeq 500 sequencing: GSM2633685: HCC1806_Control_0_6 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149864									559138050							HCC1806		GEO																NextSeq 500 sequencing: GSM2633685: HCC1806_Control_0_6 Homo sapiens RNA-Seq										SRX2837596	GSM2633685						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/002/SRR5579472/SRR5579472.fastq.gz	321265754	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/002/SRR5579472/SRR5579472.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/002/SRR5579472/SRR5579472.fastq.gz	cbe2e169df59a985a9c168c1b4a0102c		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		7455174											GSM2633685_r2			GSM2633685			HCC1806_Control_0_6						HCC1806_Control_0_6		ACH-000624	HCC1806_BREAST	HCC1806_BREAST	CONTROL	CONTROL			SRR5579471,SRR5579472	6	hours	0	micromolar				9606	Homo sapiens		SRS2211761	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/002/SRR5579472	213933741	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/002/SRR5579472	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/002/SRR5579472	a95885b398da5ea918b9d7e3f1da60e1	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579375	NextSeq 500 sequencing: GSM2633637: HCC1806_Control_0_24 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149927									511529325							HCC1806		GEO																NextSeq 500 sequencing: GSM2633637: HCC1806_Control_0_24 Homo sapiens RNA-Seq										SRX2837548	GSM2633637						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/005/SRR5579375/SRR5579375.fastq.gz	304649980	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/005/SRR5579375/SRR5579375.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/005/SRR5579375/SRR5579375.fastq.gz	7f3f9b5abe61c1f99ba75d077c1ff378		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		6820391											GSM2633637_r1			GSM2633637			HCC1806_Control_0_24						HCC1806_Control_0_24		ACH-000624	HCC1806_BREAST	HCC1806_BREAST	CONTROL	CONTROL			SRR5579375,SRR5579376	24	hours	0	micromolar				9606	Homo sapiens		SRS2211713	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/005/SRR5579375	204050501	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/005/SRR5579375	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/005/SRR5579375	67784748023e22c953c14d881338297f	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579376	NextSeq 500 sequencing: GSM2633637: HCC1806_Control_0_24 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149927									527491575							HCC1806		GEO																NextSeq 500 sequencing: GSM2633637: HCC1806_Control_0_24 Homo sapiens RNA-Seq										SRX2837548	GSM2633637						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/006/SRR5579376/SRR5579376.fastq.gz	300608083	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/006/SRR5579376/SRR5579376.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/006/SRR5579376/SRR5579376.fastq.gz	716019c50c598a36be7a8efd22640460		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		7033221											GSM2633637_r2			GSM2633637			HCC1806_Control_0_24						HCC1806_Control_0_24		ACH-000624	HCC1806_BREAST	HCC1806_BREAST	CONTROL	CONTROL			SRR5579375,SRR5579376	24	hours	0	micromolar				9606	Homo sapiens		SRS2211713	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/006/SRR5579376	199954860	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/006/SRR5579376	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/006/SRR5579376	51a166cfe2a8d49b71f2bd8955738826	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579477	NextSeq 500 sequencing: GSM2633688: HCC1806_Abemaciclib_3_6_rep2 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149861									393995775							HCC1806		GEO																NextSeq 500 sequencing: GSM2633688: HCC1806_Abemaciclib_3_6_rep2 Homo sapiens RNA-Seq										SRX2837599	GSM2633688						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/007/SRR5579477/SRR5579477.fastq.gz	237539772	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/007/SRR5579477/SRR5579477.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/007/SRR5579477/SRR5579477.fastq.gz	e398483e66631f54454c08e6d20c5317		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		5253277											GSM2633688_r1			GSM2633688			HCC1806_Abemaciclib_3_6_rep2						HCC1806_Abemaciclib_3_6_rep2		ACH-000624	HCC1806_BREAST	HCC1806_BREAST	ABEMACICLIB	DRUG			SRR5579471,SRR5579472	6	hours	3	micromolar				9606	Homo sapiens		SRS2211764	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/007/SRR5579477	159309822	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/007/SRR5579477	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/007/SRR5579477	4b8bac4a45a93d60f8874030271622f3	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579478	NextSeq 500 sequencing: GSM2633688: HCC1806_Abemaciclib_3_6_rep2 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149861									410061075							HCC1806		GEO																NextSeq 500 sequencing: GSM2633688: HCC1806_Abemaciclib_3_6_rep2 Homo sapiens RNA-Seq										SRX2837599	GSM2633688						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/008/SRR5579478/SRR5579478.fastq.gz	236828371	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/008/SRR5579478/SRR5579478.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/008/SRR5579478/SRR5579478.fastq.gz	402f6145fd0b3820cf9053a12d7da6fd		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		5467481											GSM2633688_r2			GSM2633688			HCC1806_Abemaciclib_3_6_rep2						HCC1806_Abemaciclib_3_6_rep2		ACH-000624	HCC1806_BREAST	HCC1806_BREAST	ABEMACICLIB	DRUG			SRR5579471,SRR5579472	6	hours	3	micromolar				9606	Homo sapiens		SRS2211764	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/008/SRR5579478	157801551	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/008/SRR5579478	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/008/SRR5579478	ebd2e6acf3a1028c8f3d69ab82457564	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579475	NextSeq 500 sequencing: GSM2633687: HCC1806_Abemaciclib_3_6_rep1 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149862									552494400							HCC1806		GEO																NextSeq 500 sequencing: GSM2633687: HCC1806_Abemaciclib_3_6_rep1 Homo sapiens RNA-Seq										SRX2837598	GSM2633687						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/005/SRR5579475/SRR5579475.fastq.gz	331014396	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/005/SRR5579475/SRR5579475.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/005/SRR5579475/SRR5579475.fastq.gz	740d477354056a164c304ebc1a6f6822		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		7366592											GSM2633687_r1			GSM2633687			HCC1806_Abemaciclib_3_6_rep1						HCC1806_Abemaciclib_3_6_rep1		ACH-000624	HCC1806_BREAST	HCC1806_BREAST	ABEMACICLIB	DRUG			SRR5579471,SRR5579472	6	hours	3	micromolar				9606	Homo sapiens		SRS2211763	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/005/SRR5579475	221917573	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/005/SRR5579475	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/005/SRR5579475	ca744f8f3361888a72d405afb9b974d6	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579476	NextSeq 500 sequencing: GSM2633687: HCC1806_Abemaciclib_3_6_rep1 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149862									572172375							HCC1806		GEO																NextSeq 500 sequencing: GSM2633687: HCC1806_Abemaciclib_3_6_rep1 Homo sapiens RNA-Seq										SRX2837598	GSM2633687						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/006/SRR5579476/SRR5579476.fastq.gz	328190756	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/006/SRR5579476/SRR5579476.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/006/SRR5579476/SRR5579476.fastq.gz	d2dce26ef8078f5c77b0a2157a9d1ffb		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		7628965											GSM2633687_r2			GSM2633687			HCC1806_Abemaciclib_3_6_rep1						HCC1806_Abemaciclib_3_6_rep1		ACH-000624	HCC1806_BREAST	HCC1806_BREAST	ABEMACICLIB	DRUG			SRR5579471,SRR5579472	6	hours	3	micromolar				9606	Homo sapiens		SRS2211763	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/006/SRR5579476	218569845	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/006/SRR5579476	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/006/SRR5579476	a2fd382f04602b086ae1d1435034dc2a	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579381	NextSeq 500 sequencing: GSM2633640: HCC1806_Abemaciclib_3_24_rep2 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149924									472323525							HCC1806		GEO																NextSeq 500 sequencing: GSM2633640: HCC1806_Abemaciclib_3_24_rep2 Homo sapiens RNA-Seq										SRX2837551	GSM2633640						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/001/SRR5579381/SRR5579381.fastq.gz	283311095	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/001/SRR5579381/SRR5579381.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/001/SRR5579381/SRR5579381.fastq.gz	9585b1e78997abf3d83b8f1ae331374f		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		6297647											GSM2633640_r1			GSM2633640			HCC1806_Abemaciclib_3_24_rep2						HCC1806_Abemaciclib_3_24_rep2		ACH-000624	HCC1806_BREAST	HCC1806_BREAST	ABEMACICLIB	DRUG			SRR5579375,SRR5579376	24	hours	3	micromolar				9606	Homo sapiens		SRS2211716	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/001/SRR5579381	189949402	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/001/SRR5579381	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/001/SRR5579381	1d0fe7c9bedd7c6c3704b0309857cbe2	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579382	NextSeq 500 sequencing: GSM2633640: HCC1806_Abemaciclib_3_24_rep2 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149924									492204525							HCC1806		GEO																NextSeq 500 sequencing: GSM2633640: HCC1806_Abemaciclib_3_24_rep2 Homo sapiens RNA-Seq										SRX2837551	GSM2633640						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/002/SRR5579382/SRR5579382.fastq.gz	282559950	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/002/SRR5579382/SRR5579382.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/002/SRR5579382/SRR5579382.fastq.gz	803134052bc36fe93eb6c818533e8e67		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		6562727											GSM2633640_r2			GSM2633640			HCC1806_Abemaciclib_3_24_rep2						HCC1806_Abemaciclib_3_24_rep2		ACH-000624	HCC1806_BREAST	HCC1806_BREAST	ABEMACICLIB	DRUG			SRR5579375,SRR5579376	24	hours	3	micromolar				9606	Homo sapiens		SRS2211716	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/002/SRR5579382	188156217	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/002/SRR5579382	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/002/SRR5579382	83b2e1d89b2cc1cceb211ea965f73895	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579379	NextSeq 500 sequencing: GSM2633639: HCC1806_Abemaciclib_3_24_rep1 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149925									436434675							HCC1806		GEO																NextSeq 500 sequencing: GSM2633639: HCC1806_Abemaciclib_3_24_rep1 Homo sapiens RNA-Seq										SRX2837550	GSM2633639						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/009/SRR5579379/SRR5579379.fastq.gz	260065146	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/009/SRR5579379/SRR5579379.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/009/SRR5579379/SRR5579379.fastq.gz	54bd73e4fee87758cef6346637abc1da		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		5819129											GSM2633639_r1			GSM2633639			HCC1806_Abemaciclib_3_24_rep1						HCC1806_Abemaciclib_3_24_rep1		ACH-000624	HCC1806_BREAST	HCC1806_BREAST	ABEMACICLIB	DRUG			SRR5579375,SRR5579376	24	hours	3	micromolar				9606	Homo sapiens		SRS2211715	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/009/SRR5579379	174244237	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/009/SRR5579379	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/009/SRR5579379	e1bf9c48b9c834f4c88adb642f21d3bd	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579380	NextSeq 500 sequencing: GSM2633639: HCC1806_Abemaciclib_3_24_rep1 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149925									451501950							HCC1806		GEO																NextSeq 500 sequencing: GSM2633639: HCC1806_Abemaciclib_3_24_rep1 Homo sapiens RNA-Seq										SRX2837550	GSM2633639						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/000/SRR5579380/SRR5579380.fastq.gz	257365992	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/000/SRR5579380/SRR5579380.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/000/SRR5579380/SRR5579380.fastq.gz	9b171ec67d0869a9e697b5667defe950		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		6020026											GSM2633639_r2			GSM2633639			HCC1806_Abemaciclib_3_24_rep1						HCC1806_Abemaciclib_3_24_rep1		ACH-000624	HCC1806_BREAST	HCC1806_BREAST	ABEMACICLIB	DRUG			SRR5579375,SRR5579376	24	hours	3	micromolar				9606	Homo sapiens		SRS2211715	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/000/SRR5579380	171244679	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/000/SRR5579380	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/000/SRR5579380	3ef58f27e705b83c9dbdfe0313573e3b	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579473	NextSeq 500 sequencing: GSM2633686: HCC1806_Abemaciclib_0.3_6 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149863									465645825							HCC1806		GEO																NextSeq 500 sequencing: GSM2633686: HCC1806_Abemaciclib_0.3_6 Homo sapiens RNA-Seq										SRX2837597	GSM2633686						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/003/SRR5579473/SRR5579473.fastq.gz	280069028	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/003/SRR5579473/SRR5579473.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/003/SRR5579473/SRR5579473.fastq.gz	a14a7e64ab67b6f49a3a4477c26a7c04		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		6208611											GSM2633686_r1			GSM2633686			HCC1806_Abemaciclib_0.3_6						HCC1806_Abemaciclib_0.3_6		ACH-000624	HCC1806_BREAST	HCC1806_BREAST	ABEMACICLIB	DRUG			SRR5579471,SRR5579472	6	hours	0.3	micromolar				9606	Homo sapiens		SRS2211762	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/003/SRR5579473	187760206	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/003/SRR5579473	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/003/SRR5579473	6bba9c36f290ff5bd8ac33bc53c2df5d	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579474	NextSeq 500 sequencing: GSM2633686: HCC1806_Abemaciclib_0.3_6 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149863									483701850							HCC1806		GEO																NextSeq 500 sequencing: GSM2633686: HCC1806_Abemaciclib_0.3_6 Homo sapiens RNA-Seq										SRX2837597	GSM2633686						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/004/SRR5579474/SRR5579474.fastq.gz	278745105	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/004/SRR5579474/SRR5579474.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/004/SRR5579474/SRR5579474.fastq.gz	50c458ad6c1300248bfd88b0c3945fd3		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		6449358											GSM2633686_r2			GSM2633686			HCC1806_Abemaciclib_0.3_6						HCC1806_Abemaciclib_0.3_6		ACH-000624	HCC1806_BREAST	HCC1806_BREAST	ABEMACICLIB	DRUG			SRR5579471,SRR5579472	6	hours	0.3	micromolar				9606	Homo sapiens		SRS2211762	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/004/SRR5579474	185662434	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/004/SRR5579474	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/004/SRR5579474	a8352caa6ad8b58dcebd821b75f7c4bc	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579377	NextSeq 500 sequencing: GSM2633638: HCC1806_Abemaciclib_0.3_24 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149926									310576950							HCC1806		GEO																NextSeq 500 sequencing: GSM2633638: HCC1806_Abemaciclib_0.3_24 Homo sapiens RNA-Seq										SRX2837549	GSM2633638						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/007/SRR5579377/SRR5579377.fastq.gz	184981179	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/007/SRR5579377/SRR5579377.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/007/SRR5579377/SRR5579377.fastq.gz	a0452d428da703f99f6c7cef286ac1c2		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		4141026											GSM2633638_r1			GSM2633638			HCC1806_Abemaciclib_0.3_24						HCC1806_Abemaciclib_0.3_24		ACH-000624	HCC1806_BREAST	HCC1806_BREAST	ABEMACICLIB	DRUG			SRR5579375,SRR5579376	24	hours	0.3	micromolar				9606	Homo sapiens		SRS2211714	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/007/SRR5579377	123930966	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/007/SRR5579377	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/007/SRR5579377	cb49cec41397bb46cc2bbe714aed71e9	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579378	NextSeq 500 sequencing: GSM2633638: HCC1806_Abemaciclib_0.3_24 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149926									321755925							HCC1806		GEO																NextSeq 500 sequencing: GSM2633638: HCC1806_Abemaciclib_0.3_24 Homo sapiens RNA-Seq										SRX2837549	GSM2633638						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/008/SRR5579378/SRR5579378.fastq.gz	183409018	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/008/SRR5579378/SRR5579378.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/008/SRR5579378/SRR5579378.fastq.gz	5128a0c8fcf918eb008dd02df7fe646c		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		4290079											GSM2633638_r2			GSM2633638			HCC1806_Abemaciclib_0.3_24						HCC1806_Abemaciclib_0.3_24		ACH-000624	HCC1806_BREAST	HCC1806_BREAST	ABEMACICLIB	DRUG			SRR5579375,SRR5579376	24	hours	0.3	micromolar				9606	Homo sapiens		SRS2211714	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/008/SRR5579378	122046048	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/008/SRR5579378	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/008/SRR5579378	d8db20f4fc6b0dbef3024046ede6956e	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579469	NextSeq 500 sequencing: GSM2633684: HCC1419_Ribociclib_3_6 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149865									307715400							HCC1419		GEO																NextSeq 500 sequencing: GSM2633684: HCC1419_Ribociclib_3_6 Homo sapiens RNA-Seq										SRX2837595	GSM2633684						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/009/SRR5579469/SRR5579469.fastq.gz	184900423	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/009/SRR5579469/SRR5579469.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/009/SRR5579469/SRR5579469.fastq.gz	444c0a1ca442c502b508e89b12f529ec		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		4102872											GSM2633684_r1			GSM2633684			HCC1419_Ribociclib_3_6						HCC1419_Ribociclib_3_6		ACH-000277	HCC1419_BREAST	HCC1419_BREAST	RIBOCICLIB	DRUG			SRR5579456,SRR5579455	6	hours	3	micromolar				9606	Homo sapiens		SRS2211760	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/009/SRR5579469	124123092	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/009/SRR5579469	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/009/SRR5579469	97595f26effc6408609ea56be7f8297f	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579470	NextSeq 500 sequencing: GSM2633684: HCC1419_Ribociclib_3_6 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149865									320371350							HCC1419		GEO																NextSeq 500 sequencing: GSM2633684: HCC1419_Ribociclib_3_6 Homo sapiens RNA-Seq										SRX2837595	GSM2633684						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/000/SRR5579470/SRR5579470.fastq.gz	184348787	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/000/SRR5579470/SRR5579470.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/000/SRR5579470/SRR5579470.fastq.gz	241c9e95fb05623023bf7aff844f392b		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		4271618											GSM2633684_r2			GSM2633684			HCC1419_Ribociclib_3_6						HCC1419_Ribociclib_3_6		ACH-000277	HCC1419_BREAST	HCC1419_BREAST	RIBOCICLIB	DRUG			SRR5579456,SRR5579455	6	hours	3	micromolar				9606	Homo sapiens		SRS2211760	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/000/SRR5579470	122913943	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/000/SRR5579470	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/000/SRR5579470	43a9f1865fed95e4c1086f7f4fc8b32c	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579373	NextSeq 500 sequencing: GSM2633636: HCC1419_Ribociclib_3_24 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149928									324600225							HCC1419		GEO																NextSeq 500 sequencing: GSM2633636: HCC1419_Ribociclib_3_24 Homo sapiens RNA-Seq										SRX2837547	GSM2633636						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/003/SRR5579373/SRR5579373.fastq.gz	193514772	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/003/SRR5579373/SRR5579373.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/003/SRR5579373/SRR5579373.fastq.gz	3c5ad0d74eb27000310520de19117ddc		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		4328003											GSM2633636_r1			GSM2633636			HCC1419_Ribociclib_3_24						HCC1419_Ribociclib_3_24		ACH-000277	HCC1419_BREAST	HCC1419_BREAST	RIBOCICLIB	DRUG			SRR5579360,SRR5579359	24	hours	3	micromolar				9606	Homo sapiens		SRS2211711	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/003/SRR5579373	130784433	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/003/SRR5579373	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/003/SRR5579373	0e73a307a46aad4460cb4ab0be8120e3	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579374	NextSeq 500 sequencing: GSM2633636: HCC1419_Ribociclib_3_24 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149928									337285575							HCC1419		GEO																NextSeq 500 sequencing: GSM2633636: HCC1419_Ribociclib_3_24 Homo sapiens RNA-Seq										SRX2837547	GSM2633636						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/004/SRR5579374/SRR5579374.fastq.gz	192486307	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/004/SRR5579374/SRR5579374.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/004/SRR5579374/SRR5579374.fastq.gz	f3aaf34c820a9c288b18e783e454233c		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		4497141											GSM2633636_r2			GSM2633636			HCC1419_Ribociclib_3_24						HCC1419_Ribociclib_3_24		ACH-000277	HCC1419_BREAST	HCC1419_BREAST	RIBOCICLIB	DRUG			SRR5579360,SRR5579359	24	hours	3	micromolar				9606	Homo sapiens		SRS2211711	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/004/SRR5579374	129255558	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/004/SRR5579374	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/004/SRR5579374	b609feab7e0f29cb63c84a1af11ead55	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579467	NextSeq 500 sequencing: GSM2633683: HCC1419_Ribociclib_0.3_6 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149866									368338425							HCC1419		GEO																NextSeq 500 sequencing: GSM2633683: HCC1419_Ribociclib_0.3_6 Homo sapiens RNA-Seq										SRX2837594	GSM2633683						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/007/SRR5579467/SRR5579467.fastq.gz	221102311	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/007/SRR5579467/SRR5579467.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/007/SRR5579467/SRR5579467.fastq.gz	c1209d869c3368789c99d9c5f1f8e56d		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		4911179											GSM2633683_r1			GSM2633683			HCC1419_Ribociclib_0.3_6						HCC1419_Ribociclib_0.3_6		ACH-000277	HCC1419_BREAST	HCC1419_BREAST	RIBOCICLIB	DRUG			SRR5579456,SRR5579455	6	hours	0.3	micromolar				9606	Homo sapiens		SRS2211759	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/007/SRR5579467	148446942	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/007/SRR5579467	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/007/SRR5579467	744d983c90f24b2260af50128d79f54f	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579468	NextSeq 500 sequencing: GSM2633683: HCC1419_Ribociclib_0.3_6 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149866									382987125							HCC1419		GEO																NextSeq 500 sequencing: GSM2633683: HCC1419_Ribociclib_0.3_6 Homo sapiens RNA-Seq										SRX2837594	GSM2633683						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/008/SRR5579468/SRR5579468.fastq.gz	219938154	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/008/SRR5579468/SRR5579468.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/008/SRR5579468/SRR5579468.fastq.gz	6107a9b6a9813b51163fb33b8db70195		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		5106495											GSM2633683_r2			GSM2633683			HCC1419_Ribociclib_0.3_6						HCC1419_Ribociclib_0.3_6		ACH-000277	HCC1419_BREAST	HCC1419_BREAST	RIBOCICLIB	DRUG			SRR5579456,SRR5579455	6	hours	0.3	micromolar				9606	Homo sapiens		SRS2211759	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/008/SRR5579468	146645824	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/008/SRR5579468	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/008/SRR5579468	c906b13458c1c1553b43477971d11ef1	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579371	NextSeq 500 sequencing: GSM2633635: HCC1419_Ribociclib_0.3_24 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149929									507510150							HCC1419		GEO																NextSeq 500 sequencing: GSM2633635: HCC1419_Ribociclib_0.3_24 Homo sapiens RNA-Seq										SRX2837546	GSM2633635						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/001/SRR5579371/SRR5579371.fastq.gz	303237272	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/001/SRR5579371/SRR5579371.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/001/SRR5579371/SRR5579371.fastq.gz	12d2466d95de3778779a607f9ee657a9		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		6766802											GSM2633635_r1			GSM2633635			HCC1419_Ribociclib_0.3_24						HCC1419_Ribociclib_0.3_24		ACH-000277	HCC1419_BREAST	HCC1419_BREAST	RIBOCICLIB	DRUG			SRR5579360,SRR5579359	24	hours	0.3	micromolar				9606	Homo sapiens		SRS2211712	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/001/SRR5579371	203580602	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/001/SRR5579371	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/001/SRR5579371	3a7171ae02f8aeaf1a3e1944e39cdb41	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579372	NextSeq 500 sequencing: GSM2633635: HCC1419_Ribociclib_0.3_24 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149929									527048925							HCC1419		GEO																NextSeq 500 sequencing: GSM2633635: HCC1419_Ribociclib_0.3_24 Homo sapiens RNA-Seq										SRX2837546	GSM2633635						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/002/SRR5579372/SRR5579372.fastq.gz	301160563	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/002/SRR5579372/SRR5579372.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/002/SRR5579372/SRR5579372.fastq.gz	e2f38994384269e5b8e7d49a70ea6f0b		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		7027319											GSM2633635_r2			GSM2633635			HCC1419_Ribociclib_0.3_24						HCC1419_Ribociclib_0.3_24		ACH-000277	HCC1419_BREAST	HCC1419_BREAST	RIBOCICLIB	DRUG			SRR5579360,SRR5579359	24	hours	0.3	micromolar				9606	Homo sapiens		SRS2211712	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/002/SRR5579372	200749337	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/002/SRR5579372	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/002/SRR5579372	21901a530da3ddbd513ccb1b2884abda	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579465	NextSeq 500 sequencing: GSM2633682: HCC1419_Palbociclib_3_6 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149867									277920375							HCC1419		GEO																NextSeq 500 sequencing: GSM2633682: HCC1419_Palbociclib_3_6 Homo sapiens RNA-Seq										SRX2837593	GSM2633682						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/005/SRR5579465/SRR5579465.fastq.gz	165890751	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/005/SRR5579465/SRR5579465.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/005/SRR5579465/SRR5579465.fastq.gz	bbd125d08ed16360434899e3405b73f3		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		3705605											GSM2633682_r1			GSM2633682			HCC1419_Palbociclib_3_6						HCC1419_Palbociclib_3_6		ACH-000277	HCC1419_BREAST	HCC1419_BREAST	PALBOCICLIB	DRUG			SRR5579456,SRR5579455	6	hours	3	micromolar				9606	Homo sapiens		SRS2211758	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/005/SRR5579465	111327095	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/005/SRR5579465	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/005/SRR5579465	01289cecb1f36640586ee9a436ad30d6	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579466	NextSeq 500 sequencing: GSM2633682: HCC1419_Palbociclib_3_6 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149867									287844300							HCC1419		GEO																NextSeq 500 sequencing: GSM2633682: HCC1419_Palbociclib_3_6 Homo sapiens RNA-Seq										SRX2837593	GSM2633682						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/006/SRR5579466/SRR5579466.fastq.gz	164319967	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/006/SRR5579466/SRR5579466.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/006/SRR5579466/SRR5579466.fastq.gz	238c5750d37abcff9836b6b3a58abbe3		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		3837924											GSM2633682_r2			GSM2633682			HCC1419_Palbociclib_3_6						HCC1419_Palbociclib_3_6		ACH-000277	HCC1419_BREAST	HCC1419_BREAST	PALBOCICLIB	DRUG			SRR5579456,SRR5579455	6	hours	3	micromolar				9606	Homo sapiens		SRS2211758	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/006/SRR5579466	109509303	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/006/SRR5579466	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/006/SRR5579466	01c2e14791a18ae8c81c67305444e8e7	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579369	NextSeq 500 sequencing: GSM2633634: HCC1419_Palbociclib_3_24 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149930									375726225							HCC1419		GEO																NextSeq 500 sequencing: GSM2633634: HCC1419_Palbociclib_3_24 Homo sapiens RNA-Seq										SRX2837545	GSM2633634						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/009/SRR5579369/SRR5579369.fastq.gz	223718681	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/009/SRR5579369/SRR5579369.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/009/SRR5579369/SRR5579369.fastq.gz	e18d259d22cee192ccb187fc00700fd0		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		5009683											GSM2633634_r1			GSM2633634			HCC1419_Palbociclib_3_24						HCC1419_Palbociclib_3_24		ACH-000277	HCC1419_BREAST	HCC1419_BREAST	PALBOCICLIB	DRUG			SRR5579360,SRR5579359	24	hours	3	micromolar				9606	Homo sapiens		SRS2211710	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/009/SRR5579369	150128524	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/009/SRR5579369	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/009/SRR5579369	3f223022279983962686c9dfb6c31612	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579370	NextSeq 500 sequencing: GSM2633634: HCC1419_Palbociclib_3_24 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149930									388697775							HCC1419		GEO																NextSeq 500 sequencing: GSM2633634: HCC1419_Palbociclib_3_24 Homo sapiens RNA-Seq										SRX2837545	GSM2633634						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/000/SRR5579370/SRR5579370.fastq.gz	221374329	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/000/SRR5579370/SRR5579370.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/000/SRR5579370/SRR5579370.fastq.gz	21a3c8a37cf81d8dbf1968e0b9f254a7		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		5182637											GSM2633634_r2			GSM2633634			HCC1419_Palbociclib_3_24						HCC1419_Palbociclib_3_24		ACH-000277	HCC1419_BREAST	HCC1419_BREAST	PALBOCICLIB	DRUG			SRR5579360,SRR5579359	24	hours	3	micromolar				9606	Homo sapiens		SRS2211710	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/000/SRR5579370	147515605	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/000/SRR5579370	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/000/SRR5579370	69115f7fde7a255b7a9a148720559cbe	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579463	NextSeq 500 sequencing: GSM2633681: HCC1419_Palbociclib_0.3_6 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149868									383983050							HCC1419		GEO																NextSeq 500 sequencing: GSM2633681: HCC1419_Palbociclib_0.3_6 Homo sapiens RNA-Seq										SRX2837592	GSM2633681						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/003/SRR5579463/SRR5579463.fastq.gz	231261181	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/003/SRR5579463/SRR5579463.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/003/SRR5579463/SRR5579463.fastq.gz	8bcc946827f76374571a524c80d0ba1b		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		5119774											GSM2633681_r1			GSM2633681			HCC1419_Palbociclib_0.3_6						HCC1419_Palbociclib_0.3_6		ACH-000277	HCC1419_BREAST	HCC1419_BREAST	PALBOCICLIB	DRUG			SRR5579456,SRR5579455	6	hours	0.3	micromolar				9606	Homo sapiens		SRS2211757	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/003/SRR5579463	155275823	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/003/SRR5579463	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/003/SRR5579463	e18287a95d42bde862acbd397acc520a	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579464	NextSeq 500 sequencing: GSM2633681: HCC1419_Palbociclib_0.3_6 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149868									401818725							HCC1419		GEO																NextSeq 500 sequencing: GSM2633681: HCC1419_Palbociclib_0.3_6 Homo sapiens RNA-Seq										SRX2837592	GSM2633681						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/004/SRR5579464/SRR5579464.fastq.gz	231795229	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/004/SRR5579464/SRR5579464.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/004/SRR5579464/SRR5579464.fastq.gz	5596bc42df3e814e8cfb8a04c249eeb4		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		5357583											GSM2633681_r2			GSM2633681			HCC1419_Palbociclib_0.3_6						HCC1419_Palbociclib_0.3_6		ACH-000277	HCC1419_BREAST	HCC1419_BREAST	PALBOCICLIB	DRUG			SRR5579456,SRR5579455	6	hours	0.3	micromolar				9606	Homo sapiens		SRS2211757	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/004/SRR5579464	154578318	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/004/SRR5579464	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/004/SRR5579464	bb422a585f719efe656446d720553260	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579367	NextSeq 500 sequencing: GSM2633633: HCC1419_Palbociclib_0.3_24 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149931									737755875							HCC1419		GEO																NextSeq 500 sequencing: GSM2633633: HCC1419_Palbociclib_0.3_24 Homo sapiens RNA-Seq										SRX2837544	GSM2633633						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/007/SRR5579367/SRR5579367.fastq.gz	441108701	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/007/SRR5579367/SRR5579367.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/007/SRR5579367/SRR5579367.fastq.gz	bc0f478fb81587ef22235e85f6cb9252		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		9836745											GSM2633633_r1			GSM2633633			HCC1419_Palbociclib_0.3_24						HCC1419_Palbociclib_0.3_24		ACH-000277	HCC1419_BREAST	HCC1419_BREAST	PALBOCICLIB	DRUG			SRR5579360,SRR5579359	24	hours	0.3	micromolar				9606	Homo sapiens		SRS2211709	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/007/SRR5579367	295878801	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/007/SRR5579367	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/007/SRR5579367	d93f25128d9f22949f15e16e25148185	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579368	NextSeq 500 sequencing: GSM2633633: HCC1419_Palbociclib_0.3_24 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149931									769081875							HCC1419		GEO																NextSeq 500 sequencing: GSM2633633: HCC1419_Palbociclib_0.3_24 Homo sapiens RNA-Seq										SRX2837544	GSM2633633						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/008/SRR5579368/SRR5579368.fastq.gz	440210283	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/008/SRR5579368/SRR5579368.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/008/SRR5579368/SRR5579368.fastq.gz	521f70761088f7cab84ede869f27c396		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		10254425											GSM2633633_r2			GSM2633633			HCC1419_Palbociclib_0.3_24						HCC1419_Palbociclib_0.3_24		ACH-000277	HCC1419_BREAST	HCC1419_BREAST	PALBOCICLIB	DRUG			SRR5579360,SRR5579359	24	hours	0.3	micromolar				9606	Homo sapiens		SRS2211709	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/008/SRR5579368	293191299	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/008/SRR5579368	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/008/SRR5579368	022793e750321921ac4c0f996670af92	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579455	NextSeq 500 sequencing: GSM2633677: HCC1419_Control_0_6 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149875									232235625							HCC1419		GEO																NextSeq 500 sequencing: GSM2633677: HCC1419_Control_0_6 Homo sapiens RNA-Seq										SRX2837588	GSM2633677						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/005/SRR5579455/SRR5579455.fastq.gz	139381509	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/005/SRR5579455/SRR5579455.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/005/SRR5579455/SRR5579455.fastq.gz	4d449559d1b8ba16ba40d9da5f04f821		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		3096475											GSM2633677_r1			GSM2633677			HCC1419_Control_0_6						HCC1419_Control_0_6		ACH-000277	HCC1419_BREAST	HCC1419_BREAST	CONTROL	CONTROL			SRR5579456,SRR5579455	6	hours	0	micromolar				9606	Homo sapiens		SRS2211754	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/005/SRR5579455	93688942	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/005/SRR5579455	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/005/SRR5579455	ffb66fc3efdadd4fc85ee93ef0e329f6	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579456	NextSeq 500 sequencing: GSM2633677: HCC1419_Control_0_6 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149875									240951075							HCC1419		GEO																NextSeq 500 sequencing: GSM2633677: HCC1419_Control_0_6 Homo sapiens RNA-Seq										SRX2837588	GSM2633677						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/006/SRR5579456/SRR5579456.fastq.gz	138434479	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/006/SRR5579456/SRR5579456.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/006/SRR5579456/SRR5579456.fastq.gz	e5c7f2b96c666d8e747611981b164a5b		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		3212681											GSM2633677_r2			GSM2633677			HCC1419_Control_0_6						HCC1419_Control_0_6		ACH-000277	HCC1419_BREAST	HCC1419_BREAST	CONTROL	CONTROL			SRR5579456,SRR5579455	6	hours	0	micromolar				9606	Homo sapiens		SRS2211754	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/006/SRR5579456	92420189	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/006/SRR5579456	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/006/SRR5579456	548ce12276cec4ee2b53812bd203257c	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579359	NextSeq 500 sequencing: GSM2633629: HCC1419_Control_0_24 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149816									587418975							HCC1419		GEO																NextSeq 500 sequencing: GSM2633629: HCC1419_Control_0_24 Homo sapiens RNA-Seq										SRX2837540	GSM2633629						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/009/SRR5579359/SRR5579359.fastq.gz	351791204	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/009/SRR5579359/SRR5579359.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/009/SRR5579359/SRR5579359.fastq.gz	837458f5e4af3babc139ddfb181b74f3		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		7832253											GSM2633629_r1			GSM2633629			HCC1419_Control_0_24						HCC1419_Control_0_24		ACH-000277	HCC1419_BREAST	HCC1419_BREAST	CONTROL	CONTROL			SRR5579360,SRR5579359	24	hours	0	micromolar				9606	Homo sapiens		SRS2211705	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/009/SRR5579359	236124181	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/009/SRR5579359	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/009/SRR5579359	af4e403bb3c241d683a948c8a4ed1638	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579360	NextSeq 500 sequencing: GSM2633629: HCC1419_Control_0_24 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149816									608908800							HCC1419		GEO																NextSeq 500 sequencing: GSM2633629: HCC1419_Control_0_24 Homo sapiens RNA-Seq										SRX2837540	GSM2633629						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/000/SRR5579360/SRR5579360.fastq.gz	349099184	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/000/SRR5579360/SRR5579360.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/000/SRR5579360/SRR5579360.fastq.gz	961b672cfc80a7647eb10d6a4bf5415b		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		8118784											GSM2633629_r2			GSM2633629			HCC1419_Control_0_24						HCC1419_Control_0_24		ACH-000277	HCC1419_BREAST	HCC1419_BREAST	CONTROL	CONTROL			SRR5579360,SRR5579359	24	hours	0	micromolar				9606	Homo sapiens		SRS2211705	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/000/SRR5579360	232669084	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/000/SRR5579360	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/000/SRR5579360	d800fa22a8535a460ea27eb3ee43eefe	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579461	NextSeq 500 sequencing: GSM2633680: HCC1419_Abemaciclib_3_6_rep2 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149869									296866050							HCC1419		GEO																NextSeq 500 sequencing: GSM2633680: HCC1419_Abemaciclib_3_6_rep2 Homo sapiens RNA-Seq										SRX2837591	GSM2633680						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/001/SRR5579461/SRR5579461.fastq.gz	179310813	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/001/SRR5579461/SRR5579461.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/001/SRR5579461/SRR5579461.fastq.gz	bbfebc7202f9e95bfa412545214c1cfb		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		3958214											GSM2633680_r1			GSM2633680			HCC1419_Abemaciclib_3_6_rep2						HCC1419_Abemaciclib_3_6_rep2		ACH-000277	HCC1419_BREAST	HCC1419_BREAST	ABEMACICLIB	DRUG			SRR5579456,SRR5579455	6	hours	3	micromolar				9606	Homo sapiens		SRS2211756	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/001/SRR5579461	120585504	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/001/SRR5579461	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/001/SRR5579461	08c6fe41505f7d420b0631c63d33f3bb	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579462	NextSeq 500 sequencing: GSM2633680: HCC1419_Abemaciclib_3_6_rep2 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149869									311110200							HCC1419		GEO																NextSeq 500 sequencing: GSM2633680: HCC1419_Abemaciclib_3_6_rep2 Homo sapiens RNA-Seq										SRX2837591	GSM2633680						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/002/SRR5579462/SRR5579462.fastq.gz	179964274	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/002/SRR5579462/SRR5579462.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/002/SRR5579462/SRR5579462.fastq.gz	676be0cb1eccaf09d76eb012e989e20c		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		4148136											GSM2633680_r2			GSM2633680			HCC1419_Abemaciclib_3_6_rep2						HCC1419_Abemaciclib_3_6_rep2		ACH-000277	HCC1419_BREAST	HCC1419_BREAST	ABEMACICLIB	DRUG			SRR5579456,SRR5579455	6	hours	3	micromolar				9606	Homo sapiens		SRS2211756	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/002/SRR5579462	120215677	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/002/SRR5579462	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/002/SRR5579462	2a6cf6f60452d27f1d3f63e60434bd5d	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579459	NextSeq 500 sequencing: GSM2633679: HCC1419_Abemaciclib_3_6_rep1 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149870									260397000							HCC1419		GEO																NextSeq 500 sequencing: GSM2633679: HCC1419_Abemaciclib_3_6_rep1 Homo sapiens RNA-Seq										SRX2837590	GSM2633679						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/009/SRR5579459/SRR5579459.fastq.gz	155856176	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/009/SRR5579459/SRR5579459.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/009/SRR5579459/SRR5579459.fastq.gz	6399c17ad310b1dc8187d667be6777b0		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		3471960											GSM2633679_r1			GSM2633679			HCC1419_Abemaciclib_3_6_rep1						HCC1419_Abemaciclib_3_6_rep1		ACH-000277	HCC1419_BREAST	HCC1419_BREAST	ABEMACICLIB	DRUG			SRR5579456,SRR5579455	6	hours	3	micromolar				9606	Homo sapiens		SRS2211755	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/009/SRR5579459	104698007	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/009/SRR5579459	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/009/SRR5579459	dbad001dbf31d70c089035c3f772afa1	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579460	NextSeq 500 sequencing: GSM2633679: HCC1419_Abemaciclib_3_6_rep1 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149870									270413625							HCC1419		GEO																NextSeq 500 sequencing: GSM2633679: HCC1419_Abemaciclib_3_6_rep1 Homo sapiens RNA-Seq										SRX2837590	GSM2633679						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/000/SRR5579460/SRR5579460.fastq.gz	154808301	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/000/SRR5579460/SRR5579460.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/000/SRR5579460/SRR5579460.fastq.gz	1b5f5d4c25d7a39dcb2e560a7f5c159f		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		3605515											GSM2633679_r2			GSM2633679			HCC1419_Abemaciclib_3_6_rep1						HCC1419_Abemaciclib_3_6_rep1		ACH-000277	HCC1419_BREAST	HCC1419_BREAST	ABEMACICLIB	DRUG			SRR5579456,SRR5579455	6	hours	3	micromolar				9606	Homo sapiens		SRS2211755	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/000/SRR5579460	103284952	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/000/SRR5579460	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/000/SRR5579460	c0599ab39dd5530d995e9c89468c5c17	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579365	NextSeq 500 sequencing: GSM2633632: HCC1419_Abemaciclib_3_24_rep2 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149932									401542275							HCC1419		GEO																NextSeq 500 sequencing: GSM2633632: HCC1419_Abemaciclib_3_24_rep2 Homo sapiens RNA-Seq										SRX2837543	GSM2633632						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/005/SRR5579365/SRR5579365.fastq.gz	241687179	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/005/SRR5579365/SRR5579365.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/005/SRR5579365/SRR5579365.fastq.gz	a1c089e7e7a4013cb087b035db90fb00		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		5353897											GSM2633632_r1			GSM2633632			HCC1419_Abemaciclib_3_24_rep2						HCC1419_Abemaciclib_3_24_rep2		ACH-000277	HCC1419_BREAST	HCC1419_BREAST	ABEMACICLIB	DRUG			SRR5579360,SRR5579359	24	hours	3	micromolar				9606	Homo sapiens		SRS2211707	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/005/SRR5579365	162497081	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/005/SRR5579365	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/005/SRR5579365	d7bac62f55e7b1f6f91d46393a2afd9f	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579366	NextSeq 500 sequencing: GSM2633632: HCC1419_Abemaciclib_3_24_rep2 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149932									419596275							HCC1419		GEO																NextSeq 500 sequencing: GSM2633632: HCC1419_Abemaciclib_3_24_rep2 Homo sapiens RNA-Seq										SRX2837543	GSM2633632						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/006/SRR5579366/SRR5579366.fastq.gz	241791637	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/006/SRR5579366/SRR5579366.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/006/SRR5579366/SRR5579366.fastq.gz	4254b7990352db396be5857a2abf5de2		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		5594617											GSM2633632_r2			GSM2633632			HCC1419_Abemaciclib_3_24_rep2						HCC1419_Abemaciclib_3_24_rep2		ACH-000277	HCC1419_BREAST	HCC1419_BREAST	ABEMACICLIB	DRUG			SRR5579360,SRR5579359	24	hours	3	micromolar				9606	Homo sapiens		SRS2211707	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/006/SRR5579366	161440079	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/006/SRR5579366	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/006/SRR5579366	f50626c16b143c7093f1e79819260bdb	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579363	NextSeq 500 sequencing: GSM2633631: HCC1419_Abemaciclib_3_24_rep1 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149933									375324600							HCC1419		GEO																NextSeq 500 sequencing: GSM2633631: HCC1419_Abemaciclib_3_24_rep1 Homo sapiens RNA-Seq										SRX2837542	GSM2633631						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/003/SRR5579363/SRR5579363.fastq.gz	223954165	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/003/SRR5579363/SRR5579363.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/003/SRR5579363/SRR5579363.fastq.gz	6c456a04f68adb567ba14149280350f3		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		5004328											GSM2633631_r1			GSM2633631			HCC1419_Abemaciclib_3_24_rep1						HCC1419_Abemaciclib_3_24_rep1		ACH-000277	HCC1419_BREAST	HCC1419_BREAST	ABEMACICLIB	DRUG			SRR5579360,SRR5579359	24	hours	3	micromolar				9606	Homo sapiens		SRS2211708	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/003/SRR5579363	150399273	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/003/SRR5579363	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/003/SRR5579363	095014e182fe5cfd07e634522ee332e5	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579364	NextSeq 500 sequencing: GSM2633631: HCC1419_Abemaciclib_3_24_rep1 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149933									389473725							HCC1419		GEO																NextSeq 500 sequencing: GSM2633631: HCC1419_Abemaciclib_3_24_rep1 Homo sapiens RNA-Seq										SRX2837542	GSM2633631						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/004/SRR5579364/SRR5579364.fastq.gz	222317571	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/004/SRR5579364/SRR5579364.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/004/SRR5579364/SRR5579364.fastq.gz	c48a2791e88507576ea80a4f8e0eda50		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		5192983											GSM2633631_r2			GSM2633631			HCC1419_Abemaciclib_3_24_rep1						HCC1419_Abemaciclib_3_24_rep1		ACH-000277	HCC1419_BREAST	HCC1419_BREAST	ABEMACICLIB	DRUG			SRR5579360,SRR5579359	24	hours	3	micromolar				9606	Homo sapiens		SRS2211708	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/004/SRR5579364	148265474	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/004/SRR5579364	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/004/SRR5579364	c37316b695c7650485733acf404a6e68	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579457	NextSeq 500 sequencing: GSM2633678: HCC1419_Abemaciclib_0.3_6 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149871									337371825							HCC1419		GEO																NextSeq 500 sequencing: GSM2633678: HCC1419_Abemaciclib_0.3_6 Homo sapiens RNA-Seq										SRX2837589	GSM2633678						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/007/SRR5579457/SRR5579457.fastq.gz	202682672	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/007/SRR5579457/SRR5579457.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/007/SRR5579457/SRR5579457.fastq.gz	378b6ffdf2dbe9cb349f2264d3b86d78		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		4498291											GSM2633678_r1			GSM2633678			HCC1419_Abemaciclib_0.3_6						HCC1419_Abemaciclib_0.3_6		ACH-000277	HCC1419_BREAST	HCC1419_BREAST	ABEMACICLIB	DRUG			SRR5579456,SRR5579455	6	hours	0.3	micromolar				9606	Homo sapiens		SRS2211753	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/007/SRR5579457	136092833	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/007/SRR5579457	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/007/SRR5579457	788a8b79b0a2c0c5a742c2588ef1c55d	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579458	NextSeq 500 sequencing: GSM2633678: HCC1419_Abemaciclib_0.3_6 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149871									351765675							HCC1419		GEO																NextSeq 500 sequencing: GSM2633678: HCC1419_Abemaciclib_0.3_6 Homo sapiens RNA-Seq										SRX2837589	GSM2633678						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/008/SRR5579458/SRR5579458.fastq.gz	202356837	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/008/SRR5579458/SRR5579458.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/008/SRR5579458/SRR5579458.fastq.gz	967456553cd51eb6dca31119d8fd495f		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		4690209											GSM2633678_r2			GSM2633678			HCC1419_Abemaciclib_0.3_6						HCC1419_Abemaciclib_0.3_6		ACH-000277	HCC1419_BREAST	HCC1419_BREAST	ABEMACICLIB	DRUG			SRR5579456,SRR5579455	6	hours	0.3	micromolar				9606	Homo sapiens		SRS2211753	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/008/SRR5579458	134947038	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/008/SRR5579458	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/008/SRR5579458	e7fae71d2e86ce792d59d39a0c590164	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579361	NextSeq 500 sequencing: GSM2633630: HCC1419_Abemaciclib_0.3_24 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149815									380417400							HCC1419		GEO																NextSeq 500 sequencing: GSM2633630: HCC1419_Abemaciclib_0.3_24 Homo sapiens RNA-Seq										SRX2837541	GSM2633630						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/001/SRR5579361/SRR5579361.fastq.gz	227924289	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/001/SRR5579361/SRR5579361.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/001/SRR5579361/SRR5579361.fastq.gz	5daa9e24d97782c9e9dcf2ccf1404cd6		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		5072232											GSM2633630_r1			GSM2633630			HCC1419_Abemaciclib_0.3_24						HCC1419_Abemaciclib_0.3_24		ACH-000277	HCC1419_BREAST	HCC1419_BREAST	ABEMACICLIB	DRUG			SRR5579360,SRR5579359	24	hours	0.3	micromolar				9606	Homo sapiens		SRS2211706	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/001/SRR5579361	153074631	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/001/SRR5579361	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/001/SRR5579361	6072049a3c7c220a6346c8c151ece421	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579362	NextSeq 500 sequencing: GSM2633630: HCC1419_Abemaciclib_0.3_24 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149815									396058800							HCC1419		GEO																NextSeq 500 sequencing: GSM2633630: HCC1419_Abemaciclib_0.3_24 Homo sapiens RNA-Seq										SRX2837541	GSM2633630						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/002/SRR5579362/SRR5579362.fastq.gz	227163810	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/002/SRR5579362/SRR5579362.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/002/SRR5579362/SRR5579362.fastq.gz	d5f959a139f8f251432358f457688cf2		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		5280784											GSM2633630_r2			GSM2633630			HCC1419_Abemaciclib_0.3_24						HCC1419_Abemaciclib_0.3_24		ACH-000277	HCC1419_BREAST	HCC1419_BREAST	ABEMACICLIB	DRUG			SRR5579360,SRR5579359	24	hours	0.3	micromolar				9606	Homo sapiens		SRS2211706	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/002/SRR5579362	151501174	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/002/SRR5579362	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/002/SRR5579362	63efc8e331ed66c2ad43852ff1e0a6a0	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579453	NextSeq 500 sequencing: GSM2633676: BT549_Ribociclib_3_6 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149876									370835925							BT549		GEO																NextSeq 500 sequencing: GSM2633676: BT549_Ribociclib_3_6 Homo sapiens RNA-Seq										SRX2837587	GSM2633676						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/003/SRR5579453/SRR5579453.fastq.gz	223363177	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/003/SRR5579453/SRR5579453.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/003/SRR5579453/SRR5579453.fastq.gz	8315653b7a68a4bdcbc5d9bc9c878026		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		4944479											GSM2633676_r1			GSM2633676			BT549_Ribociclib_3_6						BT549_Ribociclib_3_6		ACH-000288	BT549_BREAST	BT549_BREAST	RIBOCICLIB	DRUG			SRR5579439,SRR5579440	6	hours	3	micromolar				9606	Homo sapiens		SRS2211752	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/003/SRR5579453	149739519	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/003/SRR5579453	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/003/SRR5579453	9314fe4a8d8382329bfcc2679bfc653a	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579454	NextSeq 500 sequencing: GSM2633676: BT549_Ribociclib_3_6 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149876									385220475							BT549		GEO																NextSeq 500 sequencing: GSM2633676: BT549_Ribociclib_3_6 Homo sapiens RNA-Seq										SRX2837587	GSM2633676						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/004/SRR5579454/SRR5579454.fastq.gz	222275365	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/004/SRR5579454/SRR5579454.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/004/SRR5579454/SRR5579454.fastq.gz	ad6ff49fe8784d5dbb4046bd00ac7b98		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		5136273											GSM2633676_r2			GSM2633676			BT549_Ribociclib_3_6						BT549_Ribociclib_3_6		ACH-000288	BT549_BREAST	BT549_BREAST	RIBOCICLIB	DRUG			SRR5579439,SRR5579440	6	hours	3	micromolar				9606	Homo sapiens		SRS2211752	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/004/SRR5579454	148017530	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/004/SRR5579454	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/004/SRR5579454	82f5792532fc2a77dff4a11cde47491a	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579357	NextSeq 500 sequencing: GSM2633628: BT549_Ribociclib_3_24 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149817									458319300							BT549		GEO																NextSeq 500 sequencing: GSM2633628: BT549_Ribociclib_3_24 Homo sapiens RNA-Seq										SRX2837539	GSM2633628						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/007/SRR5579357/SRR5579357.fastq.gz	274031774	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/007/SRR5579357/SRR5579357.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/007/SRR5579357/SRR5579357.fastq.gz	a239ee5135b11a4745ce84acf831f761		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		6110924											GSM2633628_r1			GSM2633628			BT549_Ribociclib_3_24						BT549_Ribociclib_3_24		ACH-000288	BT549_BREAST	BT549_BREAST	RIBOCICLIB	DRUG			SRR5579344,SRR5579343	24	hours	3	micromolar				9606	Homo sapiens		SRS2211704	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/007/SRR5579357	183592065	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/007/SRR5579357	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/007/SRR5579357	ed5fd32d286f093051e9ea0a84e77131	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579358	NextSeq 500 sequencing: GSM2633628: BT549_Ribociclib_3_24 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149817									475365225							BT549		GEO																NextSeq 500 sequencing: GSM2633628: BT549_Ribociclib_3_24 Homo sapiens RNA-Seq										SRX2837539	GSM2633628						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/008/SRR5579358/SRR5579358.fastq.gz	272067562	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/008/SRR5579358/SRR5579358.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/008/SRR5579358/SRR5579358.fastq.gz	739527e6a8ded8fcb36e75954f1bdcfc		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		6338203											GSM2633628_r2			GSM2633628			BT549_Ribociclib_3_24						BT549_Ribociclib_3_24		ACH-000288	BT549_BREAST	BT549_BREAST	RIBOCICLIB	DRUG			SRR5579344,SRR5579343	24	hours	3	micromolar				9606	Homo sapiens		SRS2211704	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/008/SRR5579358	181036481	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/008/SRR5579358	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/008/SRR5579358	5a00f4f7d83a1ae788ef90e5517e64c4	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579451	NextSeq 500 sequencing: GSM2633675: BT549_Ribociclib_0.3_6 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149877									348690750							BT549		GEO																NextSeq 500 sequencing: GSM2633675: BT549_Ribociclib_0.3_6 Homo sapiens RNA-Seq										SRX2837586	GSM2633675						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/001/SRR5579451/SRR5579451.fastq.gz	210225868	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/001/SRR5579451/SRR5579451.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/001/SRR5579451/SRR5579451.fastq.gz	2c268ddcd1d6fdead3440301b65549cc		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		4649210											GSM2633675_r1			GSM2633675			BT549_Ribociclib_0.3_6						BT549_Ribociclib_0.3_6		ACH-000288	BT549_BREAST	BT549_BREAST	RIBOCICLIB	DRUG			SRR5579439,SRR5579440	6	hours	0.3	micromolar				9606	Homo sapiens		SRS2211751	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/001/SRR5579451	140993869	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/001/SRR5579451	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/001/SRR5579451	910dad9ac3d1c4a6fb402088905716a2	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579452	NextSeq 500 sequencing: GSM2633675: BT549_Ribociclib_0.3_6 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149877									362823000							BT549		GEO																NextSeq 500 sequencing: GSM2633675: BT549_Ribociclib_0.3_6 Homo sapiens RNA-Seq										SRX2837586	GSM2633675						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/002/SRR5579452/SRR5579452.fastq.gz	209373782	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/002/SRR5579452/SRR5579452.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/002/SRR5579452/SRR5579452.fastq.gz	36e3a2c00c657d6d4f738000c3886a0e		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		4837640											GSM2633675_r2			GSM2633675			BT549_Ribociclib_0.3_6						BT549_Ribociclib_0.3_6		ACH-000288	BT549_BREAST	BT549_BREAST	RIBOCICLIB	DRUG			SRR5579439,SRR5579440	6	hours	0.3	micromolar				9606	Homo sapiens		SRS2211751	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/002/SRR5579452	139477737	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/002/SRR5579452	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/002/SRR5579452	ba7e46bc1457a6cd58370c6a0097e3b2	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579355	NextSeq 500 sequencing: GSM2633627: BT549_Ribociclib_0.3_24 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149818									352495425							BT549		GEO																NextSeq 500 sequencing: GSM2633627: BT549_Ribociclib_0.3_24 Homo sapiens RNA-Seq										SRX2837538	GSM2633627						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/005/SRR5579355/SRR5579355.fastq.gz	210311463	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/005/SRR5579355/SRR5579355.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/005/SRR5579355/SRR5579355.fastq.gz	1a3742eb6126be720d134a65edbd4a36		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		4699939											GSM2633627_r1			GSM2633627			BT549_Ribociclib_0.3_24						BT549_Ribociclib_0.3_24		ACH-000288	BT549_BREAST	BT549_BREAST	RIBOCICLIB	DRUG			SRR5579344,SRR5579343	24	hours	0.3	micromolar				9606	Homo sapiens		SRS2211703	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/005/SRR5579355	140911037	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/005/SRR5579355	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/005/SRR5579355	296eec6eddeaea64183728a0ee8bcf9b	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579356	NextSeq 500 sequencing: GSM2633627: BT549_Ribociclib_0.3_24 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149818									364798650							BT549		GEO																NextSeq 500 sequencing: GSM2633627: BT549_Ribociclib_0.3_24 Homo sapiens RNA-Seq										SRX2837538	GSM2633627						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/006/SRR5579356/SRR5579356.fastq.gz	208147680	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/006/SRR5579356/SRR5579356.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/006/SRR5579356/SRR5579356.fastq.gz	40add407f0e3e47e9f35e2f1409185ae		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		4863982											GSM2633627_r2			GSM2633627			BT549_Ribociclib_0.3_24						BT549_Ribociclib_0.3_24		ACH-000288	BT549_BREAST	BT549_BREAST	RIBOCICLIB	DRUG			SRR5579344,SRR5579343	24	hours	0.3	micromolar				9606	Homo sapiens		SRS2211703	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/006/SRR5579356	138494349	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/006/SRR5579356	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/006/SRR5579356	1736ab18500d77dc2b7a2e3a44785cac	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579449	NextSeq 500 sequencing: GSM2633674: BT549_Palbociclib_3_6 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149814									326281800							BT549		GEO																NextSeq 500 sequencing: GSM2633674: BT549_Palbociclib_3_6 Homo sapiens RNA-Seq										SRX2837585	GSM2633674						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/009/SRR5579449/SRR5579449.fastq.gz	195263050	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/009/SRR5579449/SRR5579449.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/009/SRR5579449/SRR5579449.fastq.gz	0ee3d018cefa2032ba04d127d8d60aee		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		4350424											GSM2633674_r1			GSM2633674			BT549_Palbociclib_3_6						BT549_Palbociclib_3_6		ACH-000288	BT549_BREAST	BT549_BREAST	PALBOCICLIB	DRUG			SRR5579439,SRR5579440	6	hours	3	micromolar				9606	Homo sapiens		SRS2211750	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/009/SRR5579449	130783555	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/009/SRR5579449	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/009/SRR5579449	50ba0d3359cbe4edf4e4480a9897eed8	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579450	NextSeq 500 sequencing: GSM2633674: BT549_Palbociclib_3_6 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149814									337738350							BT549		GEO																NextSeq 500 sequencing: GSM2633674: BT549_Palbociclib_3_6 Homo sapiens RNA-Seq										SRX2837585	GSM2633674						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/000/SRR5579450/SRR5579450.fastq.gz	193407822	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/000/SRR5579450/SRR5579450.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/000/SRR5579450/SRR5579450.fastq.gz	0cfe639678b4354983e78102576711f3		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		4503178											GSM2633674_r2			GSM2633674			BT549_Palbociclib_3_6						BT549_Palbociclib_3_6		ACH-000288	BT549_BREAST	BT549_BREAST	PALBOCICLIB	DRUG			SRR5579439,SRR5579440	6	hours	3	micromolar				9606	Homo sapiens		SRS2211750	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/000/SRR5579450	128671284	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/000/SRR5579450	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/000/SRR5579450	2a7f19ce2121790eb08a5869c1880a75	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579353	NextSeq 500 sequencing: GSM2633626: BT549_Palbociclib_3_24 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149923									308167275							BT549		GEO																NextSeq 500 sequencing: GSM2633626: BT549_Palbociclib_3_24 Homo sapiens RNA-Seq										SRX2837537	GSM2633626						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/003/SRR5579353/SRR5579353.fastq.gz	183320152	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/003/SRR5579353/SRR5579353.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/003/SRR5579353/SRR5579353.fastq.gz	84914d8f8507c64aa6552fb88f10d646		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		4108897											GSM2633626_r1			GSM2633626			BT549_Palbociclib_3_24						BT549_Palbociclib_3_24		ACH-000288	BT549_BREAST	BT549_BREAST	PALBOCICLIB	DRUG			SRR5579344,SRR5579343	24	hours	3	micromolar				9606	Homo sapiens		SRS2211702	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/003/SRR5579353	122777171	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/003/SRR5579353	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/003/SRR5579353	1364f559b057c6d3311f3199ec7efb03	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579354	NextSeq 500 sequencing: GSM2633626: BT549_Palbociclib_3_24 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149923									317554950							BT549		GEO																NextSeq 500 sequencing: GSM2633626: BT549_Palbociclib_3_24 Homo sapiens RNA-Seq										SRX2837537	GSM2633626						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/004/SRR5579354/SRR5579354.fastq.gz	180708308	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/004/SRR5579354/SRR5579354.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/004/SRR5579354/SRR5579354.fastq.gz	32220cb50a33907f010632c7427fe198		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		4234066											GSM2633626_r2			GSM2633626			BT549_Palbociclib_3_24						BT549_Palbociclib_3_24		ACH-000288	BT549_BREAST	BT549_BREAST	PALBOCICLIB	DRUG			SRR5579344,SRR5579343	24	hours	3	micromolar				9606	Homo sapiens		SRS2211702	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/004/SRR5579354	120184977	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/004/SRR5579354	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/004/SRR5579354	33526d96967245368b363485e5749b41	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579447	NextSeq 500 sequencing: GSM2633673: BT549_Palbociclib_0.3_6 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149880									335379975							BT549		GEO																NextSeq 500 sequencing: GSM2633673: BT549_Palbociclib_0.3_6 Homo sapiens RNA-Seq										SRX2837584	GSM2633673						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/007/SRR5579447/SRR5579447.fastq.gz	201944135	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/007/SRR5579447/SRR5579447.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/007/SRR5579447/SRR5579447.fastq.gz	1b9670502d9dd6d0d93016c5fe2659ee		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		4471733											GSM2633673_r1			GSM2633673			BT549_Palbociclib_0.3_6						BT549_Palbociclib_0.3_6		ACH-000288	BT549_BREAST	BT549_BREAST	PALBOCICLIB	DRUG			SRR5579439,SRR5579440	6	hours	0.3	micromolar				9606	Homo sapiens		SRS2211748	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/007/SRR5579447	135377142	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/007/SRR5579447	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/007/SRR5579447	2fef2990721a94254b16c2bd1782b6fc	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579448	NextSeq 500 sequencing: GSM2633673: BT549_Palbociclib_0.3_6 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149880									350741400							BT549		GEO																NextSeq 500 sequencing: GSM2633673: BT549_Palbociclib_0.3_6 Homo sapiens RNA-Seq										SRX2837584	GSM2633673						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/008/SRR5579448/SRR5579448.fastq.gz	202311092	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/008/SRR5579448/SRR5579448.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/008/SRR5579448/SRR5579448.fastq.gz	d58f5da3297617b2039deeaf760080d0		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		4676552											GSM2633673_r2			GSM2633673			BT549_Palbociclib_0.3_6						BT549_Palbociclib_0.3_6		ACH-000288	BT549_BREAST	BT549_BREAST	PALBOCICLIB	DRUG			SRR5579439,SRR5579440	6	hours	0.3	micromolar				9606	Homo sapiens		SRS2211748	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/008/SRR5579448	134724878	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/008/SRR5579448	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/008/SRR5579448	18f1f265f7400d43cd214d5dfc508b1e	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579351	NextSeq 500 sequencing: GSM2633625: BT549_Palbociclib_0.3_24 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149910									316232250							BT549		GEO																NextSeq 500 sequencing: GSM2633625: BT549_Palbociclib_0.3_24 Homo sapiens RNA-Seq										SRX2837536	GSM2633625						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/001/SRR5579351/SRR5579351.fastq.gz	188978031	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/001/SRR5579351/SRR5579351.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/001/SRR5579351/SRR5579351.fastq.gz	e87ff7044abba4356c2cc045cb08b67f		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		4216430											GSM2633625_r1			GSM2633625			BT549_Palbociclib_0.3_24						BT549_Palbociclib_0.3_24		ACH-000288	BT549_BREAST	BT549_BREAST	PALBOCICLIB	DRUG			SRR5579344,SRR5579343	24	hours	0.3	micromolar				9606	Homo sapiens		SRS2211701	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/001/SRR5579351	126667528	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/001/SRR5579351	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/001/SRR5579351	108a6d524aa7ff5894b634dcd76b9041	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579352	NextSeq 500 sequencing: GSM2633625: BT549_Palbociclib_0.3_24 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149910									329366175							BT549		GEO																NextSeq 500 sequencing: GSM2633625: BT549_Palbociclib_0.3_24 Homo sapiens RNA-Seq										SRX2837536	GSM2633625						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/002/SRR5579352/SRR5579352.fastq.gz	188416429	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/002/SRR5579352/SRR5579352.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/002/SRR5579352/SRR5579352.fastq.gz	424831d8d95ecfa3b1c052c35a1af3ae		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		4391549											GSM2633625_r2			GSM2633625			BT549_Palbociclib_0.3_24						BT549_Palbociclib_0.3_24		ACH-000288	BT549_BREAST	BT549_BREAST	PALBOCICLIB	DRUG			SRR5579344,SRR5579343	24	hours	0.3	micromolar				9606	Homo sapiens		SRS2211701	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/002/SRR5579352	125438463	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/002/SRR5579352	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/002/SRR5579352	4fd7aa0084a04a6bb55a9bc47f2c2dd3	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579439	NextSeq 500 sequencing: GSM2633669: BT549_Control_0_6 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149881									486010725							BT549		GEO																NextSeq 500 sequencing: GSM2633669: BT549_Control_0_6 Homo sapiens RNA-Seq										SRX2837580	GSM2633669						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/009/SRR5579439/SRR5579439.fastq.gz	291907990	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/009/SRR5579439/SRR5579439.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/009/SRR5579439/SRR5579439.fastq.gz	d63dcbef99f56ffd26c273332d7efda8		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		6480143											GSM2633669_r1			GSM2633669			BT549_Control_0_6						BT549_Control_0_6		ACH-000288	BT549_BREAST	BT549_BREAST	CONTROL	CONTROL			SRR5579439,SRR5579440	6	hours	0	micromolar				9606	Homo sapiens		SRS2211745	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/009/SRR5579439	195614004	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/009/SRR5579439	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/009/SRR5579439	bd3e9a5cccf768e04309ffa7b3c243d3	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579440	NextSeq 500 sequencing: GSM2633669: BT549_Control_0_6 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149881									503283600							BT549		GEO																NextSeq 500 sequencing: GSM2633669: BT549_Control_0_6 Homo sapiens RNA-Seq										SRX2837580	GSM2633669						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/000/SRR5579440/SRR5579440.fastq.gz	289468082	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/000/SRR5579440/SRR5579440.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/000/SRR5579440/SRR5579440.fastq.gz	f1a1c6e7da01bf4cfb4422a0813e81b9		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		6710448											GSM2633669_r2			GSM2633669			BT549_Control_0_6						BT549_Control_0_6		ACH-000288	BT549_BREAST	BT549_BREAST	CONTROL	CONTROL			SRR5579439,SRR5579440	6	hours	0	micromolar				9606	Homo sapiens		SRS2211745	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/000/SRR5579440	192693161	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/000/SRR5579440	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/000/SRR5579440	32b152f50a0d50e048ff59c49decd51a	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579343	NextSeq 500 sequencing: GSM2633621: BT549_Control_0_24 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149914									336148500							BT549		GEO																NextSeq 500 sequencing: GSM2633621: BT549_Control_0_24 Homo sapiens RNA-Seq										SRX2837532	GSM2633621						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/003/SRR5579343/SRR5579343.fastq.gz	201149130	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/003/SRR5579343/SRR5579343.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/003/SRR5579343/SRR5579343.fastq.gz	8003e53687a6e35a2639bdd6a908eb86		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		4481980											GSM2633621_r1			GSM2633621			BT549_Control_0_24						BT549_Control_0_24		ACH-000288	BT549_BREAST	BT549_BREAST	CONTROL	CONTROL			SRR5579344,SRR5579343	24	hours	0	micromolar				9606	Homo sapiens		SRS2211698	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/003/SRR5579343	134865385	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/003/SRR5579343	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/003/SRR5579343	c98a1251a57a572a2b61524baf27f839	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579344	NextSeq 500 sequencing: GSM2633621: BT549_Control_0_24 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149914									347184525							BT549		GEO																NextSeq 500 sequencing: GSM2633621: BT549_Control_0_24 Homo sapiens RNA-Seq										SRX2837532	GSM2633621						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/004/SRR5579344/SRR5579344.fastq.gz	198916950	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/004/SRR5579344/SRR5579344.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/004/SRR5579344/SRR5579344.fastq.gz	bc281c52d5e864d8fe6f0cf6a504196a		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		4629127											GSM2633621_r2			GSM2633621			BT549_Control_0_24						BT549_Control_0_24		ACH-000288	BT549_BREAST	BT549_BREAST	CONTROL	CONTROL			SRR5579344,SRR5579343	24	hours	0	micromolar				9606	Homo sapiens		SRS2211698	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/004/SRR5579344	132454085	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/004/SRR5579344	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/004/SRR5579344	2c77ac7753bcbef084c1c6f35aa2a214	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579445	NextSeq 500 sequencing: GSM2633672: BT549_Abemaciclib_3_6_rep2 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149872									231264075							BT549		GEO																NextSeq 500 sequencing: GSM2633672: BT549_Abemaciclib_3_6_rep2 Homo sapiens RNA-Seq										SRX2837583	GSM2633672						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/005/SRR5579445/SRR5579445.fastq.gz	139884936	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/005/SRR5579445/SRR5579445.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/005/SRR5579445/SRR5579445.fastq.gz	aadf004e12df62e8f3076cd7d30092bd		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		3083521											GSM2633672_r1			GSM2633672			BT549_Abemaciclib_3_6_rep2						BT549_Abemaciclib_3_6_rep2		ACH-000288	BT549_BREAST	BT549_BREAST	ABEMACICLIB	DRUG			SRR5579439,SRR5579440	6	hours	3	micromolar				9606	Homo sapiens		SRS2211749	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/005/SRR5579445	93889025	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/005/SRR5579445	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/005/SRR5579445	5fd8b6af25a10a2e5e544c97997285b8	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579446	NextSeq 500 sequencing: GSM2633672: BT549_Abemaciclib_3_6_rep2 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149872									241780275							BT549		GEO																NextSeq 500 sequencing: GSM2633672: BT549_Abemaciclib_3_6_rep2 Homo sapiens RNA-Seq										SRX2837583	GSM2633672						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/006/SRR5579446/SRR5579446.fastq.gz	140081114	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/006/SRR5579446/SRR5579446.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/006/SRR5579446/SRR5579446.fastq.gz	9d338e6ad8d0aa17f0ffff6ea20d43d9		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		3223737											GSM2633672_r2			GSM2633672			BT549_Abemaciclib_3_6_rep2						BT549_Abemaciclib_3_6_rep2		ACH-000288	BT549_BREAST	BT549_BREAST	ABEMACICLIB	DRUG			SRR5579439,SRR5579440	6	hours	3	micromolar				9606	Homo sapiens		SRS2211749	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/006/SRR5579446	93403690	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/006/SRR5579446	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/006/SRR5579446	f67a4415d22251a90c6c6ee4976e190e	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579443	NextSeq 500 sequencing: GSM2633671: BT549_Abemaciclib_3_6_rep1 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149873									460965300							BT549		GEO																NextSeq 500 sequencing: GSM2633671: BT549_Abemaciclib_3_6_rep1 Homo sapiens RNA-Seq										SRX2837582	GSM2633671						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/003/SRR5579443/SRR5579443.fastq.gz	276487913	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/003/SRR5579443/SRR5579443.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/003/SRR5579443/SRR5579443.fastq.gz	f3fbadafff231f0749f9052ada6b800c		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		6146204											GSM2633671_r1			GSM2633671			BT549_Abemaciclib_3_6_rep1						BT549_Abemaciclib_3_6_rep1		ACH-000288	BT549_BREAST	BT549_BREAST	ABEMACICLIB	DRUG			SRR5579439,SRR5579440	6	hours	3	micromolar				9606	Homo sapiens		SRS2211747	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/003/SRR5579443	185262646	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/003/SRR5579443	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/003/SRR5579443	6e79988c6be2c424cde526be0c9e0927	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579444	NextSeq 500 sequencing: GSM2633671: BT549_Abemaciclib_3_6_rep1 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149873									478408275							BT549		GEO																NextSeq 500 sequencing: GSM2633671: BT549_Abemaciclib_3_6_rep1 Homo sapiens RNA-Seq										SRX2837582	GSM2633671						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/004/SRR5579444/SRR5579444.fastq.gz	274677700	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/004/SRR5579444/SRR5579444.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/004/SRR5579444/SRR5579444.fastq.gz	70f1b1ad3debfdbf2029fadd7c78e571		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		6378777											GSM2633671_r2			GSM2633671			BT549_Abemaciclib_3_6_rep1						BT549_Abemaciclib_3_6_rep1		ACH-000288	BT549_BREAST	BT549_BREAST	ABEMACICLIB	DRUG			SRR5579439,SRR5579440	6	hours	3	micromolar				9606	Homo sapiens		SRS2211747	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/004/SRR5579444	182827485	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/004/SRR5579444	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/004/SRR5579444	d39a71daed9c9ae3ededbd0c295fa609	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579349	NextSeq 500 sequencing: GSM2633624: BT549_Abemaciclib_3_24_rep2 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149911									208961325							BT549		GEO																NextSeq 500 sequencing: GSM2633624: BT549_Abemaciclib_3_24_rep2 Homo sapiens RNA-Seq										SRX2837535	GSM2633624						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/009/SRR5579349/SRR5579349.fastq.gz	125585960	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/009/SRR5579349/SRR5579349.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/009/SRR5579349/SRR5579349.fastq.gz	25fa1ddebc08b9ef851c8a27d19aecef		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		2786151											GSM2633624_r1			GSM2633624			BT549_Abemaciclib_3_24_rep2						BT549_Abemaciclib_3_24_rep2		ACH-000288	BT549_BREAST	BT549_BREAST	ABEMACICLIB	DRUG			SRR5579344,SRR5579343	24	hours	3	micromolar				9606	Homo sapiens		SRS2211700	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/009/SRR5579349	84252391	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/009/SRR5579349	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/009/SRR5579349	bdddbe0c5269ec9083b9742e3c6c889a	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579350	NextSeq 500 sequencing: GSM2633624: BT549_Abemaciclib_3_24_rep2 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149911									217172025							BT549		GEO																NextSeq 500 sequencing: GSM2633624: BT549_Abemaciclib_3_24_rep2 Homo sapiens RNA-Seq										SRX2837535	GSM2633624						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/000/SRR5579350/SRR5579350.fastq.gz	124965177	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/000/SRR5579350/SRR5579350.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/000/SRR5579350/SRR5579350.fastq.gz	4f135cec564946bf48872f9d94a6017c		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		2895627											GSM2633624_r2			GSM2633624			BT549_Abemaciclib_3_24_rep2						BT549_Abemaciclib_3_24_rep2		ACH-000288	BT549_BREAST	BT549_BREAST	ABEMACICLIB	DRUG			SRR5579344,SRR5579343	24	hours	3	micromolar				9606	Homo sapiens		SRS2211700	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/000/SRR5579350	83266773	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/000/SRR5579350	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/000/SRR5579350	4b6ee1908ac908ee264b3f318628cc58	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579347	NextSeq 500 sequencing: GSM2633623: BT549_Abemaciclib_3_24_rep1 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149912									491609850							BT549		GEO																NextSeq 500 sequencing: GSM2633623: BT549_Abemaciclib_3_24_rep1 Homo sapiens RNA-Seq										SRX2837534	GSM2633623						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/007/SRR5579347/SRR5579347.fastq.gz	293369582	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/007/SRR5579347/SRR5579347.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/007/SRR5579347/SRR5579347.fastq.gz	501771d4f67c65b6647c6201d87251eb		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		6554798											GSM2633623_r1			GSM2633623			BT549_Abemaciclib_3_24_rep1						BT549_Abemaciclib_3_24_rep1		ACH-000288	BT549_BREAST	BT549_BREAST	ABEMACICLIB	DRUG			SRR5579344,SRR5579343	24	hours	3	micromolar				9606	Homo sapiens		SRS2211699	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/007/SRR5579347	196483966	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/007/SRR5579347	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/007/SRR5579347	04c6436fc889c0685b664c833f292f91	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579348	NextSeq 500 sequencing: GSM2633623: BT549_Abemaciclib_3_24_rep1 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149912									507319950							BT549		GEO																NextSeq 500 sequencing: GSM2633623: BT549_Abemaciclib_3_24_rep1 Homo sapiens RNA-Seq										SRX2837534	GSM2633623						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/008/SRR5579348/SRR5579348.fastq.gz	289618807	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/008/SRR5579348/SRR5579348.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/008/SRR5579348/SRR5579348.fastq.gz	bb00404b5e010c9ae17e1dc543c86a67		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		6764266											GSM2633623_r2			GSM2633623			BT549_Abemaciclib_3_24_rep1						BT549_Abemaciclib_3_24_rep1		ACH-000288	BT549_BREAST	BT549_BREAST	ABEMACICLIB	DRUG			SRR5579344,SRR5579343	24	hours	3	micromolar				9606	Homo sapiens		SRS2211699	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/008/SRR5579348	192642582	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/008/SRR5579348	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/008/SRR5579348	0d51901dc66ac8d6f4206d068a42e777	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579441	NextSeq 500 sequencing: GSM2633670: BT549_Abemaciclib_0.3_6 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149874									336844725							BT549		GEO																NextSeq 500 sequencing: GSM2633670: BT549_Abemaciclib_0.3_6 Homo sapiens RNA-Seq										SRX2837581	GSM2633670						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/001/SRR5579441/SRR5579441.fastq.gz	203116604	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/001/SRR5579441/SRR5579441.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/001/SRR5579441/SRR5579441.fastq.gz	7f24f8a6de8dd996ec5e61948fbdfff1		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		4491263											GSM2633670_r1			GSM2633670			BT549_Abemaciclib_0.3_6						BT549_Abemaciclib_0.3_6		ACH-000288	BT549_BREAST	BT549_BREAST	ABEMACICLIB	DRUG			SRR5579439,SRR5579440	6	hours	0.3	micromolar				9606	Homo sapiens		SRS2211746	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/001/SRR5579441	136205201	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/001/SRR5579441	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/001/SRR5579441	74da610f08e2f128bb3b967fb01be44c	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579442	NextSeq 500 sequencing: GSM2633670: BT549_Abemaciclib_0.3_6 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149874									350957250							BT549		GEO																NextSeq 500 sequencing: GSM2633670: BT549_Abemaciclib_0.3_6 Homo sapiens RNA-Seq										SRX2837581	GSM2633670						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/002/SRR5579442/SRR5579442.fastq.gz	202738555	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/002/SRR5579442/SRR5579442.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/002/SRR5579442/SRR5579442.fastq.gz	fed9c886bda873f822e4dc5bb2e5e5ca		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		4679430											GSM2633670_r2			GSM2633670			BT549_Abemaciclib_0.3_6						BT549_Abemaciclib_0.3_6		ACH-000288	BT549_BREAST	BT549_BREAST	ABEMACICLIB	DRUG			SRR5579439,SRR5579440	6	hours	0.3	micromolar				9606	Homo sapiens		SRS2211746	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/002/SRR5579442	135047311	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/002/SRR5579442	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/002/SRR5579442	1c3a6b33cecbd9bb1ea6622f5485dd15	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579345	NextSeq 500 sequencing: GSM2633622: BT549_Abemaciclib_0.3_24 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149913									377663100							BT549		GEO																NextSeq 500 sequencing: GSM2633622: BT549_Abemaciclib_0.3_24 Homo sapiens RNA-Seq										SRX2837533	GSM2633622						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/005/SRR5579345/SRR5579345.fastq.gz	225635493	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/005/SRR5579345/SRR5579345.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/005/SRR5579345/SRR5579345.fastq.gz	cda35176b9067af53847e0c36d9c0355		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		5035508											GSM2633622_r1			GSM2633622			BT549_Abemaciclib_0.3_24						BT549_Abemaciclib_0.3_24		ACH-000288	BT549_BREAST	BT549_BREAST	ABEMACICLIB	DRUG			SRR5579344,SRR5579343	24	hours	0.3	micromolar				9606	Homo sapiens		SRS2211697	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/005/SRR5579345	151162972	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/005/SRR5579345	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/005/SRR5579345	f023246d01653769e35bb8fbf1ba41f0	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579346	NextSeq 500 sequencing: GSM2633622: BT549_Abemaciclib_0.3_24 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149913									391165275							BT549		GEO																NextSeq 500 sequencing: GSM2633622: BT549_Abemaciclib_0.3_24 Homo sapiens RNA-Seq										SRX2837533	GSM2633622						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/006/SRR5579346/SRR5579346.fastq.gz	223719840	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/006/SRR5579346/SRR5579346.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/006/SRR5579346/SRR5579346.fastq.gz	31f7c4490d477cfef72cc9ddd3b72bdc		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		5215537											GSM2633622_r2			GSM2633622			BT549_Abemaciclib_0.3_24						BT549_Abemaciclib_0.3_24		ACH-000288	BT549_BREAST	BT549_BREAST	ABEMACICLIB	DRUG			SRR5579344,SRR5579343	24	hours	0.3	micromolar				9606	Homo sapiens		SRS2211697	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/006/SRR5579346	148849179	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/006/SRR5579346	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/006/SRR5579346	560faf0d5b3c150dcb1ea1429f151c76	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579437	NextSeq 500 sequencing: GSM2633668: BT20_Ribociclib_3_6 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149882									641612775							BT20		GEO																NextSeq 500 sequencing: GSM2633668: BT20_Ribociclib_3_6 Homo sapiens RNA-Seq										SRX2837579	GSM2633668						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/007/SRR5579437/SRR5579437.fastq.gz	382408415	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/007/SRR5579437/SRR5579437.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/007/SRR5579437/SRR5579437.fastq.gz	37dd8567b61b1746b3e0d9cb4672ef70		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		8554837											GSM2633668_r1			GSM2633668			BT20_Ribociclib_3_6						BT20_Ribociclib_3_6		ACH-000536	BT20_BREAST	BT20_BREAST	RIBOCICLIB	DRUG			SRR5579424,SRR5579423	6	hours	3	micromolar				9606	Homo sapiens		SRS2211744	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/007/SRR5579437	257479608	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/007/SRR5579437	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/007/SRR5579437	87a5c834db3305ca514f27dba2d0b8cc	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579438	NextSeq 500 sequencing: GSM2633668: BT20_Ribociclib_3_6 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149882									666320025							BT20		GEO																NextSeq 500 sequencing: GSM2633668: BT20_Ribociclib_3_6 Homo sapiens RNA-Seq										SRX2837579	GSM2633668						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/008/SRR5579438/SRR5579438.fastq.gz	380000927	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/008/SRR5579438/SRR5579438.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/008/SRR5579438/SRR5579438.fastq.gz	bedf5d8939f41ed32ce3955430a095f7		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		8884267											GSM2633668_r2			GSM2633668			BT20_Ribociclib_3_6						BT20_Ribociclib_3_6		ACH-000536	BT20_BREAST	BT20_BREAST	RIBOCICLIB	DRUG			SRR5579424,SRR5579423	6	hours	3	micromolar				9606	Homo sapiens		SRS2211744	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/008/SRR5579438	254181440	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/008/SRR5579438	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/008/SRR5579438	bbdedc37446301e87eb0272bd5dc0265	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579341	NextSeq 500 sequencing: GSM2633620: BT20_Ribociclib_3_24 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149915									328864875							BT20		GEO																NextSeq 500 sequencing: GSM2633620: BT20_Ribociclib_3_24 Homo sapiens RNA-Seq										SRX2837531	GSM2633620						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/001/SRR5579341/SRR5579341.fastq.gz	195957267	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/001/SRR5579341/SRR5579341.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/001/SRR5579341/SRR5579341.fastq.gz	34fb3e0a7f6ccccccc651acd84cd3ed9		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		4384865											GSM2633620_r1			GSM2633620			BT20_Ribociclib_3_24						BT20_Ribociclib_3_24		ACH-000536	BT20_BREAST	BT20_BREAST	RIBOCICLIB	DRUG			SRR5579328,SRR5579327	24	hours	3	micromolar				9606	Homo sapiens		SRS2211696	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/001/SRR5579341	131418751	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/001/SRR5579341	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/001/SRR5579341	f8a77d89efb734612933633f199266ae	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579342	NextSeq 500 sequencing: GSM2633620: BT20_Ribociclib_3_24 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149915									340388175							BT20		GEO																NextSeq 500 sequencing: GSM2633620: BT20_Ribociclib_3_24 Homo sapiens RNA-Seq										SRX2837531	GSM2633620						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/002/SRR5579342/SRR5579342.fastq.gz	194136105	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/002/SRR5579342/SRR5579342.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/002/SRR5579342/SRR5579342.fastq.gz	4a58663236956955be2d69d5d8dc0549		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		4538509											GSM2633620_r2			GSM2633620			BT20_Ribociclib_3_24						BT20_Ribociclib_3_24		ACH-000536	BT20_BREAST	BT20_BREAST	RIBOCICLIB	DRUG			SRR5579328,SRR5579327	24	hours	3	micromolar				9606	Homo sapiens		SRS2211696	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/002/SRR5579342	129332281	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/002/SRR5579342	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/002/SRR5579342	187c8f323479660c8e72ddc313ba0d00	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579435	NextSeq 500 sequencing: GSM2633667: BT20_Ribociclib_0.3_6 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149883									391329375							BT20		GEO																NextSeq 500 sequencing: GSM2633667: BT20_Ribociclib_0.3_6 Homo sapiens RNA-Seq										SRX2837578	GSM2633667						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/005/SRR5579435/SRR5579435.fastq.gz	234477665	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/005/SRR5579435/SRR5579435.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/005/SRR5579435/SRR5579435.fastq.gz	e738957336b83c0e8e3fff2485bc7c9d		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		5217725											GSM2633667_r1			GSM2633667			BT20_Ribociclib_0.3_6						BT20_Ribociclib_0.3_6		ACH-000536	BT20_BREAST	BT20_BREAST	RIBOCICLIB	DRUG			SRR5579424,SRR5579423	6	hours	0.3	micromolar				9606	Homo sapiens		SRS2211742	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/005/SRR5579435	157402540	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/005/SRR5579435	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/005/SRR5579435	12c2471d9ea25f77137cb640eabf5f4a	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579436	NextSeq 500 sequencing: GSM2633667: BT20_Ribociclib_0.3_6 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149883									406455675							BT20		GEO																NextSeq 500 sequencing: GSM2633667: BT20_Ribociclib_0.3_6 Homo sapiens RNA-Seq										SRX2837578	GSM2633667						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/006/SRR5579436/SRR5579436.fastq.gz	232923772	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/006/SRR5579436/SRR5579436.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/006/SRR5579436/SRR5579436.fastq.gz	e0b45252af8cc41f1fb2bf748b4ff5dc		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		5419409											GSM2633667_r2			GSM2633667			BT20_Ribociclib_0.3_6						BT20_Ribociclib_0.3_6		ACH-000536	BT20_BREAST	BT20_BREAST	RIBOCICLIB	DRUG			SRR5579424,SRR5579423	6	hours	0.3	micromolar				9606	Homo sapiens		SRS2211742	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/006/SRR5579436	155259076	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/006/SRR5579436	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/006/SRR5579436	34b003f944f625a120f63a438834c0ad	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579339	NextSeq 500 sequencing: GSM2633619: BT20_Ribociclib_0.3_24 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149916									328130025							BT20		GEO																NextSeq 500 sequencing: GSM2633619: BT20_Ribociclib_0.3_24 Homo sapiens RNA-Seq										SRX2837530	GSM2633619						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/009/SRR5579339/SRR5579339.fastq.gz	195456748	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/009/SRR5579339/SRR5579339.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/009/SRR5579339/SRR5579339.fastq.gz	1fbd8fc0542b480e3f84e69b7684fb0b		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		4375067											GSM2633619_r1			GSM2633619			BT20_Ribociclib_0.3_24						BT20_Ribociclib_0.3_24		ACH-000536	BT20_BREAST	BT20_BREAST	RIBOCICLIB	DRUG			SRR5579328,SRR5579327	24	hours	0.3	micromolar				9606	Homo sapiens		SRS2211695	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/009/SRR5579339	131129095	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/009/SRR5579339	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/009/SRR5579339	43bb45482e1fce972fae5a289443fd90	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579340	NextSeq 500 sequencing: GSM2633619: BT20_Ribociclib_0.3_24 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149916									338891100							BT20		GEO																NextSeq 500 sequencing: GSM2633619: BT20_Ribociclib_0.3_24 Homo sapiens RNA-Seq										SRX2837530	GSM2633619						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/000/SRR5579340/SRR5579340.fastq.gz	193125434	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/000/SRR5579340/SRR5579340.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/000/SRR5579340/SRR5579340.fastq.gz	cc0fd4e3449cce1aea38ad785a031c78		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		4518548											GSM2633619_r2			GSM2633619			BT20_Ribociclib_0.3_24						BT20_Ribociclib_0.3_24		ACH-000536	BT20_BREAST	BT20_BREAST	RIBOCICLIB	DRUG			SRR5579328,SRR5579327	24	hours	0.3	micromolar				9606	Homo sapiens		SRS2211695	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/000/SRR5579340	128674775	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/000/SRR5579340	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/000/SRR5579340	41ef78ec41349e1d3ec41e3e97e3469a	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579433	NextSeq 500 sequencing: GSM2633666: BT20_Palbociclib_3_6 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149884									306164850							BT20		GEO																NextSeq 500 sequencing: GSM2633666: BT20_Palbociclib_3_6 Homo sapiens RNA-Seq										SRX2837577	GSM2633666						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/003/SRR5579433/SRR5579433.fastq.gz	181732956	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/003/SRR5579433/SRR5579433.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/003/SRR5579433/SRR5579433.fastq.gz	c583a181636c545733c55d375db398b5		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		4082198											GSM2633666_r1			GSM2633666			BT20_Palbociclib_3_6						BT20_Palbociclib_3_6		ACH-000536	BT20_BREAST	BT20_BREAST	PALBOCICLIB	DRUG			SRR5579424,SRR5579423	6	hours	3	micromolar				9606	Homo sapiens		SRS2211743	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/003/SRR5579433	121759354	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/003/SRR5579433	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/003/SRR5579433	9981391223853b3b045ffe175ae0d9ab	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579434	NextSeq 500 sequencing: GSM2633666: BT20_Palbociclib_3_6 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149884									315983025							BT20		GEO																NextSeq 500 sequencing: GSM2633666: BT20_Palbociclib_3_6 Homo sapiens RNA-Seq										SRX2837577	GSM2633666						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/004/SRR5579434/SRR5579434.fastq.gz	179291142	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/004/SRR5579434/SRR5579434.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/004/SRR5579434/SRR5579434.fastq.gz	87bf4e6ecee0ebd82b4c4253e955c34d		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		4213107											GSM2633666_r2			GSM2633666			BT20_Palbociclib_3_6						BT20_Palbociclib_3_6		ACH-000536	BT20_BREAST	BT20_BREAST	PALBOCICLIB	DRUG			SRR5579424,SRR5579423	6	hours	3	micromolar				9606	Homo sapiens		SRS2211743	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/004/SRR5579434	119273908	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/004/SRR5579434	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/004/SRR5579434	db24a986a716af207e46946a403ce374	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579337	NextSeq 500 sequencing: GSM2633618: BT20_Palbociclib_3_24 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149917									387908175							BT20		GEO																NextSeq 500 sequencing: GSM2633618: BT20_Palbociclib_3_24 Homo sapiens RNA-Seq										SRX2837529	GSM2633618						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/007/SRR5579337/SRR5579337.fastq.gz	230044534	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/007/SRR5579337/SRR5579337.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/007/SRR5579337/SRR5579337.fastq.gz	873739c90233f9c510152b509a6f052a		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		5172109											GSM2633618_r1			GSM2633618			BT20_Palbociclib_3_24						BT20_Palbociclib_3_24		ACH-000536	BT20_BREAST	BT20_BREAST	PALBOCICLIB	DRUG			SRR5579328,SRR5579327	24	hours	3	micromolar				9606	Homo sapiens		SRS2211693	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/007/SRR5579337	154273130	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/007/SRR5579337	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/007/SRR5579337	6e6f22f650b61c6b631b246399aaa52c	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579338	NextSeq 500 sequencing: GSM2633618: BT20_Palbociclib_3_24 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149917									399535575							BT20		GEO																NextSeq 500 sequencing: GSM2633618: BT20_Palbociclib_3_24 Homo sapiens RNA-Seq										SRX2837529	GSM2633618						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/008/SRR5579338/SRR5579338.fastq.gz	226595517	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/008/SRR5579338/SRR5579338.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/008/SRR5579338/SRR5579338.fastq.gz	958b3c121ec43ad7464adf80ba71fe1f		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		5327141											GSM2633618_r2			GSM2633618			BT20_Palbociclib_3_24						BT20_Palbociclib_3_24		ACH-000536	BT20_BREAST	BT20_BREAST	PALBOCICLIB	DRUG			SRR5579328,SRR5579327	24	hours	3	micromolar				9606	Homo sapiens		SRS2211693	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/008/SRR5579338	150922729	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/008/SRR5579338	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/008/SRR5579338	73f4710e4a3b0b56a2d25ed269b87cd2	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579431	NextSeq 500 sequencing: GSM2633665: BT20_Palbociclib_0.3_6 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149885									476536050							BT20		GEO																NextSeq 500 sequencing: GSM2633665: BT20_Palbociclib_0.3_6 Homo sapiens RNA-Seq										SRX2837576	GSM2633665						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/001/SRR5579431/SRR5579431.fastq.gz	284551508	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/001/SRR5579431/SRR5579431.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/001/SRR5579431/SRR5579431.fastq.gz	85bf45d0d4c3dfc80fada1c28122a0e9		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		6353814											GSM2633665_r1			GSM2633665			BT20_Palbociclib_0.3_6						BT20_Palbociclib_0.3_6		ACH-000536	BT20_BREAST	BT20_BREAST	PALBOCICLIB	DRUG			SRR5579424,SRR5579423	6	hours	0.3	micromolar				9606	Homo sapiens		SRS2211741	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/001/SRR5579431	190748756	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/001/SRR5579431	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/001/SRR5579431	60faf06d1a05c61ee8a846e101695bc7	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579432	NextSeq 500 sequencing: GSM2633665: BT20_Palbociclib_0.3_6 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149885									496656900							BT20		GEO																NextSeq 500 sequencing: GSM2633665: BT20_Palbociclib_0.3_6 Homo sapiens RNA-Seq										SRX2837576	GSM2633665						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/002/SRR5579432/SRR5579432.fastq.gz	283659173	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/002/SRR5579432/SRR5579432.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/002/SRR5579432/SRR5579432.fastq.gz	9f720ec2251e10ceacfb90e0fefcfb5f		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		6622092											GSM2633665_r2			GSM2633665			BT20_Palbociclib_0.3_6						BT20_Palbociclib_0.3_6		ACH-000536	BT20_BREAST	BT20_BREAST	PALBOCICLIB	DRUG			SRR5579424,SRR5579423	6	hours	0.3	micromolar				9606	Homo sapiens		SRS2211741	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/002/SRR5579432	188818908	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/002/SRR5579432	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/002/SRR5579432	2cc711b27253c7bd6f3f691df32bb460	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579335	NextSeq 500 sequencing: GSM2633617: BT20_Palbociclib_0.3_24 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149918									360514575							BT20		GEO																NextSeq 500 sequencing: GSM2633617: BT20_Palbociclib_0.3_24 Homo sapiens RNA-Seq										SRX2837528	GSM2633617						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/005/SRR5579335/SRR5579335.fastq.gz	214733686	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/005/SRR5579335/SRR5579335.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/005/SRR5579335/SRR5579335.fastq.gz	903519fabb8c6e0322df3d748f39b80f		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		4806861											GSM2633617_r1			GSM2633617			BT20_Palbociclib_0.3_24						BT20_Palbociclib_0.3_24		ACH-000536	BT20_BREAST	BT20_BREAST	PALBOCICLIB	DRUG			SRR5579328,SRR5579327	24	hours	0.3	micromolar				9606	Homo sapiens		SRS2211692	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/005/SRR5579335	144159247	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/005/SRR5579335	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/005/SRR5579335	7b3f639c8ecc0642aaa0945e4dd4bb9a	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579336	NextSeq 500 sequencing: GSM2633617: BT20_Palbociclib_0.3_24 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149918									374760450							BT20		GEO																NextSeq 500 sequencing: GSM2633617: BT20_Palbociclib_0.3_24 Homo sapiens RNA-Seq										SRX2837528	GSM2633617						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/006/SRR5579336/SRR5579336.fastq.gz	213696779	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/006/SRR5579336/SRR5579336.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/006/SRR5579336/SRR5579336.fastq.gz	778fb4ebeacd105395a92b5d989bb66d		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		4996806											GSM2633617_r2			GSM2633617			BT20_Palbociclib_0.3_24						BT20_Palbociclib_0.3_24		ACH-000536	BT20_BREAST	BT20_BREAST	PALBOCICLIB	DRUG			SRR5579328,SRR5579327	24	hours	0.3	micromolar				9606	Homo sapiens		SRS2211692	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/006/SRR5579336	142511393	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/006/SRR5579336	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/006/SRR5579336	a6c3a9b0434454202cf43d3db9a38fad	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579423	NextSeq 500 sequencing: GSM2633661: BT20_Control_0_6 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149889									484817250							BT20		GEO																NextSeq 500 sequencing: GSM2633661: BT20_Control_0_6 Homo sapiens RNA-Seq										SRX2837572	GSM2633661						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/003/SRR5579423/SRR5579423.fastq.gz	288777879	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/003/SRR5579423/SRR5579423.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/003/SRR5579423/SRR5579423.fastq.gz	9fc969aa23db2d8877adeb9a4035802e		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		6464230											GSM2633661_r1			GSM2633661			BT20_Control_0_6						BT20_Control_0_6		ACH-000536	BT20_BREAST	BT20_BREAST	CONTROL	CONTROL			SRR5579424,SRR5579423	6	hours	0	micromolar				9606	Homo sapiens		SRS2211738	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/003/SRR5579423	193556200	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/003/SRR5579423	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/003/SRR5579423	b6b8b070f9b7be58aabb97742983b74a	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579424	NextSeq 500 sequencing: GSM2633661: BT20_Control_0_6 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149889									500870925							BT20		GEO																NextSeq 500 sequencing: GSM2633661: BT20_Control_0_6 Homo sapiens RNA-Seq										SRX2837572	GSM2633661						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/004/SRR5579424/SRR5579424.fastq.gz	285300558	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/004/SRR5579424/SRR5579424.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/004/SRR5579424/SRR5579424.fastq.gz	c75b7f42398979c6f04106a698cb5c99		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		6678279											GSM2633661_r2			GSM2633661			BT20_Control_0_6						BT20_Control_0_6		ACH-000536	BT20_BREAST	BT20_BREAST	CONTROL	CONTROL			SRR5579424,SRR5579423	6	hours	0	micromolar				9606	Homo sapiens		SRS2211738	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/004/SRR5579424	189875551	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/004/SRR5579424	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/004/SRR5579424	b13f3dab6954e2cad6d5c68aabefbd39	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579327	NextSeq 500 sequencing: GSM2633613: BT20_Control_0_24 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149922									337336425							BT20		GEO																NextSeq 500 sequencing: GSM2633613: BT20_Control_0_24 Homo sapiens RNA-Seq										SRX2837524	GSM2633613						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/007/SRR5579327/SRR5579327.fastq.gz	201021927	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/007/SRR5579327/SRR5579327.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/007/SRR5579327/SRR5579327.fastq.gz	117597e55a91c74220fe602960a8211c		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		4497819											GSM2633613_r1			GSM2633613			BT20_Control_0_24						BT20_Control_0_24		ACH-000536	BT20_BREAST	BT20_BREAST	CONTROL	CONTROL			SRR5579328,SRR5579327	24	hours	0	micromolar				9606	Homo sapiens		SRS2211690	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/007/SRR5579327	134818104	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/007/SRR5579327	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/007/SRR5579327	689f7bcec054b2cb2e8d7db096079338	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579328	NextSeq 500 sequencing: GSM2633613: BT20_Control_0_24 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149922									347952000							BT20		GEO																NextSeq 500 sequencing: GSM2633613: BT20_Control_0_24 Homo sapiens RNA-Seq										SRX2837524	GSM2633613						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/008/SRR5579328/SRR5579328.fastq.gz	198440801	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/008/SRR5579328/SRR5579328.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/008/SRR5579328/SRR5579328.fastq.gz	485d6f4700fd3fb4380d11cff3e08dba		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		4639360											GSM2633613_r2			GSM2633613			BT20_Control_0_24						BT20_Control_0_24		ACH-000536	BT20_BREAST	BT20_BREAST	CONTROL	CONTROL			SRR5579328,SRR5579327	24	hours	0	micromolar				9606	Homo sapiens		SRS2211690	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/008/SRR5579328	132186680	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/008/SRR5579328	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/008/SRR5579328	1bf783e1321d9b7a44bf11f9cf805437	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579429	NextSeq 500 sequencing: GSM2633664: BT20_Abemaciclib_3_6_rep2 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149886									324091875							BT20		GEO																NextSeq 500 sequencing: GSM2633664: BT20_Abemaciclib_3_6_rep2 Homo sapiens RNA-Seq										SRX2837575	GSM2633664						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/009/SRR5579429/SRR5579429.fastq.gz	194547848	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/009/SRR5579429/SRR5579429.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/009/SRR5579429/SRR5579429.fastq.gz	af64dc6cdb38d17638597354f8aef692		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		4321225											GSM2633664_r1			GSM2633664			BT20_Abemaciclib_3_6_rep2						BT20_Abemaciclib_3_6_rep2		ACH-000536	BT20_BREAST	BT20_BREAST	ABEMACICLIB	DRUG			SRR5579424,SRR5579423	6	hours	3	micromolar				9606	Homo sapiens		SRS2211739	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/009/SRR5579429	130620952	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/009/SRR5579429	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/009/SRR5579429	99b432b0b30fbf97ba894724b8f3c555	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579430	NextSeq 500 sequencing: GSM2633664: BT20_Abemaciclib_3_6_rep2 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149886									338569125							BT20		GEO																NextSeq 500 sequencing: GSM2633664: BT20_Abemaciclib_3_6_rep2 Homo sapiens RNA-Seq										SRX2837575	GSM2633664						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/000/SRR5579430/SRR5579430.fastq.gz	194411552	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/000/SRR5579430/SRR5579430.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/000/SRR5579430/SRR5579430.fastq.gz	ba032229d4bbc67053cbe8844c08cacb		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		4514255											GSM2633664_r2			GSM2633664			BT20_Abemaciclib_3_6_rep2						BT20_Abemaciclib_3_6_rep2		ACH-000536	BT20_BREAST	BT20_BREAST	ABEMACICLIB	DRUG			SRR5579424,SRR5579423	6	hours	3	micromolar				9606	Homo sapiens		SRS2211739	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/000/SRR5579430	129624669	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/000/SRR5579430	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/000/SRR5579430	7b916e64ffa4d4577c27a24c7e3da823	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579427	NextSeq 500 sequencing: GSM2633663: BT20_Abemaciclib_3_6_rep1 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149887									551730825							BT20		GEO																NextSeq 500 sequencing: GSM2633663: BT20_Abemaciclib_3_6_rep1 Homo sapiens RNA-Seq										SRX2837574	GSM2633663						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/007/SRR5579427/SRR5579427.fastq.gz	328239931	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/007/SRR5579427/SRR5579427.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/007/SRR5579427/SRR5579427.fastq.gz	488980c1c93e2dc767e67201814792af		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		7356411											GSM2633663_r1			GSM2633663			BT20_Abemaciclib_3_6_rep1						BT20_Abemaciclib_3_6_rep1		ACH-000536	BT20_BREAST	BT20_BREAST	ABEMACICLIB	DRUG			SRR5579424,SRR5579423	6	hours	3	micromolar				9606	Homo sapiens		SRS2211740	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/007/SRR5579427	220126392	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/007/SRR5579427	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/007/SRR5579427	aa07eb2b8ea5b0ad1f0ead0db9123ffb	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579428	NextSeq 500 sequencing: GSM2633663: BT20_Abemaciclib_3_6_rep1 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149887									571571625							BT20		GEO																NextSeq 500 sequencing: GSM2633663: BT20_Abemaciclib_3_6_rep1 Homo sapiens RNA-Seq										SRX2837574	GSM2633663						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/008/SRR5579428/SRR5579428.fastq.gz	325025395	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/008/SRR5579428/SRR5579428.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/008/SRR5579428/SRR5579428.fastq.gz	3339582239b6c2e6b7385f8e79ebcba3		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		7620955											GSM2633663_r2			GSM2633663			BT20_Abemaciclib_3_6_rep1						BT20_Abemaciclib_3_6_rep1		ACH-000536	BT20_BREAST	BT20_BREAST	ABEMACICLIB	DRUG			SRR5579424,SRR5579423	6	hours	3	micromolar				9606	Homo sapiens		SRS2211740	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/008/SRR5579428	216456488	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/008/SRR5579428	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/008/SRR5579428	b5a7d72892a3f98a3fb6d7b01db08f7a	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579333	NextSeq 500 sequencing: GSM2633616: BT20_Abemaciclib_3_24_rep2 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149919									394833825							BT20		GEO																NextSeq 500 sequencing: GSM2633616: BT20_Abemaciclib_3_24_rep2 Homo sapiens RNA-Seq										SRX2837527	GSM2633616						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/003/SRR5579333/SRR5579333.fastq.gz	236677776	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/003/SRR5579333/SRR5579333.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/003/SRR5579333/SRR5579333.fastq.gz	5c25dd1abf0aae3d368aff41d9a205c2		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		5264451											GSM2633616_r1			GSM2633616			BT20_Abemaciclib_3_24_rep2						BT20_Abemaciclib_3_24_rep2		ACH-000536	BT20_BREAST	BT20_BREAST	ABEMACICLIB	DRUG			SRR5579328,SRR5579327	24	hours	3	micromolar				9606	Homo sapiens		SRS2211691	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/003/SRR5579333	158929260	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/003/SRR5579333	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/003/SRR5579333	5a05659f4e24e923e57a63fb04545336	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579334	NextSeq 500 sequencing: GSM2633616: BT20_Abemaciclib_3_24_rep2 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149919									411997125							BT20		GEO																NextSeq 500 sequencing: GSM2633616: BT20_Abemaciclib_3_24_rep2 Homo sapiens RNA-Seq										SRX2837527	GSM2633616						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/004/SRR5579334/SRR5579334.fastq.gz	236462162	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/004/SRR5579334/SRR5579334.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/004/SRR5579334/SRR5579334.fastq.gz	81efc6332b12914d2c6ec49bea4c1b9c		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		5493295											GSM2633616_r2			GSM2633616			BT20_Abemaciclib_3_24_rep2						BT20_Abemaciclib_3_24_rep2		ACH-000536	BT20_BREAST	BT20_BREAST	ABEMACICLIB	DRUG			SRR5579328,SRR5579327	24	hours	3	micromolar				9606	Homo sapiens		SRS2211691	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/004/SRR5579334	157728610	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/004/SRR5579334	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/004/SRR5579334	86b94597e796ccfcf9da0de8a825ec2d	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579331	NextSeq 500 sequencing: GSM2633615: BT20_Abemaciclib_3_24_rep1 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149920									217186875							BT20		GEO																NextSeq 500 sequencing: GSM2633615: BT20_Abemaciclib_3_24_rep1 Homo sapiens RNA-Seq										SRX2837526	GSM2633615						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/001/SRR5579331/SRR5579331.fastq.gz	129316047	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/001/SRR5579331/SRR5579331.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/001/SRR5579331/SRR5579331.fastq.gz	df8453cf38d7efd46c7ae8ae55ddcc4f		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		2895825											GSM2633615_r1			GSM2633615			BT20_Abemaciclib_3_24_rep1						BT20_Abemaciclib_3_24_rep1		ACH-000536	BT20_BREAST	BT20_BREAST	ABEMACICLIB	DRUG			SRR5579328,SRR5579327	24	hours	3	micromolar				9606	Homo sapiens		SRS2211694	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/001/SRR5579331	86888807	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/001/SRR5579331	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/001/SRR5579331	f35d1d6f01fc90df1c51a340f695b66f	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579332	NextSeq 500 sequencing: GSM2633615: BT20_Abemaciclib_3_24_rep1 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149920									225195225							BT20		GEO																NextSeq 500 sequencing: GSM2633615: BT20_Abemaciclib_3_24_rep1 Homo sapiens RNA-Seq										SRX2837526	GSM2633615						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/002/SRR5579332/SRR5579332.fastq.gz	128287859	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/002/SRR5579332/SRR5579332.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/002/SRR5579332/SRR5579332.fastq.gz	093be0293d905f2a6c462ac0d1f25ee1		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		3002603											GSM2633615_r2			GSM2633615			BT20_Abemaciclib_3_24_rep1						BT20_Abemaciclib_3_24_rep1		ACH-000536	BT20_BREAST	BT20_BREAST	ABEMACICLIB	DRUG			SRR5579328,SRR5579327	24	hours	3	micromolar				9606	Homo sapiens		SRS2211694	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/002/SRR5579332	85624837	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/002/SRR5579332	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/002/SRR5579332	0ac8ce71598400302384e7cfeaebec28	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579425	NextSeq 500 sequencing: GSM2633662: BT20_Abemaciclib_0.3_6 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149888									365095200							BT20		GEO																NextSeq 500 sequencing: GSM2633662: BT20_Abemaciclib_0.3_6 Homo sapiens RNA-Seq										SRX2837573	GSM2633662						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/005/SRR5579425/SRR5579425.fastq.gz	218122608	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/005/SRR5579425/SRR5579425.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/005/SRR5579425/SRR5579425.fastq.gz	8688e4f09b16135a6666e512d1010576		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		4867936											GSM2633662_r1			GSM2633662			BT20_Abemaciclib_0.3_6						BT20_Abemaciclib_0.3_6		ACH-000536	BT20_BREAST	BT20_BREAST	ABEMACICLIB	DRUG			SRR5579424,SRR5579423	6	hours	0.3	micromolar				9606	Homo sapiens		SRS2211737	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/005/SRR5579425	146265260	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/005/SRR5579425	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/005/SRR5579425	608eaa15cfe3276423589fe4a55f46f4	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579426	NextSeq 500 sequencing: GSM2633662: BT20_Abemaciclib_0.3_6 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149888									378574800							BT20		GEO																NextSeq 500 sequencing: GSM2633662: BT20_Abemaciclib_0.3_6 Homo sapiens RNA-Seq										SRX2837573	GSM2633662						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/006/SRR5579426/SRR5579426.fastq.gz	216370614	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/006/SRR5579426/SRR5579426.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/006/SRR5579426/SRR5579426.fastq.gz	3258c8c935216c8872aff326da284d72		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		5047664											GSM2633662_r2			GSM2633662			BT20_Abemaciclib_0.3_6						BT20_Abemaciclib_0.3_6		ACH-000536	BT20_BREAST	BT20_BREAST	ABEMACICLIB	DRUG			SRR5579424,SRR5579423	6	hours	0.3	micromolar				9606	Homo sapiens		SRS2211737	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/006/SRR5579426	144086004	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/006/SRR5579426	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/006/SRR5579426	c96d2bf15f385b4db6f056cab49b621b	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579329	NextSeq 500 sequencing: GSM2633614: BT20_Abemaciclib_0.3_24 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149921									350176650							BT20		GEO																NextSeq 500 sequencing: GSM2633614: BT20_Abemaciclib_0.3_24 Homo sapiens RNA-Seq										SRX2837525	GSM2633614						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/009/SRR5579329/SRR5579329.fastq.gz	208992793	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/009/SRR5579329/SRR5579329.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/009/SRR5579329/SRR5579329.fastq.gz	58bfdf8a472f8e857b4f43d9a234ac64		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		4669022											GSM2633614_r1			GSM2633614			BT20_Abemaciclib_0.3_24						BT20_Abemaciclib_0.3_24		ACH-000536	BT20_BREAST	BT20_BREAST	ABEMACICLIB	DRUG			SRR5579328,SRR5579327	24	hours	0.3	micromolar				9606	Homo sapiens		SRS2211689	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/009/SRR5579329	140188480	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/009/SRR5579329	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/009/SRR5579329	8c1b2bfd024bfdf9954b154cbb26f530	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR5579330	NextSeq 500 sequencing: GSM2633614: BT20_Abemaciclib_0.3_24 Homo sapiens RNA-Seq	PRJNA387311		SAMN07149921									363103650							BT20		GEO																NextSeq 500 sequencing: GSM2633614: BT20_Abemaciclib_0.3_24 Homo sapiens RNA-Seq										SRX2837525	GSM2633614						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR557/000/SRR5579330/SRR5579330.fastq.gz	207471183	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/000/SRR5579330/SRR5579330.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR557/000/SRR5579330/SRR5579330.fastq.gz	c3b84f2e3edfcf1c5799f39fef5cbc61		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		RNA was extracted using Applied Biosystems MagMax 96 total RNA isolation kit (AM1830) with DNase digestion according to the manufacturer’s protocol. Libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kit (RS-122-2103) from 500 ng of purified total RNA according to the manufacturer’s protocol in a reduced reaction volume.		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					Homo sapiens		4841382											GSM2633614_r2			GSM2633614			BT20_Abemaciclib_0.3_24						BT20_Abemaciclib_0.3_24		ACH-000536	BT20_BREAST	BT20_BREAST	ABEMACICLIB	DRUG			SRR5579328,SRR5579327	24	hours	0.3	micromolar				9606	Homo sapiens		SRS2211689	SRP107565													fasp.sra.ebi.ac.uk:/vol1/srr/SRR557/000/SRR5579330	138228161	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/000/SRR5579330	ftp.sra.ebi.ac.uk/vol1/srr/SRR557/000/SRR5579330	8fb0f25b7153edc6bceddfcf9a1c252b	public		GSE99116	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.			SRA563064										ena								
SRR8424612	NextSeq 500 sequencing: GSM3557208: 47L_Palbociclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719325									76968750									GEO																NextSeq 500 sequencing: GSM3557208: 47L_Palbociclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233153	GSM3557208						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/002/SRR8424612/SRR8424612.fastq.gz	39131309	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/002/SRR8424612/SRR8424612.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/002/SRR8424612/SRR8424612.fastq.gz	b0615e9ceb3515970d903af59ba85fc0		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1026250											GSM3557208_r1			GSM3557208			47L_Palbociclib_150.0						47L_Palbociclib_150.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	PALBOCICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236579	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/002/SRR8424612	25620249	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/002/SRR8424612	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/002/SRR8424612	d14f3349c960ebdb45db5406f8987292	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424613	NextSeq 500 sequencing: GSM3557208: 47L_Palbociclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719325									77558400									GEO																NextSeq 500 sequencing: GSM3557208: 47L_Palbociclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233153	GSM3557208						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/003/SRR8424613/SRR8424613.fastq.gz	39519894	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/003/SRR8424613/SRR8424613.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/003/SRR8424613/SRR8424613.fastq.gz	082ded6d3fb6cdd8c7c864061d9aeeb4		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1034112											GSM3557208_r2			GSM3557208			47L_Palbociclib_150.0						47L_Palbociclib_150.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	PALBOCICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236579	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/003/SRR8424613	25884981	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/003/SRR8424613	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/003/SRR8424613	d50131da0f71007e14cedd5fcc18e378	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424614	NextSeq 500 sequencing: GSM3557208: 47L_Palbociclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719325									78651075									GEO																NextSeq 500 sequencing: GSM3557208: 47L_Palbociclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233153	GSM3557208						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/004/SRR8424614/SRR8424614.fastq.gz	40160640	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/004/SRR8424614/SRR8424614.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/004/SRR8424614/SRR8424614.fastq.gz	ca442d068d9fc0049f7a3204f49be15d		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1048681											GSM3557208_r3			GSM3557208			47L_Palbociclib_150.0						47L_Palbociclib_150.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	PALBOCICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236579	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/004/SRR8424614	26315481	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/004/SRR8424614	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/004/SRR8424614	574a5bcdd4936f089ba2e3fdfa060666	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424615	NextSeq 500 sequencing: GSM3557208: 47L_Palbociclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719325									79303425									GEO																NextSeq 500 sequencing: GSM3557208: 47L_Palbociclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233153	GSM3557208						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/005/SRR8424615/SRR8424615.fastq.gz	40318162	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/005/SRR8424615/SRR8424615.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/005/SRR8424615/SRR8424615.fastq.gz	ef7044b870cbde8bce1b92da01164a7d		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1057379											GSM3557208_r4			GSM3557208			47L_Palbociclib_150.0						47L_Palbociclib_150.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	PALBOCICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	0	mg/kg				9606	Homo sapiens		SRS4236579	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/005/SRR8424615	26413197	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/005/SRR8424615	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/005/SRR8424615	b84f8e2748b53893e9e6a81a8834ed53	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424608	NextSeq 500 sequencing: GSM3557207: 46R_Abemaciclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719326									113210325									GEO																NextSeq 500 sequencing: GSM3557207: 46R_Abemaciclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233152	GSM3557207						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/008/SRR8424608/SRR8424608.fastq.gz	57436070	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/008/SRR8424608/SRR8424608.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/008/SRR8424608/SRR8424608.fastq.gz	e2aa10d6fe27038a22f254b35b185879		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1509471											GSM3557207_r1			GSM3557207			46R_Abemaciclib_150.0						46R_Abemaciclib_150.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236578	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/008/SRR8424608	37626189	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/008/SRR8424608	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/008/SRR8424608	1c0858134ed78c9003f794b7ea0c34ea	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424609	NextSeq 500 sequencing: GSM3557207: 46R_Abemaciclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719326									114364650									GEO																NextSeq 500 sequencing: GSM3557207: 46R_Abemaciclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233152	GSM3557207						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/009/SRR8424609/SRR8424609.fastq.gz	58153616	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/009/SRR8424609/SRR8424609.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/009/SRR8424609/SRR8424609.fastq.gz	89498298e19a13581f7fcab49f98a2ee		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1524862											GSM3557207_r2			GSM3557207			46R_Abemaciclib_150.0						46R_Abemaciclib_150.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236578	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/009/SRR8424609	38112157	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/009/SRR8424609	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/009/SRR8424609	e6844e7d91eddae5400b6b330cce602f	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424610	NextSeq 500 sequencing: GSM3557207: 46R_Abemaciclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719326									115696275									GEO																NextSeq 500 sequencing: GSM3557207: 46R_Abemaciclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233152	GSM3557207						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/000/SRR8424610/SRR8424610.fastq.gz	58960166	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/000/SRR8424610/SRR8424610.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/000/SRR8424610/SRR8424610.fastq.gz	9935717759208c936ce40c1a930103cb		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1542617											GSM3557207_r3			GSM3557207			46R_Abemaciclib_150.0						46R_Abemaciclib_150.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236578	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/000/SRR8424610	38657685	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/000/SRR8424610	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/000/SRR8424610	5cad4b5c237c9611ad6eca2ff434afb8	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424611	NextSeq 500 sequencing: GSM3557207: 46R_Abemaciclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719326									116676450									GEO																NextSeq 500 sequencing: GSM3557207: 46R_Abemaciclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233152	GSM3557207						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/001/SRR8424611/SRR8424611.fastq.gz	59166575	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/001/SRR8424611/SRR8424611.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/001/SRR8424611/SRR8424611.fastq.gz	7d0f33a6308765fc87023b66c78016f9		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1555686											GSM3557207_r4			GSM3557207			46R_Abemaciclib_150.0						46R_Abemaciclib_150.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236578	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/001/SRR8424611	38784207	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/001/SRR8424611	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/001/SRR8424611	b9fc71790adc5a047c20ee9b4de8c5ba	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424604	NextSeq 500 sequencing: GSM3557206: 46L_Abemaciclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719327									99000675									GEO																NextSeq 500 sequencing: GSM3557206: 46L_Abemaciclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233151	GSM3557206						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/004/SRR8424604/SRR8424604.fastq.gz	50023607	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/004/SRR8424604/SRR8424604.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/004/SRR8424604/SRR8424604.fastq.gz	4093334d6c1c0c567acb92d3ff9fc2b4		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1320009											GSM3557206_r1			GSM3557206			46L_Abemaciclib_150.0						46L_Abemaciclib_150.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236577	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/004/SRR8424604	32711023	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/004/SRR8424604	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/004/SRR8424604	6d5706b2e447a6ef0069a65ef04ec047	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424605	NextSeq 500 sequencing: GSM3557206: 46L_Abemaciclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719327									99795675									GEO																NextSeq 500 sequencing: GSM3557206: 46L_Abemaciclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233151	GSM3557206						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/005/SRR8424605/SRR8424605.fastq.gz	50542410	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/005/SRR8424605/SRR8424605.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/005/SRR8424605/SRR8424605.fastq.gz	31ffb907cecc15be00b71f7c6643219e		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1330609											GSM3557206_r2			GSM3557206			46L_Abemaciclib_150.0						46L_Abemaciclib_150.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236577	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/005/SRR8424605	33057388	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/005/SRR8424605	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/005/SRR8424605	83b18c5bb36d1ccd67629dc800be386a	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424606	NextSeq 500 sequencing: GSM3557206: 46L_Abemaciclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719327									100962075									GEO																NextSeq 500 sequencing: GSM3557206: 46L_Abemaciclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233151	GSM3557206						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/006/SRR8424606/SRR8424606.fastq.gz	51221129	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/006/SRR8424606/SRR8424606.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/006/SRR8424606/SRR8424606.fastq.gz	0f547fe46e63563a7e8ba5118fc5b5df		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1346161											GSM3557206_r3			GSM3557206			46L_Abemaciclib_150.0						46L_Abemaciclib_150.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236577	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/006/SRR8424606	33522718	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/006/SRR8424606	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/006/SRR8424606	da1d92cd60ab0746c05dd94b2e9b2b65	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424607	NextSeq 500 sequencing: GSM3557206: 46L_Abemaciclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719327									101812275									GEO																NextSeq 500 sequencing: GSM3557206: 46L_Abemaciclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233151	GSM3557206						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/007/SRR8424607/SRR8424607.fastq.gz	51424393	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/007/SRR8424607/SRR8424607.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/007/SRR8424607/SRR8424607.fastq.gz	11008a1016d4c99d041260995538f81e		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1357497											GSM3557206_r4			GSM3557206			46L_Abemaciclib_150.0						46L_Abemaciclib_150.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236577	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/007/SRR8424607	33635889	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/007/SRR8424607	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/007/SRR8424607	e679e2e647edce9bc88d7770729f1629	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424600	NextSeq 500 sequencing: GSM3557205: 45R_Vehicle Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719328									69670050									GEO																NextSeq 500 sequencing: GSM3557205: 45R_Vehicle Homo sapiens Mus musculus RNA-Seq										SRX5233150	GSM3557205						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/000/SRR8424600/SRR8424600.fastq.gz	35608751	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/000/SRR8424600/SRR8424600.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/000/SRR8424600/SRR8424600.fastq.gz	826c5c0dcbb1b43d873ffee802aa4225		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		928934											GSM3557205_r1			GSM3557205			45R_Vehicle						45R_Vehicle	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	CONTROL	CONTROL			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	0	mg/kg				9606	Homo sapiens		SRS4236576	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/000/SRR8424600	23418663	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/000/SRR8424600	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/000/SRR8424600	4b814c2c87e34d7456db3c22a7dc356b	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424601	NextSeq 500 sequencing: GSM3557205: 45R_Vehicle Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719328									70155675									GEO																NextSeq 500 sequencing: GSM3557205: 45R_Vehicle Homo sapiens Mus musculus RNA-Seq										SRX5233150	GSM3557205						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/001/SRR8424601/SRR8424601.fastq.gz	35951457	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/001/SRR8424601/SRR8424601.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/001/SRR8424601/SRR8424601.fastq.gz	87689019cef3d06b47eaf96cf7bd7b0a		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		935409											GSM3557205_r2			GSM3557205			45R_Vehicle						45R_Vehicle	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	CONTROL	CONTROL			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	0	mg/kg				9606	Homo sapiens		SRS4236576	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/001/SRR8424601	23648801	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/001/SRR8424601	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/001/SRR8424601	e2f0aa3a26dbfda69886c596f62ae893	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424602	NextSeq 500 sequencing: GSM3557205: 45R_Vehicle Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719328									71294250									GEO																NextSeq 500 sequencing: GSM3557205: 45R_Vehicle Homo sapiens Mus musculus RNA-Seq										SRX5233150	GSM3557205						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/002/SRR8424602/SRR8424602.fastq.gz	36578400	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/002/SRR8424602/SRR8424602.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/002/SRR8424602/SRR8424602.fastq.gz	d68d9bd31df7b65af76ca591ddca6db2		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		950590											GSM3557205_r3			GSM3557205			45R_Vehicle						45R_Vehicle	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	CONTROL	CONTROL			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	0	mg/kg				9606	Homo sapiens		SRS4236576	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/002/SRR8424602	24071448	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/002/SRR8424602	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/002/SRR8424602	3e34e36bacd6dc2a2bbd7ab0f65024eb	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424603	NextSeq 500 sequencing: GSM3557205: 45R_Vehicle Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719328									71633700									GEO																NextSeq 500 sequencing: GSM3557205: 45R_Vehicle Homo sapiens Mus musculus RNA-Seq										SRX5233150	GSM3557205						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/003/SRR8424603/SRR8424603.fastq.gz	36586041	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/003/SRR8424603/SRR8424603.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/003/SRR8424603/SRR8424603.fastq.gz	da409b9a48ce0741b1add62ecc401fde		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		955116											GSM3557205_r4			GSM3557205			45R_Vehicle						45R_Vehicle	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	CONTROL	CONTROL			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	0	mg/kg				9606	Homo sapiens		SRS4236576	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/003/SRR8424603	24071032	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/003/SRR8424603	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/003/SRR8424603	0e51a64185fcc3486e3abc2f012b8e42	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424596	NextSeq 500 sequencing: GSM3557204: 45L_Vehicle Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719329									102356850									GEO																NextSeq 500 sequencing: GSM3557204: 45L_Vehicle Homo sapiens Mus musculus RNA-Seq										SRX5233149	GSM3557204						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/006/SRR8424596/SRR8424596.fastq.gz	52532183	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/006/SRR8424596/SRR8424596.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/006/SRR8424596/SRR8424596.fastq.gz	3ee20758753d75ffb9c7e27b2f47c887		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1364758											GSM3557204_r1			GSM3557204			45L_Vehicle						45L_Vehicle	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	CONTROL	CONTROL			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	0	mg/kg				9606	Homo sapiens		SRS4236575	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/006/SRR8424596	34497875	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/006/SRR8424596	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/006/SRR8424596	2b13cd3ac294210f6ef6b7a796e12598	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424597	NextSeq 500 sequencing: GSM3557204: 45L_Vehicle Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719329									103584375									GEO																NextSeq 500 sequencing: GSM3557204: 45L_Vehicle Homo sapiens Mus musculus RNA-Seq										SRX5233149	GSM3557204						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/007/SRR8424597/SRR8424597.fastq.gz	53313525	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/007/SRR8424597/SRR8424597.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/007/SRR8424597/SRR8424597.fastq.gz	8f65e2c57ce0aed711ed541a67fda6f7		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1381125											GSM3557204_r2			GSM3557204			45L_Vehicle						45L_Vehicle	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	CONTROL	CONTROL			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	0	mg/kg				9606	Homo sapiens		SRS4236575	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/007/SRR8424597	35024651	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/007/SRR8424597	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/007/SRR8424597	60b9068704b6f45b12cb32b319339850	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424598	NextSeq 500 sequencing: GSM3557204: 45L_Vehicle Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719329									105221100									GEO																NextSeq 500 sequencing: GSM3557204: 45L_Vehicle Homo sapiens Mus musculus RNA-Seq										SRX5233149	GSM3557204						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/008/SRR8424598/SRR8424598.fastq.gz	54228679	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/008/SRR8424598/SRR8424598.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/008/SRR8424598/SRR8424598.fastq.gz	92f8f44180c110ed7d4c05ea219bb3cf		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1402948											GSM3557204_r3			GSM3557204			45L_Vehicle						45L_Vehicle	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	CONTROL	CONTROL			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	0	mg/kg				9606	Homo sapiens		SRS4236575	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/008/SRR8424598	35642761	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/008/SRR8424598	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/008/SRR8424598	e1dcd1e550500a9321ff8fc1aa7644d5	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424599	NextSeq 500 sequencing: GSM3557204: 45L_Vehicle Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719329									105819900									GEO																NextSeq 500 sequencing: GSM3557204: 45L_Vehicle Homo sapiens Mus musculus RNA-Seq										SRX5233149	GSM3557204						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/009/SRR8424599/SRR8424599.fastq.gz	54350180	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/009/SRR8424599/SRR8424599.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/009/SRR8424599/SRR8424599.fastq.gz	f58a6e93d59d93495f5c06f1e8e6233e		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1410932											GSM3557204_r4			GSM3557204			45L_Vehicle						45L_Vehicle	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	CONTROL	CONTROL			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	0	mg/kg				9606	Homo sapiens		SRS4236575	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/009/SRR8424599	35714300	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/009/SRR8424599	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/009/SRR8424599	4c5daf67b7456eb2b340e3a291d1f8a3	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424592	NextSeq 500 sequencing: GSM3557203: 44R_Abemaciclib_125.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719320									95829150									GEO																NextSeq 500 sequencing: GSM3557203: 44R_Abemaciclib_125.0 Homo sapiens Mus musculus RNA-Seq										SRX5233148	GSM3557203						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/002/SRR8424592/SRR8424592.fastq.gz	48876867	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/002/SRR8424592/SRR8424592.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/002/SRR8424592/SRR8424592.fastq.gz	e4f7e33af18bb88dee3482590a851aad		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1277722											GSM3557203_r1			GSM3557203			44R_Abemaciclib_125.0						44R_Abemaciclib_125.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	125	mg/kg				9606	Homo sapiens		SRS4236574	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/002/SRR8424592	32043276	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/002/SRR8424592	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/002/SRR8424592	56a9d8653bd34001e533c6248494d59b	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424593	NextSeq 500 sequencing: GSM3557203: 44R_Abemaciclib_125.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719320									96705975									GEO																NextSeq 500 sequencing: GSM3557203: 44R_Abemaciclib_125.0 Homo sapiens Mus musculus RNA-Seq										SRX5233148	GSM3557203						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/003/SRR8424593/SRR8424593.fastq.gz	49434869	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/003/SRR8424593/SRR8424593.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/003/SRR8424593/SRR8424593.fastq.gz	72291466e976b386883ec81c74709c6b		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1289413											GSM3557203_r2			GSM3557203			44R_Abemaciclib_125.0						44R_Abemaciclib_125.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	125	mg/kg				9606	Homo sapiens		SRS4236574	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/003/SRR8424593	32416003	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/003/SRR8424593	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/003/SRR8424593	13ae1eae2c9f0e0ab242784552d78eff	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424594	NextSeq 500 sequencing: GSM3557203: 44R_Abemaciclib_125.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719320									98103150									GEO																NextSeq 500 sequencing: GSM3557203: 44R_Abemaciclib_125.0 Homo sapiens Mus musculus RNA-Seq										SRX5233148	GSM3557203						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/004/SRR8424594/SRR8424594.fastq.gz	50265484	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/004/SRR8424594/SRR8424594.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/004/SRR8424594/SRR8424594.fastq.gz	5fea585513897a5e72e45a637db53354		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1308042											GSM3557203_r3			GSM3557203			44R_Abemaciclib_125.0						44R_Abemaciclib_125.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	125	mg/kg				9606	Homo sapiens		SRS4236574	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/004/SRR8424594	32981124	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/004/SRR8424594	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/004/SRR8424594	9dde8c57a3152eeb0fa8c8449f27c9a1	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424595	NextSeq 500 sequencing: GSM3557203: 44R_Abemaciclib_125.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719320									98820675									GEO																NextSeq 500 sequencing: GSM3557203: 44R_Abemaciclib_125.0 Homo sapiens Mus musculus RNA-Seq										SRX5233148	GSM3557203						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/005/SRR8424595/SRR8424595.fastq.gz	50374153	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/005/SRR8424595/SRR8424595.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/005/SRR8424595/SRR8424595.fastq.gz	6342ae4ba35ca8acbaff8a55400df5fc		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1317609											GSM3557203_r4			GSM3557203			44R_Abemaciclib_125.0						44R_Abemaciclib_125.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	125	mg/kg				9606	Homo sapiens		SRS4236574	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/005/SRR8424595	33036086	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/005/SRR8424595	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/005/SRR8424595	ff578188951a3a0ec805533437131b36	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424588	NextSeq 500 sequencing: GSM3557202: 44L_Abemaciclib_125.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719321									78611925									GEO																NextSeq 500 sequencing: GSM3557202: 44L_Abemaciclib_125.0 Homo sapiens Mus musculus RNA-Seq										SRX5233147	GSM3557202						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/008/SRR8424588/SRR8424588.fastq.gz	39942202	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/008/SRR8424588/SRR8424588.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/008/SRR8424588/SRR8424588.fastq.gz	8c7442033857f3a6de586f3066e27170		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1048159											GSM3557202_r1			GSM3557202			44L_Abemaciclib_125.0						44L_Abemaciclib_125.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	125	mg/kg				9606	Homo sapiens		SRS4236573	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/008/SRR8424588	26138923	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/008/SRR8424588	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/008/SRR8424588	dc8a022329d3748468064cbed6293555	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424589	NextSeq 500 sequencing: GSM3557202: 44L_Abemaciclib_125.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719321									79355625									GEO																NextSeq 500 sequencing: GSM3557202: 44L_Abemaciclib_125.0 Homo sapiens Mus musculus RNA-Seq										SRX5233147	GSM3557202						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/009/SRR8424589/SRR8424589.fastq.gz	40430125	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/009/SRR8424589/SRR8424589.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/009/SRR8424589/SRR8424589.fastq.gz	23696cbf8f78edbccc6513dfcf1ff263		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1058075											GSM3557202_r2			GSM3557202			44L_Abemaciclib_125.0						44L_Abemaciclib_125.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	125	mg/kg				9606	Homo sapiens		SRS4236573	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/009/SRR8424589	26469811	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/009/SRR8424589	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/009/SRR8424589	f54c9e112685a5856ec2a2865f0751fb	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424590	NextSeq 500 sequencing: GSM3557202: 44L_Abemaciclib_125.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719321									80373600									GEO																NextSeq 500 sequencing: GSM3557202: 44L_Abemaciclib_125.0 Homo sapiens Mus musculus RNA-Seq										SRX5233147	GSM3557202						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/000/SRR8424590/SRR8424590.fastq.gz	41018070	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/000/SRR8424590/SRR8424590.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/000/SRR8424590/SRR8424590.fastq.gz	fff6c43284540c9663a7543c72d19cf7		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1071648											GSM3557202_r3			GSM3557202			44L_Abemaciclib_125.0						44L_Abemaciclib_125.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	125	mg/kg				9606	Homo sapiens		SRS4236573	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/000/SRR8424590	26864399	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/000/SRR8424590	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/000/SRR8424590	6e0e2355587ef812711ce6a1e6f2965e	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424591	NextSeq 500 sequencing: GSM3557202: 44L_Abemaciclib_125.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719321									80909775									GEO																NextSeq 500 sequencing: GSM3557202: 44L_Abemaciclib_125.0 Homo sapiens Mus musculus RNA-Seq										SRX5233147	GSM3557202						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/001/SRR8424591/SRR8424591.fastq.gz	41123152	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/001/SRR8424591/SRR8424591.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/001/SRR8424591/SRR8424591.fastq.gz	10b26875d91e137a352109278799d646		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1078797											GSM3557202_r4			GSM3557202			44L_Abemaciclib_125.0						44L_Abemaciclib_125.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	125	mg/kg				9606	Homo sapiens		SRS4236573	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/001/SRR8424591	26924501	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/001/SRR8424591	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/001/SRR8424591	39dd7ea9b3f67b53daefcfaeafc07bcc	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424584	NextSeq 500 sequencing: GSM3557201: 43R_Abemaciclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719322									53431200									GEO																NextSeq 500 sequencing: GSM3557201: 43R_Abemaciclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233146	GSM3557201						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/004/SRR8424584/SRR8424584.fastq.gz	27175954	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/004/SRR8424584/SRR8424584.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/004/SRR8424584/SRR8424584.fastq.gz	07f2fe6dcc33580997dcabf3d7e41b4c		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		712416											GSM3557201_r1			GSM3557201			43R_Abemaciclib_150.0						43R_Abemaciclib_150.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236572	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/004/SRR8424584	17870579	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/004/SRR8424584	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/004/SRR8424584	c688c6230f8003e77e4aa933530012e8	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424585	NextSeq 500 sequencing: GSM3557201: 43R_Abemaciclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719322									53968425									GEO																NextSeq 500 sequencing: GSM3557201: 43R_Abemaciclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233146	GSM3557201						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/005/SRR8424585/SRR8424585.fastq.gz	27528202	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/005/SRR8424585/SRR8424585.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/005/SRR8424585/SRR8424585.fastq.gz	d405fa9489d84076eb196efbcbe4fa3e		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		719579											GSM3557201_r2			GSM3557201			43R_Abemaciclib_150.0						43R_Abemaciclib_150.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236572	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/005/SRR8424585	18106338	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/005/SRR8424585	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/005/SRR8424585	3bb3ff10f1fdb8539f4afd52867b29c4	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424586	NextSeq 500 sequencing: GSM3557201: 43R_Abemaciclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719322									54644550									GEO																NextSeq 500 sequencing: GSM3557201: 43R_Abemaciclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233146	GSM3557201						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/006/SRR8424586/SRR8424586.fastq.gz	27944495	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/006/SRR8424586/SRR8424586.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/006/SRR8424586/SRR8424586.fastq.gz	4e0ed4d062c7dbf82a897d5922fb70c2		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		728594											GSM3557201_r3			GSM3557201			43R_Abemaciclib_150.0						43R_Abemaciclib_150.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236572	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/006/SRR8424586	18391182	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/006/SRR8424586	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/006/SRR8424586	623f309cdb85e34551a06a0d27c3beac	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424587	NextSeq 500 sequencing: GSM3557201: 43R_Abemaciclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719322									54925650									GEO																NextSeq 500 sequencing: GSM3557201: 43R_Abemaciclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233146	GSM3557201						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/007/SRR8424587/SRR8424587.fastq.gz	27944522	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/007/SRR8424587/SRR8424587.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/007/SRR8424587/SRR8424587.fastq.gz	e7c977f7835d8253766d0447bad6ea97		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		732342											GSM3557201_r4			GSM3557201			43R_Abemaciclib_150.0						43R_Abemaciclib_150.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236572	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/007/SRR8424587	18387348	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/007/SRR8424587	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/007/SRR8424587	82cd39b7616f1391267442e4bd6e1fd1	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424580	NextSeq 500 sequencing: GSM3557200: 43L_Abemaciclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719323									81205575									GEO																NextSeq 500 sequencing: GSM3557200: 43L_Abemaciclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233145	GSM3557200						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/000/SRR8424580/SRR8424580.fastq.gz	40877380	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/000/SRR8424580/SRR8424580.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/000/SRR8424580/SRR8424580.fastq.gz	0a5102b89ad8ffeadabc25b6a3952b0b		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1082741											GSM3557200_r1			GSM3557200			43L_Abemaciclib_150.0						43L_Abemaciclib_150.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236571	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/000/SRR8424580	26754920	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/000/SRR8424580	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/000/SRR8424580	7f5d7c4cc38701e84fda898ad20c1b26	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424581	NextSeq 500 sequencing: GSM3557200: 43L_Abemaciclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719323									81632625									GEO																NextSeq 500 sequencing: GSM3557200: 43L_Abemaciclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233145	GSM3557200						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/001/SRR8424581/SRR8424581.fastq.gz	41204151	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/001/SRR8424581/SRR8424581.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/001/SRR8424581/SRR8424581.fastq.gz	7e459de539ef48e32ea3c28bc87241fd		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1088435											GSM3557200_r2			GSM3557200			43L_Abemaciclib_150.0						43L_Abemaciclib_150.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236571	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/001/SRR8424581	26983524	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/001/SRR8424581	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/001/SRR8424581	e0d7673008ac8dbcc1fe14fd62498ef4	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424582	NextSeq 500 sequencing: GSM3557200: 43L_Abemaciclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719323									82812450									GEO																NextSeq 500 sequencing: GSM3557200: 43L_Abemaciclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233145	GSM3557200						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/002/SRR8424582/SRR8424582.fastq.gz	41849101	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/002/SRR8424582/SRR8424582.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/002/SRR8424582/SRR8424582.fastq.gz	8a504adddea8b764b9badf38e95b0043		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1104166											GSM3557200_r3			GSM3557200			43L_Abemaciclib_150.0						43L_Abemaciclib_150.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236571	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/002/SRR8424582	27415725	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/002/SRR8424582	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/002/SRR8424582	1d5fbb6388d5a526e39949cc041c254a	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424583	NextSeq 500 sequencing: GSM3557200: 43L_Abemaciclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719323									83333175									GEO																NextSeq 500 sequencing: GSM3557200: 43L_Abemaciclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233145	GSM3557200						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/003/SRR8424583/SRR8424583.fastq.gz	41920277	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/003/SRR8424583/SRR8424583.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/003/SRR8424583/SRR8424583.fastq.gz	1c7d765b16dd989bff0e74db59fc9f06		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1111109											GSM3557200_r4			GSM3557200			43L_Abemaciclib_150.0						43L_Abemaciclib_150.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236571	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/003/SRR8424583	27452229	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/003/SRR8424583	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/003/SRR8424583	b98f6056ef2dc865af6d6c532a646946	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424576	NextSeq 500 sequencing: GSM3557199: 42R_Abemaciclib_100.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719324									94671675									GEO																NextSeq 500 sequencing: GSM3557199: 42R_Abemaciclib_100.0 Homo sapiens Mus musculus RNA-Seq										SRX5233144	GSM3557199						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/006/SRR8424576/SRR8424576.fastq.gz	47784133	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/006/SRR8424576/SRR8424576.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/006/SRR8424576/SRR8424576.fastq.gz	70f79a0ff581ff03af1e3806b63fa019		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1262289											GSM3557199_r1			GSM3557199			42R_Abemaciclib_100.0						42R_Abemaciclib_100.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	100	mg/kg				9606	Homo sapiens		SRS4236570	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/006/SRR8424576	31256263	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/006/SRR8424576	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/006/SRR8424576	d08fdfecae9f7c6fd9fd59d7cb326d97	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424577	NextSeq 500 sequencing: GSM3557199: 42R_Abemaciclib_100.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719324									95631225									GEO																NextSeq 500 sequencing: GSM3557199: 42R_Abemaciclib_100.0 Homo sapiens Mus musculus RNA-Seq										SRX5233144	GSM3557199						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/007/SRR8424577/SRR8424577.fastq.gz	48355409	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/007/SRR8424577/SRR8424577.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/007/SRR8424577/SRR8424577.fastq.gz	c47c73136b12cab43adbdd45027db218		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1275083											GSM3557199_r2			GSM3557199			42R_Abemaciclib_100.0						42R_Abemaciclib_100.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	100	mg/kg				9606	Homo sapiens		SRS4236570	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/007/SRR8424577	31642718	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/007/SRR8424577	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/007/SRR8424577	61acb13dc5f32aa3fa0037cd5292835e	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424578	NextSeq 500 sequencing: GSM3557199: 42R_Abemaciclib_100.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719324									96844800									GEO																NextSeq 500 sequencing: GSM3557199: 42R_Abemaciclib_100.0 Homo sapiens Mus musculus RNA-Seq										SRX5233144	GSM3557199						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/008/SRR8424578/SRR8424578.fastq.gz	49066690	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/008/SRR8424578/SRR8424578.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/008/SRR8424578/SRR8424578.fastq.gz	a71070cf13c8912aa1e81c0543a3afdc		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1291264											GSM3557199_r3			GSM3557199			42R_Abemaciclib_100.0						42R_Abemaciclib_100.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	100	mg/kg				9606	Homo sapiens		SRS4236570	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/008/SRR8424578	32121440	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/008/SRR8424578	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/008/SRR8424578	39ce70563fb8c467b2ae3c709524a9c3	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424579	NextSeq 500 sequencing: GSM3557199: 42R_Abemaciclib_100.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719324									97354800									GEO																NextSeq 500 sequencing: GSM3557199: 42R_Abemaciclib_100.0 Homo sapiens Mus musculus RNA-Seq										SRX5233144	GSM3557199						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/009/SRR8424579/SRR8424579.fastq.gz	49075260	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/009/SRR8424579/SRR8424579.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/009/SRR8424579/SRR8424579.fastq.gz	40a3a77829c7ce6bb7476ab866142b80		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1298064											GSM3557199_r4			GSM3557199			42R_Abemaciclib_100.0						42R_Abemaciclib_100.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	100	mg/kg				9606	Homo sapiens		SRS4236570	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/009/SRR8424579	32110585	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/009/SRR8424579	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/009/SRR8424579	badc7f277f3e92de78afc9d1ef589140	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424572	NextSeq 500 sequencing: GSM3557198: 42L_Abemaciclib_100.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719285									89494125									GEO																NextSeq 500 sequencing: GSM3557198: 42L_Abemaciclib_100.0 Homo sapiens Mus musculus RNA-Seq										SRX5233143	GSM3557198						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/002/SRR8424572/SRR8424572.fastq.gz	45012950	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/002/SRR8424572/SRR8424572.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/002/SRR8424572/SRR8424572.fastq.gz	5078abe2dbdc46396eb4f09268ee3f1d		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1193255											GSM3557198_r1			GSM3557198			42L_Abemaciclib_100.0						42L_Abemaciclib_100.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	100	mg/kg				9606	Homo sapiens		SRS4236569	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/002/SRR8424572	29470908	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/002/SRR8424572	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/002/SRR8424572	485636df2cdcc4f7df3308020bbffe4d	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424573	NextSeq 500 sequencing: GSM3557198: 42L_Abemaciclib_100.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719285									90235575									GEO																NextSeq 500 sequencing: GSM3557198: 42L_Abemaciclib_100.0 Homo sapiens Mus musculus RNA-Seq										SRX5233143	GSM3557198						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/003/SRR8424573/SRR8424573.fastq.gz	45491279	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/003/SRR8424573/SRR8424573.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/003/SRR8424573/SRR8424573.fastq.gz	960a87b97074b672aaf45b8ec336efa0		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1203141											GSM3557198_r2			GSM3557198			42L_Abemaciclib_100.0						42L_Abemaciclib_100.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	100	mg/kg				9606	Homo sapiens		SRS4236569	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/003/SRR8424573	29798381	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/003/SRR8424573	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/003/SRR8424573	f79fc03c7d9a0c93f3e162346885ef06	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424574	NextSeq 500 sequencing: GSM3557198: 42L_Abemaciclib_100.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719285									91384425									GEO																NextSeq 500 sequencing: GSM3557198: 42L_Abemaciclib_100.0 Homo sapiens Mus musculus RNA-Seq										SRX5233143	GSM3557198						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/004/SRR8424574/SRR8424574.fastq.gz	46129827	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/004/SRR8424574/SRR8424574.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/004/SRR8424574/SRR8424574.fastq.gz	f08522046522a95d180bfd75edf6b1b9		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1218459											GSM3557198_r3			GSM3557198			42L_Abemaciclib_100.0						42L_Abemaciclib_100.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	100	mg/kg				9606	Homo sapiens		SRS4236569	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/004/SRR8424574	30227357	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/004/SRR8424574	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/004/SRR8424574	8fde1ac647d567c0409a2a0ac4db2ce2	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424575	NextSeq 500 sequencing: GSM3557198: 42L_Abemaciclib_100.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719285									91996425									GEO																NextSeq 500 sequencing: GSM3557198: 42L_Abemaciclib_100.0 Homo sapiens Mus musculus RNA-Seq										SRX5233143	GSM3557198						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/005/SRR8424575/SRR8424575.fastq.gz	46235647	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/005/SRR8424575/SRR8424575.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/005/SRR8424575/SRR8424575.fastq.gz	8b7f978e4ecfdabbde57793207d4aa27		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1226619											GSM3557198_r4			GSM3557198			42L_Abemaciclib_100.0						42L_Abemaciclib_100.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	100	mg/kg				9606	Homo sapiens		SRS4236569	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/005/SRR8424575	30284563	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/005/SRR8424575	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/005/SRR8424575	791f98bab226da4e1f0c9207b7826319	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424568	NextSeq 500 sequencing: GSM3557197: 41R_Palbociclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719286									91554750									GEO																NextSeq 500 sequencing: GSM3557197: 41R_Palbociclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233142	GSM3557197						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/008/SRR8424568/SRR8424568.fastq.gz	46291183	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/008/SRR8424568/SRR8424568.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/008/SRR8424568/SRR8424568.fastq.gz	29f37b8d52819ee05edd3e16e56a4a6b		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1220730											GSM3557197_r1			GSM3557197			41R_Palbociclib_150.0						41R_Palbociclib_150.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	PALBOCICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236568	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/008/SRR8424568	30346915	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/008/SRR8424568	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/008/SRR8424568	94a31daadc862712c0cbda0b20df6c24	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424569	NextSeq 500 sequencing: GSM3557197: 41R_Palbociclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719286									92386200									GEO																NextSeq 500 sequencing: GSM3557197: 41R_Palbociclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233142	GSM3557197						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/009/SRR8424569/SRR8424569.fastq.gz	46819608	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/009/SRR8424569/SRR8424569.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/009/SRR8424569/SRR8424569.fastq.gz	cc4c1af9d72dda3914ec4d19d153d79b		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1231816											GSM3557197_r2			GSM3557197			41R_Palbociclib_150.0						41R_Palbociclib_150.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	PALBOCICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236568	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/009/SRR8424569	30706691	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/009/SRR8424569	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/009/SRR8424569	b54259b0fb07b182496a49796c4517ec	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424570	NextSeq 500 sequencing: GSM3557197: 41R_Palbociclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719286									93612300									GEO																NextSeq 500 sequencing: GSM3557197: 41R_Palbociclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233142	GSM3557197						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/000/SRR8424570/SRR8424570.fastq.gz	47497881	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/000/SRR8424570/SRR8424570.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/000/SRR8424570/SRR8424570.fastq.gz	66f40fe647d1d01b574d829f42487231		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1248164											GSM3557197_r3			GSM3557197			41R_Palbociclib_150.0						41R_Palbociclib_150.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	PALBOCICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236568	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/000/SRR8424570	31163520	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/000/SRR8424570	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/000/SRR8424570	4ed077e786a6a2a5134596e8cc27be9f	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424571	NextSeq 500 sequencing: GSM3557197: 41R_Palbociclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719286									94158000									GEO																NextSeq 500 sequencing: GSM3557197: 41R_Palbociclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233142	GSM3557197						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/001/SRR8424571/SRR8424571.fastq.gz	47556086	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/001/SRR8424571/SRR8424571.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/001/SRR8424571/SRR8424571.fastq.gz	0dc0d11c64406f0ebafbf1dc45be8d69		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1255440											GSM3557197_r4			GSM3557197			41R_Palbociclib_150.0						41R_Palbociclib_150.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	PALBOCICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236568	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/001/SRR8424571	31193314	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/001/SRR8424571	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/001/SRR8424571	00367f3b763c39755570aee65451d612	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424564	NextSeq 500 sequencing: GSM3557196: 40R_Palbociclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719287									115787400									GEO																NextSeq 500 sequencing: GSM3557196: 40R_Palbociclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233141	GSM3557196						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/004/SRR8424564/SRR8424564.fastq.gz	58748150	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/004/SRR8424564/SRR8424564.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/004/SRR8424564/SRR8424564.fastq.gz	5cd7ffc48cad3030d7ad49e942015e5f		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1543832											GSM3557196_r1			GSM3557196			40R_Palbociclib_150.0						40R_Palbociclib_150.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	PALBOCICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236567	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/004/SRR8424564	38543554	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/004/SRR8424564	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/004/SRR8424564	b776b1f10adbfc3aa2c9e9ceac730b1f	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424565	NextSeq 500 sequencing: GSM3557196: 40R_Palbociclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719287									117008100									GEO																NextSeq 500 sequencing: GSM3557196: 40R_Palbociclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233141	GSM3557196						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/005/SRR8424565/SRR8424565.fastq.gz	59534102	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/005/SRR8424565/SRR8424565.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/005/SRR8424565/SRR8424565.fastq.gz	34789c31217e4fb2063775d87feee685		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1560108											GSM3557196_r2			GSM3557196			40R_Palbociclib_150.0						40R_Palbociclib_150.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	PALBOCICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236567	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/005/SRR8424565	39081162	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/005/SRR8424565	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/005/SRR8424565	0432303ca437a09fe8684b6dd749ff9f	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424566	NextSeq 500 sequencing: GSM3557196: 40R_Palbociclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719287									118179225									GEO																NextSeq 500 sequencing: GSM3557196: 40R_Palbociclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233141	GSM3557196						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/006/SRR8424566/SRR8424566.fastq.gz	60158892	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/006/SRR8424566/SRR8424566.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/006/SRR8424566/SRR8424566.fastq.gz	140fd026414af71eca7e0197742ecafd		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1575723											GSM3557196_r3			GSM3557196			40R_Palbociclib_150.0						40R_Palbociclib_150.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	PALBOCICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236567	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/006/SRR8424566	39502504	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/006/SRR8424566	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/006/SRR8424566	a0d74042384c73c606b88ce79e180436	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424567	NextSeq 500 sequencing: GSM3557196: 40R_Palbociclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719287									119138325									GEO																NextSeq 500 sequencing: GSM3557196: 40R_Palbociclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233141	GSM3557196						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/007/SRR8424567/SRR8424567.fastq.gz	60408007	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/007/SRR8424567/SRR8424567.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/007/SRR8424567/SRR8424567.fastq.gz	a10c6df8491323cd7a672668d8bddb7b		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1588511											GSM3557196_r4			GSM3557196			40R_Palbociclib_150.0						40R_Palbociclib_150.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	PALBOCICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236567	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/007/SRR8424567	39657984	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/007/SRR8424567	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/007/SRR8424567	46ae3a9b4655c894c448d974d3cb459a	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424560	NextSeq 500 sequencing: GSM3557195: 40L_Palbociclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719288									83967750									GEO																NextSeq 500 sequencing: GSM3557195: 40L_Palbociclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233140	GSM3557195						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/000/SRR8424560/SRR8424560.fastq.gz	42272026	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/000/SRR8424560/SRR8424560.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/000/SRR8424560/SRR8424560.fastq.gz	e982a6196b030873f42b253013de8217		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1119570											GSM3557195_r1			GSM3557195			40L_Palbociclib_150.0						40L_Palbociclib_150.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	PALBOCICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236566	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/000/SRR8424560	27870497	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/000/SRR8424560	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/000/SRR8424560	c5b0f8696ed163cbc8a4c11234339829	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424561	NextSeq 500 sequencing: GSM3557195: 40L_Palbociclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719288									84678000									GEO																NextSeq 500 sequencing: GSM3557195: 40L_Palbociclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233140	GSM3557195						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/001/SRR8424561/SRR8424561.fastq.gz	42729861	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/001/SRR8424561/SRR8424561.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/001/SRR8424561/SRR8424561.fastq.gz	5da7b33ad3fa137a463804b3a34f35ae		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1129040											GSM3557195_r2			GSM3557195			40L_Palbociclib_150.0						40L_Palbociclib_150.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	PALBOCICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236566	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/001/SRR8424561	28180990	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/001/SRR8424561	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/001/SRR8424561	95eb3b0b33309cb49fbd76ee869ea404	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424562	NextSeq 500 sequencing: GSM3557195: 40L_Palbociclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719288									85708200									GEO																NextSeq 500 sequencing: GSM3557195: 40L_Palbociclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233140	GSM3557195						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/002/SRR8424562/SRR8424562.fastq.gz	43323130	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/002/SRR8424562/SRR8424562.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/002/SRR8424562/SRR8424562.fastq.gz	8f61879f37ffe4ca6075161c00a807fd		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1142776											GSM3557195_r3			GSM3557195			40L_Palbociclib_150.0						40L_Palbociclib_150.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	PALBOCICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236566	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/002/SRR8424562	28585841	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/002/SRR8424562	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/002/SRR8424562	735ef0c68872a7cae1c3908d98e16d5e	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424563	NextSeq 500 sequencing: GSM3557195: 40L_Palbociclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719288									86465100									GEO																NextSeq 500 sequencing: GSM3557195: 40L_Palbociclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233140	GSM3557195						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/003/SRR8424563/SRR8424563.fastq.gz	43484552	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/003/SRR8424563/SRR8424563.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/003/SRR8424563/SRR8424563.fastq.gz	9a37ac82a5a0878cd6ba0659c97638d7		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1152868											GSM3557195_r4			GSM3557195			40L_Palbociclib_150.0						40L_Palbociclib_150.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	PALBOCICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236566	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/003/SRR8424563	28680921	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/003/SRR8424563	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/003/SRR8424563	2ba93738c9dcf547e63a3cb692d2f637	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424556	NextSeq 500 sequencing: GSM3557194: 39R_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719289									73116000									GEO																NextSeq 500 sequencing: GSM3557194: 39R_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233139	GSM3557194						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/006/SRR8424556/SRR8424556.fastq.gz	36952049	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/006/SRR8424556/SRR8424556.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/006/SRR8424556/SRR8424556.fastq.gz	c2ad7128a64b5602fcfbc2568b8178e6		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		974880											GSM3557194_r1			GSM3557194			39R_Ribociclib_150.0						39R_Ribociclib_150.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	RIBOCICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236565	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/006/SRR8424556	24181816	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/006/SRR8424556	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/006/SRR8424556	ed53e57fe5f3891fad87ff1425395ff0	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424557	NextSeq 500 sequencing: GSM3557194: 39R_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719289									73898325									GEO																NextSeq 500 sequencing: GSM3557194: 39R_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233139	GSM3557194						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/007/SRR8424557/SRR8424557.fastq.gz	37435040	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/007/SRR8424557/SRR8424557.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/007/SRR8424557/SRR8424557.fastq.gz	92a78ee654df56916a5312a107d53c45		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		985311											GSM3557194_r2			GSM3557194			39R_Ribociclib_150.0						39R_Ribociclib_150.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	RIBOCICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236565	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/007/SRR8424557	24511772	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/007/SRR8424557	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/007/SRR8424557	7abcc60eb697b8e23dddfc82382ba779	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424558	NextSeq 500 sequencing: GSM3557194: 39R_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719289									74917725									GEO																NextSeq 500 sequencing: GSM3557194: 39R_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233139	GSM3557194						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/008/SRR8424558/SRR8424558.fastq.gz	38001597	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/008/SRR8424558/SRR8424558.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/008/SRR8424558/SRR8424558.fastq.gz	428a9dbaa8475a40aa93bcc6c473ec52		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		998903											GSM3557194_r3			GSM3557194			39R_Ribociclib_150.0						39R_Ribociclib_150.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	RIBOCICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236565	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/008/SRR8424558	24893634	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/008/SRR8424558	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/008/SRR8424558	542f1de8e97d6ce8e2c37cea5f0b7063	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424559	NextSeq 500 sequencing: GSM3557194: 39R_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719289									75303450									GEO																NextSeq 500 sequencing: GSM3557194: 39R_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233139	GSM3557194						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/009/SRR8424559/SRR8424559.fastq.gz	38041588	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/009/SRR8424559/SRR8424559.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/009/SRR8424559/SRR8424559.fastq.gz	dd5a4bc0e4905a504626314c000342bb		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1004046											GSM3557194_r4			GSM3557194			39R_Ribociclib_150.0						39R_Ribociclib_150.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	RIBOCICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236565	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/009/SRR8424559	24913314	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/009/SRR8424559	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/009/SRR8424559	bf58ea22ab3c490578c9c1277a92a01a	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424552	NextSeq 500 sequencing: GSM3557193: 39L_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719290									78314100									GEO																NextSeq 500 sequencing: GSM3557193: 39L_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233138	GSM3557193						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/002/SRR8424552/SRR8424552.fastq.gz	39390630	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/002/SRR8424552/SRR8424552.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/002/SRR8424552/SRR8424552.fastq.gz	a0b8811f630b6487892c1f5468d2f4e3		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1044188											GSM3557193_r1			GSM3557193			39L_Ribociclib_150.0						39L_Ribociclib_150.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	RIBOCICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236564	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/002/SRR8424552	25753069	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/002/SRR8424552	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/002/SRR8424552	82080e991506be5996042dfc0d703c52	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424553	NextSeq 500 sequencing: GSM3557193: 39L_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719290									78941700									GEO																NextSeq 500 sequencing: GSM3557193: 39L_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233138	GSM3557193						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/003/SRR8424553/SRR8424553.fastq.gz	39794679	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/003/SRR8424553/SRR8424553.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/003/SRR8424553/SRR8424553.fastq.gz	3f1560ecc655245bcbf650a213a22492		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1052556											GSM3557193_r2			GSM3557193			39L_Ribociclib_150.0						39L_Ribociclib_150.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	RIBOCICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236564	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/003/SRR8424553	26028677	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/003/SRR8424553	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/003/SRR8424553	6028b961037ba6951d12eb378379bc3e	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424554	NextSeq 500 sequencing: GSM3557193: 39L_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719290									80030025									GEO																NextSeq 500 sequencing: GSM3557193: 39L_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233138	GSM3557193						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/004/SRR8424554/SRR8424554.fastq.gz	40423229	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/004/SRR8424554/SRR8424554.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/004/SRR8424554/SRR8424554.fastq.gz	778b9450a0a55da552a98b57d2e1568a		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1067067											GSM3557193_r3			GSM3557193			39L_Ribociclib_150.0						39L_Ribociclib_150.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	RIBOCICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236564	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/004/SRR8424554	26453277	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/004/SRR8424554	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/004/SRR8424554	e7c4571d10687b175ec1457d4fa6aff3	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424555	NextSeq 500 sequencing: GSM3557193: 39L_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719290									80521800									GEO																NextSeq 500 sequencing: GSM3557193: 39L_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233138	GSM3557193						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/005/SRR8424555/SRR8424555.fastq.gz	40491482	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/005/SRR8424555/SRR8424555.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/005/SRR8424555/SRR8424555.fastq.gz	0578b8c8eceacba1c0018bfd8d9fc374		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1073624											GSM3557193_r4			GSM3557193			39L_Ribociclib_150.0						39L_Ribociclib_150.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	RIBOCICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236564	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/005/SRR8424555	26485421	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/005/SRR8424555	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/005/SRR8424555	62dd8c350899b64e2ac84e5632ffa2e6	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424548	NextSeq 500 sequencing: GSM3557192: 38R_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719291									92005050									GEO																NextSeq 500 sequencing: GSM3557192: 38R_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233137	GSM3557192						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/008/SRR8424548/SRR8424548.fastq.gz	46309613	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/008/SRR8424548/SRR8424548.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/008/SRR8424548/SRR8424548.fastq.gz	babc95619a0006baf0b8c67b7abddb01		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1226734											GSM3557192_r1			GSM3557192			38R_Ribociclib_150.0						38R_Ribociclib_150.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	RIBOCICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236563	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/008/SRR8424548	30302678	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/008/SRR8424548	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/008/SRR8424548	67b9d04a31ebbf3896541b7ce8dd0355	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424549	NextSeq 500 sequencing: GSM3557192: 38R_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719291									93093750									GEO																NextSeq 500 sequencing: GSM3557192: 38R_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233137	GSM3557192						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/009/SRR8424549/SRR8424549.fastq.gz	46984848	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/009/SRR8424549/SRR8424549.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/009/SRR8424549/SRR8424549.fastq.gz	46bc121678caa1fb3cf4f09a8e3bfd65		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1241250											GSM3557192_r2			GSM3557192			38R_Ribociclib_150.0						38R_Ribociclib_150.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	RIBOCICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236563	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/009/SRR8424549	30759165	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/009/SRR8424549	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/009/SRR8424549	1e86d8567b76d4dff8330c0c6c119394	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424550	NextSeq 500 sequencing: GSM3557192: 38R_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719291									94046700									GEO																NextSeq 500 sequencing: GSM3557192: 38R_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233137	GSM3557192						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/000/SRR8424550/SRR8424550.fastq.gz	47538416	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/000/SRR8424550/SRR8424550.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/000/SRR8424550/SRR8424550.fastq.gz	5dfe40077ad79090f3abb2d75e6242bf		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1253956											GSM3557192_r3			GSM3557192			38R_Ribociclib_150.0						38R_Ribociclib_150.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	RIBOCICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236563	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/000/SRR8424550	31133220	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/000/SRR8424550	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/000/SRR8424550	b628b22aee5e17cc6de68b241139e6e6	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424551	NextSeq 500 sequencing: GSM3557192: 38R_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719291									94814475									GEO																NextSeq 500 sequencing: GSM3557192: 38R_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233137	GSM3557192						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/001/SRR8424551/SRR8424551.fastq.gz	47714253	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/001/SRR8424551/SRR8424551.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/001/SRR8424551/SRR8424551.fastq.gz	290a1a91ef943900238e8fd2f601d8f8		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1264193											GSM3557192_r4			GSM3557192			38R_Ribociclib_150.0						38R_Ribociclib_150.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	RIBOCICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236563	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/001/SRR8424551	31238603	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/001/SRR8424551	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/001/SRR8424551	8ab74c0f6290755542f0126c3bcb3b93	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424544	NextSeq 500 sequencing: GSM3557191: 38L_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719292									86841225									GEO																NextSeq 500 sequencing: GSM3557191: 38L_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233136	GSM3557191						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/004/SRR8424544/SRR8424544.fastq.gz	43907253	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/004/SRR8424544/SRR8424544.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/004/SRR8424544/SRR8424544.fastq.gz	1cba2976659f1b6b07f22443c024dbd3		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1157883											GSM3557191_r1			GSM3557191			38L_Ribociclib_150.0						38L_Ribociclib_150.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	RIBOCICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236562	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/004/SRR8424544	28730118	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/004/SRR8424544	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/004/SRR8424544	8507e2ba5840d9a19850cd074d04f578	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424545	NextSeq 500 sequencing: GSM3557191: 38L_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719292									87790575									GEO																NextSeq 500 sequencing: GSM3557191: 38L_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233136	GSM3557191						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/005/SRR8424545/SRR8424545.fastq.gz	44488724	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/005/SRR8424545/SRR8424545.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/005/SRR8424545/SRR8424545.fastq.gz	09f90c2c65acb26790bea713db78e627		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1170541											GSM3557191_r2			GSM3557191			38L_Ribociclib_150.0						38L_Ribociclib_150.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	RIBOCICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236562	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/005/SRR8424545	29120787	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/005/SRR8424545	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/005/SRR8424545	d898dcd01af59e8655957024ea147f9f	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424546	NextSeq 500 sequencing: GSM3557191: 38L_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719292									88833825									GEO																NextSeq 500 sequencing: GSM3557191: 38L_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233136	GSM3557191						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/006/SRR8424546/SRR8424546.fastq.gz	45090891	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/006/SRR8424546/SRR8424546.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/006/SRR8424546/SRR8424546.fastq.gz	0bfbba79dafb316c36646fc1bc12c931		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1184451											GSM3557191_r3			GSM3557191			38L_Ribociclib_150.0						38L_Ribociclib_150.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	RIBOCICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236562	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/006/SRR8424546	29526544	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/006/SRR8424546	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/006/SRR8424546	ffbe65b71711b54560da6d40c5335178	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424547	NextSeq 500 sequencing: GSM3557191: 38L_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719292									89268750									GEO																NextSeq 500 sequencing: GSM3557191: 38L_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233136	GSM3557191						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/007/SRR8424547/SRR8424547.fastq.gz	45072064	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/007/SRR8424547/SRR8424547.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/007/SRR8424547/SRR8424547.fastq.gz	0a1e5fec4362207ff0699ef6de98c4e8		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1190250											GSM3557191_r4			GSM3557191			38L_Ribociclib_150.0						38L_Ribociclib_150.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	RIBOCICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236562	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/007/SRR8424547	29500463	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/007/SRR8424547	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/007/SRR8424547	334791b4b8c8db2361c164c3030bf5c5	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424540	NextSeq 500 sequencing: GSM3557190: 37R_Vehicle Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719293									74067600									GEO																NextSeq 500 sequencing: GSM3557190: 37R_Vehicle Homo sapiens Mus musculus RNA-Seq										SRX5233135	GSM3557190						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/000/SRR8424540/SRR8424540.fastq.gz	37211394	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/000/SRR8424540/SRR8424540.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/000/SRR8424540/SRR8424540.fastq.gz	4dd9357a69811cb71465eda3c813f4e8		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		987568											GSM3557190_r1			GSM3557190			37R_Vehicle						37R_Vehicle	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	CONTROL	CONTROL			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	0	mg/kg				9606	Homo sapiens		SRS4236561	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/000/SRR8424540	24388295	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/000/SRR8424540	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/000/SRR8424540	13cac15f7171a3f8ec20b81bf828b726	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424541	NextSeq 500 sequencing: GSM3557190: 37R_Vehicle Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719293									74732625									GEO																NextSeq 500 sequencing: GSM3557190: 37R_Vehicle Homo sapiens Mus musculus RNA-Seq										SRX5233135	GSM3557190						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/001/SRR8424541/SRR8424541.fastq.gz	37628916	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/001/SRR8424541/SRR8424541.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/001/SRR8424541/SRR8424541.fastq.gz	a6acad466d1fe17eefdd521d079259af		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		996435											GSM3557190_r2			GSM3557190			37R_Vehicle						37R_Vehicle	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	CONTROL	CONTROL			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	0	mg/kg				9606	Homo sapiens		SRS4236561	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/001/SRR8424541	24675166	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/001/SRR8424541	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/001/SRR8424541	de7c50e5f029ebca410a8c75c87182c6	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424542	NextSeq 500 sequencing: GSM3557190: 37R_Vehicle Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719293									75892800									GEO																NextSeq 500 sequencing: GSM3557190: 37R_Vehicle Homo sapiens Mus musculus RNA-Seq										SRX5233135	GSM3557190						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/002/SRR8424542/SRR8424542.fastq.gz	38284483	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/002/SRR8424542/SRR8424542.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/002/SRR8424542/SRR8424542.fastq.gz	27042a908d03c329455cd372c555f2f7		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1011904											GSM3557190_r3			GSM3557190			37R_Vehicle						37R_Vehicle	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	CONTROL	CONTROL			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	0	mg/kg				9606	Homo sapiens		SRS4236561	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/002/SRR8424542	25113560	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/002/SRR8424542	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/002/SRR8424542	a2c51af5f5c21daeed9d8d9066e47ac3	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424543	NextSeq 500 sequencing: GSM3557190: 37R_Vehicle Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719293									76351725									GEO																NextSeq 500 sequencing: GSM3557190: 37R_Vehicle Homo sapiens Mus musculus RNA-Seq										SRX5233135	GSM3557190						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/003/SRR8424543/SRR8424543.fastq.gz	38319962	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/003/SRR8424543/SRR8424543.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/003/SRR8424543/SRR8424543.fastq.gz	c67f806e6e3b85f149eb51c3d63d57a5		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1018023											GSM3557190_r4			GSM3557190			37R_Vehicle						37R_Vehicle	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	CONTROL	CONTROL			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	0	mg/kg				9606	Homo sapiens		SRS4236561	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/003/SRR8424543	25124675	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/003/SRR8424543	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/003/SRR8424543	9d553840d8f1647c53fa430bf5c18a35	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424536	NextSeq 500 sequencing: GSM3557189: 37L_Vehicle Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719294									77676900									GEO																NextSeq 500 sequencing: GSM3557189: 37L_Vehicle Homo sapiens Mus musculus RNA-Seq										SRX5233134	GSM3557189						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/006/SRR8424536/SRR8424536.fastq.gz	39433197	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/006/SRR8424536/SRR8424536.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/006/SRR8424536/SRR8424536.fastq.gz	b5d49f2e76d3ffc0688d9f0e6d8713d0		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1035692											GSM3557189_r1			GSM3557189			37L_Vehicle						37L_Vehicle	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	CONTROL	CONTROL			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	0	mg/kg				9606	Homo sapiens		SRS4236560	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/006/SRR8424536	25834951	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/006/SRR8424536	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/006/SRR8424536	a4ba50864afed14e3e07c1f4785fa180	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424537	NextSeq 500 sequencing: GSM3557189: 37L_Vehicle Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719294									78201525									GEO																NextSeq 500 sequencing: GSM3557189: 37L_Vehicle Homo sapiens Mus musculus RNA-Seq										SRX5233134	GSM3557189						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/007/SRR8424537/SRR8424537.fastq.gz	39796739	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/007/SRR8424537/SRR8424537.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/007/SRR8424537/SRR8424537.fastq.gz	ca4ed19d17f897c06a6eb00b1e00539a		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1042687											GSM3557189_r2			GSM3557189			37L_Vehicle						37L_Vehicle	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	CONTROL	CONTROL			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	0	mg/kg				9606	Homo sapiens		SRS4236560	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/007/SRR8424537	26084248	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/007/SRR8424537	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/007/SRR8424537	ee0dcae826112907303e5939426776ce	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424538	NextSeq 500 sequencing: GSM3557189: 37L_Vehicle Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719294									79477800									GEO																NextSeq 500 sequencing: GSM3557189: 37L_Vehicle Homo sapiens Mus musculus RNA-Seq										SRX5233134	GSM3557189						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/008/SRR8424538/SRR8424538.fastq.gz	40511003	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/008/SRR8424538/SRR8424538.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/008/SRR8424538/SRR8424538.fastq.gz	24413a4fd7f77df067d2dc0751e9b47f		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1059704											GSM3557189_r3			GSM3557189			37L_Vehicle						37L_Vehicle	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	CONTROL	CONTROL			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	0	mg/kg				9606	Homo sapiens		SRS4236560	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/008/SRR8424538	26562102	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/008/SRR8424538	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/008/SRR8424538	98f3946ac5d0b197c3d46284ef6cb912	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424539	NextSeq 500 sequencing: GSM3557189: 37L_Vehicle Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719294									79936500									GEO																NextSeq 500 sequencing: GSM3557189: 37L_Vehicle Homo sapiens Mus musculus RNA-Seq										SRX5233134	GSM3557189						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/009/SRR8424539/SRR8424539.fastq.gz	40575721	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/009/SRR8424539/SRR8424539.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/009/SRR8424539/SRR8424539.fastq.gz	4d9b3cd00a1faf5471a871b2c554f86e		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1065820											GSM3557189_r4			GSM3557189			37L_Vehicle						37L_Vehicle	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	CONTROL	CONTROL			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	0	mg/kg				9606	Homo sapiens		SRS4236560	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/009/SRR8424539	26597810	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/009/SRR8424539	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/009/SRR8424539	0e88a3aa51d06c17b6739713c21897cb	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424532	NextSeq 500 sequencing: GSM3557188: 36R_Palbociclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719295									98572350									GEO																NextSeq 500 sequencing: GSM3557188: 36R_Palbociclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233133	GSM3557188						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/002/SRR8424532/SRR8424532.fastq.gz	50215708	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/002/SRR8424532/SRR8424532.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/002/SRR8424532/SRR8424532.fastq.gz	77c0ea80a558e3ba356d281804442d14		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1314298											GSM3557188_r1			GSM3557188			36R_Palbociclib_150.0						36R_Palbociclib_150.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	PALBOCICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236559	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/002/SRR8424532	33006563	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/002/SRR8424532	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/002/SRR8424532	c242309323579e0feeb697b92dc0fefc	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424533	NextSeq 500 sequencing: GSM3557188: 36R_Palbociclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719295									99478275									GEO																NextSeq 500 sequencing: GSM3557188: 36R_Palbociclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233133	GSM3557188						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/003/SRR8424533/SRR8424533.fastq.gz	50816718	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/003/SRR8424533/SRR8424533.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/003/SRR8424533/SRR8424533.fastq.gz	4b8b7e7ba78aeb41cc13e06cca33d00f		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1326377											GSM3557188_r2			GSM3557188			36R_Palbociclib_150.0						36R_Palbociclib_150.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	PALBOCICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236559	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/003/SRR8424533	33417468	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/003/SRR8424533	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/003/SRR8424533	2f1a20e1f89f96401b455819cb56945b	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424534	NextSeq 500 sequencing: GSM3557188: 36R_Palbociclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719295									101034000									GEO																NextSeq 500 sequencing: GSM3557188: 36R_Palbociclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233133	GSM3557188						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/004/SRR8424534/SRR8424534.fastq.gz	51704297	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/004/SRR8424534/SRR8424534.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/004/SRR8424534/SRR8424534.fastq.gz	05e72e0506a44f0cf72d5837eb94faf7		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1347120											GSM3557188_r3			GSM3557188			36R_Palbociclib_150.0						36R_Palbociclib_150.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	PALBOCICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236559	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/004/SRR8424534	34009260	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/004/SRR8424534	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/004/SRR8424534	1894e423c731bd19041c6efaf8ea5254	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424535	NextSeq 500 sequencing: GSM3557188: 36R_Palbociclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719295									101576625									GEO																NextSeq 500 sequencing: GSM3557188: 36R_Palbociclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233133	GSM3557188						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/005/SRR8424535/SRR8424535.fastq.gz	51760677	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/005/SRR8424535/SRR8424535.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/005/SRR8424535/SRR8424535.fastq.gz	7facd20e993978b17e27e841935cc30a		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1354355											GSM3557188_r4			GSM3557188			36R_Palbociclib_150.0						36R_Palbociclib_150.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	PALBOCICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236559	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/005/SRR8424535	34040094	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/005/SRR8424535	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/005/SRR8424535	4cc9549c2572d80b772709783929aa92	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424528	NextSeq 500 sequencing: GSM3557187: 36L_Palbociclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719296									90756750									GEO																NextSeq 500 sequencing: GSM3557187: 36L_Palbociclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233132	GSM3557187						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/008/SRR8424528/SRR8424528.fastq.gz	46111561	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/008/SRR8424528/SRR8424528.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/008/SRR8424528/SRR8424528.fastq.gz	743a6a7ebb97cc51da22047a2799447c		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1210090											GSM3557187_r1			GSM3557187			36L_Palbociclib_150.0						36L_Palbociclib_150.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	PALBOCICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236558	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/008/SRR8424528	30199603	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/008/SRR8424528	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/008/SRR8424528	ef2b2e543c74bfd3bf9ca4446a1dd0f4	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424529	NextSeq 500 sequencing: GSM3557187: 36L_Palbociclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719296									91590375									GEO																NextSeq 500 sequencing: GSM3557187: 36L_Palbociclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233132	GSM3557187						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/009/SRR8424529/SRR8424529.fastq.gz	46648923	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/009/SRR8424529/SRR8424529.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/009/SRR8424529/SRR8424529.fastq.gz	b7c0daa05f1ac93726feea24a1588e5d		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1221205											GSM3557187_r2			GSM3557187			36L_Palbociclib_150.0						36L_Palbociclib_150.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	PALBOCICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236558	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/009/SRR8424529	30565034	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/009/SRR8424529	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/009/SRR8424529	fa2ec90a1c2dc3ae0cda8076b72e2519	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424530	NextSeq 500 sequencing: GSM3557187: 36L_Palbociclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719296									92876175									GEO																NextSeq 500 sequencing: GSM3557187: 36L_Palbociclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233132	GSM3557187						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/000/SRR8424530/SRR8424530.fastq.gz	47389965	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/000/SRR8424530/SRR8424530.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/000/SRR8424530/SRR8424530.fastq.gz	c00393c3a407acf1da97eb36b92d5f16		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1238349											GSM3557187_r3			GSM3557187			36L_Palbociclib_150.0						36L_Palbociclib_150.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	PALBOCICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236558	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/000/SRR8424530	31062476	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/000/SRR8424530	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/000/SRR8424530	73f28d383894491ee34587f85b3f56c2	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424531	NextSeq 500 sequencing: GSM3557187: 36L_Palbociclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719296									93396525									GEO																NextSeq 500 sequencing: GSM3557187: 36L_Palbociclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233132	GSM3557187						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/001/SRR8424531/SRR8424531.fastq.gz	47417051	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/001/SRR8424531/SRR8424531.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/001/SRR8424531/SRR8424531.fastq.gz	602d3f3d93022327429cafde4a369e42		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1245287											GSM3557187_r4			GSM3557187			36L_Palbociclib_150.0						36L_Palbociclib_150.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	PALBOCICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236558	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/001/SRR8424531	31074420	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/001/SRR8424531	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/001/SRR8424531	642d0b671494002560d1dd8925142e63	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424524	NextSeq 500 sequencing: GSM3557186: 35R_Abemaciclib_100.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719297									72438600									GEO																NextSeq 500 sequencing: GSM3557186: 35R_Abemaciclib_100.0 Homo sapiens Mus musculus RNA-Seq										SRX5233131	GSM3557186						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/004/SRR8424524/SRR8424524.fastq.gz	36691810	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/004/SRR8424524/SRR8424524.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/004/SRR8424524/SRR8424524.fastq.gz	14287586ee831ff60b9a8f31cad9f39c		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		965848											GSM3557186_r1			GSM3557186			35R_Abemaciclib_100.0						35R_Abemaciclib_100.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	100	mg/kg				9606	Homo sapiens		SRS4236557	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/004/SRR8424524	24012939	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/004/SRR8424524	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/004/SRR8424524	0292f5f66f7561ccf1fd9b9b0970b604	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424525	NextSeq 500 sequencing: GSM3557186: 35R_Abemaciclib_100.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719297									72928125									GEO																NextSeq 500 sequencing: GSM3557186: 35R_Abemaciclib_100.0 Homo sapiens Mus musculus RNA-Seq										SRX5233131	GSM3557186						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/005/SRR8424525/SRR8424525.fastq.gz	37035825	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/005/SRR8424525/SRR8424525.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/005/SRR8424525/SRR8424525.fastq.gz	209399498abe477c2f97bf9d1e35aa0e		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		972375											GSM3557186_r2			GSM3557186			35R_Abemaciclib_100.0						35R_Abemaciclib_100.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	100	mg/kg				9606	Homo sapiens		SRS4236557	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/005/SRR8424525	24247579	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/005/SRR8424525	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/005/SRR8424525	839e251321b9f9554a3c00d0fb24fce5	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424526	NextSeq 500 sequencing: GSM3557186: 35R_Abemaciclib_100.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719297									74083950									GEO																NextSeq 500 sequencing: GSM3557186: 35R_Abemaciclib_100.0 Homo sapiens Mus musculus RNA-Seq										SRX5233131	GSM3557186						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/006/SRR8424526/SRR8424526.fastq.gz	37681701	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/006/SRR8424526/SRR8424526.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/006/SRR8424526/SRR8424526.fastq.gz	ff4f7e1baa3f0bcdad20f37bfc94380d		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		987786											GSM3557186_r3			GSM3557186			35R_Abemaciclib_100.0						35R_Abemaciclib_100.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	100	mg/kg				9606	Homo sapiens		SRS4236557	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/006/SRR8424526	24683461	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/006/SRR8424526	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/006/SRR8424526	56a19fd2096495b7f3296230a17de162	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424527	NextSeq 500 sequencing: GSM3557186: 35R_Abemaciclib_100.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719297									74534775									GEO																NextSeq 500 sequencing: GSM3557186: 35R_Abemaciclib_100.0 Homo sapiens Mus musculus RNA-Seq										SRX5233131	GSM3557186						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/007/SRR8424527/SRR8424527.fastq.gz	37749757	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/007/SRR8424527/SRR8424527.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/007/SRR8424527/SRR8424527.fastq.gz	cd9fbfcbffe46a26f26243450e2730ed		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		993797											GSM3557186_r4			GSM3557186			35R_Abemaciclib_100.0						35R_Abemaciclib_100.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	100	mg/kg				9606	Homo sapiens		SRS4236557	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/007/SRR8424527	24721428	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/007/SRR8424527	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/007/SRR8424527	3b3b6675e1d7b975c638a226c5a14811	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424520	NextSeq 500 sequencing: GSM3557185: 35L_Abemaciclib_100.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719298									81809775									GEO																NextSeq 500 sequencing: GSM3557185: 35L_Abemaciclib_100.0 Homo sapiens Mus musculus RNA-Seq										SRX5233130	GSM3557185						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/000/SRR8424520/SRR8424520.fastq.gz	41311029	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/000/SRR8424520/SRR8424520.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/000/SRR8424520/SRR8424520.fastq.gz	363df7696d56459ed51dbb0240751fd6		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1090797											GSM3557185_r1			GSM3557185			35L_Abemaciclib_100.0						35L_Abemaciclib_100.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	100	mg/kg				9606	Homo sapiens		SRS4236556	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/000/SRR8424520	27075310	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/000/SRR8424520	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/000/SRR8424520	0a2b7837b09133bface3f1a6c257db41	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424521	NextSeq 500 sequencing: GSM3557185: 35L_Abemaciclib_100.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719298									82431675									GEO																NextSeq 500 sequencing: GSM3557185: 35L_Abemaciclib_100.0 Homo sapiens Mus musculus RNA-Seq										SRX5233130	GSM3557185						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/001/SRR8424521/SRR8424521.fastq.gz	41740724	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/001/SRR8424521/SRR8424521.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/001/SRR8424521/SRR8424521.fastq.gz	5b8dd11a8f4d1b4a827d74f1ae569ede		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1099089											GSM3557185_r2			GSM3557185			35L_Abemaciclib_100.0						35L_Abemaciclib_100.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	100	mg/kg				9606	Homo sapiens		SRS4236556	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/001/SRR8424521	27369000	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/001/SRR8424521	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/001/SRR8424521	98f3919f494c832f38dc71c17b9464ed	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424522	NextSeq 500 sequencing: GSM3557185: 35L_Abemaciclib_100.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719298									83690700									GEO																NextSeq 500 sequencing: GSM3557185: 35L_Abemaciclib_100.0 Homo sapiens Mus musculus RNA-Seq										SRX5233130	GSM3557185						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/002/SRR8424522/SRR8424522.fastq.gz	42452521	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/002/SRR8424522/SRR8424522.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/002/SRR8424522/SRR8424522.fastq.gz	b78573c6b053a940acef04c0e218aa9e		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1115876											GSM3557185_r3			GSM3557185			35L_Abemaciclib_100.0						35L_Abemaciclib_100.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	100	mg/kg				9606	Homo sapiens		SRS4236556	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/002/SRR8424522	27845023	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/002/SRR8424522	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/002/SRR8424522	6e1c2a931f58ac745c06cea81e6732a9	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424523	NextSeq 500 sequencing: GSM3557185: 35L_Abemaciclib_100.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719298									84180450									GEO																NextSeq 500 sequencing: GSM3557185: 35L_Abemaciclib_100.0 Homo sapiens Mus musculus RNA-Seq										SRX5233130	GSM3557185						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/003/SRR8424523/SRR8424523.fastq.gz	42505914	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/003/SRR8424523/SRR8424523.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/003/SRR8424523/SRR8424523.fastq.gz	effe1aef4a81d12e38903f2985acc37e		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1122406											GSM3557185_r4			GSM3557185			35L_Abemaciclib_100.0						35L_Abemaciclib_100.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	100	mg/kg				9606	Homo sapiens		SRS4236556	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/003/SRR8424523	27873478	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/003/SRR8424523	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/003/SRR8424523	cffd869ad1af3b7a41f4274df2f5f1e7	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424516	NextSeq 500 sequencing: GSM3557184: 34R_Abemaciclib_75.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719299									84315450									GEO																NextSeq 500 sequencing: GSM3557184: 34R_Abemaciclib_75.0 Homo sapiens Mus musculus RNA-Seq										SRX5233129	GSM3557184						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/006/SRR8424516/SRR8424516.fastq.gz	42505796	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/006/SRR8424516/SRR8424516.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/006/SRR8424516/SRR8424516.fastq.gz	197105ac448b8e397720b4e14034b878		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1124206											GSM3557184_r1			GSM3557184			34R_Abemaciclib_75.0						34R_Abemaciclib_75.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	75	mg/kg				9606	Homo sapiens		SRS4236555	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/006/SRR8424516	27823818	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/006/SRR8424516	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/006/SRR8424516	117707a86e34f71b0105bccb1860d798	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424517	NextSeq 500 sequencing: GSM3557184: 34R_Abemaciclib_75.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719299									85253850									GEO																NextSeq 500 sequencing: GSM3557184: 34R_Abemaciclib_75.0 Homo sapiens Mus musculus RNA-Seq										SRX5233129	GSM3557184						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/007/SRR8424517/SRR8424517.fastq.gz	43088157	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/007/SRR8424517/SRR8424517.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/007/SRR8424517/SRR8424517.fastq.gz	38d2363c72b36b0588de97fe29f7f824		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1136718											GSM3557184_r2			GSM3557184			34R_Abemaciclib_75.0						34R_Abemaciclib_75.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	75	mg/kg				9606	Homo sapiens		SRS4236555	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/007/SRR8424517	28217317	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/007/SRR8424517	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/007/SRR8424517	3a4a59fe247fa5d93158a9879cc527ad	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424518	NextSeq 500 sequencing: GSM3557184: 34R_Abemaciclib_75.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719299									86160600									GEO																NextSeq 500 sequencing: GSM3557184: 34R_Abemaciclib_75.0 Homo sapiens Mus musculus RNA-Seq										SRX5233129	GSM3557184						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/008/SRR8424518/SRR8424518.fastq.gz	43607117	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/008/SRR8424518/SRR8424518.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/008/SRR8424518/SRR8424518.fastq.gz	0c2b70011c29d227a24c2552f87dbebb		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1148808											GSM3557184_r3			GSM3557184			34R_Abemaciclib_75.0						34R_Abemaciclib_75.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	75	mg/kg				9606	Homo sapiens		SRS4236555	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/008/SRR8424518	28570243	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/008/SRR8424518	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/008/SRR8424518	7546f54222958547ad56ce7d0d24f9b2	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424519	NextSeq 500 sequencing: GSM3557184: 34R_Abemaciclib_75.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719299									86835750									GEO																NextSeq 500 sequencing: GSM3557184: 34R_Abemaciclib_75.0 Homo sapiens Mus musculus RNA-Seq										SRX5233129	GSM3557184						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/009/SRR8424519/SRR8424519.fastq.gz	43767399	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/009/SRR8424519/SRR8424519.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/009/SRR8424519/SRR8424519.fastq.gz	9f393a0e6008f1c47a18397747031dfe		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1157810											GSM3557184_r4			GSM3557184			34R_Abemaciclib_75.0						34R_Abemaciclib_75.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	75	mg/kg				9606	Homo sapiens		SRS4236555	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/009/SRR8424519	28666435	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/009/SRR8424519	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/009/SRR8424519	cfb3ef50366f685d565f5cd2493dd221	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424512	NextSeq 500 sequencing: GSM3557183: 34L_Abemaciclib_75.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719300									90094875									GEO																NextSeq 500 sequencing: GSM3557183: 34L_Abemaciclib_75.0 Homo sapiens Mus musculus RNA-Seq										SRX5233128	GSM3557183						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/002/SRR8424512/SRR8424512.fastq.gz	45610052	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/002/SRR8424512/SRR8424512.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/002/SRR8424512/SRR8424512.fastq.gz	07d8561c5fee9fc76335eebc7cee9135		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1201265											GSM3557183_r1			GSM3557183			34L_Abemaciclib_75.0						34L_Abemaciclib_75.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	75	mg/kg				9606	Homo sapiens		SRS4236554	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/002/SRR8424512	29875398	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/002/SRR8424512	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/002/SRR8424512	bf9aab7d4723d66b1f6b3a23a41e7119	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424513	NextSeq 500 sequencing: GSM3557183: 34L_Abemaciclib_75.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719300									90903675									GEO																NextSeq 500 sequencing: GSM3557183: 34L_Abemaciclib_75.0 Homo sapiens Mus musculus RNA-Seq										SRX5233128	GSM3557183						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/003/SRR8424513/SRR8424513.fastq.gz	46119275	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/003/SRR8424513/SRR8424513.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/003/SRR8424513/SRR8424513.fastq.gz	7df8840e9dd917509736c6ddbc9ffd4e		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1212049											GSM3557183_r2			GSM3557183			34L_Abemaciclib_75.0						34L_Abemaciclib_75.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	75	mg/kg				9606	Homo sapiens		SRS4236554	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/003/SRR8424513	30220386	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/003/SRR8424513	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/003/SRR8424513	326e173ac1824900e450c9f53848b27b	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424514	NextSeq 500 sequencing: GSM3557183: 34L_Abemaciclib_75.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719300									92099925									GEO																NextSeq 500 sequencing: GSM3557183: 34L_Abemaciclib_75.0 Homo sapiens Mus musculus RNA-Seq										SRX5233128	GSM3557183						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/004/SRR8424514/SRR8424514.fastq.gz	46821374	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/004/SRR8424514/SRR8424514.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/004/SRR8424514/SRR8424514.fastq.gz	d408c93f2bab32379124ab7c9ab86a81		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1227999											GSM3557183_r3			GSM3557183			34L_Abemaciclib_75.0						34L_Abemaciclib_75.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	75	mg/kg				9606	Homo sapiens		SRS4236554	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/004/SRR8424514	30694860	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/004/SRR8424514	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/004/SRR8424514	cfbf38bde09f7dffd9268c4a7580a4fb	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424515	NextSeq 500 sequencing: GSM3557183: 34L_Abemaciclib_75.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719300									92621850									GEO																NextSeq 500 sequencing: GSM3557183: 34L_Abemaciclib_75.0 Homo sapiens Mus musculus RNA-Seq										SRX5233128	GSM3557183						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/005/SRR8424515/SRR8424515.fastq.gz	46861443	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/005/SRR8424515/SRR8424515.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/005/SRR8424515/SRR8424515.fastq.gz	7150d8215ba9c2e3a32b49245c8e4482		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1234958											GSM3557183_r4			GSM3557183			34L_Abemaciclib_75.0						34L_Abemaciclib_75.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	75	mg/kg				9606	Homo sapiens		SRS4236554	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/005/SRR8424515	30710574	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/005/SRR8424515	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/005/SRR8424515	9b14a014012b36509b7f038861502b07	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424508	NextSeq 500 sequencing: GSM3557182: 33R_Abemaciclib_25.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719301									66721950									GEO																NextSeq 500 sequencing: GSM3557182: 33R_Abemaciclib_25.0 Homo sapiens Mus musculus RNA-Seq										SRX5233127	GSM3557182						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/008/SRR8424508/SRR8424508.fastq.gz	33748056	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/008/SRR8424508/SRR8424508.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/008/SRR8424508/SRR8424508.fastq.gz	026e358db6751775a60ac8af7b161d88		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		889626											GSM3557182_r1			GSM3557182			33R_Abemaciclib_25.0						33R_Abemaciclib_25.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	25	mg/kg				9606	Homo sapiens		SRS4236553	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/008/SRR8424508	22112584	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/008/SRR8424508	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/008/SRR8424508	65f26290b05538c5b6fa55c4a24be32f	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424509	NextSeq 500 sequencing: GSM3557182: 33R_Abemaciclib_25.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719301									67418025									GEO																NextSeq 500 sequencing: GSM3557182: 33R_Abemaciclib_25.0 Homo sapiens Mus musculus RNA-Seq										SRX5233127	GSM3557182						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/009/SRR8424509/SRR8424509.fastq.gz	34194659	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/009/SRR8424509/SRR8424509.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/009/SRR8424509/SRR8424509.fastq.gz	4f8b545cee5706caf57a61c06e6d290f		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		898907											GSM3557182_r2			GSM3557182			33R_Abemaciclib_25.0						33R_Abemaciclib_25.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	25	mg/kg				9606	Homo sapiens		SRS4236553	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/009/SRR8424509	22413264	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/009/SRR8424509	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/009/SRR8424509	5f6a4b7f1947d3d9045fb55faddd7330	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424510	NextSeq 500 sequencing: GSM3557182: 33R_Abemaciclib_25.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719301									68484975									GEO																NextSeq 500 sequencing: GSM3557182: 33R_Abemaciclib_25.0 Homo sapiens Mus musculus RNA-Seq										SRX5233127	GSM3557182						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/000/SRR8424510/SRR8424510.fastq.gz	34782464	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/000/SRR8424510/SRR8424510.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/000/SRR8424510/SRR8424510.fastq.gz	376064b24480abfb03c2487e9f31b89f		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		913133											GSM3557182_r3			GSM3557182			33R_Abemaciclib_25.0						33R_Abemaciclib_25.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	25	mg/kg				9606	Homo sapiens		SRS4236553	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/000/SRR8424510	22812845	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/000/SRR8424510	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/000/SRR8424510	120fbec6cb0dcf32955bc8272d367403	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424511	NextSeq 500 sequencing: GSM3557182: 33R_Abemaciclib_25.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719301									68783325									GEO																NextSeq 500 sequencing: GSM3557182: 33R_Abemaciclib_25.0 Homo sapiens Mus musculus RNA-Seq										SRX5233127	GSM3557182						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/001/SRR8424511/SRR8424511.fastq.gz	34766883	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/001/SRR8424511/SRR8424511.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/001/SRR8424511/SRR8424511.fastq.gz	2155ec03d2dbe4132036851543442340		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		917111											GSM3557182_r4			GSM3557182			33R_Abemaciclib_25.0						33R_Abemaciclib_25.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	25	mg/kg				9606	Homo sapiens		SRS4236553	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/001/SRR8424511	22793953	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/001/SRR8424511	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/001/SRR8424511	cbb044a0e9dd7a72d8ae92ac89baf46e	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424504	NextSeq 500 sequencing: GSM3557181: 33L_Abemaciclib_25.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719302									84133425									GEO																NextSeq 500 sequencing: GSM3557181: 33L_Abemaciclib_25.0 Homo sapiens Mus musculus RNA-Seq										SRX5233126	GSM3557181						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/004/SRR8424504/SRR8424504.fastq.gz	42567703	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/004/SRR8424504/SRR8424504.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/004/SRR8424504/SRR8424504.fastq.gz	70bcef258e1a9b34a2bb200c1dbe6178		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1121779											GSM3557181_r1			GSM3557181			33L_Abemaciclib_25.0						33L_Abemaciclib_25.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	25	mg/kg				9606	Homo sapiens		SRS4236552	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/004/SRR8424504	27861192	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/004/SRR8424504	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/004/SRR8424504	e02cfa014e40748f2b18c1cc390df3ba	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424505	NextSeq 500 sequencing: GSM3557181: 33L_Abemaciclib_25.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719302									84767400									GEO																NextSeq 500 sequencing: GSM3557181: 33L_Abemaciclib_25.0 Homo sapiens Mus musculus RNA-Seq										SRX5233126	GSM3557181						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/005/SRR8424505/SRR8424505.fastq.gz	42979322	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/005/SRR8424505/SRR8424505.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/005/SRR8424505/SRR8424505.fastq.gz	823137758d8e964e501d3e6594aa901d		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1130232											GSM3557181_r2			GSM3557181			33L_Abemaciclib_25.0						33L_Abemaciclib_25.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	25	mg/kg				9606	Homo sapiens		SRS4236552	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/005/SRR8424505	28144473	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/005/SRR8424505	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/005/SRR8424505	f0884dea83be3656ae4c9b9efa26a6b8	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424506	NextSeq 500 sequencing: GSM3557181: 33L_Abemaciclib_25.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719302									86074725									GEO																NextSeq 500 sequencing: GSM3557181: 33L_Abemaciclib_25.0 Homo sapiens Mus musculus RNA-Seq										SRX5233126	GSM3557181						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/006/SRR8424506/SRR8424506.fastq.gz	43734338	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/006/SRR8424506/SRR8424506.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/006/SRR8424506/SRR8424506.fastq.gz	036375b1d43f4c1a81c496873f82f28d		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1147663											GSM3557181_r3			GSM3557181			33L_Abemaciclib_25.0						33L_Abemaciclib_25.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	25	mg/kg				9606	Homo sapiens		SRS4236552	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/006/SRR8424506	28653343	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/006/SRR8424506	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/006/SRR8424506	a3120f5e06f0de3b610bf04d2f63f1c1	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424507	NextSeq 500 sequencing: GSM3557181: 33L_Abemaciclib_25.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719302									86578425									GEO																NextSeq 500 sequencing: GSM3557181: 33L_Abemaciclib_25.0 Homo sapiens Mus musculus RNA-Seq										SRX5233126	GSM3557181						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/007/SRR8424507/SRR8424507.fastq.gz	43769236	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/007/SRR8424507/SRR8424507.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/007/SRR8424507/SRR8424507.fastq.gz	9f54ad8351b3b4bfe35ce8573af998be		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1154379											GSM3557181_r4			GSM3557181			33L_Abemaciclib_25.0						33L_Abemaciclib_25.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	25	mg/kg				9606	Homo sapiens		SRS4236552	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/007/SRR8424507	28661321	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/007/SRR8424507	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/007/SRR8424507	7dee9c0ffeac7125118f8c7e088c2828	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424500	NextSeq 500 sequencing: GSM3557180: 32R_Abemaciclib_25.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719303									95966325									GEO																NextSeq 500 sequencing: GSM3557180: 32R_Abemaciclib_25.0 Homo sapiens Mus musculus RNA-Seq										SRX5233125	GSM3557180						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/000/SRR8424500/SRR8424500.fastq.gz	48735930	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/000/SRR8424500/SRR8424500.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/000/SRR8424500/SRR8424500.fastq.gz	6a6a0983532e8142807bc701ddb685df		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1279551											GSM3557180_r1			GSM3557180			32R_Abemaciclib_25.0						32R_Abemaciclib_25.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	25	mg/kg				9606	Homo sapiens		SRS4236551	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/000/SRR8424500	31991420	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/000/SRR8424500	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/000/SRR8424500	f772052c2a319fe64a6dca696f7b7965	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424501	NextSeq 500 sequencing: GSM3557180: 32R_Abemaciclib_25.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719303									96787725									GEO																NextSeq 500 sequencing: GSM3557180: 32R_Abemaciclib_25.0 Homo sapiens Mus musculus RNA-Seq										SRX5233125	GSM3557180						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/001/SRR8424501/SRR8424501.fastq.gz	49283744	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/001/SRR8424501/SRR8424501.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/001/SRR8424501/SRR8424501.fastq.gz	07f0d8bc20ae430cd68b7755a02545e9		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1290503											GSM3557180_r2			GSM3557180			32R_Abemaciclib_25.0						32R_Abemaciclib_25.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	25	mg/kg				9606	Homo sapiens		SRS4236551	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/001/SRR8424501	32370211	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/001/SRR8424501	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/001/SRR8424501	1f322d285b00192c35a9745a03e31bf9	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424502	NextSeq 500 sequencing: GSM3557180: 32R_Abemaciclib_25.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719303									98310975									GEO																NextSeq 500 sequencing: GSM3557180: 32R_Abemaciclib_25.0 Homo sapiens Mus musculus RNA-Seq										SRX5233125	GSM3557180						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/002/SRR8424502/SRR8424502.fastq.gz	50144599	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/002/SRR8424502/SRR8424502.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/002/SRR8424502/SRR8424502.fastq.gz	5ce89f3e7715567a3551c9d70835c9ed		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1310813											GSM3557180_r3			GSM3557180			32R_Abemaciclib_25.0						32R_Abemaciclib_25.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	25	mg/kg				9606	Homo sapiens		SRS4236551	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/002/SRR8424502	32946849	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/002/SRR8424502	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/002/SRR8424502	8c76fa2826633b61a872bfc6a593161d	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424503	NextSeq 500 sequencing: GSM3557180: 32R_Abemaciclib_25.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719303									98741400									GEO																NextSeq 500 sequencing: GSM3557180: 32R_Abemaciclib_25.0 Homo sapiens Mus musculus RNA-Seq										SRX5233125	GSM3557180						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/003/SRR8424503/SRR8424503.fastq.gz	50169159	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/003/SRR8424503/SRR8424503.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/003/SRR8424503/SRR8424503.fastq.gz	a09aa4d8f2ca3ce125c1344bb1e64a31		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1316552											GSM3557180_r4			GSM3557180			32R_Abemaciclib_25.0						32R_Abemaciclib_25.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	25	mg/kg				9606	Homo sapiens		SRS4236551	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/003/SRR8424503	32956045	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/003/SRR8424503	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/003/SRR8424503	2b50966abd2676d043316149ee0cbae9	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424496	NextSeq 500 sequencing: GSM3557179: 32L_Abemaciclib_25.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719304									74234925									GEO																NextSeq 500 sequencing: GSM3557179: 32L_Abemaciclib_25.0 Homo sapiens Mus musculus RNA-Seq										SRX5233124	GSM3557179						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/006/SRR8424496/SRR8424496.fastq.gz	37536084	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/006/SRR8424496/SRR8424496.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/006/SRR8424496/SRR8424496.fastq.gz	b38a37c156e9e4cc9ddcb3e0e1d334e4		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		989799											GSM3557179_r1			GSM3557179			32L_Abemaciclib_25.0						32L_Abemaciclib_25.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	25	mg/kg				9606	Homo sapiens		SRS4236550	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/006/SRR8424496	24560325	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/006/SRR8424496	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/006/SRR8424496	497c6f9cc534509975efdf54d996308b	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424497	NextSeq 500 sequencing: GSM3557179: 32L_Abemaciclib_25.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719304									75033375									GEO																NextSeq 500 sequencing: GSM3557179: 32L_Abemaciclib_25.0 Homo sapiens Mus musculus RNA-Seq										SRX5233124	GSM3557179						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/007/SRR8424497/SRR8424497.fastq.gz	38033398	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/007/SRR8424497/SRR8424497.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/007/SRR8424497/SRR8424497.fastq.gz	46087534f5ef1b0f8c2ba1459cdbd743		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1000445											GSM3557179_r2			GSM3557179			32L_Abemaciclib_25.0						32L_Abemaciclib_25.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	25	mg/kg				9606	Homo sapiens		SRS4236550	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/007/SRR8424497	24898842	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/007/SRR8424497	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/007/SRR8424497	02026b64ab2e0b83be23f815aa3b6757	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424498	NextSeq 500 sequencing: GSM3557179: 32L_Abemaciclib_25.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719304									76125525									GEO																NextSeq 500 sequencing: GSM3557179: 32L_Abemaciclib_25.0 Homo sapiens Mus musculus RNA-Seq										SRX5233124	GSM3557179						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/008/SRR8424498/SRR8424498.fastq.gz	38678509	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/008/SRR8424498/SRR8424498.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/008/SRR8424498/SRR8424498.fastq.gz	c728bb89e285ab134513c601db9c6fd5		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1015007											GSM3557179_r3			GSM3557179			32L_Abemaciclib_25.0						32L_Abemaciclib_25.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	25	mg/kg				9606	Homo sapiens		SRS4236550	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/008/SRR8424498	25335486	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/008/SRR8424498	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/008/SRR8424498	69f27d53bfa1514dfdd2f584c09d5c35	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424499	NextSeq 500 sequencing: GSM3557179: 32L_Abemaciclib_25.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719304									76772850									GEO																NextSeq 500 sequencing: GSM3557179: 32L_Abemaciclib_25.0 Homo sapiens Mus musculus RNA-Seq										SRX5233124	GSM3557179						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/009/SRR8424499/SRR8424499.fastq.gz	38813584	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/009/SRR8424499/SRR8424499.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/009/SRR8424499/SRR8424499.fastq.gz	4579630ee3d2eff6bc76e1c14e34395d		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1023638											GSM3557179_r4			GSM3557179			32L_Abemaciclib_25.0						32L_Abemaciclib_25.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	25	mg/kg				9606	Homo sapiens		SRS4236550	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/009/SRR8424499	25412302	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/009/SRR8424499	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/009/SRR8424499	3e3bbc85c94a22cd41c0962c3dabec67	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424492	NextSeq 500 sequencing: GSM3557178: 31R_Palbociclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719305									79295175									GEO																NextSeq 500 sequencing: GSM3557178: 31R_Palbociclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233123	GSM3557178						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/002/SRR8424492/SRR8424492.fastq.gz	40217326	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/002/SRR8424492/SRR8424492.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/002/SRR8424492/SRR8424492.fastq.gz	27f78452f9d7c0a1c263a6fe0f94ed34		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1057269											GSM3557178_r1			GSM3557178			31R_Palbociclib_150.0						31R_Palbociclib_150.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	PALBOCICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236549	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/002/SRR8424492	26364393	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/002/SRR8424492	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/002/SRR8424492	2dc9c5ebf2079c7d03deaccf41e5cb11	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424493	NextSeq 500 sequencing: GSM3557178: 31R_Palbociclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719305									79815150									GEO																NextSeq 500 sequencing: GSM3557178: 31R_Palbociclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233123	GSM3557178						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/003/SRR8424493/SRR8424493.fastq.gz	40594724	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/003/SRR8424493/SRR8424493.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/003/SRR8424493/SRR8424493.fastq.gz	6247fa196202c6502a1214a31bc0860d		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1064202											GSM3557178_r2			GSM3557178			31R_Palbociclib_150.0						31R_Palbociclib_150.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	PALBOCICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236549	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/003/SRR8424493	26623784	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/003/SRR8424493	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/003/SRR8424493	2bd71fc2a6234e301be032b225bb2a93	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424494	NextSeq 500 sequencing: GSM3557178: 31R_Palbociclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719305									81128025									GEO																NextSeq 500 sequencing: GSM3557178: 31R_Palbociclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233123	GSM3557178						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/004/SRR8424494/SRR8424494.fastq.gz	41314885	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/004/SRR8424494/SRR8424494.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/004/SRR8424494/SRR8424494.fastq.gz	3426d61528cdb3ffaf045ecb5e46d3c2		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1081707											GSM3557178_r3			GSM3557178			31R_Palbociclib_150.0						31R_Palbociclib_150.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	PALBOCICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236549	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/004/SRR8424494	27111916	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/004/SRR8424494	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/004/SRR8424494	2b281d5f4b07c55266ce2783205aa3c1	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424495	NextSeq 500 sequencing: GSM3557178: 31R_Palbociclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719305									81637575									GEO																NextSeq 500 sequencing: GSM3557178: 31R_Palbociclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233123	GSM3557178						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/005/SRR8424495/SRR8424495.fastq.gz	41407272	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/005/SRR8424495/SRR8424495.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/005/SRR8424495/SRR8424495.fastq.gz	a070e3bb6837c063b9e581afc658c7cc		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1088501											GSM3557178_r4			GSM3557178			31R_Palbociclib_150.0						31R_Palbociclib_150.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	PALBOCICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236549	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/005/SRR8424495	27161197	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/005/SRR8424495	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/005/SRR8424495	e0594c114fbf3505cd77ea3f8cec87fc	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424488	NextSeq 500 sequencing: GSM3557177: 31L_Palbociclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719306									84847350									GEO																NextSeq 500 sequencing: GSM3557177: 31L_Palbociclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233122	GSM3557177						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/008/SRR8424488/SRR8424488.fastq.gz	42827437	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/008/SRR8424488/SRR8424488.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/008/SRR8424488/SRR8424488.fastq.gz	88e128af5e88faceff653306bc5a6986		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1131298											GSM3557177_r1			GSM3557177			31L_Palbociclib_150.0						31L_Palbociclib_150.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	PALBOCICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236548	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/008/SRR8424488	28038089	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/008/SRR8424488	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/008/SRR8424488	d7880e138500060de83816f0a5d1e05e	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424489	NextSeq 500 sequencing: GSM3557177: 31L_Palbociclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719306									85554525									GEO																NextSeq 500 sequencing: GSM3557177: 31L_Palbociclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233122	GSM3557177						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/009/SRR8424489/SRR8424489.fastq.gz	43305569	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/009/SRR8424489/SRR8424489.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/009/SRR8424489/SRR8424489.fastq.gz	ca4b7f2c06583cfa65d74f7237ab27b3		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1140727											GSM3557177_r2			GSM3557177			31L_Palbociclib_150.0						31L_Palbociclib_150.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	PALBOCICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236548	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/009/SRR8424489	28363138	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/009/SRR8424489	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/009/SRR8424489	9a8247ff54e60e47fdde87150a666246	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424490	NextSeq 500 sequencing: GSM3557177: 31L_Palbociclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719306									86906475									GEO																NextSeq 500 sequencing: GSM3557177: 31L_Palbociclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233122	GSM3557177						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/000/SRR8424490/SRR8424490.fastq.gz	44073226	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/000/SRR8424490/SRR8424490.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/000/SRR8424490/SRR8424490.fastq.gz	c8b6e5fa00ef7817f79dbd4a018a423b		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1158753											GSM3557177_r3			GSM3557177			31L_Palbociclib_150.0						31L_Palbociclib_150.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	PALBOCICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236548	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/000/SRR8424490	28881981	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/000/SRR8424490	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/000/SRR8424490	41b1c5bfe82fd6e0d39b5142e866919e	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424491	NextSeq 500 sequencing: GSM3557177: 31L_Palbociclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719306									87336750									GEO																NextSeq 500 sequencing: GSM3557177: 31L_Palbociclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233122	GSM3557177						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/001/SRR8424491/SRR8424491.fastq.gz	44083095	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/001/SRR8424491/SRR8424491.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/001/SRR8424491/SRR8424491.fastq.gz	aaf18292bab6e7a994bfe9fa06f95585		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1164490											GSM3557177_r4			GSM3557177			31L_Palbociclib_150.0						31L_Palbociclib_150.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	PALBOCICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236548	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/001/SRR8424491	28874204	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/001/SRR8424491	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/001/SRR8424491	7e2b1b4ce51125de8b96b0fa9eb6aba6	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424484	NextSeq 500 sequencing: GSM3557176: 30R_Abemaciclib_125.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719307									83592900									GEO																NextSeq 500 sequencing: GSM3557176: 30R_Abemaciclib_125.0 Homo sapiens Mus musculus RNA-Seq										SRX5233121	GSM3557176						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/004/SRR8424484/SRR8424484.fastq.gz	42082530	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/004/SRR8424484/SRR8424484.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/004/SRR8424484/SRR8424484.fastq.gz	53ecee7f8600bc55c0b161188300d127		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1114572											GSM3557176_r1			GSM3557176			30R_Abemaciclib_125.0						30R_Abemaciclib_125.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	125	mg/kg				9606	Homo sapiens		SRS4236547	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/004/SRR8424484	27531850	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/004/SRR8424484	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/004/SRR8424484	4fe25d1391c32c63825bc3733ef143b3	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424485	NextSeq 500 sequencing: GSM3557176: 30R_Abemaciclib_125.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719307									84418350									GEO																NextSeq 500 sequencing: GSM3557176: 30R_Abemaciclib_125.0 Homo sapiens Mus musculus RNA-Seq										SRX5233121	GSM3557176						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/005/SRR8424485/SRR8424485.fastq.gz	42618972	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/005/SRR8424485/SRR8424485.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/005/SRR8424485/SRR8424485.fastq.gz	f26109c8149b04bb13f60f18db5a8362		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1125578											GSM3557176_r2			GSM3557176			30R_Abemaciclib_125.0						30R_Abemaciclib_125.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	125	mg/kg				9606	Homo sapiens		SRS4236547	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/005/SRR8424485	27896832	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/005/SRR8424485	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/005/SRR8424485	0a5580855caeea03afb89983775356bf	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424486	NextSeq 500 sequencing: GSM3557176: 30R_Abemaciclib_125.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719307									85515525									GEO																NextSeq 500 sequencing: GSM3557176: 30R_Abemaciclib_125.0 Homo sapiens Mus musculus RNA-Seq										SRX5233121	GSM3557176						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/006/SRR8424486/SRR8424486.fastq.gz	43227723	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/006/SRR8424486/SRR8424486.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/006/SRR8424486/SRR8424486.fastq.gz	99ad06c9f1c08f36d9fc1559db07db1a		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1140207											GSM3557176_r3			GSM3557176			30R_Abemaciclib_125.0						30R_Abemaciclib_125.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	125	mg/kg				9606	Homo sapiens		SRS4236547	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/006/SRR8424486	28307528	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/006/SRR8424486	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/006/SRR8424486	0bdd0d2cdef881f23e3034a3b301a6d4	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424487	NextSeq 500 sequencing: GSM3557176: 30R_Abemaciclib_125.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719307									86128500									GEO																NextSeq 500 sequencing: GSM3557176: 30R_Abemaciclib_125.0 Homo sapiens Mus musculus RNA-Seq										SRX5233121	GSM3557176						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/007/SRR8424487/SRR8424487.fastq.gz	43342845	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/007/SRR8424487/SRR8424487.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/007/SRR8424487/SRR8424487.fastq.gz	758ebdc31388b2edf6c2ebb1a3301714		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1148380											GSM3557176_r4			GSM3557176			30R_Abemaciclib_125.0						30R_Abemaciclib_125.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	125	mg/kg				9606	Homo sapiens		SRS4236547	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/007/SRR8424487	28375936	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/007/SRR8424487	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/007/SRR8424487	a78735c793e24c5c573e43160cb5a585	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424480	NextSeq 500 sequencing: GSM3557175: 30L_Abemaciclib_125.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719308									86962425									GEO																NextSeq 500 sequencing: GSM3557175: 30L_Abemaciclib_125.0 Homo sapiens Mus musculus RNA-Seq										SRX5233120	GSM3557175						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/000/SRR8424480/SRR8424480.fastq.gz	43976956	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/000/SRR8424480/SRR8424480.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/000/SRR8424480/SRR8424480.fastq.gz	372a872e88067d9d4c0adc70dd81fb55		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1159499											GSM3557175_r1			GSM3557175			30L_Abemaciclib_125.0						30L_Abemaciclib_125.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	125	mg/kg				9606	Homo sapiens		SRS4236546	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/000/SRR8424480	28803832	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/000/SRR8424480	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/000/SRR8424480	1c6afda718256844bb4a5707e5c2d488	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424481	NextSeq 500 sequencing: GSM3557175: 30L_Abemaciclib_125.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719308									87757275									GEO																NextSeq 500 sequencing: GSM3557175: 30L_Abemaciclib_125.0 Homo sapiens Mus musculus RNA-Seq										SRX5233120	GSM3557175						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/001/SRR8424481/SRR8424481.fastq.gz	44472446	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/001/SRR8424481/SRR8424481.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/001/SRR8424481/SRR8424481.fastq.gz	17083b32b132831ebba473fbdab05fff		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1170097											GSM3557175_r2			GSM3557175			30L_Abemaciclib_125.0						30L_Abemaciclib_125.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	125	mg/kg				9606	Homo sapiens		SRS4236546	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/001/SRR8424481	29141011	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/001/SRR8424481	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/001/SRR8424481	434a262c4c56a6b161f5249803e5ff8d	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424482	NextSeq 500 sequencing: GSM3557175: 30L_Abemaciclib_125.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719308									89082975									GEO																NextSeq 500 sequencing: GSM3557175: 30L_Abemaciclib_125.0 Homo sapiens Mus musculus RNA-Seq										SRX5233120	GSM3557175						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/002/SRR8424482/SRR8424482.fastq.gz	45244868	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/002/SRR8424482/SRR8424482.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/002/SRR8424482/SRR8424482.fastq.gz	498f8771f6a0315fcc6b266503ca202e		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1187773											GSM3557175_r3			GSM3557175			30L_Abemaciclib_125.0						30L_Abemaciclib_125.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	125	mg/kg				9606	Homo sapiens		SRS4236546	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/002/SRR8424482	29661764	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/002/SRR8424482	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/002/SRR8424482	811ac00fafe61d3a23f2d3b81b00cb0f	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424483	NextSeq 500 sequencing: GSM3557175: 30L_Abemaciclib_125.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719308									89555625									GEO																NextSeq 500 sequencing: GSM3557175: 30L_Abemaciclib_125.0 Homo sapiens Mus musculus RNA-Seq										SRX5233120	GSM3557175						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/003/SRR8424483/SRR8424483.fastq.gz	45281185	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/003/SRR8424483/SRR8424483.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/003/SRR8424483/SRR8424483.fastq.gz	361e9bb630049a17d419f89bc3a56bf1		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1194075											GSM3557175_r4			GSM3557175			30L_Abemaciclib_125.0						30L_Abemaciclib_125.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	125	mg/kg				9606	Homo sapiens		SRS4236546	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/003/SRR8424483	29674680	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/003/SRR8424483	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/003/SRR8424483	5bb4048f8288223e31bf134720946e6c	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424476	NextSeq 500 sequencing: GSM3557174: 29R_Abemaciclib_75.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719309									83319600									GEO																NextSeq 500 sequencing: GSM3557174: 29R_Abemaciclib_75.0 Homo sapiens Mus musculus RNA-Seq										SRX5233119	GSM3557174						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/006/SRR8424476/SRR8424476.fastq.gz	41922081	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/006/SRR8424476/SRR8424476.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/006/SRR8424476/SRR8424476.fastq.gz	e6c91336e964b5e6b32ffa75d7eef315		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1110928											GSM3557174_r1			GSM3557174			29R_Abemaciclib_75.0						29R_Abemaciclib_75.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	75	mg/kg				9606	Homo sapiens		SRS4236545	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/006/SRR8424476	27419794	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/006/SRR8424476	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/006/SRR8424476	3857a346afbec85612832f95b37ba7fb	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424477	NextSeq 500 sequencing: GSM3557174: 29R_Abemaciclib_75.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719309									83772600									GEO																NextSeq 500 sequencing: GSM3557174: 29R_Abemaciclib_75.0 Homo sapiens Mus musculus RNA-Seq										SRX5233119	GSM3557174						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/007/SRR8424477/SRR8424477.fastq.gz	42262561	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/007/SRR8424477/SRR8424477.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/007/SRR8424477/SRR8424477.fastq.gz	0bd770a3c973f4ad1332d2f6d1461f8f		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1116968											GSM3557174_r2			GSM3557174			29R_Abemaciclib_75.0						29R_Abemaciclib_75.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	75	mg/kg				9606	Homo sapiens		SRS4236545	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/007/SRR8424477	27656156	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/007/SRR8424477	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/007/SRR8424477	2ad89ba99ec5d9c7070ae0bf3034d20e	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424478	NextSeq 500 sequencing: GSM3557174: 29R_Abemaciclib_75.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719309									84976950									GEO																NextSeq 500 sequencing: GSM3557174: 29R_Abemaciclib_75.0 Homo sapiens Mus musculus RNA-Seq										SRX5233119	GSM3557174						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/008/SRR8424478/SRR8424478.fastq.gz	42931411	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/008/SRR8424478/SRR8424478.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/008/SRR8424478/SRR8424478.fastq.gz	12e323a96add2789d6faebf30dfff61d		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1133026											GSM3557174_r3			GSM3557174			29R_Abemaciclib_75.0						29R_Abemaciclib_75.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	75	mg/kg				9606	Homo sapiens		SRS4236545	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/008/SRR8424478	28106948	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/008/SRR8424478	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/008/SRR8424478	7111e28e6686ea079776aed5569434b1	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424479	NextSeq 500 sequencing: GSM3557174: 29R_Abemaciclib_75.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719309									85681275									GEO																NextSeq 500 sequencing: GSM3557174: 29R_Abemaciclib_75.0 Homo sapiens Mus musculus RNA-Seq										SRX5233119	GSM3557174						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/009/SRR8424479/SRR8424479.fastq.gz	43087716	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/009/SRR8424479/SRR8424479.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/009/SRR8424479/SRR8424479.fastq.gz	49b6328bdebfa3c4f2dd2cdca026a874		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1142417											GSM3557174_r4			GSM3557174			29R_Abemaciclib_75.0						29R_Abemaciclib_75.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	75	mg/kg				9606	Homo sapiens		SRS4236545	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/009/SRR8424479	28200172	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/009/SRR8424479	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/009/SRR8424479	2f681246d1729298b5258a2f554920d1	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424472	NextSeq 500 sequencing: GSM3557173: 29L_Abemaciclib_75.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719334									89074725									GEO																NextSeq 500 sequencing: GSM3557173: 29L_Abemaciclib_75.0 Homo sapiens Mus musculus RNA-Seq										SRX5233118	GSM3557173						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/002/SRR8424472/SRR8424472.fastq.gz	44931804	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/002/SRR8424472/SRR8424472.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/002/SRR8424472/SRR8424472.fastq.gz	56d2b98326311450538a45b95c0c1d87		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1187663											GSM3557173_r1			GSM3557173			29L_Abemaciclib_75.0						29L_Abemaciclib_75.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	75	mg/kg				9606	Homo sapiens		SRS4236544	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/002/SRR8424472	29376815	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/002/SRR8424472	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/002/SRR8424472	610c2ad309e16fd58a87399abedf9541	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424473	NextSeq 500 sequencing: GSM3557173: 29L_Abemaciclib_75.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719334									89698950									GEO																NextSeq 500 sequencing: GSM3557173: 29L_Abemaciclib_75.0 Homo sapiens Mus musculus RNA-Seq										SRX5233118	GSM3557173						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/003/SRR8424473/SRR8424473.fastq.gz	45382882	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/003/SRR8424473/SRR8424473.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/003/SRR8424473/SRR8424473.fastq.gz	c771fc5f093519c08f6ee4b21eedeb16		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1195986											GSM3557173_r2			GSM3557173			29L_Abemaciclib_75.0						29L_Abemaciclib_75.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	75	mg/kg				9606	Homo sapiens		SRS4236544	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/003/SRR8424473	29688902	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/003/SRR8424473	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/003/SRR8424473	5e34dd6885c4d1f362dc02549fbc4dfa	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424474	NextSeq 500 sequencing: GSM3557173: 29L_Abemaciclib_75.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719334									91113675									GEO																NextSeq 500 sequencing: GSM3557173: 29L_Abemaciclib_75.0 Homo sapiens Mus musculus RNA-Seq										SRX5233118	GSM3557173						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/004/SRR8424474/SRR8424474.fastq.gz	46151205	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/004/SRR8424474/SRR8424474.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/004/SRR8424474/SRR8424474.fastq.gz	50bf6b01dba1a50a4fd08f790429f05a		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1214849											GSM3557173_r3			GSM3557173			29L_Abemaciclib_75.0						29L_Abemaciclib_75.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	75	mg/kg				9606	Homo sapiens		SRS4236544	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/004/SRR8424474	30202485	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/004/SRR8424474	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/004/SRR8424474	33ad8a30f66fba7b65cc2b1f622ce503	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424475	NextSeq 500 sequencing: GSM3557173: 29L_Abemaciclib_75.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719334									91557300									GEO																NextSeq 500 sequencing: GSM3557173: 29L_Abemaciclib_75.0 Homo sapiens Mus musculus RNA-Seq										SRX5233118	GSM3557173						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/005/SRR8424475/SRR8424475.fastq.gz	46182504	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/005/SRR8424475/SRR8424475.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/005/SRR8424475/SRR8424475.fastq.gz	475b4d5fb1997feb20d9e8ca084b0a2f		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1220764											GSM3557173_r4			GSM3557173			29L_Abemaciclib_75.0						29L_Abemaciclib_75.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	75	mg/kg				9606	Homo sapiens		SRS4236544	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/005/SRR8424475	30213030	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/005/SRR8424475	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/005/SRR8424475	224db2f7c0f88ebe9834b9f6e7c206fa	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424468	NextSeq 500 sequencing: GSM3557172: 28R_Abemaciclib_75.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719335									77739600									GEO																NextSeq 500 sequencing: GSM3557172: 28R_Abemaciclib_75.0 Homo sapiens Mus musculus RNA-Seq										SRX5233117	GSM3557172						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/008/SRR8424468/SRR8424468.fastq.gz	39532397	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/008/SRR8424468/SRR8424468.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/008/SRR8424468/SRR8424468.fastq.gz	b868f13b2ffe7abfc70c005c318c18fe		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1036528											GSM3557172_r1			GSM3557172			28R_Abemaciclib_75.0						28R_Abemaciclib_75.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	75	mg/kg				9606	Homo sapiens		SRS4236543	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/008/SRR8424468	25987837	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/008/SRR8424468	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/008/SRR8424468	7f312c926ff25e5625e0a53c526cd120	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424469	NextSeq 500 sequencing: GSM3557172: 28R_Abemaciclib_75.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719335									78280050									GEO																NextSeq 500 sequencing: GSM3557172: 28R_Abemaciclib_75.0 Homo sapiens Mus musculus RNA-Seq										SRX5233117	GSM3557172						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/009/SRR8424469/SRR8424469.fastq.gz	39922276	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/009/SRR8424469/SRR8424469.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/009/SRR8424469/SRR8424469.fastq.gz	b6aed27d944d140754672d30a34a9111		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1043734											GSM3557172_r2			GSM3557172			28R_Abemaciclib_75.0						28R_Abemaciclib_75.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	75	mg/kg				9606	Homo sapiens		SRS4236543	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/009/SRR8424469	26258338	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/009/SRR8424469	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/009/SRR8424469	695f7a83ebd37ed5e943a9916634fe80	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424470	NextSeq 500 sequencing: GSM3557172: 28R_Abemaciclib_75.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719335									79650600									GEO																NextSeq 500 sequencing: GSM3557172: 28R_Abemaciclib_75.0 Homo sapiens Mus musculus RNA-Seq										SRX5233117	GSM3557172						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/000/SRR8424470/SRR8424470.fastq.gz	40656234	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/000/SRR8424470/SRR8424470.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/000/SRR8424470/SRR8424470.fastq.gz	2c01ac4ec8efed9f0ac8611ffffbfa77		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1062008											GSM3557172_r3			GSM3557172			28R_Abemaciclib_75.0						28R_Abemaciclib_75.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	75	mg/kg				9606	Homo sapiens		SRS4236543	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/000/SRR8424470	26752500	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/000/SRR8424470	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/000/SRR8424470	90de8018e860ab519a5538cdf421e6e6	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424471	NextSeq 500 sequencing: GSM3557172: 28R_Abemaciclib_75.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719335									79999575									GEO																NextSeq 500 sequencing: GSM3557172: 28R_Abemaciclib_75.0 Homo sapiens Mus musculus RNA-Seq										SRX5233117	GSM3557172						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/001/SRR8424471/SRR8424471.fastq.gz	40680981	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/001/SRR8424471/SRR8424471.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/001/SRR8424471/SRR8424471.fastq.gz	4312a308a9e8c7e893df6641a2ff5a6f		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1066661											GSM3557172_r4			GSM3557172			28R_Abemaciclib_75.0						28R_Abemaciclib_75.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	75	mg/kg				9606	Homo sapiens		SRS4236543	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/001/SRR8424471	26759426	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/001/SRR8424471	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/001/SRR8424471	fc49d12332aaaa945bf89ce11f33acb7	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424464	NextSeq 500 sequencing: GSM3557171: 28L_Abemaciclib_75.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719330									77103000									GEO																NextSeq 500 sequencing: GSM3557171: 28L_Abemaciclib_75.0 Homo sapiens Mus musculus RNA-Seq										SRX5233116	GSM3557171						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/004/SRR8424464/SRR8424464.fastq.gz	39021669	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/004/SRR8424464/SRR8424464.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/004/SRR8424464/SRR8424464.fastq.gz	73150d160d7e85af41a37596e2f13652		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1028040											GSM3557171_r1			GSM3557171			28L_Abemaciclib_75.0						28L_Abemaciclib_75.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	75	mg/kg				9606	Homo sapiens		SRS4236542	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/004/SRR8424464	25542135	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/004/SRR8424464	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/004/SRR8424464	d49a3811e354d7f101b0285867eda2d7	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424465	NextSeq 500 sequencing: GSM3557171: 28L_Abemaciclib_75.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719330									77837700									GEO																NextSeq 500 sequencing: GSM3557171: 28L_Abemaciclib_75.0 Homo sapiens Mus musculus RNA-Seq										SRX5233116	GSM3557171						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/005/SRR8424465/SRR8424465.fastq.gz	39493310	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/005/SRR8424465/SRR8424465.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/005/SRR8424465/SRR8424465.fastq.gz	679597cb6ac4e9137d5fa67c1d96fbe0		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1037836											GSM3557171_r2			GSM3557171			28L_Abemaciclib_75.0						28L_Abemaciclib_75.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	75	mg/kg				9606	Homo sapiens		SRS4236542	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/005/SRR8424465	25861352	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/005/SRR8424465	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/005/SRR8424465	cf30ede8d09ba27eb0dea31d3905fa11	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424466	NextSeq 500 sequencing: GSM3557171: 28L_Abemaciclib_75.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719330									79128825									GEO																NextSeq 500 sequencing: GSM3557171: 28L_Abemaciclib_75.0 Homo sapiens Mus musculus RNA-Seq										SRX5233116	GSM3557171						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/006/SRR8424466/SRR8424466.fastq.gz	40255718	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/006/SRR8424466/SRR8424466.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/006/SRR8424466/SRR8424466.fastq.gz	6e338e8494592119a3ed232143892439		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1055051											GSM3557171_r3			GSM3557171			28L_Abemaciclib_75.0						28L_Abemaciclib_75.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	75	mg/kg				9606	Homo sapiens		SRS4236542	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/006/SRR8424466	26374504	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/006/SRR8424466	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/006/SRR8424466	104c4d6d7b3810adcdddccf8e4621865	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424467	NextSeq 500 sequencing: GSM3557171: 28L_Abemaciclib_75.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719330									79664250									GEO																NextSeq 500 sequencing: GSM3557171: 28L_Abemaciclib_75.0 Homo sapiens Mus musculus RNA-Seq										SRX5233116	GSM3557171						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/007/SRR8424467/SRR8424467.fastq.gz	40322844	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/007/SRR8424467/SRR8424467.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/007/SRR8424467/SRR8424467.fastq.gz	8a8cab415e0f6c2a1f4c09d9c964490d		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1062190											GSM3557171_r4			GSM3557171			28L_Abemaciclib_75.0						28L_Abemaciclib_75.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	75	mg/kg				9606	Homo sapiens		SRS4236542	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/007/SRR8424467	26410555	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/007/SRR8424467	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/007/SRR8424467	5edb8903f6da2a7cb968c8f426352443	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424460	NextSeq 500 sequencing: GSM3557170: 27R_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719331									84327075									GEO																NextSeq 500 sequencing: GSM3557170: 27R_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233115	GSM3557170						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/000/SRR8424460/SRR8424460.fastq.gz	42718109	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/000/SRR8424460/SRR8424460.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/000/SRR8424460/SRR8424460.fastq.gz	2c50ad14d2b3a16dc33ecab2108b2846		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1124361											GSM3557170_r1			GSM3557170			27R_Ribociclib_150.0						27R_Ribociclib_150.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	RIBOCICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236541	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/000/SRR8424460	28013953	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/000/SRR8424460	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/000/SRR8424460	915fcc8d0a61d9117a5f11767a3a25f3	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424461	NextSeq 500 sequencing: GSM3557170: 27R_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719331									84997275									GEO																NextSeq 500 sequencing: GSM3557170: 27R_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233115	GSM3557170						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/001/SRR8424461/SRR8424461.fastq.gz	43158816	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/001/SRR8424461/SRR8424461.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/001/SRR8424461/SRR8424461.fastq.gz	55d519e1de46b2f14f90f23da6eac5cd		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1133297											GSM3557170_r2			GSM3557170			27R_Ribociclib_150.0						27R_Ribociclib_150.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	RIBOCICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236541	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/001/SRR8424461	28312960	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/001/SRR8424461	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/001/SRR8424461	66bc51d69e3f0cdbe8a6f7794a3fb5ab	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424462	NextSeq 500 sequencing: GSM3557170: 27R_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719331									86292300									GEO																NextSeq 500 sequencing: GSM3557170: 27R_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233115	GSM3557170						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/002/SRR8424462/SRR8424462.fastq.gz	43857083	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/002/SRR8424462/SRR8424462.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/002/SRR8424462/SRR8424462.fastq.gz	4fff72baad8a2d8dc2aecb6373ee5af9		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1150564											GSM3557170_r3			GSM3557170			27R_Ribociclib_150.0						27R_Ribociclib_150.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	RIBOCICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236541	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/002/SRR8424462	28781039	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/002/SRR8424462	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/002/SRR8424462	350b70baff696c96ccec811df464a307	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424463	NextSeq 500 sequencing: GSM3557170: 27R_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719331									86843175									GEO																NextSeq 500 sequencing: GSM3557170: 27R_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233115	GSM3557170						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/003/SRR8424463/SRR8424463.fastq.gz	43943207	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/003/SRR8424463/SRR8424463.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/003/SRR8424463/SRR8424463.fastq.gz	e7e9242a8fbfd8a075acf755a09980ab		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1157909											GSM3557170_r4			GSM3557170			27R_Ribociclib_150.0						27R_Ribociclib_150.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	RIBOCICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236541	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/003/SRR8424463	28826405	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/003/SRR8424463	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/003/SRR8424463	bc0622b2efa4cc64a9adf94249b26be9	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424456	NextSeq 500 sequencing: GSM3557169: 27L_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719332									80394375									GEO																NextSeq 500 sequencing: GSM3557169: 27L_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233114	GSM3557169						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/006/SRR8424456/SRR8424456.fastq.gz	40741765	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/006/SRR8424456/SRR8424456.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/006/SRR8424456/SRR8424456.fastq.gz	701f49d40a40aa1476479bb23ec54d9c		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1071925											GSM3557169_r1			GSM3557169			27L_Ribociclib_150.0						27L_Ribociclib_150.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	RIBOCICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236540	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/006/SRR8424456	26679070	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/006/SRR8424456	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/006/SRR8424456	ba022bfdfa91a57f69864bdae20b2eff	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424457	NextSeq 500 sequencing: GSM3557169: 27L_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719332									81029325									GEO																NextSeq 500 sequencing: GSM3557169: 27L_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233114	GSM3557169						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/007/SRR8424457/SRR8424457.fastq.gz	41178138	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/007/SRR8424457/SRR8424457.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/007/SRR8424457/SRR8424457.fastq.gz	b4f63db9358514639d0f6f19d0eafa07		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1080391											GSM3557169_r2			GSM3557169			27L_Ribociclib_150.0						27L_Ribociclib_150.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	RIBOCICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236540	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/007/SRR8424457	26975978	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/007/SRR8424457	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/007/SRR8424457	cec097e533d8b789edf9b90de82af4ea	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424458	NextSeq 500 sequencing: GSM3557169: 27L_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719332									82092600									GEO																NextSeq 500 sequencing: GSM3557169: 27L_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233114	GSM3557169						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/008/SRR8424458/SRR8424458.fastq.gz	41764196	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/008/SRR8424458/SRR8424458.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/008/SRR8424458/SRR8424458.fastq.gz	6e5d585fde239937cc1b243951883609		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1094568											GSM3557169_r3			GSM3557169			27L_Ribociclib_150.0						27L_Ribociclib_150.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	RIBOCICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236540	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/008/SRR8424458	27371921	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/008/SRR8424458	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/008/SRR8424458	2d17454ed079e683bea2fe6c930031ee	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424459	NextSeq 500 sequencing: GSM3557169: 27L_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719332									82893150									GEO																NextSeq 500 sequencing: GSM3557169: 27L_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233114	GSM3557169						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/009/SRR8424459/SRR8424459.fastq.gz	41979978	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/009/SRR8424459/SRR8424459.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/009/SRR8424459/SRR8424459.fastq.gz	7899a63e90e5e2f152bcfe1cb42f2c8c		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1105242											GSM3557169_r4			GSM3557169			27L_Ribociclib_150.0						27L_Ribociclib_150.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	RIBOCICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236540	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/009/SRR8424459	27508633	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/009/SRR8424459	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/009/SRR8424459	2dadf2da31c2e683f747bab47b556f94	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424452	NextSeq 500 sequencing: GSM3557168: 26R_Vehicle Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719333									83827575									GEO																NextSeq 500 sequencing: GSM3557168: 26R_Vehicle Homo sapiens Mus musculus RNA-Seq										SRX5233113	GSM3557168						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/002/SRR8424452/SRR8424452.fastq.gz	42434129	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/002/SRR8424452/SRR8424452.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/002/SRR8424452/SRR8424452.fastq.gz	e74bac6afb820faf473100b20f7002b8		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1117701											GSM3557168_r1			GSM3557168			26R_Vehicle						26R_Vehicle	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	CONTROL	CONTROL			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	0	mg/kg				9606	Homo sapiens		SRS4236539	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/002/SRR8424452	27784556	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/002/SRR8424452	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/002/SRR8424452	f2b3dc09b0953a62c1c8075f9d84aed7	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424453	NextSeq 500 sequencing: GSM3557168: 26R_Vehicle Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719333									84597075									GEO																NextSeq 500 sequencing: GSM3557168: 26R_Vehicle Homo sapiens Mus musculus RNA-Seq										SRX5233113	GSM3557168						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/003/SRR8424453/SRR8424453.fastq.gz	42938215	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/003/SRR8424453/SRR8424453.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/003/SRR8424453/SRR8424453.fastq.gz	3710d009105c22aa69087f2a8d22d1dd		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1127961											GSM3557168_r2			GSM3557168			26R_Vehicle						26R_Vehicle	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	CONTROL	CONTROL			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	0	mg/kg				9606	Homo sapiens		SRS4236539	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/003/SRR8424453	28128489	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/003/SRR8424453	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/003/SRR8424453	bc73118f4ee3ee7edefb727371094be7	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424454	NextSeq 500 sequencing: GSM3557168: 26R_Vehicle Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719333									85735650									GEO																NextSeq 500 sequencing: GSM3557168: 26R_Vehicle Homo sapiens Mus musculus RNA-Seq										SRX5233113	GSM3557168						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/004/SRR8424454/SRR8424454.fastq.gz	43594602	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/004/SRR8424454/SRR8424454.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/004/SRR8424454/SRR8424454.fastq.gz	1c5dfc79b9449bc8f916aca28aaa22c2		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1143142											GSM3557168_r3			GSM3557168			26R_Vehicle						26R_Vehicle	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	CONTROL	CONTROL			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	0	mg/kg				9606	Homo sapiens		SRS4236539	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/004/SRR8424454	28568668	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/004/SRR8424454	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/004/SRR8424454	2d9881682d88cfc9cddc7136a3d069e7	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424455	NextSeq 500 sequencing: GSM3557168: 26R_Vehicle Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719333									86262900									GEO																NextSeq 500 sequencing: GSM3557168: 26R_Vehicle Homo sapiens Mus musculus RNA-Seq										SRX5233113	GSM3557168						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/005/SRR8424455/SRR8424455.fastq.gz	43673571	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/005/SRR8424455/SRR8424455.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/005/SRR8424455/SRR8424455.fastq.gz	5f18037f90d772c5ab060e3706c3f519		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1150172											GSM3557168_r4			GSM3557168			26R_Vehicle						26R_Vehicle	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	CONTROL	CONTROL			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	0	mg/kg				9606	Homo sapiens		SRS4236539	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/005/SRR8424455	28611620	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/005/SRR8424455	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/005/SRR8424455	863f53975246e6b985e7cede710bde98	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424448	NextSeq 500 sequencing: GSM3557167: 26L_Vehicle Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719338									83534925									GEO																NextSeq 500 sequencing: GSM3557167: 26L_Vehicle Homo sapiens Mus musculus RNA-Seq										SRX5233112	GSM3557167						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/008/SRR8424448/SRR8424448.fastq.gz	42470023	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/008/SRR8424448/SRR8424448.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/008/SRR8424448/SRR8424448.fastq.gz	51bea0410b6182c8d9fed643fb8ae729		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1113799											GSM3557167_r1			GSM3557167			26L_Vehicle						26L_Vehicle	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	CONTROL	CONTROL			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	0	mg/kg				9606	Homo sapiens		SRS4236538	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/008/SRR8424448	27881244	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/008/SRR8424448	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/008/SRR8424448	4759a7ca087af195caf66d5270ce91a0	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424449	NextSeq 500 sequencing: GSM3557167: 26L_Vehicle Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719338									84457650									GEO																NextSeq 500 sequencing: GSM3557167: 26L_Vehicle Homo sapiens Mus musculus RNA-Seq										SRX5233112	GSM3557167						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/009/SRR8424449/SRR8424449.fastq.gz	43041608	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/009/SRR8424449/SRR8424449.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/009/SRR8424449/SRR8424449.fastq.gz	c8dada177555bc61544e8a322e02b10c		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1126102											GSM3557167_r2			GSM3557167			26L_Vehicle						26L_Vehicle	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	CONTROL	CONTROL			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	0	mg/kg				9606	Homo sapiens		SRS4236538	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/009/SRR8424449	28263390	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/009/SRR8424449	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/009/SRR8424449	ef46cd8d5b2920c435bfa3892abf78ba	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424450	NextSeq 500 sequencing: GSM3557167: 26L_Vehicle Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719338									85629750									GEO																NextSeq 500 sequencing: GSM3557167: 26L_Vehicle Homo sapiens Mus musculus RNA-Seq										SRX5233112	GSM3557167						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/000/SRR8424450/SRR8424450.fastq.gz	43717507	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/000/SRR8424450/SRR8424450.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/000/SRR8424450/SRR8424450.fastq.gz	ea1f9e67382b293c1ce736d9f61ee2fe		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1141730											GSM3557167_r3			GSM3557167			26L_Vehicle						26L_Vehicle	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	CONTROL	CONTROL			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	0	mg/kg				9606	Homo sapiens		SRS4236538	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/000/SRR8424450	28721607	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/000/SRR8424450	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/000/SRR8424450	c8403e166df6d08db59cb8605bdc25f8	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424451	NextSeq 500 sequencing: GSM3557167: 26L_Vehicle Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719338									86203650									GEO																NextSeq 500 sequencing: GSM3557167: 26L_Vehicle Homo sapiens Mus musculus RNA-Seq										SRX5233112	GSM3557167						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/001/SRR8424451/SRR8424451.fastq.gz	43778701	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/001/SRR8424451/SRR8424451.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/001/SRR8424451/SRR8424451.fastq.gz	ae7688fac97953b7f10d3c135aea1fc7		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1149382											GSM3557167_r4			GSM3557167			26L_Vehicle						26L_Vehicle	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	CONTROL	CONTROL			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	0	mg/kg				9606	Homo sapiens		SRS4236538	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/001/SRR8424451	28751264	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/001/SRR8424451	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/001/SRR8424451	a8b4cde03e9d2ad449839cba9b00c8eb	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424444	NextSeq 500 sequencing: GSM3557166: 25R_Vehicle Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719339									64019250									GEO																NextSeq 500 sequencing: GSM3557166: 25R_Vehicle Homo sapiens Mus musculus RNA-Seq										SRX5233111	GSM3557166						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/004/SRR8424444/SRR8424444.fastq.gz	32269560	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/004/SRR8424444/SRR8424444.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/004/SRR8424444/SRR8424444.fastq.gz	1a13f4029c30ad4c65d67569a2a57297		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		853590											GSM3557166_r1			GSM3557166			25R_Vehicle						25R_Vehicle	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	CONTROL	CONTROL			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	0	mg/kg				9606	Homo sapiens		SRS4236537	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/004/SRR8424444	21122578	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/004/SRR8424444	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/004/SRR8424444	847624d4f27db3de6efd5aac83fcda97	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424445	NextSeq 500 sequencing: GSM3557166: 25R_Vehicle Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719339									64802550									GEO																NextSeq 500 sequencing: GSM3557166: 25R_Vehicle Homo sapiens Mus musculus RNA-Seq										SRX5233111	GSM3557166						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/005/SRR8424445/SRR8424445.fastq.gz	32734835	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/005/SRR8424445/SRR8424445.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/005/SRR8424445/SRR8424445.fastq.gz	1d2ee4c1a740fa5a71457f4d262d1e29		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		864034											GSM3557166_r2			GSM3557166			25R_Vehicle						25R_Vehicle	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	CONTROL	CONTROL			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	0	mg/kg				9606	Homo sapiens		SRS4236537	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/005/SRR8424445	21438209	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/005/SRR8424445	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/005/SRR8424445	23f7813e2515bc6a27a577ae48ed5c5c	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424446	NextSeq 500 sequencing: GSM3557166: 25R_Vehicle Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719339									65581950									GEO																NextSeq 500 sequencing: GSM3557166: 25R_Vehicle Homo sapiens Mus musculus RNA-Seq										SRX5233111	GSM3557166						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/006/SRR8424446/SRR8424446.fastq.gz	33188765	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/006/SRR8424446/SRR8424446.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/006/SRR8424446/SRR8424446.fastq.gz	3c383592779c041c67a4122952ec7cb3		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		874426											GSM3557166_r3			GSM3557166			25R_Vehicle						25R_Vehicle	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	CONTROL	CONTROL			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	0	mg/kg				9606	Homo sapiens		SRS4236537	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/006/SRR8424446	21743669	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/006/SRR8424446	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/006/SRR8424446	e9715ef28242c86a9fb0de47a3267efb	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424447	NextSeq 500 sequencing: GSM3557166: 25R_Vehicle Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719339									66025800									GEO																NextSeq 500 sequencing: GSM3557166: 25R_Vehicle Homo sapiens Mus musculus RNA-Seq										SRX5233111	GSM3557166						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/007/SRR8424447/SRR8424447.fastq.gz	33260953	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/007/SRR8424447/SRR8424447.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/007/SRR8424447/SRR8424447.fastq.gz	265cbc1baf1dba4e1e0e3e521a38ff87		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		880344											GSM3557166_r4			GSM3557166			25R_Vehicle						25R_Vehicle	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	CONTROL	CONTROL			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	0	mg/kg				9606	Homo sapiens		SRS4236537	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/007/SRR8424447	21782219	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/007/SRR8424447	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/007/SRR8424447	2c1191aed557ca2c9e4fbdd6b4c1d7eb	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424440	NextSeq 500 sequencing: GSM3557165: 25L_Vehicle Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719340									71629650									GEO																NextSeq 500 sequencing: GSM3557165: 25L_Vehicle Homo sapiens Mus musculus RNA-Seq										SRX5233110	GSM3557165						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/000/SRR8424440/SRR8424440.fastq.gz	36413680	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/000/SRR8424440/SRR8424440.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/000/SRR8424440/SRR8424440.fastq.gz	14be08b498d70dbf6b996fa59934a281		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		955062											GSM3557165_r1			GSM3557165			25L_Vehicle						25L_Vehicle	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	CONTROL	CONTROL			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	0	mg/kg				9606	Homo sapiens		SRS4236536	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/000/SRR8424440	23921703	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/000/SRR8424440	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/000/SRR8424440	728b42351152e51a7bce73000d27af6f	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424441	NextSeq 500 sequencing: GSM3557165: 25L_Vehicle Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719340									72338550									GEO																NextSeq 500 sequencing: GSM3557165: 25L_Vehicle Homo sapiens Mus musculus RNA-Seq										SRX5233110	GSM3557165						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/001/SRR8424441/SRR8424441.fastq.gz	36872372	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/001/SRR8424441/SRR8424441.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/001/SRR8424441/SRR8424441.fastq.gz	e1ce06d958c7a46e92409230f322e735		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		964514											GSM3557165_r2			GSM3557165			25L_Vehicle						25L_Vehicle	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	CONTROL	CONTROL			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	0	mg/kg				9606	Homo sapiens		SRS4236536	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/001/SRR8424441	24237139	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/001/SRR8424441	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/001/SRR8424441	b6436dea5c39e4aff068f574aa767c6a	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424442	NextSeq 500 sequencing: GSM3557165: 25L_Vehicle Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719340									73377225									GEO																NextSeq 500 sequencing: GSM3557165: 25L_Vehicle Homo sapiens Mus musculus RNA-Seq										SRX5233110	GSM3557165						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/002/SRR8424442/SRR8424442.fastq.gz	37445797	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/002/SRR8424442/SRR8424442.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/002/SRR8424442/SRR8424442.fastq.gz	88df9aec5e41922fa52bace8c7875855		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		978363											GSM3557165_r3			GSM3557165			25L_Vehicle						25L_Vehicle	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	CONTROL	CONTROL			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	0	mg/kg				9606	Homo sapiens		SRS4236536	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/002/SRR8424442	24618346	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/002/SRR8424442	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/002/SRR8424442	1658545fe062ed823f29ad8140a6b1f8	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424443	NextSeq 500 sequencing: GSM3557165: 25L_Vehicle Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719340									73871700									GEO																NextSeq 500 sequencing: GSM3557165: 25L_Vehicle Homo sapiens Mus musculus RNA-Seq										SRX5233110	GSM3557165						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/003/SRR8424443/SRR8424443.fastq.gz	37546163	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/003/SRR8424443/SRR8424443.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/003/SRR8424443/SRR8424443.fastq.gz	ef3532ded50944ca9c2b59c29cdefa8a		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		984956											GSM3557165_r4			GSM3557165			25L_Vehicle						25L_Vehicle	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	CONTROL	CONTROL			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	0	mg/kg				9606	Homo sapiens		SRS4236536	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/003/SRR8424443	24678623	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/003/SRR8424443	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/003/SRR8424443	60e754962954ba7f39d902607a3132cc	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424436	NextSeq 500 sequencing: GSM3557164: 24R_Vehicle Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719336									74088675									GEO																NextSeq 500 sequencing: GSM3557164: 24R_Vehicle Homo sapiens Mus musculus RNA-Seq										SRX5233109	GSM3557164						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/006/SRR8424436/SRR8424436.fastq.gz	37697904	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/006/SRR8424436/SRR8424436.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/006/SRR8424436/SRR8424436.fastq.gz	c127fbaa08f8ea905ac44a06c94e21f8		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		987849											GSM3557164_r1			GSM3557164			24R_Vehicle						24R_Vehicle	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	CONTROL	CONTROL			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	0	mg/kg				9606	Homo sapiens		SRS4236535	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/006/SRR8424436	24688820	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/006/SRR8424436	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/006/SRR8424436	d076b80afb1097819dea7732c6e0fbea	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424437	NextSeq 500 sequencing: GSM3557164: 24R_Vehicle Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719336									74847300									GEO																NextSeq 500 sequencing: GSM3557164: 24R_Vehicle Homo sapiens Mus musculus RNA-Seq										SRX5233109	GSM3557164						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/007/SRR8424437/SRR8424437.fastq.gz	38195494	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/007/SRR8424437/SRR8424437.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/007/SRR8424437/SRR8424437.fastq.gz	4ea9ffc6fa2555a69346cda8cf725d6f		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		997964											GSM3557164_r2			GSM3557164			24R_Vehicle						24R_Vehicle	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	CONTROL	CONTROL			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	0	mg/kg				9606	Homo sapiens		SRS4236535	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/007/SRR8424437	25027616	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/007/SRR8424437	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/007/SRR8424437	482251a680fb9cfadd048124ab3b691e	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424438	NextSeq 500 sequencing: GSM3557164: 24R_Vehicle Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719336									75799275									GEO																NextSeq 500 sequencing: GSM3557164: 24R_Vehicle Homo sapiens Mus musculus RNA-Seq										SRX5233109	GSM3557164						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/008/SRR8424438/SRR8424438.fastq.gz	38748355	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/008/SRR8424438/SRR8424438.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/008/SRR8424438/SRR8424438.fastq.gz	49757c4d813c888ed656250364e6e39a		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1010657											GSM3557164_r3			GSM3557164			24R_Vehicle						24R_Vehicle	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	CONTROL	CONTROL			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	0	mg/kg				9606	Homo sapiens		SRS4236535	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/008/SRR8424438	25402765	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/008/SRR8424438	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/008/SRR8424438	e80c2507e6a4750866472530d089fe05	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424439	NextSeq 500 sequencing: GSM3557164: 24R_Vehicle Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719336									76402275									GEO																NextSeq 500 sequencing: GSM3557164: 24R_Vehicle Homo sapiens Mus musculus RNA-Seq										SRX5233109	GSM3557164						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/009/SRR8424439/SRR8424439.fastq.gz	38912952	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/009/SRR8424439/SRR8424439.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/009/SRR8424439/SRR8424439.fastq.gz	ddb88d57916ed82904b2dae5f308e223		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1018697											GSM3557164_r4			GSM3557164			24R_Vehicle						24R_Vehicle	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	CONTROL	CONTROL			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	0	mg/kg				9606	Homo sapiens		SRS4236535	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/009/SRR8424439	25501520	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/009/SRR8424439	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/009/SRR8424439	e78f7d12a1bfd037b91d76247e629953	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424432	NextSeq 500 sequencing: GSM3557163: 24L_Vehicle Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719337									72901650									GEO																NextSeq 500 sequencing: GSM3557163: 24L_Vehicle Homo sapiens Mus musculus RNA-Seq										SRX5233108	GSM3557163						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/002/SRR8424432/SRR8424432.fastq.gz	36925077	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/002/SRR8424432/SRR8424432.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/002/SRR8424432/SRR8424432.fastq.gz	9e43339f890410056f3e16a48608fc3b		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		972022											GSM3557163_r1			GSM3557163			24L_Vehicle						24L_Vehicle	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	CONTROL	CONTROL			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	0	mg/kg				9606	Homo sapiens		SRS4236534	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/002/SRR8424432	24161738	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/002/SRR8424432	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/002/SRR8424432	e681ed9a08a2a5ed8cdaf1a10e97916e	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424433	NextSeq 500 sequencing: GSM3557163: 24L_Vehicle Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719337									73530525									GEO																NextSeq 500 sequencing: GSM3557163: 24L_Vehicle Homo sapiens Mus musculus RNA-Seq										SRX5233108	GSM3557163						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/003/SRR8424433/SRR8424433.fastq.gz	37317949	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/003/SRR8424433/SRR8424433.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/003/SRR8424433/SRR8424433.fastq.gz	49e1fe95c90f2cf8b8d9b7d0754ae8c6		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		980407											GSM3557163_r2			GSM3557163			24L_Vehicle						24L_Vehicle	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	CONTROL	CONTROL			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	0	mg/kg				9606	Homo sapiens		SRS4236534	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/003/SRR8424433	24430720	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/003/SRR8424433	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/003/SRR8424433	feb43b1c7f189a2b57f1be0c631dd859	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424434	NextSeq 500 sequencing: GSM3557163: 24L_Vehicle Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719337									74499750									GEO																NextSeq 500 sequencing: GSM3557163: 24L_Vehicle Homo sapiens Mus musculus RNA-Seq										SRX5233108	GSM3557163						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/004/SRR8424434/SRR8424434.fastq.gz	37923883	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/004/SRR8424434/SRR8424434.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/004/SRR8424434/SRR8424434.fastq.gz	48e2ed7b3d2696dded8d4ade3bec80a9		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		993330											GSM3557163_r3			GSM3557163			24L_Vehicle						24L_Vehicle	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	CONTROL	CONTROL			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	0	mg/kg				9606	Homo sapiens		SRS4236534	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/004/SRR8424434	24839006	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/004/SRR8424434	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/004/SRR8424434	e3f82ea62992829ca82924da8fbed56f	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424435	NextSeq 500 sequencing: GSM3557163: 24L_Vehicle Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719337									75072150									GEO																NextSeq 500 sequencing: GSM3557163: 24L_Vehicle Homo sapiens Mus musculus RNA-Seq										SRX5233108	GSM3557163						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/005/SRR8424435/SRR8424435.fastq.gz	38018255	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/005/SRR8424435/SRR8424435.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/005/SRR8424435/SRR8424435.fastq.gz	bfa1ac397eb4a32ac80e00f928e2e6ac		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1000962											GSM3557163_r4			GSM3557163			24L_Vehicle						24L_Vehicle	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	CONTROL	CONTROL			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	0	mg/kg				9606	Homo sapiens		SRS4236534	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/005/SRR8424435	24890549	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/005/SRR8424435	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/005/SRR8424435	d940743efa1e4bdb94869670a9bc8156	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424428	NextSeq 500 sequencing: GSM3557162: 23R_Abemaciclib_125.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719341									80211525									GEO																NextSeq 500 sequencing: GSM3557162: 23R_Abemaciclib_125.0 Homo sapiens Mus musculus RNA-Seq										SRX5233107	GSM3557162						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/008/SRR8424428/SRR8424428.fastq.gz	40749228	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/008/SRR8424428/SRR8424428.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/008/SRR8424428/SRR8424428.fastq.gz	2870fc63a65eeb471cd65e41050984e2		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1069487											GSM3557162_r1			GSM3557162			23R_Abemaciclib_125.0						23R_Abemaciclib_125.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	125	mg/kg				9606	Homo sapiens		SRS4236533	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/008/SRR8424428	26754343	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/008/SRR8424428	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/008/SRR8424428	09351bb2123d9ff656a336d28862021b	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424429	NextSeq 500 sequencing: GSM3557162: 23R_Abemaciclib_125.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719341									81037125									GEO																NextSeq 500 sequencing: GSM3557162: 23R_Abemaciclib_125.0 Homo sapiens Mus musculus RNA-Seq										SRX5233107	GSM3557162						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/009/SRR8424429/SRR8424429.fastq.gz	41282457	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/009/SRR8424429/SRR8424429.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/009/SRR8424429/SRR8424429.fastq.gz	085d5880285bf9a97c13fdaccab035c0		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1080495											GSM3557162_r2			GSM3557162			23R_Abemaciclib_125.0						23R_Abemaciclib_125.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	125	mg/kg				9606	Homo sapiens		SRS4236533	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/009/SRR8424429	27114108	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/009/SRR8424429	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/009/SRR8424429	628df256e097a949975d18a8a4befe1c	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424430	NextSeq 500 sequencing: GSM3557162: 23R_Abemaciclib_125.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719341									82045575									GEO																NextSeq 500 sequencing: GSM3557162: 23R_Abemaciclib_125.0 Homo sapiens Mus musculus RNA-Seq										SRX5233107	GSM3557162						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/000/SRR8424430/SRR8424430.fastq.gz	41862245	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/000/SRR8424430/SRR8424430.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/000/SRR8424430/SRR8424430.fastq.gz	61a88db1a8ae0631b31d6b4484b9c705		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1093941											GSM3557162_r3			GSM3557162			23R_Abemaciclib_125.0						23R_Abemaciclib_125.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	125	mg/kg				9606	Homo sapiens		SRS4236533	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/000/SRR8424430	27506166	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/000/SRR8424430	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/000/SRR8424430	13d88526d69f4634d044fe28ebd8d62d	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424431	NextSeq 500 sequencing: GSM3557162: 23R_Abemaciclib_125.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719341									82524225									GEO																NextSeq 500 sequencing: GSM3557162: 23R_Abemaciclib_125.0 Homo sapiens Mus musculus RNA-Seq										SRX5233107	GSM3557162						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/001/SRR8424431/SRR8424431.fastq.gz	41911990	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/001/SRR8424431/SRR8424431.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/001/SRR8424431/SRR8424431.fastq.gz	b375465f46cba4f25d3a3aff4a9c37ab		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1100323											GSM3557162_r4			GSM3557162			23R_Abemaciclib_125.0						23R_Abemaciclib_125.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	125	mg/kg				9606	Homo sapiens		SRS4236533	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/001/SRR8424431	27528893	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/001/SRR8424431	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/001/SRR8424431	7aa9329d9249d1693e6ded964bd83d30	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424424	NextSeq 500 sequencing: GSM3557161: 23L_Abemaciclib_125.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719342									78679500									GEO																NextSeq 500 sequencing: GSM3557161: 23L_Abemaciclib_125.0 Homo sapiens Mus musculus RNA-Seq										SRX5233106	GSM3557161						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/004/SRR8424424/SRR8424424.fastq.gz	39894914	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/004/SRR8424424/SRR8424424.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/004/SRR8424424/SRR8424424.fastq.gz	fe0bea40e5b3f534084ad0d5f4797008		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1049060											GSM3557161_r1			GSM3557161			23L_Abemaciclib_125.0						23L_Abemaciclib_125.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	125	mg/kg				9606	Homo sapiens		SRS4236532	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/004/SRR8424424	26130417	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/004/SRR8424424	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/004/SRR8424424	8300eeeb50c973ecf61e18749d21b9a3	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424425	NextSeq 500 sequencing: GSM3557161: 23L_Abemaciclib_125.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719342									79338450									GEO																NextSeq 500 sequencing: GSM3557161: 23L_Abemaciclib_125.0 Homo sapiens Mus musculus RNA-Seq										SRX5233106	GSM3557161						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/005/SRR8424425/SRR8424425.fastq.gz	40324749	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/005/SRR8424425/SRR8424425.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/005/SRR8424425/SRR8424425.fastq.gz	42afd11a53aafbe0e100f8dd30e0b1fa		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1057846											GSM3557161_r2			GSM3557161			23L_Abemaciclib_125.0						23L_Abemaciclib_125.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	125	mg/kg				9606	Homo sapiens		SRS4236532	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/005/SRR8424425	26421903	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/005/SRR8424425	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/005/SRR8424425	288d7425eef249efd780197b8b2eebe2	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424426	NextSeq 500 sequencing: GSM3557161: 23L_Abemaciclib_125.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719342									80326575									GEO																NextSeq 500 sequencing: GSM3557161: 23L_Abemaciclib_125.0 Homo sapiens Mus musculus RNA-Seq										SRX5233106	GSM3557161						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/006/SRR8424426/SRR8424426.fastq.gz	40914789	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/006/SRR8424426/SRR8424426.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/006/SRR8424426/SRR8424426.fastq.gz	fdc6d265e6425db75b9f6f1efbcdf25e		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1071021											GSM3557161_r3			GSM3557161			23L_Abemaciclib_125.0						23L_Abemaciclib_125.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	125	mg/kg				9606	Homo sapiens		SRS4236532	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/006/SRR8424426	26820008	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/006/SRR8424426	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/006/SRR8424426	0de27e6d6cdd53b48ad0b45fe4cc36cb	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424427	NextSeq 500 sequencing: GSM3557161: 23L_Abemaciclib_125.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719342									80907300									GEO																NextSeq 500 sequencing: GSM3557161: 23L_Abemaciclib_125.0 Homo sapiens Mus musculus RNA-Seq										SRX5233106	GSM3557161						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/007/SRR8424427/SRR8424427.fastq.gz	41023495	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/007/SRR8424427/SRR8424427.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/007/SRR8424427/SRR8424427.fastq.gz	d2621a7aaeb25f6810f40054f8b271c0		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1078764											GSM3557161_r4			GSM3557161			23L_Abemaciclib_125.0						23L_Abemaciclib_125.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	125	mg/kg				9606	Homo sapiens		SRS4236532	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/007/SRR8424427	26884823	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/007/SRR8424427	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/007/SRR8424427	679607c450fef5e5e77cc93f1a4ea418	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424420	NextSeq 500 sequencing: GSM3557160: 21R_Abemaciclib_100.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719343									82347750									GEO																NextSeq 500 sequencing: GSM3557160: 21R_Abemaciclib_100.0 Homo sapiens Mus musculus RNA-Seq										SRX5233105	GSM3557160						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/000/SRR8424420/SRR8424420.fastq.gz	41527320	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/000/SRR8424420/SRR8424420.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/000/SRR8424420/SRR8424420.fastq.gz	58963c3311dda503d9f74cd1078765ed		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1097970											GSM3557160_r1			GSM3557160			21R_Abemaciclib_100.0						21R_Abemaciclib_100.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	100	mg/kg				9606	Homo sapiens		SRS4236531	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/000/SRR8424420	27203109	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/000/SRR8424420	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/000/SRR8424420	9ccc3cf38c338a60ede21cdc18aa9f1e	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424421	NextSeq 500 sequencing: GSM3557160: 21R_Abemaciclib_100.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719343									83311950									GEO																NextSeq 500 sequencing: GSM3557160: 21R_Abemaciclib_100.0 Homo sapiens Mus musculus RNA-Seq										SRX5233105	GSM3557160						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/001/SRR8424421/SRR8424421.fastq.gz	42121198	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/001/SRR8424421/SRR8424421.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/001/SRR8424421/SRR8424421.fastq.gz	4fe4d02a94d76b2de249d86d2db0513e		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1110826											GSM3557160_r2			GSM3557160			21R_Abemaciclib_100.0						21R_Abemaciclib_100.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	100	mg/kg				9606	Homo sapiens		SRS4236531	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/001/SRR8424421	27604698	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/001/SRR8424421	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/001/SRR8424421	0f7563c92a02253a7574320f3a489941	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424422	NextSeq 500 sequencing: GSM3557160: 21R_Abemaciclib_100.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719343									83929125									GEO																NextSeq 500 sequencing: GSM3557160: 21R_Abemaciclib_100.0 Homo sapiens Mus musculus RNA-Seq										SRX5233105	GSM3557160						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/002/SRR8424422/SRR8424422.fastq.gz	42504775	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/002/SRR8424422/SRR8424422.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/002/SRR8424422/SRR8424422.fastq.gz	028ba420d9a2d334ca2f108836b6baeb		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1119055											GSM3557160_r3			GSM3557160			21R_Abemaciclib_100.0						21R_Abemaciclib_100.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	100	mg/kg				9606	Homo sapiens		SRS4236531	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/002/SRR8424422	27865269	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/002/SRR8424422	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/002/SRR8424422	35d5fc8204fc7507d515ce0068fe5771	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424423	NextSeq 500 sequencing: GSM3557160: 21R_Abemaciclib_100.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719343									84824925									GEO																NextSeq 500 sequencing: GSM3557160: 21R_Abemaciclib_100.0 Homo sapiens Mus musculus RNA-Seq										SRX5233105	GSM3557160						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/003/SRR8424423/SRR8424423.fastq.gz	42787840	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/003/SRR8424423/SRR8424423.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/003/SRR8424423/SRR8424423.fastq.gz	dd430a49df8ee0021418b1af78175d92		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1130999											GSM3557160_r4			GSM3557160			21R_Abemaciclib_100.0						21R_Abemaciclib_100.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	100	mg/kg				9606	Homo sapiens		SRS4236531	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/003/SRR8424423	28043649	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/003/SRR8424423	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/003/SRR8424423	6a37db9b03c16685ae00172f1806cf09	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424416	NextSeq 500 sequencing: GSM3557159: 21L_Abemaciclib_100.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719344									75822525									GEO																NextSeq 500 sequencing: GSM3557159: 21L_Abemaciclib_100.0 Homo sapiens Mus musculus RNA-Seq										SRX5233104	GSM3557159						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/006/SRR8424416/SRR8424416.fastq.gz	38455900	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/006/SRR8424416/SRR8424416.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/006/SRR8424416/SRR8424416.fastq.gz	e202d9d12b9256c9a7ff9c34a01468df		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1010967											GSM3557159_r1			GSM3557159			21L_Abemaciclib_100.0						21L_Abemaciclib_100.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	100	mg/kg				9606	Homo sapiens		SRS4236530	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/006/SRR8424416	25237550	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/006/SRR8424416	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/006/SRR8424416	9db3eec41e0d90312fb1c1454fc990b0	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424417	NextSeq 500 sequencing: GSM3557159: 21L_Abemaciclib_100.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719344									76799850									GEO																NextSeq 500 sequencing: GSM3557159: 21L_Abemaciclib_100.0 Homo sapiens Mus musculus RNA-Seq										SRX5233104	GSM3557159						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/007/SRR8424417/SRR8424417.fastq.gz	39038066	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/007/SRR8424417/SRR8424417.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/007/SRR8424417/SRR8424417.fastq.gz	8f3051173e8704aebfd1fa3a4b85e062		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1023998											GSM3557159_r2			GSM3557159			21L_Abemaciclib_100.0						21L_Abemaciclib_100.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	100	mg/kg				9606	Homo sapiens		SRS4236530	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/007/SRR8424417	25627006	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/007/SRR8424417	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/007/SRR8424417	3bcda2b48d8c2c4f3ae6c4e3462d7fe7	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424418	NextSeq 500 sequencing: GSM3557159: 21L_Abemaciclib_100.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719344									77873250									GEO																NextSeq 500 sequencing: GSM3557159: 21L_Abemaciclib_100.0 Homo sapiens Mus musculus RNA-Seq										SRX5233104	GSM3557159						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/008/SRR8424418/SRR8424418.fastq.gz	39680134	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/008/SRR8424418/SRR8424418.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/008/SRR8424418/SRR8424418.fastq.gz	25ecf68fd17a15297eb7bc3c1eac1401		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1038310											GSM3557159_r3			GSM3557159			21L_Abemaciclib_100.0						21L_Abemaciclib_100.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	100	mg/kg				9606	Homo sapiens		SRS4236530	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/008/SRR8424418	26067991	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/008/SRR8424418	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/008/SRR8424418	16f9e45a53ae42a5daac750fe026e42d	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424419	NextSeq 500 sequencing: GSM3557159: 21L_Abemaciclib_100.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719344									78300300									GEO																NextSeq 500 sequencing: GSM3557159: 21L_Abemaciclib_100.0 Homo sapiens Mus musculus RNA-Seq										SRX5233104	GSM3557159						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/009/SRR8424419/SRR8424419.fastq.gz	39722580	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/009/SRR8424419/SRR8424419.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/009/SRR8424419/SRR8424419.fastq.gz	94a3e034beee181ef03da2ab19b780ea		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1044004											GSM3557159_r4			GSM3557159			21L_Abemaciclib_100.0						21L_Abemaciclib_100.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	100	mg/kg				9606	Homo sapiens		SRS4236530	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/009/SRR8424419	26081985	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/009/SRR8424419	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/009/SRR8424419	884ef10ada67620431c9155ad8fc8479	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424412	NextSeq 500 sequencing: GSM3557158: 20R_Vehicle Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719345									65263725									GEO																NextSeq 500 sequencing: GSM3557158: 20R_Vehicle Homo sapiens Mus musculus RNA-Seq										SRX5233103	GSM3557158						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/002/SRR8424412/SRR8424412.fastq.gz	33023113	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/002/SRR8424412/SRR8424412.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/002/SRR8424412/SRR8424412.fastq.gz	e835291527b421736ba7abea41985d69		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		870183											GSM3557158_r1			GSM3557158			20R_Vehicle						20R_Vehicle	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	CONTROL	CONTROL			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	0	mg/kg				9606	Homo sapiens		SRS4236529	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/002/SRR8424412	21621365	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/002/SRR8424412	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/002/SRR8424412	69e6e02a7250e9d0f4f6ba5dc89e00c5	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424413	NextSeq 500 sequencing: GSM3557158: 20R_Vehicle Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719345									66032775									GEO																NextSeq 500 sequencing: GSM3557158: 20R_Vehicle Homo sapiens Mus musculus RNA-Seq										SRX5233103	GSM3557158						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/003/SRR8424413/SRR8424413.fastq.gz	33502405	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/003/SRR8424413/SRR8424413.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/003/SRR8424413/SRR8424413.fastq.gz	7cdfa7c632f2e1f8f2772f8f0536ed94		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		880437											GSM3557158_r2			GSM3557158			20R_Vehicle						20R_Vehicle	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	CONTROL	CONTROL			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	0	mg/kg				9606	Homo sapiens		SRS4236529	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/003/SRR8424413	21944305	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/003/SRR8424413	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/003/SRR8424413	1f83f3dfb8d36e3bddeed4c8a87ade5a	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424414	NextSeq 500 sequencing: GSM3557158: 20R_Vehicle Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719345									66909450									GEO																NextSeq 500 sequencing: GSM3557158: 20R_Vehicle Homo sapiens Mus musculus RNA-Seq										SRX5233103	GSM3557158						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/004/SRR8424414/SRR8424414.fastq.gz	34001501	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/004/SRR8424414/SRR8424414.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/004/SRR8424414/SRR8424414.fastq.gz	b9b1e97e1dd9b28a0f292544d92c4cdd		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		892126											GSM3557158_r3			GSM3557158			20R_Vehicle						20R_Vehicle	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	CONTROL	CONTROL			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	0	mg/kg				9606	Homo sapiens		SRS4236529	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/004/SRR8424414	22282863	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/004/SRR8424414	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/004/SRR8424414	50fda1b24ed30e3bd8893b1407c3cc7a	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424415	NextSeq 500 sequencing: GSM3557158: 20R_Vehicle Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719345									67412925									GEO																NextSeq 500 sequencing: GSM3557158: 20R_Vehicle Homo sapiens Mus musculus RNA-Seq										SRX5233103	GSM3557158						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/005/SRR8424415/SRR8424415.fastq.gz	34103816	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/005/SRR8424415/SRR8424415.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/005/SRR8424415/SRR8424415.fastq.gz	ea2e282f607ead2f3e07043c2828c949		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		898839											GSM3557158_r4			GSM3557158			20R_Vehicle						20R_Vehicle	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	CONTROL	CONTROL			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	0	mg/kg				9606	Homo sapiens		SRS4236529	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/005/SRR8424415	22336814	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/005/SRR8424415	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/005/SRR8424415	1c97519cf2de909e6d4365ccc02ef648	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424408	NextSeq 500 sequencing: GSM3557157: 20L_Vehicle Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719346									85853850									GEO																NextSeq 500 sequencing: GSM3557157: 20L_Vehicle Homo sapiens Mus musculus RNA-Seq										SRX5233102	GSM3557157						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/008/SRR8424408/SRR8424408.fastq.gz	43546214	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/008/SRR8424408/SRR8424408.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/008/SRR8424408/SRR8424408.fastq.gz	5a99941376cefe03a75a446e74a34047		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1144718											GSM3557157_r1			GSM3557157			20L_Vehicle						20L_Vehicle	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	CONTROL	CONTROL			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	0	mg/kg				9606	Homo sapiens		SRS4236528	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/008/SRR8424408	28524610	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/008/SRR8424408	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/008/SRR8424408	9ac71b0cc432b9740dea26aaa5f80432	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424409	NextSeq 500 sequencing: GSM3557157: 20L_Vehicle Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719346									86544000									GEO																NextSeq 500 sequencing: GSM3557157: 20L_Vehicle Homo sapiens Mus musculus RNA-Seq										SRX5233102	GSM3557157						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/009/SRR8424409/SRR8424409.fastq.gz	44026939	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/009/SRR8424409/SRR8424409.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/009/SRR8424409/SRR8424409.fastq.gz	461977596bfc89ce0f43b0c47476a0a3		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1153920											GSM3557157_r2			GSM3557157			20L_Vehicle						20L_Vehicle	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	CONTROL	CONTROL			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	0	mg/kg				9606	Homo sapiens		SRS4236528	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/009/SRR8424409	28852961	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/009/SRR8424409	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/009/SRR8424409	a6515ec3aadd3645385e16f071d28184	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424410	NextSeq 500 sequencing: GSM3557157: 20L_Vehicle Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719346									87574950									GEO																NextSeq 500 sequencing: GSM3557157: 20L_Vehicle Homo sapiens Mus musculus RNA-Seq										SRX5233102	GSM3557157						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/000/SRR8424410/SRR8424410.fastq.gz	44603011	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/000/SRR8424410/SRR8424410.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/000/SRR8424410/SRR8424410.fastq.gz	e10e20c438e26a275a4322d82d28e68d		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1167666											GSM3557157_r3			GSM3557157			20L_Vehicle						20L_Vehicle	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	CONTROL	CONTROL			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	0	mg/kg				9606	Homo sapiens		SRS4236528	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/000/SRR8424410	29239967	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/000/SRR8424410	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/000/SRR8424410	7a373de3ea9646bda7ac7fc98cd349fd	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424411	NextSeq 500 sequencing: GSM3557157: 20L_Vehicle Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719346									88273050									GEO																NextSeq 500 sequencing: GSM3557157: 20L_Vehicle Homo sapiens Mus musculus RNA-Seq										SRX5233102	GSM3557157						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/001/SRR8424411/SRR8424411.fastq.gz	44760462	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/001/SRR8424411/SRR8424411.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/001/SRR8424411/SRR8424411.fastq.gz	b90ddbcbe76aa1f5f943300fbbf212d6		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1176974											GSM3557157_r4			GSM3557157			20L_Vehicle						20L_Vehicle	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	CONTROL	CONTROL			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	0	mg/kg				9606	Homo sapiens		SRS4236528	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/001/SRR8424411	29336599	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/001/SRR8424411	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/001/SRR8424411	6dfdd953ab0c29ac1f1c9de0e830bc15	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424404	NextSeq 500 sequencing: GSM3557156: 18R_Vehicle Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719347									80659275									GEO																NextSeq 500 sequencing: GSM3557156: 18R_Vehicle Homo sapiens Mus musculus RNA-Seq										SRX5233101	GSM3557156						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/004/SRR8424404/SRR8424404.fastq.gz	40888874	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/004/SRR8424404/SRR8424404.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/004/SRR8424404/SRR8424404.fastq.gz	877a4827f49dc8b44873d036e4fa66b1		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1075457											GSM3557156_r1			GSM3557156			18R_Vehicle						18R_Vehicle	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	CONTROL	CONTROL			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	0	mg/kg				9606	Homo sapiens		SRS4236527	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/004/SRR8424404	26768287	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/004/SRR8424404	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/004/SRR8424404	3ca9d3b13d0fcb426c0c975bfdf1ed59	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424405	NextSeq 500 sequencing: GSM3557156: 18R_Vehicle Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719347									81446175									GEO																NextSeq 500 sequencing: GSM3557156: 18R_Vehicle Homo sapiens Mus musculus RNA-Seq										SRX5233101	GSM3557156						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/005/SRR8424405/SRR8424405.fastq.gz	41412808	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/005/SRR8424405/SRR8424405.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/005/SRR8424405/SRR8424405.fastq.gz	9f02c17100aad08db501c106812c4338		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1085949											GSM3557156_r2			GSM3557156			18R_Vehicle						18R_Vehicle	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	CONTROL	CONTROL			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	0	mg/kg				9606	Homo sapiens		SRS4236527	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/005/SRR8424405	27122312	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/005/SRR8424405	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/005/SRR8424405	cba0778609da55f665d70f8d7d121084	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424406	NextSeq 500 sequencing: GSM3557156: 18R_Vehicle Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719347									82484400									GEO																NextSeq 500 sequencing: GSM3557156: 18R_Vehicle Homo sapiens Mus musculus RNA-Seq										SRX5233101	GSM3557156						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/006/SRR8424406/SRR8424406.fastq.gz	42000059	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/006/SRR8424406/SRR8424406.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/006/SRR8424406/SRR8424406.fastq.gz	7731129b38fde94d4e0f2a680b1431af		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1099792											GSM3557156_r3			GSM3557156			18R_Vehicle						18R_Vehicle	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	CONTROL	CONTROL			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	0	mg/kg				9606	Homo sapiens		SRS4236527	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/006/SRR8424406	27515933	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/006/SRR8424406	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/006/SRR8424406	863827f1298321175b320c0f6c04577f	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424407	NextSeq 500 sequencing: GSM3557156: 18R_Vehicle Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719347									83138775									GEO																NextSeq 500 sequencing: GSM3557156: 18R_Vehicle Homo sapiens Mus musculus RNA-Seq										SRX5233101	GSM3557156						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/007/SRR8424407/SRR8424407.fastq.gz	42167008	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/007/SRR8424407/SRR8424407.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/007/SRR8424407/SRR8424407.fastq.gz	0aa56501ea7e8f7aac07a6b270f34578		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1108517											GSM3557156_r4			GSM3557156			18R_Vehicle						18R_Vehicle	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	CONTROL	CONTROL			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	0	mg/kg				9606	Homo sapiens		SRS4236527	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/007/SRR8424407	27621037	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/007/SRR8424407	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/007/SRR8424407	8e75fae39c41a10db25a97b2cdeb269b	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424400	NextSeq 500 sequencing: GSM3557155: 18L_Vehicle Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719348									75471975									GEO																NextSeq 500 sequencing: GSM3557155: 18L_Vehicle Homo sapiens Mus musculus RNA-Seq										SRX5233100	GSM3557155						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/000/SRR8424400/SRR8424400.fastq.gz	38263560	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/000/SRR8424400/SRR8424400.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/000/SRR8424400/SRR8424400.fastq.gz	26fed36a399f5f434ac13f76385c1b18		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1006293											GSM3557155_r1			GSM3557155			18L_Vehicle						18L_Vehicle	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	CONTROL	CONTROL			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	0	mg/kg				9606	Homo sapiens		SRS4236526	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/000/SRR8424400	25034779	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/000/SRR8424400	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/000/SRR8424400	edcc4d60cc67d6d222840e4fd3e439ac	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424401	NextSeq 500 sequencing: GSM3557155: 18L_Vehicle Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719348									76299000									GEO																NextSeq 500 sequencing: GSM3557155: 18L_Vehicle Homo sapiens Mus musculus RNA-Seq										SRX5233100	GSM3557155						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/001/SRR8424401/SRR8424401.fastq.gz	38756612	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/001/SRR8424401/SRR8424401.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/001/SRR8424401/SRR8424401.fastq.gz	d8285822d084fcc31cf8cffd28fc57f1		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1017320											GSM3557155_r2			GSM3557155			18L_Vehicle						18L_Vehicle	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	CONTROL	CONTROL			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	0	mg/kg				9606	Homo sapiens		SRS4236526	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/001/SRR8424401	25364647	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/001/SRR8424401	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/001/SRR8424401	33a1a4c84d9c021f5d20c64e2c26319a	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424402	NextSeq 500 sequencing: GSM3557155: 18L_Vehicle Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719348									77188425									GEO																NextSeq 500 sequencing: GSM3557155: 18L_Vehicle Homo sapiens Mus musculus RNA-Seq										SRX5233100	GSM3557155						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/002/SRR8424402/SRR8424402.fastq.gz	39296921	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/002/SRR8424402/SRR8424402.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/002/SRR8424402/SRR8424402.fastq.gz	49cd302bf45fbf488a683cca8483d20d		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1029179											GSM3557155_r3			GSM3557155			18L_Vehicle						18L_Vehicle	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	CONTROL	CONTROL			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	0	mg/kg				9606	Homo sapiens		SRS4236526	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/002/SRR8424402	25731695	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/002/SRR8424402	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/002/SRR8424402	bef6fbbfc8e1d5777c298ce2eee7a17c	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424403	NextSeq 500 sequencing: GSM3557155: 18L_Vehicle Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719348									77886825									GEO																NextSeq 500 sequencing: GSM3557155: 18L_Vehicle Homo sapiens Mus musculus RNA-Seq										SRX5233100	GSM3557155						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/003/SRR8424403/SRR8424403.fastq.gz	39462448	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/003/SRR8424403/SRR8424403.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/003/SRR8424403/SRR8424403.fastq.gz	4be4063b8c926a6ba5da548959c4c854		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1038491											GSM3557155_r4			GSM3557155			18L_Vehicle						18L_Vehicle	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	CONTROL	CONTROL			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	0	mg/kg				9606	Homo sapiens		SRS4236526	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/003/SRR8424403	25830785	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/003/SRR8424403	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/003/SRR8424403	b7190bf6561dcbd0f20c8dd08ff0682d	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424396	NextSeq 500 sequencing: GSM3557154: 17R_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719310									75029400									GEO																NextSeq 500 sequencing: GSM3557154: 17R_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233099	GSM3557154						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/006/SRR8424396/SRR8424396.fastq.gz	38134842	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/006/SRR8424396/SRR8424396.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/006/SRR8424396/SRR8424396.fastq.gz	d7cea152ccbbe07dceadd6421be8183d		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1000392											GSM3557154_r1			GSM3557154			17R_Ribociclib_150.0						17R_Ribociclib_150.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	RIBOCICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236525	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/006/SRR8424396	25102306	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/006/SRR8424396	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/006/SRR8424396	3e246a7164562a2564a9068153f6f083	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424397	NextSeq 500 sequencing: GSM3557154: 17R_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719310									75611700									GEO																NextSeq 500 sequencing: GSM3557154: 17R_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233099	GSM3557154						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/007/SRR8424397/SRR8424397.fastq.gz	38517877	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/007/SRR8424397/SRR8424397.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/007/SRR8424397/SRR8424397.fastq.gz	a2387bf605675c9108d5c0c4558dcd40		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1008156											GSM3557154_r2			GSM3557154			17R_Ribociclib_150.0						17R_Ribociclib_150.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	RIBOCICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236525	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/007/SRR8424397	25363508	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/007/SRR8424397	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/007/SRR8424397	c94e78d71ae92e47f4ad9912d0d16fb0	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424398	NextSeq 500 sequencing: GSM3557154: 17R_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719310									76708275									GEO																NextSeq 500 sequencing: GSM3557154: 17R_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233099	GSM3557154						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/008/SRR8424398/SRR8424398.fastq.gz	39145133	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/008/SRR8424398/SRR8424398.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/008/SRR8424398/SRR8424398.fastq.gz	b54d944df46f329a9950bd47416033a0		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1022777											GSM3557154_r3			GSM3557154			17R_Ribociclib_150.0						17R_Ribociclib_150.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	RIBOCICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236525	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/008/SRR8424398	25786461	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/008/SRR8424398	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/008/SRR8424398	2ce7cbe33782fb8f1bc7f5359bbbff22	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424399	NextSeq 500 sequencing: GSM3557154: 17R_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719310									77083425									GEO																NextSeq 500 sequencing: GSM3557154: 17R_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233099	GSM3557154						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/009/SRR8424399/SRR8424399.fastq.gz	39146056	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/009/SRR8424399/SRR8424399.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/009/SRR8424399/SRR8424399.fastq.gz	ca0f758877a151226030ba0af2ec35ff		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1027779											GSM3557154_r4			GSM3557154			17R_Ribociclib_150.0						17R_Ribociclib_150.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	RIBOCICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236525	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/009/SRR8424399	25781823	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/009/SRR8424399	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/009/SRR8424399	7deac1e3f2cab66c37430f23da8bd9ba	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424392	NextSeq 500 sequencing: GSM3557153: 17L_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719311									83595750									GEO																NextSeq 500 sequencing: GSM3557153: 17L_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233098	GSM3557153						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/002/SRR8424392/SRR8424392.fastq.gz	42179880	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/002/SRR8424392/SRR8424392.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/002/SRR8424392/SRR8424392.fastq.gz	de0d4848570180af154f5ef2732cc675		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1114610											GSM3557153_r1			GSM3557153			17L_Ribociclib_150.0						17L_Ribociclib_150.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	RIBOCICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236524	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/002/SRR8424392	27627001	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/002/SRR8424392	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/002/SRR8424392	a921bbbceae55a74d513c2d545efcea4	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424393	NextSeq 500 sequencing: GSM3557153: 17L_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719311									84671550									GEO																NextSeq 500 sequencing: GSM3557153: 17L_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233098	GSM3557153						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/003/SRR8424393/SRR8424393.fastq.gz	42835053	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/003/SRR8424393/SRR8424393.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/003/SRR8424393/SRR8424393.fastq.gz	be8f75fe2e9def455cbe0a49f4a07254		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1128954											GSM3557153_r2			GSM3557153			17L_Ribociclib_150.0						17L_Ribociclib_150.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	RIBOCICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236524	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/003/SRR8424393	28070462	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/003/SRR8424393	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/003/SRR8424393	a53e72418c82943527b988ad06b94ed4	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424394	NextSeq 500 sequencing: GSM3557153: 17L_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719311									85714275									GEO																NextSeq 500 sequencing: GSM3557153: 17L_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233098	GSM3557153						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/004/SRR8424394/SRR8424394.fastq.gz	43448883	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/004/SRR8424394/SRR8424394.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/004/SRR8424394/SRR8424394.fastq.gz	82fd329369d7ebb8c8614ccf7753abd6		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1142857											GSM3557153_r3			GSM3557153			17L_Ribociclib_150.0						17L_Ribociclib_150.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	RIBOCICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236524	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/004/SRR8424394	28483604	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/004/SRR8424394	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/004/SRR8424394	2268be96ea8de9fb3a1f1414e80c1994	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424395	NextSeq 500 sequencing: GSM3557153: 17L_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719311									86273325									GEO																NextSeq 500 sequencing: GSM3557153: 17L_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233098	GSM3557153						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/005/SRR8424395/SRR8424395.fastq.gz	43514597	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/005/SRR8424395/SRR8424395.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/005/SRR8424395/SRR8424395.fastq.gz	9348cef75e7f2ae3b83a9f29ad9e159b		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1150311											GSM3557153_r4			GSM3557153			17L_Ribociclib_150.0						17L_Ribociclib_150.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	RIBOCICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236524	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/005/SRR8424395	28519118	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/005/SRR8424395	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/005/SRR8424395	9e9b1c3e1db97a0aeaea99b48862327d	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424388	NextSeq 500 sequencing: GSM3557152: 16R_Abemaciclib_25.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719312									80568975									GEO																NextSeq 500 sequencing: GSM3557152: 16R_Abemaciclib_25.0 Homo sapiens Mus musculus RNA-Seq										SRX5233097	GSM3557152						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/008/SRR8424388/SRR8424388.fastq.gz	40554050	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/008/SRR8424388/SRR8424388.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/008/SRR8424388/SRR8424388.fastq.gz	637d39abd0213ef1e14f486247d1562c		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1074253											GSM3557152_r1			GSM3557152			16R_Abemaciclib_25.0						16R_Abemaciclib_25.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	25	mg/kg				9606	Homo sapiens		SRS4236523	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/008/SRR8424388	26526408	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/008/SRR8424388	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/008/SRR8424388	7ab6d56d06860687c9ab27358568bd4d	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424389	NextSeq 500 sequencing: GSM3557152: 16R_Abemaciclib_25.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719312									81557175									GEO																NextSeq 500 sequencing: GSM3557152: 16R_Abemaciclib_25.0 Homo sapiens Mus musculus RNA-Seq										SRX5233097	GSM3557152						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/009/SRR8424389/SRR8424389.fastq.gz	41171803	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/009/SRR8424389/SRR8424389.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/009/SRR8424389/SRR8424389.fastq.gz	17c2ba42a41a6d7ba8cde07433994c35		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1087429											GSM3557152_r2			GSM3557152			16R_Abemaciclib_25.0						16R_Abemaciclib_25.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	25	mg/kg				9606	Homo sapiens		SRS4236523	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/009/SRR8424389	26945321	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/009/SRR8424389	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/009/SRR8424389	169cdb634a761ae342cf0af4cbd5bd22	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424390	NextSeq 500 sequencing: GSM3557152: 16R_Abemaciclib_25.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719312									82096200									GEO																NextSeq 500 sequencing: GSM3557152: 16R_Abemaciclib_25.0 Homo sapiens Mus musculus RNA-Seq										SRX5233097	GSM3557152						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/000/SRR8424390/SRR8424390.fastq.gz	41511087	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/000/SRR8424390/SRR8424390.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/000/SRR8424390/SRR8424390.fastq.gz	6d3069b8a5029a1aedd4582493bd7392		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1094616											GSM3557152_r3			GSM3557152			16R_Abemaciclib_25.0						16R_Abemaciclib_25.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	25	mg/kg				9606	Homo sapiens		SRS4236523	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/000/SRR8424390	27178003	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/000/SRR8424390	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/000/SRR8424390	6c924d4a3979c006485a80b029fc590a	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424391	NextSeq 500 sequencing: GSM3557152: 16R_Abemaciclib_25.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719312									83073525									GEO																NextSeq 500 sequencing: GSM3557152: 16R_Abemaciclib_25.0 Homo sapiens Mus musculus RNA-Seq										SRX5233097	GSM3557152						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/001/SRR8424391/SRR8424391.fastq.gz	41828576	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/001/SRR8424391/SRR8424391.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/001/SRR8424391/SRR8424391.fastq.gz	1a3633aa5bab42f6973538b2d0d87226		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1107647											GSM3557152_r4			GSM3557152			16R_Abemaciclib_25.0						16R_Abemaciclib_25.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	25	mg/kg				9606	Homo sapiens		SRS4236523	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/001/SRR8424391	27374860	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/001/SRR8424391	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/001/SRR8424391	891363040eb91773069d2d24145325c6	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424384	NextSeq 500 sequencing: GSM3557151: 16L_Abemaciclib_25.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719313									88924500									GEO																NextSeq 500 sequencing: GSM3557151: 16L_Abemaciclib_25.0 Homo sapiens Mus musculus RNA-Seq										SRX5233096	GSM3557151						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/004/SRR8424384/SRR8424384.fastq.gz	44758772	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/004/SRR8424384/SRR8424384.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/004/SRR8424384/SRR8424384.fastq.gz	105ecef3770efdd8c5a66f538a8527a1		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1185660											GSM3557151_r1			GSM3557151			16L_Abemaciclib_25.0						16L_Abemaciclib_25.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	25	mg/kg				9606	Homo sapiens		SRS4236522	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/004/SRR8424384	29269874	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/004/SRR8424384	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/004/SRR8424384	bcdaf2e952f4c23fd21edc695b1a7122	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424385	NextSeq 500 sequencing: GSM3557151: 16L_Abemaciclib_25.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719313									90103350									GEO																NextSeq 500 sequencing: GSM3557151: 16L_Abemaciclib_25.0 Homo sapiens Mus musculus RNA-Seq										SRX5233096	GSM3557151						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/005/SRR8424385/SRR8424385.fastq.gz	45462574	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/005/SRR8424385/SRR8424385.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/005/SRR8424385/SRR8424385.fastq.gz	80eabd932c0b0fc35ae64a28a56007b2		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1201378											GSM3557151_r2			GSM3557151			16L_Abemaciclib_25.0						16L_Abemaciclib_25.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	25	mg/kg				9606	Homo sapiens		SRS4236522	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/005/SRR8424385	29743024	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/005/SRR8424385	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/005/SRR8424385	d32ef7373ec1fe984a9270d936532e17	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424386	NextSeq 500 sequencing: GSM3557151: 16L_Abemaciclib_25.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719313									90615225									GEO																NextSeq 500 sequencing: GSM3557151: 16L_Abemaciclib_25.0 Homo sapiens Mus musculus RNA-Seq										SRX5233096	GSM3557151						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/006/SRR8424386/SRR8424386.fastq.gz	45806926	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/006/SRR8424386/SRR8424386.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/006/SRR8424386/SRR8424386.fastq.gz	20f8af31f69a64c441173a68c72585c5		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1208203											GSM3557151_r3			GSM3557151			16L_Abemaciclib_25.0						16L_Abemaciclib_25.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	25	mg/kg				9606	Homo sapiens		SRS4236522	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/006/SRR8424386	29983974	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/006/SRR8424386	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/006/SRR8424386	ba8e2a14b90a309b2559ea9417845579	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424387	NextSeq 500 sequencing: GSM3557151: 16L_Abemaciclib_25.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719313									91710000									GEO																NextSeq 500 sequencing: GSM3557151: 16L_Abemaciclib_25.0 Homo sapiens Mus musculus RNA-Seq										SRX5233096	GSM3557151						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/007/SRR8424387/SRR8424387.fastq.gz	46112771	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/007/SRR8424387/SRR8424387.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/007/SRR8424387/SRR8424387.fastq.gz	8b3ebbc21cb3f3987c48feee1e289632		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1222800											GSM3557151_r4			GSM3557151			16L_Abemaciclib_25.0						16L_Abemaciclib_25.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	25	mg/kg				9606	Homo sapiens		SRS4236522	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/007/SRR8424387	30169515	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/007/SRR8424387	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/007/SRR8424387	e2eeb4303e099f917f4960af466e59c4	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424380	NextSeq 500 sequencing: GSM3557150: 15R_Abemaciclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719314									74857875									GEO																NextSeq 500 sequencing: GSM3557150: 15R_Abemaciclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233095	GSM3557150						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/000/SRR8424380/SRR8424380.fastq.gz	37665010	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/000/SRR8424380/SRR8424380.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/000/SRR8424380/SRR8424380.fastq.gz	39af9734748d1cd1d176be5f56aa9627		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		998105											GSM3557150_r1			GSM3557150			15R_Abemaciclib_150.0						15R_Abemaciclib_150.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236521	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/000/SRR8424380	24708559	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/000/SRR8424380	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/000/SRR8424380	ca69f6fb8281aff9321ca53db7c38f1d	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424381	NextSeq 500 sequencing: GSM3557150: 15R_Abemaciclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719314									75814200									GEO																NextSeq 500 sequencing: GSM3557150: 15R_Abemaciclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233095	GSM3557150						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/001/SRR8424381/SRR8424381.fastq.gz	38248213	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/001/SRR8424381/SRR8424381.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/001/SRR8424381/SRR8424381.fastq.gz	76e536395a396326678ae8955a86b229		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1010856											GSM3557150_r2			GSM3557150			15R_Abemaciclib_150.0						15R_Abemaciclib_150.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236521	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/001/SRR8424381	25109357	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/001/SRR8424381	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/001/SRR8424381	07e21ea8b1dd4e607a2f82ad4bd1017e	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424382	NextSeq 500 sequencing: GSM3557150: 15R_Abemaciclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719314									76353225									GEO																NextSeq 500 sequencing: GSM3557150: 15R_Abemaciclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233095	GSM3557150						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/002/SRR8424382/SRR8424382.fastq.gz	38563499	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/002/SRR8424382/SRR8424382.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/002/SRR8424382/SRR8424382.fastq.gz	f5b617463dffb6765e320f3b04e85d99		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1018043											GSM3557150_r3			GSM3557150			15R_Abemaciclib_150.0						15R_Abemaciclib_150.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236521	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/002/SRR8424382	25320655	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/002/SRR8424382	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/002/SRR8424382	a7d216cfed2fc68902f7fb8d02f0339f	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424383	NextSeq 500 sequencing: GSM3557150: 15R_Abemaciclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719314									77037750									GEO																NextSeq 500 sequencing: GSM3557150: 15R_Abemaciclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233095	GSM3557150						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/003/SRR8424383/SRR8424383.fastq.gz	38725819	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/003/SRR8424383/SRR8424383.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/003/SRR8424383/SRR8424383.fastq.gz	a041d6f3222fa4a48e9e89aba86fd1e6		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1027170											GSM3557150_r4			GSM3557150			15R_Abemaciclib_150.0						15R_Abemaciclib_150.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236521	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/003/SRR8424383	25414968	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/003/SRR8424383	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/003/SRR8424383	387c9ede6e9633e33aa99e20ada2b52b	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424376	NextSeq 500 sequencing: GSM3557149: 15L_Abemaciclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719315									74709225									GEO																NextSeq 500 sequencing: GSM3557149: 15L_Abemaciclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233094	GSM3557149						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/006/SRR8424376/SRR8424376.fastq.gz	37870790	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/006/SRR8424376/SRR8424376.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/006/SRR8424376/SRR8424376.fastq.gz	3336d6232011b63b7e60141c19b45fcf		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		996123											GSM3557149_r1			GSM3557149			15L_Abemaciclib_150.0						15L_Abemaciclib_150.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236520	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/006/SRR8424376	24823463	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/006/SRR8424376	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/006/SRR8424376	83fdd8972d4d482d7ed29a32f6349d05	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424377	NextSeq 500 sequencing: GSM3557149: 15L_Abemaciclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719315									75370800									GEO																NextSeq 500 sequencing: GSM3557149: 15L_Abemaciclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233094	GSM3557149						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/007/SRR8424377/SRR8424377.fastq.gz	38299129	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/007/SRR8424377/SRR8424377.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/007/SRR8424377/SRR8424377.fastq.gz	a5859abaa7e671090e97306f2aeb908d		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1004944											GSM3557149_r2			GSM3557149			15L_Abemaciclib_150.0						15L_Abemaciclib_150.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236520	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/007/SRR8424377	25116299	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/007/SRR8424377	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/007/SRR8424377	d6dbafe76d570e9ad00f6e7797f3cbd6	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424378	NextSeq 500 sequencing: GSM3557149: 15L_Abemaciclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719315									76273500									GEO																NextSeq 500 sequencing: GSM3557149: 15L_Abemaciclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233094	GSM3557149						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/008/SRR8424378/SRR8424378.fastq.gz	38823710	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/008/SRR8424378/SRR8424378.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/008/SRR8424378/SRR8424378.fastq.gz	9eeb6113d33f39cd5df6a53ba4f7fc54		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1016980											GSM3557149_r3			GSM3557149			15L_Abemaciclib_150.0						15L_Abemaciclib_150.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236520	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/008/SRR8424378	25471232	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/008/SRR8424378	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/008/SRR8424378	61fbf2d461d466092fa00935e07618ec	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424379	NextSeq 500 sequencing: GSM3557149: 15L_Abemaciclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719315									76705875									GEO																NextSeq 500 sequencing: GSM3557149: 15L_Abemaciclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233094	GSM3557149						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/009/SRR8424379/SRR8424379.fastq.gz	38856945	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/009/SRR8424379/SRR8424379.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/009/SRR8424379/SRR8424379.fastq.gz	73a91c53a670e47c6b7b10bccf69d03e		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1022745											GSM3557149_r4			GSM3557149			15L_Abemaciclib_150.0						15L_Abemaciclib_150.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	ABEMACICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236520	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/009/SRR8424379	25484471	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/009/SRR8424379	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/009/SRR8424379	fd3c12cc38be2cbfb032c90d494fb7cf	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424372	NextSeq 500 sequencing: GSM3557148: 14R_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719316									75478350									GEO																NextSeq 500 sequencing: GSM3557148: 14R_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233093	GSM3557148						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/002/SRR8424372/SRR8424372.fastq.gz	38357340	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/002/SRR8424372/SRR8424372.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/002/SRR8424372/SRR8424372.fastq.gz	9cd9103d41602953ebfe0c5f78c89093		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1006378											GSM3557148_r1			GSM3557148			14R_Ribociclib_150.0						14R_Ribociclib_150.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	RIBOCICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236519	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/002/SRR8424372	25162151	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/002/SRR8424372	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/002/SRR8424372	691806f3e6a6a47d677ad8ccbd80a2c7	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424373	NextSeq 500 sequencing: GSM3557148: 14R_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719316									76303875									GEO																NextSeq 500 sequencing: GSM3557148: 14R_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233093	GSM3557148						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/003/SRR8424373/SRR8424373.fastq.gz	38886654	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/003/SRR8424373/SRR8424373.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/003/SRR8424373/SRR8424373.fastq.gz	9b56cde1e72f53a149eee7553d7bff80		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1017385											GSM3557148_r2			GSM3557148			14R_Ribociclib_150.0						14R_Ribociclib_150.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	RIBOCICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236519	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/003/SRR8424373	25518238	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/003/SRR8424373	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/003/SRR8424373	d00a3d1f94e51c84f1dfc418ebb6724a	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424374	NextSeq 500 sequencing: GSM3557148: 14R_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719316									77251500									GEO																NextSeq 500 sequencing: GSM3557148: 14R_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233093	GSM3557148						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/004/SRR8424374/SRR8424374.fastq.gz	39434834	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/004/SRR8424374/SRR8424374.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/004/SRR8424374/SRR8424374.fastq.gz	2dbc97464356c540a0418b0586c002af		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1030020											GSM3557148_r3			GSM3557148			14R_Ribociclib_150.0						14R_Ribociclib_150.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	RIBOCICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236519	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/004/SRR8424374	25891643	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/004/SRR8424374	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/004/SRR8424374	19ad2a6b6f0f09fbbc2b4f9eab5a9acb	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424375	NextSeq 500 sequencing: GSM3557148: 14R_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719316									77932350									GEO																NextSeq 500 sequencing: GSM3557148: 14R_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233093	GSM3557148						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/005/SRR8424375/SRR8424375.fastq.gz	39628519	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/005/SRR8424375/SRR8424375.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/005/SRR8424375/SRR8424375.fastq.gz	fd627aca4657d5174049259ebf4262b6		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1039098											GSM3557148_r4			GSM3557148			14R_Ribociclib_150.0						14R_Ribociclib_150.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	RIBOCICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236519	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/005/SRR8424375	26008735	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/005/SRR8424375	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/005/SRR8424375	5295fee83b1092224e813e3da7189794	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424368	NextSeq 500 sequencing: GSM3557147: 14L_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719317									71622000									GEO																NextSeq 500 sequencing: GSM3557147: 14L_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233092	GSM3557147						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/008/SRR8424368/SRR8424368.fastq.gz	36344765	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/008/SRR8424368/SRR8424368.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/008/SRR8424368/SRR8424368.fastq.gz	dc2386069f12e51ad4d74ec20cc74d95		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		954960											GSM3557147_r1			GSM3557147			14L_Ribociclib_150.0						14L_Ribociclib_150.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	RIBOCICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236518	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/008/SRR8424368	23828459	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/008/SRR8424368	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/008/SRR8424368	0e1165c7bf328dfbe9832b05d6d008b6	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424369	NextSeq 500 sequencing: GSM3557147: 14L_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719317									72686550									GEO																NextSeq 500 sequencing: GSM3557147: 14L_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233092	GSM3557147						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/009/SRR8424369/SRR8424369.fastq.gz	36971756	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/009/SRR8424369/SRR8424369.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/009/SRR8424369/SRR8424369.fastq.gz	1eebf8b6083dfd2e1d12abe982853f01		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		969154											GSM3557147_r2			GSM3557147			14L_Ribociclib_150.0						14L_Ribociclib_150.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	RIBOCICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236518	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/009/SRR8424369	24252469	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/009/SRR8424369	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/009/SRR8424369	edb2d51bca153488b83a78c2a113cade	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424370	NextSeq 500 sequencing: GSM3557147: 14L_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719317									73442400									GEO																NextSeq 500 sequencing: GSM3557147: 14L_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233092	GSM3557147						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/000/SRR8424370/SRR8424370.fastq.gz	37446011	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/000/SRR8424370/SRR8424370.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/000/SRR8424370/SRR8424370.fastq.gz	5c3589f9e37888f874cb7e235ade730c		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		979232											GSM3557147_r3			GSM3557147			14L_Ribociclib_150.0						14L_Ribociclib_150.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	RIBOCICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236518	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/000/SRR8424370	24574644	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/000/SRR8424370	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/000/SRR8424370	3d59b7dc32d83c5c49290430a1d5546b	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424371	NextSeq 500 sequencing: GSM3557147: 14L_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719317									74070900									GEO																NextSeq 500 sequencing: GSM3557147: 14L_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233092	GSM3557147						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/001/SRR8424371/SRR8424371.fastq.gz	37559616	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/001/SRR8424371/SRR8424371.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/001/SRR8424371/SRR8424371.fastq.gz	852e22f3132b38c2d6bd6a3d684997bc		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		987612											GSM3557147_r4			GSM3557147			14L_Ribociclib_150.0						14L_Ribociclib_150.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	RIBOCICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236518	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/001/SRR8424371	24638576	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/001/SRR8424371	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/001/SRR8424371	f0d7d0093b1b2dcb4af00aa86c21cd16	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424364	NextSeq 500 sequencing: GSM3557146: 13R_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719318									83006625									GEO																NextSeq 500 sequencing: GSM3557146: 13R_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233091	GSM3557146						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/004/SRR8424364/SRR8424364.fastq.gz	41844213	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/004/SRR8424364/SRR8424364.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/004/SRR8424364/SRR8424364.fastq.gz	8d33718b1afb61510f63120e00aa443b		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1106755											GSM3557146_r1			GSM3557146			13R_Ribociclib_150.0						13R_Ribociclib_150.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	RIBOCICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236516	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/004/SRR8424364	27380218	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/004/SRR8424364	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/004/SRR8424364	c17979b3885dcf0ebca27d1a85ef07d5	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424365	NextSeq 500 sequencing: GSM3557146: 13R_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719318									84062400									GEO																NextSeq 500 sequencing: GSM3557146: 13R_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233091	GSM3557146						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/005/SRR8424365/SRR8424365.fastq.gz	42479977	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/005/SRR8424365/SRR8424365.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/005/SRR8424365/SRR8424365.fastq.gz	cde212c1b3ba59b86ae648a908b0f882		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1120832											GSM3557146_r2			GSM3557146			13R_Ribociclib_150.0						13R_Ribociclib_150.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	RIBOCICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236516	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/005/SRR8424365	27809487	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/005/SRR8424365	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/005/SRR8424365	246c3da1cbcd88207cd814663672a34e	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424366	NextSeq 500 sequencing: GSM3557146: 13R_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719318									84695625									GEO																NextSeq 500 sequencing: GSM3557146: 13R_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233091	GSM3557146						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/006/SRR8424366/SRR8424366.fastq.gz	42880062	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/006/SRR8424366/SRR8424366.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/006/SRR8424366/SRR8424366.fastq.gz	e0b5399f2d2764d42b03bb2fc00372dc		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1129275											GSM3557146_r3			GSM3557146			13R_Ribociclib_150.0						13R_Ribociclib_150.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	RIBOCICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236516	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/006/SRR8424366	28081658	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/006/SRR8424366	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/006/SRR8424366	401d258330ae5b4723c7034ec8b4b1e7	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424367	NextSeq 500 sequencing: GSM3557146: 13R_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719318									85597350									GEO																NextSeq 500 sequencing: GSM3557146: 13R_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233091	GSM3557146						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/007/SRR8424367/SRR8424367.fastq.gz	43141753	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/007/SRR8424367/SRR8424367.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/007/SRR8424367/SRR8424367.fastq.gz	bc9b0ae965e915c271316ea3e7a226fb		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1141298											GSM3557146_r4			GSM3557146			13R_Ribociclib_150.0						13R_Ribociclib_150.0	right	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	RIBOCICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236516	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/007/SRR8424367	28245205	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/007/SRR8424367	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/007/SRR8424367	73c3d0a4294c576432672bdc08cf08ea	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424360	NextSeq 500 sequencing: GSM3557145: 13L_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719319									76593075									GEO																NextSeq 500 sequencing: GSM3557145: 13L_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233090	GSM3557145						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/000/SRR8424360/SRR8424360.fastq.gz	38460003	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/000/SRR8424360/SRR8424360.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/000/SRR8424360/SRR8424360.fastq.gz	3799108e64c4caaad86f421f61bed54e		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1021241											GSM3557145_r1			GSM3557145			13L_Ribociclib_150.0						13L_Ribociclib_150.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	RIBOCICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236517	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/000/SRR8424360	25294796	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/000/SRR8424360	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/000/SRR8424360	706fdef88efe4d827fd0993add600384	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424361	NextSeq 500 sequencing: GSM3557145: 13L_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719319									77776500									GEO																NextSeq 500 sequencing: GSM3557145: 13L_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233090	GSM3557145						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/001/SRR8424361/SRR8424361.fastq.gz	39170242	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/001/SRR8424361/SRR8424361.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/001/SRR8424361/SRR8424361.fastq.gz	1675bb4d020b0655aaf51e74e5e3f2fb		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1037020											GSM3557145_r2			GSM3557145			13L_Ribociclib_150.0						13L_Ribociclib_150.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	RIBOCICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236517	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/001/SRR8424361	25787902	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/001/SRR8424361	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/001/SRR8424361	10f254c682d4d62b596cf5f2cb7dbf7b	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424362	NextSeq 500 sequencing: GSM3557145: 13L_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719319									78386700									GEO																NextSeq 500 sequencing: GSM3557145: 13L_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233090	GSM3557145						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/002/SRR8424362/SRR8424362.fastq.gz	39513861	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/002/SRR8424362/SRR8424362.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/002/SRR8424362/SRR8424362.fastq.gz	c149f066614e4841bcb1f5d8168315ae		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1045156											GSM3557145_r3			GSM3557145			13L_Ribociclib_150.0						13L_Ribociclib_150.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	RIBOCICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236517	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/002/SRR8424362	26022527	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/002/SRR8424362	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/002/SRR8424362	59edb6fa619e40a59636bf1441cbf806	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
SRR8424363	NextSeq 500 sequencing: GSM3557145: 13L_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq	PRJNA514039		SAMN10719319									79076325									GEO																NextSeq 500 sequencing: GSM3557145: 13L_Ribociclib_150.0 Homo sapiens Mus musculus RNA-Seq										SRX5233090	GSM3557145						fasp.sra.ebi.ac.uk:/vol1/fastq/SRR842/003/SRR8424363/SRR8424363.fastq.gz	39680918	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/003/SRR8424363/SRR8424363.fastq.gz	ftp.sra.ebi.ac.uk/vol1/fastq/SRR842/003/SRR8424363/SRR8424363.fastq.gz	5be4b2caad13f3aa3f23bc61d9976716		2019-06-30	2019-06-30														NextSeq 500	ILLUMINA				2019-06-30		Animals were sacrificed two hours after receiving the last dose. The tumors were excised and cut in half, one half was fixed in 4% formaldehyde at 4˚C and transferred to 0.1% sodium azide after 48 hours, the other flash frozen, and a thin slice from the center of the tumor was placed in RNAlater at 4˚C (Qiagen, Hilden, Germany), after 48 hours the RNAlater was aspirated, and samples were transferred to -80˚C. Libraries were prepared using a TruSeq Stranded mRNA sample preparation kit		SINGLE										cDNA	TRANSCRIPTOMIC	RNA-Seq								Generic					RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors		1054351											GSM3557145_r4			GSM3557145			13L_Ribociclib_150.0						13L_Ribociclib_150.0	left	ACH-000019	MCF7_BREAST	MCF7_BREAST_IN_NUNUNUDE	RIBOCICLIB	DRUG			SRR8424600,SRR8424601,SRR8424602,SRR8424603,SRR8424596,SRR8424597,SRR8424598,SRR8424599,SRR8424540,SRR8424541,SRR8424542,SRR8424543,SRR8424536,SRR8424537,SRR8424538,SRR8424539,SRR8424452,SRR8424453,SRR8424454,SRR8424455,SRR8424448,SRR8424449,SRR8424450,SRR8424451,SRR8424444,SRR8424445,SRR8424446,SRR8424447,SRR8424440,SRR8424441,SRR8424442,SRR8424443,SRR8424436,SRR8424437,SRR8424438,SRR8424439,SRR8424432,SRR8424433,SRR8424434,SRR8424435,SRR8424412,SRR8424413,SRR8424414,SRR8424415,SRR8424408,SRR8424409,SRR8424410,SRR8424411,SRR8424404,SRR8424405,SRR8424406,SRR8424407,SRR8424400,SRR8424401,SRR8424402,SRR8424403	4	days	150	mg/kg				9606	Homo sapiens		SRS4236517	SRP178115													fasp.sra.ebi.ac.uk:/vol1/srr/SRR842/003/SRR8424363	26110190	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/003/SRR8424363	ftp.sra.ebi.ac.uk/vol1/srr/SRR842/003/SRR8424363	1c3d9cd257e319f1f9fc7dd9ad9d5603	public		GSE124854	RNAseq based trascript profilling of MCF7-xenograft mice treated with one of three CDK4/6 inhibitiors			SRA832355										ena								
